<SEC-DOCUMENT>0000950170-24-045297.txt : 20240418
<SEC-HEADER>0000950170-24-045297.hdr.sgml : 20240418
<ACCEPTANCE-DATETIME>20240418060644
ACCESSION NUMBER:		0000950170-24-045297
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240515
FILED AS OF DATE:		20240418
DATE AS OF CHANGE:		20240418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			enGene Holdings Inc.
		CENTRAL INDEX KEY:			0001980845
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41854
		FILM NUMBER:		24852725

	BUSINESS ADDRESS:	
		STREET 1:		4868 RUE LEVY, SUITE 220
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4R 2P1
		BUSINESS PHONE:		(514) 332-4888

	MAIL ADDRESS:	
		STREET 1:		4868 RUE LEVY, SUITE 220
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4R 2P1
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>engene_2024_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<html>
 <head>
  <title>DEF 14A</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION<br>Washington, D.C. 20549</font></p>
  <p style="margin-left:33.333%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;border-bottom:0.5pt solid;margin-right:33.333%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SCHEDULE 14A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proxy Statement Pursuant to Section 14(a) of the <br>Securities Exchange Act of 1934 (Amendment No.    )</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Filed by the Registrant </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Filed by a Party other than the Registrant </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Preliminary Proxy Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Confidential, for Use of the Commission Only (as permitted by Rule 14a</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6(e)(2))</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Definitive Proxy Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Definitive Additional Materials</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Soliciting Material under &#167;240.14a-12</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">enGene Holdings Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Name of Registrant as Specified in its Charter)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">N/A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Payment of Filing Fee (Check the appropriate box):</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> No fee required.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Fee paid previously with preliminary materials.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img18171159_0.jpg" alt="img18171159_0.jpg" style="width:271px;height:86px;">&#160;</p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:20pt;font-family:Times New Roman;min-width:fit-content;">ENGENE HOLDINGS INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:20pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS<br>OF ENGENE HOLDINGS INC. <br>AND<br>PROXY STATEMENT<br>FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS<br>TO BE HELD ON MAY 15, 2024<br>April 18, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:0.5pt solid;padding-top:1pt;border-right:0.5pt solid;font-size:10pt;margin-right:13.333%;margin-left:13.333%;border-left:0.5pt solid;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you have questions regarding the Meeting or require assistance with voting,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">you may contact Broadridge as follows:</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email: Proxy.request@broadridge.com</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">North America Proxy Line:</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-916-0609</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9305</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">French Canadian Proxy Line (voicemail):</font></p>
  <p style="margin-left:13.333%;border-right:0.5pt solid;border-left:0.5pt solid;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;margin-right:13.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-973-0593</font></p>
  <p style="border-right:0.5pt solid;padding-bottom:1pt;font-size:10pt;border-bottom:0.5pt solid;margin-right:13.333%;margin-left:13.333%;border-left:0.5pt solid;margin-top:0;font-family:Times New Roman;margin-bottom:0;padding-right:0.747%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9306</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;">ENGENE HOLDINGS INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;min-width:fit-content;">4868 Rue Levy, Suite 220</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;min-width:fit-content;">Saint-Laurent, QC</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;min-width:fit-content;">Canada H4R 2P1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE IS HEREBY GIVEN</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that the annual general meeting (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Meeting</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the shareholders of enGene Holdings Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) will be held on May 15, 2024 at 10:00 a.m. (Eastern time).  The Meeting will be held in a virtual meeting format at www.virtualshareholdermeeting.com/ENGN2024.  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You will not be able to attend the Meeting in person.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At the Meeting, shareholders will act on the following matters:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to receive and consider the audited financial statements of the Company for the year ended October 31, 2023, together with the auditor&#x2019;s report thereon; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to elect three director nominees to serve as directors until the 2027 annual meeting of shareholders or until their successors are elected and qualified, subject to their earlier resignation or removal; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to approve an amendment to the enGene Holdings Inc. 2023 Incentive Equity Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive Equity Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), in substantially the form attached to the accompanying proxy statement as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule B</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, to provide for annual increases on the first business day of each calendar year of (i) the Plan Share Reserve (as defined herein) by such number of common shares of the Company, no par value, (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) as equals 5% of the aggregate number of Common Shares outstanding on the final day of the immediately preceding calendar year (or such smaller number of shares as is determined by the compensation committee), and (ii) the ISO Sublimit (as defined herein) by the lesser of 2,500,000 Common Shares and the increase in the Plan Share Reserve (or such smaller number of shares may be determined by the compensation committee) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amended Evergreen Provision</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, and such proposal, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Amendment Proposal</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to appoint KPMG LLP, Montreal, Canada (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">KPMG</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), as the Company&#x2019;s auditor for the ensuing year and authorize the directors to approve the remuneration to be paid to the auditor; and </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof. </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene will hold the Meeting in a virtual only format, which will be conducted via live audio webcast. Shareholders will have an equal opportunity to participate at the Meeting online regardless of their geographic location. Registered shareholders and duly appointed proxyholders can attend the Meeting online at www.virtualshareholdermeeting.com/ENGN2024 where they can participate, vote, or submit questions during the Meeting&#x2019;s live webcast.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You are entitled to receive notice of and vote at the Meeting or at any adjournment or postponement thereof only if you were a shareholder of the Company at the close of business on April 10, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Record Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). You are entitled to attend the Meeting or any adjournment or postponement thereof only if you were a shareholder at the Record Date or if you hold a valid proxy to vote at the Meeting. If you plan to attend the virtual Meeting, log in at www.virtualshareholdermeeting.com/ENGN2024. Shareholders will need their unique 16-digit control number which appears on the notice, the proxy card or the voting instructions that accompanied the proxy materials. If you do not have a control number, please contact your broker, bank, or other nominee as soon as possible, so that you can be provided with a control number and gain access to the Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Whether or not you plan to attend the Meeting, we encourage you to read this proxy statement and accompanying proxy materials and promptly vote your shares. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote by completing, signing and dating the enclosed proxy card or voting instruction card and returning it in the enclosed envelope, or you may vote by telephone at 1-800-474-7493 (English) or 1-800-474-7501 (French), or via the Internet at www.proxyvote.com or by scanning the QR Code to access the website. You will need your 16-digit control number located on the form of proxy/voting instruction form.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For specific instructions on how to vote your shares, please refer to the section herein entitled &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Questions and Answers - How You Can Vote</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and to the instructions on your proxy or voting instruction card. If your shares are held in &#x201c;street name&#x201d; by your bank, broker or other nominee, your bank, broker or other nominee will be unable to vote your shares without instructions from you. You should instruct your bank, broker or other nominee to vote your shares in accordance with the procedures provided by your bank, broker or other nominee.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Further information regarding voting rights and the matters to be voted upon is presented in the accompanying proxy statement.  In addition, financial and other information about the Company is contained in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Annual Report</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), as filed with the Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) on January 29, 2024, as available on the SEC&#x2019;s website at www.sec.gov and SEDAR+ at www.sedarplus.ca.  The business to be considered at the Meeting may be considered at the Meeting or at any adjournment or postponement of the Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DATED</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> this 18th day of April 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:53.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:1.961%;"></td>
    <td style="width:98.039%;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">ON BEHALF OF THE BOARD OF DIRECTORS</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">/s/ </font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Executive Officer and Director</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Important Notice Regarding the Availability of Proxy Statement Materials for the Annual General Meeting of Shareholders to be Held on May 15, 2024.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This proxy statement, the Annual Report and the accompanying form of proxy or voting instruction card are first being provided to shareholders beginning on or about April 18, 2024. Unless the context otherwise requires, references to the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">we</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; refer to enGene Holdings Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <p style="text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:96%;"></td>
    <td style="width:4%;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#questions_and_answers"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">QUESTIONS AND ANSWERS</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#share_ownership"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">SHARE OWNERSHIP</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#governance"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">GOVERNANCE</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proposals_to_be_voted_on"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROPOSALS TO BE VOTED ON</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proposal_1"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROPOSAL 1 - ELECTION OF DIRECTORS</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proposal_2"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROPOSAL 2 - APPROVAL OF THE PLAN AMENDMENT PROPOSAL</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proposal_3"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROPOSAL 3 - APPOINTMENT AND REMUNERATION OF AUDITORS</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">48</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#audit_committee_report"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">AUDIT COMMITTEE REPORT</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#executive_officers"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">EXECUTIVE OFFICERS</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#executive_compensation"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">EXECUTIVE COMPENSATION</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">52</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#director_compensation"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">DIRECTOR COMPENSATION</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">63</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#equity_compensation_plan_information"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">EQUITY COMPENSATION PLAN INFORMATION</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#directors_approval"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">DIRECTORS&#x2019; APPROVAL</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#schedule_a"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">SCHEDULE A</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#schedule_b"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">SCHEDULE B</font></a></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
   </tr>
  </table>
  <p style="text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="questions_and_answers"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">QUESTIONS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> AND ANSWERS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All amounts are in United States dollars (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">US$</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), unless otherwise stated. Canadian dollars are presented as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">C$</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, where indicated.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proxy Materials</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What is the format of the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Meeting will be held in a virtual only format, which will be conducted via live audio webcast.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders will not be able to attend the Meeting in person. We believe hosting a virtual annual meeting will enable shareholders to attend and participate fully and equally and improve our ability to effectively communicate and engage with our shareholders. A summary of the information shareholders will need to attend the Meeting online is provided below.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Why am I receiving these materials?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our board of directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is making these proxy materials available by mailing paper copies to you in connection with our Meeting to be held on May 15, 2024. You may also view the proxy materials online at https://materials.proxyvote.com/29286M.  As a shareholder, you are invited to attend the virtual Meeting to be held via live webcast at www.virtualshareholdermeeting.com/ENGN2024 and are entitled and requested to vote on the business items described in this proxy statement. This proxy statement is furnished in connection with the solicitation of proxies by or on behalf of the Company's management. This proxy statement is designed to assist you in voting your shares and includes information that we are required to provide under the rules of the SEC and applicable Canadian securities laws.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">These proxy materials are being sent to both registered and non-registered shareholders. Please return your voting instructions as specified in the request for voting instructions.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There are two kinds of non-registered, or beneficial, shareholders &#x2013; those who object to their name being made known to the issuers of securities which they own (called &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OBOs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; for Objecting Beneficial Owners) and those who do not object to the issuers of the securities they own knowing who they are (called &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOBOs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; for Non-Objecting Beneficial Owners).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In accordance with Canadian National Instrument 54-101 &#x2013; </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Communication with Beneficial Owners of Securities of a Reporting Issuer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NI 54-101</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), the Company has elected to not send the proxy materials directly to NOBOs and will pay for intermediaries to deliver the proxy materials to OBOs.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What is included in the proxy materials?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The proxy materials include:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our notice of meeting; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our proxy statement for the Meeting, including any schedules thereto; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a proxy or voting instruction card; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a financial statement request form; and</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our 2023 Annual Report on Form 10-K. </font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What information is contained in this proxy statement?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information in this proxy statement relates to the proposals to be voted on at the Meeting, the voting process, our Board and Board committees, corporate governance, the compensation of our directors and named executive officers and other required information.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">I share an address with another shareholder, and we received only one paper copy of the proxy materials. How may I obtain an additional copy?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you share an address with another shareholder, you may receive only one set of proxy materials unless you have provided contrary instructions. If you wish to receive a separate set of the materials, please request the additional copy by contacting Broadridge at:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email: Proxy.request@broadridge.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">North America Proxy Line:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-916-0609</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9305</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">French Canadian Proxy Line (voicemail):</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-973-0593</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9306</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A set of the materials will be sent promptly following receipt of your request.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you are a registered shareholder and wish to receive a separate set of proxy materials in the future, or if you have received multiple sets of proxy materials and would like to receive only one set in the future, please contact our transfer agent, Continental Stock Transfer &amp; Trust Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Continental</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) at:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Continental Stock Transfer &amp; Trust Company<br>1 State Street 30</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Floor <br>New York, NY 10004<br>1-800-450-7155 (Canada or the United States)<br>+1-857-999-9155 (International toll free)</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you are a beneficial shareholder and you wish to receive a separate set of proxy materials in the future, or if you have received multiple sets of proxy materials and would like to receive only one set in the future, please contact your bank or broker directly.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders also may write to, or email us, at the address below to request a separate copy of the proxy materials:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene Holdings Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attn: Corporate Secretary</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4868 Rue Levy, Suite 220,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Saint-Laurent, QC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Canada H4R 2P1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We will not transmit proxy materials using notice-and-access, as such term is defined in NI 54-101.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Who pays the cost of soliciting proxies for the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We will bear the cost of solicitation. This solicitation of proxies is being made to shareholders by mail, but may be supplemented by telephone or other personal contact.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We will reimburse brokerage houses and other custodians, nominees and fiduciaries for forwarding proxy materials to beneficial shareholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you have any questions regarding the Meeting or require assistance with voting, you may contact Broadridge at the email address and telephone numbers listed above.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What items of business will be voted on at the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The business items to be voted on at the Meeting are:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the election of three members of the Board to hold office for a three year term expiring on the annual general meeting to be held in 2027, or until their successors are elected and qualified, subject to earlier resignation or removal; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the approval of an amendment to the Incentive Equity Plan, in substantially the form attached to the accompanying proxy statement as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule B</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, to provide for annual increases on the first business day of each calendar year of (i) the Plan Share Reserve by such number of Common Shares as equals 5% of the aggregate number of Common Shares outstanding on the final day of the immediately preceding calendar year (or such smaller number of shares as is determined by the compensation committee), and (ii) the ISO Sublimit by the lesser of 2,500,000 Common Shares and the increase in the Plan Share Reserve (or such smaller number of shares may be determined by the compensation committee) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amended Evergreen Provision</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, and such proposal, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Amendment Proposal</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;);  </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the appointment of KPMG LLP (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">KPMG</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), chartered professional accountants, as auditors for the Company for the ensuing year and the authorization of the Board to fix the remuneration to be paid to the auditor; and </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to transact such other business as may properly come before the Meeting. </font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What are my voting choices?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote: (1) &#x201c;FOR&#x201d; or &#x201c;WITHHOLD&#x201d; for the election of any or all nominees for election as directors; (2) &#x201c;FOR&#x201d;, &#x201c;AGAINST&#x201d; or &#x201c;ABSTAIN&#x201d; from amending the Incentive Equity Plan to Adopt the Amended Evergreen Provision; and (3) &#x201c;FOR&#x201d; or &#x201c;WITHHOLD&#x201d; for the appointment of KPMG as auditors for the ensuing year and the authorization of the Board to fix the auditor&#x2019;s remuneration.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How does the Board recommend that I vote?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board recommends that you vote your shares: (1) &#x201c;FOR&#x201d; each of its nominees for election to the Board; (2) &#x201c;FOR&#x201d; amending the Incentive Equity Plan to Adopt the Amended Evergreen Provision; and (3) &#x201c;FOR&#x201d; the appointment of KPMG as auditors for the ensuing year and the authorization of the Board to fix the auditor&#x2019;s remuneration.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What vote is required to approve each item?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To conduct business at the Meeting, a quorum must be present, consisting of at least two persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least 33 1&#x2215;3% of the shares entitled to vote at the Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you indicate &#x201c;WITHHOLD&#x201d; in respect to the election of directors, your vote will be counted for purposes of determining the presence or absence of a quorum for the transaction of business at the Meeting and will be considered a vote cast (described under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Proposal 1 - Election of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). You are not entitled to cumulative voting in the election of directors.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As described below, broker non-votes will be counted for determining the presence or absence of a quorum for the transaction of business at the Meeting, but will not be considered votes cast with respect to the election of any director nominee or on any other proposal.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following chart describes the proposals to be considered at the Meeting, the voting options, the votes required for each matter, and the manner in which votes will be counted:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:22.995%;"></td>
    <td style="width:17.477%;"></td>
    <td style="width:19.816%;"></td>
    <td style="width:19.816%;"></td>
    <td style="width:19.896%;"></td>
   </tr>
   <tr style="height:28.8pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-top:1.5pt double #000000;border-right:0.5pt solid #000000;border-left:1.5pt double #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Matter</font></p></td>
    <td style="border-top:1.5pt double #000000;border-right:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Voting Options</font></p></td>
    <td style="border-top:1.5pt double #000000;border-right:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Board Recommendation</font></p></td>
    <td style="border-top:1.5pt double #000000;border-right:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Required Vote</font></p></td>
    <td style="border-top:1.5pt double #000000;border-right:1.5pt double #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Impact of Abstentions or Broker Non-Votes</font></p></td>
   </tr>
   <tr style="height:57.6pt;word-break:break-word;white-space:pre-wrap;">
    <td style="border-right:0.5pt solid #000000;text-indent:20.9pt;border-left:1.5pt double #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><div style="margin-left:0.040277777777777746in;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;margin-right:0.19027777777777777in;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.3509948423031686%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Election of Three Directors to Each Hold Office For a Three Year Term Expiring on the 2027 Annual Meeting of Shareholders</font></div></div></td>
    <td style="border-right:0.5pt solid #000000;text-indent:9pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:9pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.125in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;For&#x201d;; &#x201c;Withhold&#x201d;</font></p></td>
    <td style="border-right:0.5pt solid #000000;text-indent:8.3pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:8.3pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.10416666666666667in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;For&#x201d;</font></p></td>
    <td style="border-right:0.5pt solid #000000;text-indent:6pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:6pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.13541666666666666in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Simple majority of votes cast (only votes &#x201c;for&#x201d; are considered votes cast)</font></p></td>
    <td style="border-right:1.5pt double #000000;text-indent:3.75pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:3.75pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.10486111111111111in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No effect. Abstentions and broker non-votes will not be counted for or against the proposal and will therefore have no effect.</font></p></td>
   </tr>
   <tr style="height:69.1pt;word-break:break-word;white-space:pre-wrap;">
    <td style="border-right:0.5pt solid #000000;text-indent:20.9pt;border-left:1.5pt double #000000;vertical-align:top;border-bottom:1.5pt double #000000;"><div style="margin-left:0.040277777777777746in;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;margin-right:0.19027777777777777in;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.3509948423031686%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amending the Incentive Equity Plan to Adopt the Amended Evergreen Provision </font></div></div></td>
    <td style="border-right:0.5pt solid #000000;text-indent:9pt;vertical-align:top;border-bottom:1.5pt double #000000;"><p style="margin-left:9pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.125in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;For&#x201d;; &#x201c;Against&#x201d;; &#x201c;Abstain&#x201d;</font></p></td>
    <td style="border-right:0.5pt solid #000000;text-indent:8.3pt;vertical-align:top;border-bottom:1.5pt double #000000;"><p style="margin-left:8.3pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.10416666666666667in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;For&#x201d;</font></p></td>
    <td style="border-right:0.5pt solid #000000;text-indent:6pt;vertical-align:top;border-bottom:1.5pt double #000000;"><p style="margin-left:6pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.13541666666666666in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Simple majority of votes cast (only votes &#x201c;for&#x201d; are considered votes cast)</font></p></td>
    <td style="border-right:1.5pt double #000000;text-indent:3.75pt;vertical-align:top;border-bottom:1.5pt double #000000;"><p style="margin-left:3.75pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.10486111111111111in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">No effect. Abstentions and broker non-votes will not be counted for or against the proposal and will therefore have no effect.</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p><p style="margin-left:3.75pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.10486111111111111in;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:80.65pt;word-break:break-word;white-space:pre-wrap;">
    <td style="border-right:0.5pt solid #000000;text-indent:20.9pt;border-left:1.5pt double #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><div style="margin-left:0.040277777777777746in;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;margin-right:0.19027777777777777in;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.3509948423031686%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Appointment of Auditors</font></div></div></td>
    <td style="border-right:0.5pt solid #000000;text-indent:9pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:9pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.125in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;For&#x201d;; &#x201c;Withhold&#x201d;</font></p></td>
    <td style="border-right:0.5pt solid #000000;text-indent:8.3pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:8.3pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.10416666666666667in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x201c;For&#x201d;</font></p></td>
    <td style="border-right:0.5pt solid #000000;text-indent:6pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:6pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.13541666666666666in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Simple majority of votes cast (only votes &#x201c;for&#x201d; are considered votes cast)</font></p></td>
    <td style="border-right:1.5pt double #000000;text-indent:3.75pt;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:3.75pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.10486111111111111in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Abstentions will not be counted for or against the proposal and will therefore have no effect.  This item is considered a &#x2018;routine&#x2019; matter and therefore brokers may vote without specific instruction on this matter.</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p><p style="margin-left:3.75pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.10486111111111111in;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What happens if additional items are presented at the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are not aware of any item that may be voted on at the Meeting that is not described in this proxy statement. However, the holders of the proxies that we are soliciting will have the discretion to vote them in accordance with their best judgment on any additional matters that may be voted on, including matters incidental to the conduct of the Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Where can I find the voting results?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We expect to announce preliminary voting results at the Meeting and to publish final results in a current report on Form 8-K that we will file with the SEC and in a press release that we will file on the System for Electronic Data Analysis and Retrieval+ (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SEDAR+</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) promptly following the Meeting. Both the Form 8-K and press release will also be available on our website at www.engene.com. Our website and the information contained therein are not a part of this proxy statement and are specifically not incorporated herein by reference, unless otherwise stated.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How You Can Vote</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What shares can I vote?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You are entitled to one vote for each Common Share that you owned at the close of business on April 10, 2024, the Record Date for the Meeting, at the Meeting and any adjournment or postponement thereof. You may vote all shares owned by you on the Record Date, including (1) shares held directly in your name as the registered shareholder and (2) shares held for you as the beneficial owner through a bank, broker or other nominee. On the Record Date, there were 78 registered shareholders holding 34,465,703 of the 44,100,906 Common Shares that were outstanding, and the remaining 9,635,203 outstanding Common Shares were held through Cede &amp; Co.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each shareholder has the right to appoint a person or a company (who need not be a shareholder) to attend and act for such shareholder and on such shareholder&#x2019;s behalf at the Meeting other than the persons designated in the enclosed form of proxy.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Appointment of a Third Party as Proxy</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; below.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What is the difference between holding shares as a registered shareholder and as a beneficial shareholder?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Most of our shareholders hold their shares through a bank, broker or other nominee rather than having the shares registered directly in their own name. Summarized below are some distinctions between shares held directly and those owned beneficially.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Registered Shareholder</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If your shares are registered directly in your name with our transfer agent, Continental Stock Transfer &amp; Trust Company, you are the registered holder of the shares. As the registered shareholder, you have the right to grant a proxy to vote your shares to representatives from the Company or to another person, or to vote your shares at the Meeting. You have received a proxy card to use in voting your shares either by mail or email.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Beneficial Owner</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If your shares are held through a bank, broker or other nominee, it is likely that they are registered in the name of the nominee and you are the beneficial owner of shares held in street name.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As the beneficial owner of shares held for your account, you have the right to direct the registered holder to vote your shares as you instruct. Your bank, broker, plan trustee or other nominee has provided a voting instruction card for you to use in directing how your shares are to be voted. Since a beneficial owner is not the registered shareholder, you may not vote your shares at the Meeting, or any adjournment or postponement thereof, unless you obtain a legal proxy from the registered holder of the shares giving you the right to do so. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Appointment of a Third Party as Proxy</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; below.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How can I vote at the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registered shareholders may vote at the Meeting by completing a ballot online during the Meeting, as further described below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I attend and participate at the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote shares for which you are the beneficial owner only by obtaining a legal proxy giving you the right to vote the shares from the bank, broker or other nominee that is the registered holder of your shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How can I vote without attending the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Whether you hold your shares as a registered shareholder or as a beneficial shareholder, you may direct how your shares are to be voted without attending the Meeting or any adjournment or postponement thereof. If you are a registered shareholder, you may vote by submitting a proxy. If you hold shares as a beneficial owner, you may vote by submitting voting instructions to the registered owner of your shares. Each shareholder submitting a proxy has the right to appoint one or more proxyholders to represent the shareholder at the Meeting to the extent and with the powers conferred by the proxy.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For directions on how to vote, please refer to the following instructions and those included on your proxy or voting instruction card. A proxy form will not be valid unless completed and deposited in accordance with the instructions set out in the proxy form.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Registered Shareholder: Shares Registered in Your Name.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> If you are a registered shareholder, you can vote in one of the following ways:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote via the Internet</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. To vote via the Internet, go to www.proxyvote.com to complete an electronic proxy card or scan the QR Code to access the website. You will be asked to provide the control number from the proxy card when you vote. Your vote must be received by 10:00 a.m. Eastern Time on May 13, 2024 to be counted.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote by telephone</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. To vote by telephone, dial 1-800-474-7493 (English) or 1-800-474-7501 (French) and follow the recorded instructions. You will be asked to provide the control number from the proxy card. Your vote must be received by 10:00 a.m. Eastern Time on May 13, 2024 to be counted. If you vote by telephone, you do not need to return a proxy card by mail.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote by mail</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. To vote by mail using the proxy card, you need to complete, date and sign the proxy card and return it promptly by mail in the envelope provided so that it is received no later than 10:00 a.m. Eastern Time on May 13, 2024. The persons named in the proxy card will vote the shares you own in accordance with your instructions on the proxy card you mail.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may vote at the Meeting</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. To vote at the meeting, follow the instructions at www.proxyvote.com (have your Notice or proxy card in hand when you visit the website).</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Beneficial Owners: Shares Registered in the Name of a Broker, Bank or Other Nominee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> If you are the beneficial owner of shares held directly by a broker, bank or other nominee, you will receive voting instructions from your broker, bank or other nominee. You must follow the voting instructions provided by your broker, bank or other nominee in order to instruct your broker, bank or other nominee how to vote your shares. The availability of internet and telephone voting options will depend on the voting process of your broker, bank or other nominee.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A record holder who executes a proxy may revoke it before or at the Meeting by: (i) entering a new vote by internet or telephone; (ii) attending the Meeting and voting at that time; (iii) duly executing, dating and delivering a new proxy card with a later date; or (iv) delivering to our Corporate Secretary a written notice of revocation of a previously delivered proxy, with such notice dated after the previously delivered proxy. Attending the Meeting will not, in and of itself, constitute revocation of a proxy. Any written notice revoking a proxy should be delivered to enGene Holdings Inc. 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1., Attention: Corporate Secretary. If your Common Shares are held in a brokerage account, you must follow your broker&#x2019;s instructions to revoke a proxy. For how to attend and vote at the meeting as a beneficial holder, see &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Appointment of a Third Party as Proxy</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; below.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I attend and participate at the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Meeting will be held &#x201c;virtually&#x201d; through a live audio webcast on Wednesday, May 15, 2024, at 10:00 a.m. Eastern Time. There will be no physical meeting location. The meeting will only be conducted via an audio webcast.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Access to the Audio Webcast of the Meeting</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The live audio webcast of the Meeting will begin promptly at 10:00 a.m. Eastern Time. Online access to the audio webcast will open approximately fifteen minutes prior to the start of the Meeting to allow time for you to log in and test the computer audio system. We encourage our shareholders to access the meeting prior to its start time. A replay of the webcast will be made publicly available 24 hours after the Meeting at www.virtualshareholdermeetings.com/ENGN2024</font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font></font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Log in Instructions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To participate in the virtual Meeting, log in at </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">www.virtualshareholdermeeting.com/ENGN2024.</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Shareholders will need their unique 16-digit control number which appears on the notice, the proxy card or the voting instructions that accompanied the proxy materials. If you do not have a control number, please contact your broker, bank, or other nominee as soon as possible, so that you can be provided with a control number and gain access to the Meeting.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Submitting Questions at the Virtual Meeting</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As part of the Meeting, we will hold a live Q&amp;A session, during which we intend to answer all questions submitted during the Meeting that are pertinent to the Company and the meeting matters, as time permits. If you wish to submit a question during the Meeting, visit </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">www.virtualshareholdermeeting.com/ENGN2024,</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> type your question into the &#x201c;Ask a Question&#x201d; field, and click &#x201c;Submit.&#x201d; Answers to any such questions that are not addressed during the Meeting will be published following the meeting on the Company&#x2019;s website at www.engene.com under the link &#x201c;Governance.&#x201d; Questions and answers will be grouped by topic and substantially similar questions will be grouped and answered once.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Technical Assistance</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Beginning fifteen minutes prior to the start of and during the virtual Meeting, we will have a support team ready to assist shareholders with any technical difficulties they may have accessing or hearing the virtual Meeting.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you encounter any difficulties accessing the virtual Meeting during the check-in or meeting time, please call the technical support number that will be posted on the virtual Meeting log-in page.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Voting shares prior to and at the virtual Meeting</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders may vote their shares at www.proxyvote.com, by telephone or by mail, prior to the virtual Meeting or at www.virtualshareholdermeeting.com/ENGN2024 during the virtual Meeting.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Following the Meeting, a recording of the audio webcast of the Meeting will be made available for listening on the Company&#x2019;s website at www.engene.com/investors and will remain available until the filing of the Company&#x2019;s proxy statement for its 2025 shareholder meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How will my shares be voted?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Your shares will be voted as you specifically instruct on your proxy or voting instruction card. If you sign and return your proxy or voting instruction card without giving specific instructions, your shares will be voted as recommended by our Board. Additionally, the form of proxy confers discretionary authority upon the persons named therein with respect to: (i) the matters set out in the proxy if no choice is specified; (ii) amendments or variations to matters identified in this proxy statement; and (iii) other matters which may properly come before the Meeting; provided that, in the case of items (ii) and (iii), such amendments, variations or other matters were not known to our management a reasonable time prior to the solicitation of proxies. If any matters which are not now known should properly come before the Meeting, persons named in the form of proxy will vote on such matters in accordance with their best judgment. As of the date hereof, our management is not aware of any amendment, variation or other matters which are to come before the Meeting other than those matters identified in the accompanying Notice.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Beneficial Owners: Shares Registered in the Name of a Broker, Bank or Other Nominee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If you are a beneficial owner and you do not provide your broker, bank or other nominee that holds your shares with voting instructions, then your broker, bank or other nominee will determine if it has discretion to vote on each matter. Brokers do not have discretion to vote on non-routine matters. Proposal 1 (Election of Directors) and Proposal 2 (Amending the Incentive Equity Plan to Adopt the Amended Evergreen Provision) are each non-routine matters, while Proposal 3 (Appointment of Auditors) may be considered a routine matter. As a result, if you do not provide voting instructions to your broker, bank or other nominee, then your broker, bank or other nominee may not vote your shares with respect to Proposal 1 or Proposal 2, which would result in a &#x201c;broker non-vote,&#x201d; but may, in its discretion, vote your shares with respect to Proposal 3.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Will shares I hold in my brokerage account be voted if I do not provide timely voting instructions?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If your shares are held through a brokerage firm, they will be voted as you instruct on the voting instruction card provided by your broker. If you sign and return your card without giving specific instructions, your shares will be voted in accordance with the recommendations of our Board.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Broker non-votes occur when a nominee holding shares of voting securities for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power on that item and has not received instructions from the beneficial owner. If you do not return your voting instruction card on a timely basis, your broker may in its discretion vote your brokerage shares on matters deemed 'routine', which includes Proposal 3 (Appointment of Auditors).  Your broker will be prohibited from voting your shares without your instructions on the election of directors and on any other proposal.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Abstentions, withheld votes, and broker non-votes are included in determining whether a quorum is present but are not deemed a vote cast &#x201c;FOR&#x201d; or &#x201c;AGAINST&#x201d; a given proposal. As such, abstentions, withheld votes and broker non-votes do not affect the voting results with respect to any of the proposals.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Will shares that I own as a registered shareholder be voted if I do not timely return my proxy card?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shares that you own as a registered shareholder will be voted as you instruct on your proxy card. If you sign and return your proxy card without giving specific instructions, they will be voted in accordance with the procedure set out above under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How will my shares be voted?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you do not timely return your proxy card, your shares will not be voted unless you or your proxyholder attends the online Meeting and any adjournment or postponement thereof and votes as described above under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How can I vote at the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">When is the deadline to vote?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you hold shares as a registered shareholder, your vote by proxy must be received before 10:00 a.m. Eastern Time on May 13, 2024, or 48-hours prior to the Meeting date or any adjournment thereof (excluding Saturdays, Sundays or holidays).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you hold shares as a beneficial owner, please follow the voting instructions provided by your bank, broker or other nominee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">May I change or revoke my vote?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you are a registered shareholder, you may change your vote by: (i) providing a written notice of revocation to our Corporate Secretary at the address set out below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I obtain additional copies of this proxy statement or voting materials?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; provided that such notice is received by 10:00 a.m. Eastern Time on May 13, 2024; (ii) by attending the online Meeting and voting; or (iii) by granting a subsequent proxy. To be effective, the subsequent proxy must be deposited before the time specified above under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">When is the deadline to vote?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; for the deposit of proxies.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you have followed the process for attending and voting at the Meeting online, voting at the Meeting online will revoke your previous proxy.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For shares you hold as a beneficial owner, you may change your vote by timely submitting new voting instructions to your bank, broker or other nominee (which revokes your earlier instructions), or, if you have obtained a legal proxy from the nominee giving you the right to vote your shares, by attending the online Meeting and voting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Appointment of a Third Party as Proxy</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following applies to shareholders who wish to appoint someone as their proxyholder other than the persons designated in the enclosed form of proxy or voting instruction form. This includes non-registered shareholders who wish to appoint themselves as proxyholder to attend, participate or vote at the Meeting.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders who wish to appoint a third party proxyholder to attend and participate at the Meeting as their proxy and vote their shares MUST submit their form of proxy or voting instruction form, as applicable, appointing that person as proxyholder AND register that proxyholder online, as described below. Registering your proxyholder is an additional step to be completed AFTER you have submitted your form of proxy or voting instruction form. Failure to register the proxyholder will result in the proxyholder not receiving a Username to participate in the Meeting.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any shareholder who wishes to appoint themselves or such other person (other than the named proxyholders) as proxy must do so online at www.proxyvote.com as this will reduce the risk of any mail disruptions in the current environment and will allow you to share the Appointee Information you have created with any other person you have appointed to represent you at the meeting more easily. If you do not designate the Appointee Information when completing your form of proxy or voting information form or if you do not provide the exact Appointee Identification Number and Appointee Name to any other person (other than the named proxyholders) who has been appointed to access and vote at the meeting on your behalf, that other person will not be able to access the meeting and vote on your behalf.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You must provide your Appointee the exact name and eight character appointee identification number to access the Meeting. Appointees can only be validated at the Meeting using the exact name and eight character appointee identification you enter.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you do not create an eight character appointee identification number, your appointee will not be able to access the virtual meeting.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attending the Meeting</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Who can attend the Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may attend the Meeting and any adjournment or postponement thereof only if you were a shareholder of enGene at the close of business on April 10, 2024, the Record Date for the Meeting, or you hold a valid proxy to vote at the Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Meeting will begin promptly at 10:00 a.m. (Eastern time). Please allow ample time to check into the Meeting online and complete the related procedure.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholder Proposals</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What is the deadline to submit shareholder proposals to be included in the proxy materials for next year&#x2019;s annual meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to the rules of both the SEC under the Exchange Act and provisions of the </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Corporations Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (British Columbia) (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BCBCA</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) with respect to shareholder proposals. As clearly indicated under the BCBCA and SEC rules under the Exchange Act, simply submitting a shareholder proposal does not guarantee its inclusion in the proxy materials.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholder proposals submitted pursuant to SEC rules under the Exchange Act for inclusion in the Company&#x2019;s proxy materials for next year&#x2019;s annual meeting must be received by our Corporate Secretary no later than 5:00 p.m. (Eastern time) on December 19, 2024, and must be submitted in writing to our Corporate Secretary at enGene Holdings Inc., 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1. Such proposals must also comply with all applicable provisions of Rule 14a-8 under the Exchange Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The BCBCA also sets out the requirements for a valid proposal and provides for the rights and obligations of the Company and the submitter upon a valid proposal being made. Proposals submitted under the applicable provisions of the BCBCA that a shareholder intends to present at next year&#x2019;s annual meeting and wishes to be considered for inclusion in the Company&#x2019;s proxy statement and form of proxy relating to next year&#x2019;s annual meeting must be received at least three months before the anniversary of the Company&#x2019;s last annual general meeting. Such proposals must also comply with all applicable provisions of the BCBCA and the regulations thereunder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proposals that are not timely submitted or are submitted to the incorrect address or other than to the attention of our Corporate Secretary may, at our discretion, be excluded from our proxy materials.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How may I nominate director candidates or present other business for consideration at a meeting?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; for a description of the procedures through which shareholders may nominate director candidates for consideration.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How may I nominate director candidates?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders who wish to (1) submit director nominees for election to the board at an annual or special meeting or (2) present other items of business directly at next year&#x2019;s annual meeting must give written notice of their intention to do so, in accordance with the deadlines described below, to our Corporate Secretary at the address set forth below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I obtain additional copies of this proxy statement or voting materials</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">?&#x201d;. Any such notice also must include the information required by the articles of the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Articles</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) (which may be obtained as provided below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How may I obtain financial and other information about enGene Holdings Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">?&#x201d;) and must be updated and supplemented as provided in the Articles.  Additionally, the nominating and corporate governance committee will consider director candidates recommended by shareholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written notice of director nominees must be received, in the case of an annual meeting (including an annual and special meeting), not later than the close of business on the 30th day prior to the date of the meeting; provided, however, that in the event that the meeting is to be held on a date that is less than 50 days after the date on which the first public announcement of the meeting was made, notice must be made not later than the close of business on the 10th day following the date of such first public announcement. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Advance Notice Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Proposal 1 &#x2013; Election of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; in this proxy statement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to satisfying the foregoing requirements under the Articles with respect to advance notice of any nomination, shareholders who intend to solicit proxies in support of director nominees other than the Company&#x2019;s nominees for the 2025 annual meeting of shareholders in accordance with Exchange Act Rule 14a-19 must provide notice in accordance with the Articles, which, in general, require that such notice be received within the time periods described above. Any such notice of intent to solicit proxies must comply with all the requirements of SEC Rule 14a-19.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How may I present other business for consideration at a meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders who wish to present other items of business directly at next year&#x2019;s annual meeting must give written notice of their intention to do so to our Corporate Secretary at the address set forth below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I obtain additional copies of this proxy statement or voting materials?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; Any such notice also must include the information required by the Articles (which may be obtained as provided below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How may I obtain financial and other information about enGene Holdings Inc.?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and must be provided by the deadline as provided in the Articles and updated and supplemented as provided in the Articles.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Obtaining Additional Information</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How may I obtain financial and other information about enGene Holdings Inc.?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our consolidated financial statements are included in our 2023 Annual Report on Form 10-K. We filed our Annual Report on Form 10-K with the SEC, 100 F Street, N.E., Washington, D.C. 20549. In Canada, additional information relating to the Company, including financial information provided in the Company&#x2019;s annual financial statements and related management discussion and analysis for the year ended October 31, 2023, is available on SEDAR+ at http://www.sedarplus.ca under the Company&#x2019;s profile.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We also will furnish a copy of our 2023 Annual Report on Form 10-K (excluding exhibits, except those that are specifically requested) without charge to any shareholder who so requests by writing to our Corporate Secretary at the address below under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I obtain additional copies of this proxy statement or voting materials?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By writing to us, shareholders also may obtain, without charge, a copy of the Articles, corporate governance guidelines, code of conduct and Board standing committee charters.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What if I have questions on the Meeting or need assistance with voting my Common Shares?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you have any questions regarding the Meeting or require assistance with voting, you may contact Broadridge at:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email: Proxy.request@broadridge.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">North American Proxy Line:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-916-0609</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9305</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">French Canadian Proxy Line (voicemail):</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-973-0593</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9306</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">What if I have questions for the Company&#x2019;s transfer agent?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you are a registered shareholder and have questions concerning share certificates, ownership transfer or other matters relating to your share account, please contact our transfer agent at the following address:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Continental Stock Transfer &amp; Trust Company<br>1 State Street 30</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Floor <br>New York, NY 10004<br>1-800-450-7155 (Canada or the United States)<br>+1-857-999-9155 (International toll free)</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">How do I obtain additional copies of this proxy statement or voting materials?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you need additional copies of this proxy statement or voting materials, please contact us at:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene Holdings Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attn: Corporate Secretary</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4868 Rue Levy, Suite 220,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Saint-Laurent, QC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Canada H4R 2P1</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="share_ownership"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SHARE O</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">WNERSHIP</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth information known to the Company regarding the beneficial ownership of the Company&#x2019;s Common Shares as of April 4, 2024 regarding the beneficial ownership of our Common Shares for:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each person known to the Company to be the beneficial owner of more than 5% of outstanding Common Shares;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each director (including those nominated for election at the Meeting) and each of the Company&#x2019;s named executive officers; and </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">all executive officers and directors of the Company as a group. </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of April 4, 2024, 44,083,077 Common Shares were issued and outstanding. Unless otherwise indicated, we believe that all persons named in the below table have sole voting and investment power with respect to all Common Shares beneficially owned by them. Except as otherwise noted herein, the number and percentage of Common Shares beneficially owned is determined in accordance with Rule 13d-3 of the Exchange Act, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, a person is deemed to be a beneficial owner of a security if that person has sole or shared voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes the power to dispose of or to direct the disposition of the security. In determining beneficial ownership percentages, we deem shares that a person will have the right to acquire within 60 days following April 4, 2024, if any, to be outstanding and to be beneficially owned by the person with such right to acquire additional Common Shares for the purposes of computing the percentage ownership of that person (including in the total when calculating the applicable beneficial owner&#x2019;s percentage of ownership), but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unless otherwise indicated, the address of each person named below is 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.98%;"></td>
    <td style="width:1.16%;"></td>
    <td style="width:1%;"></td>
    <td style="width:13.36%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.16%;"></td>
    <td style="width:1%;"></td>
    <td style="width:13.34%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name and Address<br>of Beneficial Owner</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number<br>of Shares</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Percent<br>of Total Voting Power</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">enGene greater than 5% holders</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forbion Growth (1)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,169,004</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.6</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lumira Ventures III, L.P. and affiliates (2)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,181,853</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.4</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Forbion Capital Fund III Co&ouml;perarief U.A. (3)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,369,275</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.6</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fonds de solidarit&eacute; des travailleurs du Qu&eacute;bec (4)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,088,682</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.9</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Biotechnology Value Fund, L.P. and affiliates (5)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,196,439</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.1</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Blue Owl Healthcare Opportunities IV Public Investments LP (6)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,534,790</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foresite Capital Fund VI LP (7)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,500,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.7</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Venrock Healthcare Capital Partners EG, L.P. and affiliates (8)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,565,841</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deep Track Biotechnology Master Fund, Ltd. (9)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,250,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.1</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">enGene directors, director nominees and named executive officers</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson (10)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,216,266</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.7</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. Alex Nichols (10)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">208,850</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. James C. Sullivan (10)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">141,738</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Gerald Brunk (11)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,181,853</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.4</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jasper Bos (12)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lota S. Zoth</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. Richard Glickman (13)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90,436</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Wouter Joustra (12)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul Hastings</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;%</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">enGene directors and executive officers as a group (12 persons)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,374,585</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.7</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:0.463%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">* Less than 1%.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unless otherwise indicated, the address of each person named below is c/o enGene Holdings Inc., 4868 Rue Levy, Suite 220, Saint-Laurent, QC H4R 2P1, Canada.</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forbion Growth Sponsor FEAC I B.V., or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC Sponsor</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, is the record holder of 3,765,932 of the enGene Common Shares reported herein. Forbion Growth Opportunities Fund I Cooperatief U.A. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FGOF</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the record holder of 2,000,000 enGene Common Shares reported herein, for an aggregate of 5,765,932 enGene Common Shares, or approximately 13.1% of the issued and outstanding enGene Common Shares. The number of shares reported also includes warrants held by FEAC Sponsor that may be exercised to acquire 1,736,406 enGene Common Shares, and warrants held by FGOF that may be exercised to acquire 666,666 enGene Common Shares. FGOF wholly owns the FEAC Sponsor and therefore the FEAC Sponsor and FGOF have shared voting and investment power over the enGene Common Shares held by the FEAC Sponsor. Forbion Growth Management B.V. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forbion Management</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the sole director of FGOF and therefore shares voting and investment power (i) with FGOF over the enGene Common Shares that will be held by FGOF and (ii) with FGOF and, indirectly, the FEAC Sponsor, over the enGene Common Shares that will be held by the FEAC Sponsor. Forbion Management exercises voting and investment power through its investment committee (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Investment Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) consisting of Sander Slootweg, Martien van Osch, Geert-Jan Mulder, Vincent van Houten, Dirk Kersten, Nanna L&uuml;neborg, Wouter Joustra and Jasper Bos. None of the members of the Investment Committee has individual voting and investment power with respect to the FEAC Shares, and each such member disclaims beneficial ownership of the FEAC Shares except to the extent of his or her proportionate pecuniary interest therein. Jasper Bos, Cyril Lesser, Sander Slootweg and Wouter Joustra, who are directors of the FEAC Sponsor, have voting and investment discretion with respect to the enGene Common Shares owned by the FEAC Sponsor and may be deemed to have indirect shared beneficial ownership of the enGene Common Shares owned by the FEAC Sponsor. Jasper Bos, Cyril Lesser, Sander Slootweg and Wouter Joustra each disclaim beneficial ownership over the enGene Common Shares except to the extent of their pecuniary interest therein. FGOF, FEAC Sponsor, Forbion Management and such members of the Investment Committee each disclaims any affiliation with Forbion III and its directors, officers or other affiliates. The business address of the above-named Forbion persons is c/o Forbion, Gooimeer 2-35, 1411 DC Naarden, The Netherlands.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consists of 1,341,790 shares held by Lumira Ventures III, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lumira III</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), 44,647 shares held by Lumira Ventures III (International), L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lumira III Int&#x2019;l</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), 993,651 shares held by Lumira Ventures IV, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lumira IV</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), 238,851 shares held by Lumira Ventures IV (International), L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lumira IV Int&#x2019;l</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), 1,077,386 shares held by Merck Lumira Biosciences Fund, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Merck-Lumira</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and 152,974 shares held by Merck Lumira Biosciences Fund (Qu&eacute;bec), L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Merck-Lumira B</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and, together with Lumira III, Lumira III Int&#x2019;l, Lumira IV, Lumira IV Int&#x2019;l, and Merck-Lumira, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lumira entities</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) for an aggregate of 3,849,299 enGene Common Shares, or approximately 8.7% of the issued and outstanding enGene Common Shares. The number of shares reported also includes warrants held by Lumira III that may be exercised to acquire 114,945 enGene Common Shares, warrants held by Lumira III Int&#x2019;l that may be exercised to acquire 3,825 enGene Common Shares, warrants held by Lumira IV that may be exercised to acquire 38,301 enGene Common Shares, warrants held by Lumira IV Int&#x2019;l that may be exercised to acquire 9,207 enGene Common Shares, warrants held by Merck-Lumira that may be exercised to acquire 145,603 enGene Common Shares, and warrants held by Merck-Lumira B that may be exercised to acquire 20,673 enGene Common Shares. Lumira III and Lumira III Int&#x2019;l are controlled by their general partner, Lumira Ventures III GP, L.P., and managed by Lumira Capital Investment Management Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lumira Mgmt</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). Lumira Ventures III GP, L.P. is controlled by its general partners, Lumira III GP Inc. and Lumira III GP Holdings Co. Lumira IV and Lumira IV Int&#x2019;l are controlled by their general partner, Lumira IV GP 2020 Inc., and managed by Lumira Mgmt. Merck- Lumira and Merck-Lumira B are controlled by their general partner, Lumira Capital GP, L.P., and managed by Lumira Mgmt. Lumira Capital GP, L.P. is controlled by its general partners, Lumira GP Inc. and Lumira GP Holdings Co. Mr. Brunk is an executive officer of each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co. and Lumira Mgmt. Each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co., Lumira Mgmt and Mr. Brunk may be deemed to beneficially own the securities held by the respective Lumira entities, but each disclaims beneficial ownership except to the extent of their respective pecuniary interests therein, if any. The business address of the Lumira entities is 141 Adelaide Street West, Suite 770, Toronto, Ontario, Canada M5H 3L5.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forbion Capital Fund III Co&ouml;peratief U.A. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forbion III COOP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the record holder of 2,894,199 enGene Common Shares, or approximately 6.6% of the issued and outstanding enGene Common Shares. The number of shares reported includes warrants that may be exercised to acquire 475,076 enGene Common Shares. Forbion III Management B.V. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forbion III</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the director of Forbion III COOP with voting and investment power over the shares held by Forbion III COOP. Such voting and investment power are exercised by Forbion III through its investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder, H.N. Reithinger, Dr. M. Boorsma and S. J. H. van Deventer. None of the members of the investment committee have individual voting and investment power with respect to such shares, and the members of the investment committee, including Dr. Boorsma, who is currently a director of enGene, disclaim beneficial ownership of such shares except to the extent of their proportionate pecuniary interests therein. Forbion III COOP disclaims any affiliation with FEAC, FEAC Sponsor, or any of FEAC&#x2019;s or FEAC Sponsor&#x2019;s direct or indirect directors, officers or other affiliates. The business address of Forbion III COOP and Forbion III is Gooimeer 2-35, 1411 DC Naarden, The Netherlands.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fonds de solidarit&eacute; des travailleurs du Qu&eacute;bec (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fonds</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the record holder of 2,642,110 enGene Common Shares, or approximately 6.0% of the issued and outstanding enGene Common Shares.  The number of shares reported includes warrants that may be exercised to acquire 446,572 enGene Common Shares. The Fonds is managed by a 19-member board of directors, which is majority independent and includes Mr. Claude S&eacute;guin, the chair of the board, and Ms. Janie C. B&eacute;&iuml;que, who is also the President and Chief Executive Officer of the Fonds. Investment power over the enGene shares held by the Fonds is exercised either by its board of directors or by a 9-member investment committee of the Fonds&#x2019; board of directors, which is majority independent and includes Pierre- Maurice Vachon, who is also the Second Vice-Chair of the board of the Fonds, and Magali Picard, who is also first vice-chair of the board. None of the members of the Fonds&#x2019; board of directors or investment committee have individual voting or investment power over the enGene shares held by the Fonds. Mr. S&eacute;guin, Ms. B&eacute;&iuml;que, Mr. Vachon and Ms. Picard each disclaim beneficial ownership of such shares except to the extent of their pecuniary interests therein. The business address of the Fonds is 545 Cr&eacute;mazie Blvd. East, Suite 200, Montr&eacute;al, Qu&eacute;bec, Canada H2M 2W4.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consists of 1,204,412 enGene Common Shares held by Biotechnology Value Fund, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BVF</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), 912,776 enGene Common Shares held by Biotechnology Value Fund II, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BVF2</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), 104,257 enGene Common Shares held by Biotechnology Value Trading Fund OS LP (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trading Fund OS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and 29,592 enGene Common Shares held by MSI BVF SPV, LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">MSI BVF</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), for an aggregate of 2,251,037 enGene Common Shares, or approximately 5.1% of the issued and outstanding enGene Common Shares. The number of shares reported also includes warrants held by BVF that may be exercised to acquire 505,835 enGene Common Shares, warrants held by BVF2 that may be exercised to acquire 383,352 enGene Common Shares, warrants held by Trading Fund OS that may be exercised to acquire 43,786 enGene Common Shares, and warrants held by MSI BVF that may be exercised to acquire 12,429 enGene Common Shares. BVF I GP LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BVF GP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the general partner of BVF, and may be deemed to beneficially own the enGene Common Shares held by BVF; BVF II GP LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BVF2 GP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the general partner of BVF2, and may be deemed to beneficially own the enGene Common Shares held by BVF2; BVF Partners OS Ltd. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Partners OS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the general partner of Trading Fund OS, and may be deemed to beneficially own the enGene Common Shares held by Trading Fund OS. BVF GP Holdings LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BVF GPH</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the sole member of each of BVF GP and BVF2 GP, and may be deemed to beneficially own the enGene Common Shares beneficially owned by BVF and BVF2. BVF Partners L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Partners</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the investment manager of BVF, BVF2, Trading Fund OS and MSI BVF and the sole member of Partners OS, and may be deemed to beneficially own the enGene Common Shares beneficially owned by BVF, BVF2, Trading Fund OS, and MSI BVF. BVF Inc. is the general partner of Partners, and may be deemed to beneficially own the enGene Common Shares beneficially owned by Partners. Mark N. Lampert is a director and officer of BVF Inc., and may be deemed to beneficially own the enGene Common Shares beneficially owned by BVF Inc. Each of BVF GP, BVF2 GP, Partners OS, BVF GPH, Partners, BVF Inc. and Mr. Lampert disclaims beneficial ownership of the shares beneficially owned by BVF, BVF2, Trading Fund OS and MSI BVF. The business address of BVF, BVF GP, BVF2, BVF2 GP, BVF GPH, MSI BVF, Partners, BVF Inc. and Mark N. Lampert is 44 Montgomery St., 40th Floor, San Francisco, California 94104. The business address of Trading Fund OS and Partners OS is PO Box 309 Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The business address of Blue Owl Healthcare Opportunities IV Public Investments LP is 399 Park Avenue, Floor 37, New York, New York 10022. </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The shares are owned directly by: Foresite Capital Fund VI LP (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fund VI</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). Foresite Capital Management VI LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FCM VI</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the general partner of Fund VI. FCM VI may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dr. Tananbaum</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over these shares. Each reporting person disclaims the existence of a &#x201c;group.&#x201d; Each of FCM VI and Dr. Tananbaum disclaim beneficial ownership of these shares except to the extent of any pecuniary interest herein, and nothing herein shall be deemed an admission that FCM VI or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose. The business address of Fund VI is 900 Larkspur Landing Circle, Suite 150, Larkspur, California 94939.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(8)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to a Schedule 13G filed by the reporting persons on February 26, 2024, consists of 1,825,207 Common Shares held by Venrock Healthcare Capital Partners EG, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">VHCP E</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">G&#x201d;), 673,281  Common Shares held by Venrock Healthcare Capital Partners III, L.P. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">VHCP III</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and 67,353 Common Shares held by VHCP Co-Investment Holdings III, LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">VHCP Co-Invest</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). VHCP Management III, LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">VHCPM</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the sole general partner of VHCP III and the sole manager of VHCP Co-Invest. VHCP Management EG, LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">VHCPM EG</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is the sole general partner of VHC PEG. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM and VHCPM EG. The address of each of these persons and entities is 7 Bryant Park, 23rd Floor, New York, NY 10018.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(9)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This information is based on the Schedule 13G filed with the SEC on February 23, 2024, by Deep Track Capital, LP and Deep Track Biotechnology Master Fund, Ltd. and David Kroin, pursuant to which the reporting persons reported sole voting power with respect to 0 shares, shared voting power with respect to 2,250,000 shares, sole dispositive power with respect to 0 shares, and shared dispositive power with respect to 2,250,000 as of February 23, 2024. David Kroin is the Managing Member of Deep Track Capital GP, LLC the General Partner for Deep Track Capital, LP. Deep Track Capital, LP is the investment manager of Deep Track Biotechnology Master Fund, Ltd. The business address of Deep Track Capital, LP is 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830; the business address of Deep Track Biotechnology Master Fund, Ltd. is c/o Walkers Corporate Limited, 190 Elgin Ave, George Town, KY1-9001, Cayman Islands, and the business address of Mr. Kroin is c/o Deep Track Capital, LP, 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(10)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Represents options to acquire enGene Common Shares that are exercisable within 60 days following April 4, 2024.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(11)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consists of enGene Common Shares and warrants to purchase enGene Common Shares held by the Lumira entities. See footnote (2) above. Mr. Brunk is an executive officer of certain entities controlling and/or managing the Lumira entities. Mr. Brunk disclaims beneficial ownership of the enGene Common Shares held by the Lumira entities, except to the extent of his pecuniary interest therein, if any.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(12)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each of Mr. Bos and Mr. Joustra is a director of FEAC Sponsor, and a member of the investment committee of Forbion Management. Each of Mr. Bos and Mr. Joustra disclaims beneficial ownership over the enGene Common Shares held by FEAC Sponsor and FGOF, except to the extent of his proportionate pecuniary interest therein.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(13)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consists of 24,555 enGene Common Shares and options to acquire 65,881 enGene Common Shares that are exercisable within 60 days following April 4, 2024.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="governance"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GOVE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RNANCE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our business and affairs are managed, and all corporate powers are exercised, under the direction of our Board. Our Board establishes fundamental corporate policies and oversees our performance and our Chief Executive Officer and the other officers to whom our Board has delegated authority to manage day-to-day business operations.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board has adopted corporate governance guidelines that set forth expectations for directors, director independence standards, Board committee structure and functions and other policies for the Company&#x2019;s governance. It also has adopted a Code of Business Conduct and Ethics (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Code of Conduct</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) that applies to members of our Board and our executive officers as well as all of our employees. The Board has three standing committees: audit, compensation, and nominating and corporate governance.  Each of our standing committees assists our Board in carrying out its responsibilities and operates under a written committee charter adopted by our Board.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our corporate governance guidelines, audit, compensation, and nominating and corporate governance committee charters and Code of Conduct are posted on our website at www.engene.com. We intend to post on our website any amendments or waivers to our Code of Conduct requiring disclosure under applicable SEC or Nasdaq Capital Market (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) rules. Paper copies of these documents, as well as our constating documents (including our Articles), may be obtained upon request by writing to: enGene Holdings Inc., 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1, Attention: Corporate Secretary.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board believes that good corporate governance improves corporate performance and benefits all shareholders. The Canadian Securities Administrators (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CSA</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) have adopted National Policy 58-201 - </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Corporate Governance Guidelines</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which provides non-prescriptive guidelines on corporate governance practices for reporting issuers such as the Company. In addition, the CSA have implemented National Instrument 58-101 - </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Disclosure of Corporate Governance Practices</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NI 58-101</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">), which prescribes certain disclosure by the Company of its corporate governance practices. This section sets out the Company&#x2019;s approach to corporate governance and addresses the Company&#x2019;s compliance with NI 58-101. enGene recognizes that good corporate governance plays an important role in its overall success and in enhancing shareholder value and, accordingly, enGene has adopted certain corporate governance policies and practices which reflect its consideration of the recommended Corporate Governance Guidelines.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Anti-Hedging Policy</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Company</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2019;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">s Insider Trading Policy, every Company insider is prohibited from speculative or indirect trading in Company securities &#x2013; such as short sales, trading in puts, calls or options (not stock options granted by the Company) &#x2013; or similar rights or obligations to buy or sell Company securities, or the purchase of Company securities with the intention of quickly reselling them.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company insiders may not buy Company securities on margin, and are prohibited from purchasing financial instruments designed to hedge or offset a decrease in the market value of Company Securities. Insiders are strongly discouraged from using Company securities as collateral for loans or in margin accounts.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Whistleblower Policy</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s audit committee has adopted a Whistleblower Policy, which establishes procedures for confidential, anonymous submissions by employees, representatives and associates of the Company regarding accounting practices, auditing matters and any known or suspected violations of any Anti-Corruption Policy or other corporate policies that may be in place from time to time. The policy establishes and describes procedures governing the receipt, retention, investigation and treatment of complaints, encourages concerned parties to report suspected wrongdoing or misconduct in a timely way and protects employees who make good faith reports from retaliation.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">17</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Board Composition</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board currently consists of five (5) directors: (i) Jason D. Hanson, the Chief Executive Officer of enGene, (ii) Jasper Bos, (iii) Gerry Brunk, (iv) Dr. Richard Glickman and (v) Lota Zoth. Under the BCBCA, a director may be removed with or without cause by a resolution passed by a special majority of the votes cast by shareholders present in person or by proxy at a meeting and who are entitled to vote.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth, as of April 4, 2024, certain information regarding our directors who are responsible for overseeing the management of our business.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.005%;"></td>
    <td style="width:1%;"></td>
    <td style="width:9.002%;"></td>
    <td style="width:1%;"></td>
    <td style="width:22.004%;"></td>
    <td style="width:1%;"></td>
    <td style="width:24.825%;"></td>
    <td style="width:1.26%;"></td>
    <td style="width:13.903%;"></td>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Age</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Position</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Committees of the Board</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Expiry of</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Director Term</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Executive Officer; Director</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026 AGM</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jasper Bos</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026 AGM</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Gerry Brunk</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit; Comp. (chair); NCG</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025 AGM</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. Richard Glickman</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit; Comp.; NCG (chair)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025 AGM</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lota S. Zoth</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit (chair)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2024 AGM</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Key: A = Audit Committee; Comp. = Compensation Committee; NCG = Nominating and Corporate Governance Committee</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Staggered Board Provisions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Articles, for the purposes of facilitating staggered terms of the directors on the Board, certain staggered board provisions apply. For a description of the staggered board provisions and the terms of the directors, see &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Proposal 1 &#x2013; Election of Directors &#x2013; Staggered Board Provisions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Mandate of the Board of Directors</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board is responsible for the stewardship of the Company and providing oversight as to the management of enGene and its affairs, including providing guidance and strategic oversight to management. The Board has adopted a formal mandate that includes the following:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">appointing enGene&#x2019;s Chief Executive Officer; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">developing the corporate goals and objectives that enGene&#x2019;s Chief Executive Officer is responsible for meeting and reviewing the performance of enGene&#x2019;s Chief Executive Officer against such corporate goals and objectives; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">taking steps to satisfy itself as to the integrity of enGene&#x2019;s Chief Executive Officer and other executive officers and that enGene&#x2019;s Chief Executive Officer and other executive officers create a culture of integrity throughout the organization; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and approving enGene&#x2019;s Code of Conduct (as defined herein) and reviewing and monitoring compliance with the Code of Conduct and enGene&#x2019;s enterprise risk management processes;</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adopting a strategic planning process to establish objectives and goals for enGene&#x2019;s business and reviewing, approving, and modifying, as appropriate, the strategies proposed by management to achieve such objectives and goals; and </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and approving material transactions not in the ordinary course of business.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A copy of the Board&#x2019;s mandate is attached hereto as Schedule A.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Meetings of Directors</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board may meet together for the conduct of business, adjourn and otherwise regulate their meetings as they think fit, and meetings of the directors held at regular intervals may be held at the place, at the time and on the notice, if any, as the directors may from time to time determine. Prior to the completion of the Business Combination (as defined herein) on October 31, 2023, the independent directors of the Board did not meet.  Following the completion of the Business Combination, the independent members of the Board meet, as required, without the non-independent directors and members of management before or after each regularly scheduled board meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A director who has a material interest in a matter before the Board or any committee on which they serve is required to disclose such interest as soon as the director becomes aware of it. In situations where a director has a material interest in a matter to be considered by the Board or any committee on which they serve, such director may be required to absent themselves from the meeting while discussions and voting with respect to the matter are taking place. Directors will also be required to comply with the relevant provisions of the BCBCA regarding conflicts of interest.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The frequency of meetings of the Board and the nature of agenda items may change from year to year depending upon the Company&#x2019;s activities. However, since the completion of the Business Combination, the Board meets at least quarterly and at each meeting there is a review of enGene&#x2019;s business. The Board facilitates its exercise of independent supervision over the Company&#x2019;s management by holding regular meetings of the Board where the directors discuss significant corporate activities and plans, both with and without members of the Company&#x2019;s management being in attendance</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Board Leadership</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board Mandate, attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule A</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, provides that at the appropriate time, and from time to time, the Board shall choose one of its members to be its Chair by majority vote, which Chair shall have the duties and responsibilities set out in the Mandate. The Company has determined the Chair should be an independent director, however where this is not appropriate, an independent director will be appointed to act as Lead Director.  The Board has not yet appointed these roles.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have a separate chair for each committee of the Board. The chairs of each committee are expected to report regularly to the Board on the activities of their committee in fulfilling their responsibilities as detailed in their respective charters or specify any shortcomings should that be the case.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our chief executive officer and other executive officers regularly report to the non-executive directors and the audit, the compensation and the nominating and corporate governance committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. We believe that the leadership structure of the Board provides appropriate risk oversight of our activities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Role of the Board in Risk Oversight</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">One of the key functions of the Board is informed oversight of the Company&#x2019;s risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through the Board&#x2019;s various standing committees that address risks inherent in their respective areas of oversight. Specifically, the audit committee of the Board is responsible for overseeing the management of risks associated with the Company&#x2019;s financial reporting, accounting, and auditing matters, and the compensation committee of the Board oversees the management of risks associated with the Company&#x2019;s compensation policies and programs.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Director Independence</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Applicable Nasdaq rules require a majority of a listed company&#x2019;s board of directors to be comprised of independent directors. Under applicable Nasdaq rules, a director will only qualify as an &#x201c;independent director&#x201d; if, in the opinion of the listed company&#x2019;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Under NI 58-101, a director is considered to be independent if that person is independent within the meaning of National Instrument 52-110 &#x2014; Audit Committees (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NI 52-110</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). Pursuant to NI 52-110, an independent director is a director who is free from any direct or indirect relationship which could, in the view of the Board, be reasonably expected to interfere with a director&#x2019;s independent judgment.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on its evaluation of the existing directors and Mr. Joustra and Mr. Hastings, as director nominees, the Board has determined that:</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each of Jasper Bos, Gerald Brunk, Richard Glickman and Lota Zoth, and, if elected to the Board at the Meeting, director nominees Wouter Joustra and Paul Hastings, meet the applicable independence standards established by Nasdaq and the SEC and that they are each &#x201c;independent&#x201d; within the meaning of National Instrument 52-110 &#x2013; Audit Committees (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NI 52-110</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); and</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each of Gerald Brunk, Richard Glickman and Lota Zoth, and, if elected to the Board at the Meeting, director nominee Paul Hastings, are independent under the heightened independence standards of NI 52-110, the SEC and Nasdaq rules for audit committee independence.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The independent directors of enGene&#x2019;s Board of Directors hold regularly scheduled meetings at which non-independent directors and members of management are not in attendance.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following directors and director nominees of the Company are also directors of other reporting issuers as set out below:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30%;"></td>
    <td style="width:2%;"></td>
    <td style="width:35%;"></td>
    <td style="width:2%;"></td>
    <td style="width:31%;"></td>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name of Director</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name of Reporting Issuer</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name of Exchange Listed On</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:18pt;vertical-align:top;"><p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Richard Glickman</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Eupraxia Pharmaceuticals Inc.</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Essa Pharma Inc.</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">TSX; Nasdaq</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:18pt;vertical-align:top;"><p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Bullfrog AI Holdings, Inc.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:18pt;vertical-align:top;"><p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul Hastings</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nkarta, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Pacira Biosciences, Inc.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:18pt;vertical-align:top;"><p style="text-indent:-18pt;padding-left:18pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lota Zoth</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lumos Pharma, Inc.</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Inovio Pharmaceuticals, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">89BIO, Inc.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jasper Bos, Gerry Brunk and Wouter Joustra do not currently serve on the board of directors of any other reporting issuers.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jason D. Hanson is not an independent director as he is CEO of the Company.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Director Attendance at Board Meetings</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s Business Combination transaction closed October 31, 2023, which date coincided with the Company&#x2019;s fiscal year end.  During the fiscal year ended October 31, 2023, there were no meetings of our Board or any committee of the Board, other than one meeting of the audit committee, as the majority of the directors of the Company were not appointed until August 2023.  No director attended fewer than 75% of the total number of meetings of our Board and of committees of our Board on which he or she served during fiscal 2023. While we do not have a formal policy on director attendance at annual meetings, directors are expected to attend our annual meeting of shareholders. As this is our first annual meeting of shareholders, the Meeting will be the first annual meeting of shareholders that our directors are eligible to attend.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Position Descriptions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board has not developed independent written position descriptions for the CEO, the Chairman of the Board and the chairs of each of the committees of the Board. Given the size of the Company, the Board does not feel that it is necessary at this time to formalize such position descriptions. Guidance is generally provided through reference to industry norms, past practice and relying upon the provisions of the constating documents of the Company and the statutory and common law. The CEO is principally responsible for overseeing the operations and affairs of the Company, including strategic organizational and financial management, business development, regulatory compliance and clinical development. The Chair of the Board, or Lead Director, is principally responsible for overseeing the operations and affairs of the Board. The Board plans to designate the Board Chair or Lead Director at a future date.  With respect to the chairs of each of the committees of the Board, it is currently the Board&#x2019;s view that the general mandates of committees on which such directors may sit are sufficient to delineate the role and responsibilities of the chair of each committee. The chair of each Board committee is required to ensure the committee meets regularly and performs the duties as set forth in the committee mandate and reports to the Board on the activities of the committee.  In the interim, the Board provides leadership to its independent directors by fostering open communication among the independent directors, management and the non-independent directors.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Orientation and Continuing Education</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The nominating and corporate governance committee may implement an orientation process for directors that includes background material on the Company&#x2019;s policies and procedures and meetings with senior management. The Company may also offer continuing education programs to assist the directors in maintaining the level of expertise necessary to perform their duties.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Code of Business Conduct and Ethics</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene has established a Code of Conduct applicable to all of enGene&#x2019;s directors, officers and employees, including its Chief Executive Officer, Chief Financial Officer, controller or principal accounting officer, or other persons performing similar functions, which will be a &#x201c;code of ethics&#x201d; as defined in Item 406(b) of Form 10-K promulgated by the SEC and which will be a &#x201c;code&#x201d; under NI 58-101. The Code of Conduct sets out the fundamental values and standards of behavior that are expected from enGene&#x2019;s directors, officers, employees, consultants and contractors with respect to all aspects of its business. The objective of the Code of Conduct is to provide guidelines to promote integrity and deter wrongdoing.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The full text of the Code of Conduct is posted on enGene&#x2019;s website at www.engene.com. The written Code of Conduct is filed with the Canadian securities regulatory authorities on SEDAR+ at www.sedarplus.ca. If enGene makes any amendment to the Code of Conduct or grant any waivers, including any implicit waiver, from a provision of the code of ethics, enGene will disclose the nature of such amendment or waiver on its website to the extent required by the rules and regulations of the SEC and the CSA. enGene intends to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or a waiver from, a provision of its Code of Ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions, by posting such information on enGene&#x2019;s internet website.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s nominating and corporate governance committee is responsible for reviewing and evaluating the Code of Conduct at least annually and recommending any necessary or appropriate changes to its board of directors for consideration. Additionally, the nominating and corporate governance committee assists the Board with the monitoring of compliance with the Code of Conduct, and will be responsible for considering any waivers of the Code of Conduct (other than waivers applicable to members of the nominating and corporate governance committee, which shall be considered by the audit committee, or waivers applicable to enGene&#x2019;s directors or executive officers, which shall be subject to review by its board of directors as a whole).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assessments</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The nominating and corporate governance committee is mandated to undertake assessments of the overall performance and effectiveness of the Board and each standing committee of the Board and report on such</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">21</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">assessments to the Board. The purpose of the assessments is to ensure the continued effectiveness of the Board in discharging its duties and responsibilities and the effective operation of the governance framework and to contribute to a process of continuing improvement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For further information, see director nominee considerations under heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Board Committees</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compensation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The CEO&#x2019;s compensation is determined by the Board (excluding the CEO), based on the recommendation of the compensation committee. The compensation committee, in making its recommendations regarding the CEO&#x2019;s compensation, reviews and considers the Company&#x2019;s corporate goals and objectives as well as performance.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For further information, see the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Executive Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board Committees</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board is responsible for the stewardship of the Company and has adopted the Board Mandate setting out the Board&#x2019;s responsibilities with respect to the stewardship and oversight of the Company and providing for the establishment of standing committees of the Board (which committees currently consist of the audit committee, the compensation committee and the nominating and corporate governance committee). The mandates of these committees are set out in their respective charters.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board shall review and assess, or may delegate to the nominating and corporate governance committee to review and assess, the adequacy of the Board and committee mandates and recommend any proposed changes to the Board for consideration.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Audit Committee</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under SEC and the Nasdaq rules, there are heightened independence standards for members of the audit committee.  enGene has established an audit committee comprised of independent directors as required by such applicable SEC rules and regulations, Nasdaq rules and NI 52-110 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NI 52-110</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). At least one member of the audit committee will qualify as an &#x201c;audit committee financial expert&#x201d;, as such term is defined the rules and regulation established by the SEC, and all members of the audit committee are &#x201c;financially literate&#x201d;, as such term is defined in NI 52-110 (except as may be permitted by NI 52-110). The principal purpose of enGene&#x2019;s audit committee will be to assist the Board in its oversight of:</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the quality and integrity of enGene&#x2019;s financial statements and related information; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the independence, qualifications, appointment and performance of enGene&#x2019;s external auditor; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s disclosure controls and procedures, internal control over financial reporting and management&#x2019;s responsibility for assessing and reporting on the effectiveness of such controls; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s compliance with applicable legal and regulatory requirements; and </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s enterprise risk management processes.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board has established a written charter setting forth the purpose, composition, authority and responsibility of its audit committee, consistent with the rules of the Nasdaq, the SEC and NI 52-110.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s audit committee has access to all of its books, records, facilities and personnel and may request any information about enGene as it may deem appropriate. It also has the authority in its sole discretion and at enGene&#x2019;s expense, to retain and set the compensation of outside legal, accounting or other advisors as necessary to assist in the performance of its duties and responsibilities.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">22</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The audit committee currently consists of Lota Zoth, Chair, Gerry Brunk and Richard Glickman. The Board has determined that Ms. Zoth qualifies as an audit committee financial expert. A description of the education and experience of each audit committee member that is relevant to the performance of their responsibilities as an audit committee member may be found in this proxy statement under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Election of Directors - Director Biographies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d; The audit committee charter can be found on the Company&#x2019;s website at www.engene.com.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation Committee</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under SEC and the Nasdaq rules, there are heightened independence standards for members of the compensation committee. enGene&#x2019;s compensation committee members meet this heightened standard and are also independent for purposes of NI 58-101. The functions of the compensation committee include:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and making recommendations with respect to compensation policy and programs and determining and recommending option grants under enGene&#x2019;s incentive stock plan; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and recommending to the Board the manner in which executive compensation should be tied to corporate goals and objectives; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and approving annually the corporate goals and objectives applicable to the compensation of the Chief Executive Officer, evaluating at least annually the Chief Executive Officer&#x2019;s performance in light of those goals and objectives and determining and approving the Chief Executive Officer&#x2019;s compensation level based on this evaluation; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">making recommendations to the Board regarding the compensation of all other executive officers; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and making recommendations to the Board regarding incentive compensation plans and equity-based plans; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">authority to oversee enGene&#x2019;s non-executive incentive compensation plans and equity-based plans, including the discharge of any duties imposed on the compensation committee by any of those plans; and </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing director compensation for service on the Board and board committees at least once a year and to recommending any changes to its Board.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board has established a written charter that sets forth the purpose, composition, authority and responsibility of enGene&#x2019;s compensation committee consistent with the rules of the Nasdaq, the SEC and the guidance of the CSA.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The compensation committee currently consists of Gerry Brunk, Chair, and Richard Glickman. Each of the members of the compensation committee is familiar with designing and reviewing executive compensation packages through his roles within those companies described under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Election of Directors- Director Biographies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d; The compensation committee charter can be found on the Company&#x2019;s website at www.engene.com.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board is satisfied that the composition of the compensation committee ensures an objective process for determining compensation.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Nominating and Corporate Governance Committee</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The members of the nominating and governance committee are independent for purposes of NI 58-101.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board has established a written charter that sets forth the purpose, composition, authority and responsibility of enGene&#x2019;s nominating and corporate governance committee. The nominating and corporate governance committee&#x2019;s purpose is to assist the Board in:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">identifying individuals qualified to become members of the Board; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">selecting or recommending that the Board select director nominees for the next annual meeting of shareholders and determining the composition of the Board and its committees; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">developing and overseeing a process to assess the Board, the Chair of the Board, the committees of the board, the chairs of the committees, individual directors and management; and </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">developing and implementing enGene&#x2019;s corporate governance guidelines.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In identifying new candidates for the Board, the nominating and corporate governance committee will consider what competencies and skills its board of directors, as a whole, should possess and assess what competencies and skills each existing director possesses, considering the Board as a group, and the personality and other qualities of each director, as these may ultimately determine the boardroom dynamic.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">It is the responsibility of the nominating and corporate governance committee to regularly evaluate the overall efficiency of the Board and its Chair and all Board committees and their chairs. As part of its mandate, the nominating and corporate governance committee will conduct the process for the assessment of the Board, each committee and each director regarding their or its effectiveness and contribution, and report evaluation results to its board of directors on a regular basis.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The nominating and corporate governance committee currently consists of Richard Glickman, Chair, and Gerry Brunk. The nominating and corporate governance committee charter can be found on the Company&#x2019;s website at www.engene.com.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Board Committees</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board may amend the Board committee structure and authorize and appoint other committees as it considers appropriate, including ad hoc committees for special purposes.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Director Term Limits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board has not adopted director term limits or other automatic mechanisms of board renewal. Rather than adopting formal term limits, mandatory age-related retirement policies and other mechanisms of board renewal, enGene expects that the nominating and corporate governance committee of its Board will develop a skills and competencies matrix for the Board as a whole and for individual directors. enGene further expects that the nominating and corporate governance committee will also conduct a process for the assessment of its board of directors, each committee and each director regarding their or its effectiveness and contribution, and will report evaluation results to its board of directors on a regular basis.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Diversity</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene does not have a formal policy nor measurable objectives (such as a target) regarding board diversity or for the representation of women on their board of directors, management team or executive officers. enGene expects that its priority in the selection of the Board members will be to identify members who will further the interests of its shareholders through their established record of professional accomplishment, the ability to contribute positively to the collaborative culture among board members, and knowledge of enGene&#x2019;s business and understanding of the competitive landscape. enGene&#x2019;s nominating and corporate governance committee and management team are expected to take gender and other diversity representation into consideration as part of their overall recruitment and selection process.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene expects to facilitate the representation of women on its Board and in executive officer positions by ensuring that diversity considerations are taken into account in senior management, monitoring the level of female representation on the Board and in senior management positions, continuing to broaden recruiting efforts to attract</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">24</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and interview qualified female candidates, and committing to retention and training to ensure that enGene&#x2019;s most talented employees are promoted from within the organization.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Currently, one of the five members (20%) of the Board are women. If Mr. Joustra and Mr. Hastings are elected at the meeting, one</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the seven members (14%) of the Board will be women. Currently, none of our executive officers (0%) are women.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board Diversity Matrix</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Members of our Board have voluntarily self-disclosed the following diversity statistics as set forth in the table below:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.34%;"></td>
    <td style="width:1.22%;"></td>
    <td style="width:11.196%;"></td>
    <td style="width:1.22%;"></td>
    <td style="width:11.196%;"></td>
    <td style="width:1.22%;"></td>
    <td style="width:11.196%;"></td>
    <td style="width:1.22%;"></td>
    <td style="width:11.196%;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="border-top:0.5pt solid #000000;border-left:0.5pt solid #000000;vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="7" style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of April 4, 2024</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Number of Directors</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Female</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Male</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Non-Binary</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Did Not Disclose<br>Gender</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Part I: Gender Identity</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Directors</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Part II: Demographic Background</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">African American or Black</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alaskan Native or Native American</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Asian</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hispanic or Latinx</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Native Hawaiian or Pacific Islander</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">White</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Two or More Races or Ethnicities</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LGBTQ+</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="text-indent:30pt;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;border-left:0.5pt solid #000000;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Did Not Disclose Demographic Background</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</font></p></td>
    <td style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Communications with the Board</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders and other interested parties may contact any member (or all members) of our Board (including, without limitation, the non-management directors as a group), any committee of our Board or the chair of any such committee. Written correspondence may be sent addressed to our Board, any committee or any individual director, c/o Corporate Secretary, enGene Holdings Inc., 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">25</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proposals_to_be_voted_on"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROPOSALS TO </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BE VOTED ON</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proposals 1, 2 and 3 are included in this proxy statement at the direction of our Board. Our Board unanimously recommends that you vote &#x201c;FOR&#x201d; each of the nominees in Proposal 1, &#x201c;FOR&#x201d; Proposal 2 and &#x201c;FOR&#x201d; Proposal 3.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proposal_1"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROPOSAL 1 - ELECTI</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ON OF DIRECTORS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Number of Directors</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 11, 2024, the Board set the number of directors at seven, of which three are being put forward as nominees for election as directors at the Meeting, as further described herein.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nominees</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The nominating and corporate governance committee has recommended and our Board has nominated, the following three individuals for election for a three year term:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lota S. Zoth (currently a director);</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Wouter Joustra; and</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Paul Hastings.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Properly executed proxies will be voted for these three nominees unless other instructions are specified. In no event may the proxies be voted for more than three nominees.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board determined that Ms. Zoth, Mr. Joustra and Mr. Hastings satisfy the requirements to be considered an independent director under applicable Nasdaq rules and pursuant to NI 52-110.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Biographical information regarding each director nominee and their qualifications to serve as a director are set forth below. Unless otherwise indicated, each director has held their principal occupation or other positions with the same or predecessor organizations for at least the last five years.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other than as disclosed herein, none of the proposed nominees for election as a director of the Company are proposed for election pursuant to any arrangement or understanding between the nominee and any other person, except the directors and senior officers of the Company acting solely in such capacity. See &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share Ownership</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; above.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Lota Zoth, Director Nominee</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lota Zoth has served as a member of the Board and as chair of the Board&#x2019;s audit committee since December 18, 2023. Ms. Zoth is a Certified Public Accountant and has also served as a member of the board of directors of 89BIO, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company, since June 2020. She has served as a member of the board of directors and as chair of the audit committee of Lumos Pharma, Inc. (Nasdaq: LUMO) (previously, NewLink Genetics Corporation), a biopharmaceutical company, since November 2012. She has also served as a member of the board of directors and chair of the audit committee of Inovio Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company, since January 2018 and August 2018, respectively. Ms. Zoth previously served as a member of the board of directors and chair of the audit committee of Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company, from November 2016, as chair of the board of directors from September 2019 to January 2022 and as lead director since January 2022, until stepping down from the Zymeworks Inc. board in December 2023. In addition, she previously served as a member of the board of Spark Therapeutics, Inc., a gene therapy platform company, from January 2016 to December 2019, Circassia Pharmaceuticals, plc (LON: CIR), a specialty biopharmaceutical company, from February 2015 to February 2019, Orexigen Therapeutics, Inc., a biopharmaceutical company, from April 2012 to May 2019, Aeras, a non-profit</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">product development organization, from November 2011 to October 2018, Hyperion Therapeutics, Inc., a commercial-stage biopharmaceutical company, from February 2008 to May 2015 and Ikaria, Inc., a commercial stage biopharmaceutical company, from January 2008 to February 2014. Prior to her retirement, Ms. Zoth most recently served as Senior Vice President and Chief Financial Officer of MedImmune, Inc., a biotechnology company, from April 2004 to July 2007 and as Vice President, Controller &amp; Chief Accounting Officer from August 2002 to April 2004. Ms. Zoth received her B.B.A. from Texas Tech University. We believe Ms. Zoth is qualified to serve on our Board because of her experience as a senior executive and member of the board of other life science companies.  Ms. Zoth is a resident of Texas, USA.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Wouter Joustra, Director Nominee</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Wouter Joustra, age 35, is a General Partner at Forbion, a leading European life sciences venture capital firm. At Forbion, Mr. Joustra is responsible for deal origination, general portfolio management and divestment strategies, and focuses on Forbion&#x2019;s Growth Opportunities Funds, which concentrates on investing in late-stage life sciences companies. Prior to joining Forbion in 2019, Mr. Joustra previously was a Senior Trader, as well as Executive Board member of the Life Sciences franchise at Kempen, a European boutique investment bank. In this role, Mr. Joustra managed Kempen&#x2019;s trading portfolio, and was involved in deal structuring and equity capital markets transactions, as well as larger block trades.  Mr. Joustra also served as a member of the board of directors of Gyroscope Therapeutics until the closing of its acquisition by Novartis in February 2022 for up to $1.5 billion, the board of directors of VectivBio (NASDAQ: VECT) from December 2022 until the closing of its $1.2 billion acquisition by Ironwood Pharmaceuticals in December 2023, the board of directors of Aiolos Bio until the closing of its acquisition by GSK plc in February 2024 for up to $1.4 billion and the board of Forbion&#x2019;s SPAC vehicle until the completion of the business combination of enGene Holdings Inc. (NASDAQ: ENGN) in October 2023. Currently Mr. Joustra serves on the board of directors of VectorY Therapeutics, and holds a position as a board observer at NewAmsterdam Pharma N.V. (NASDAQ: NAMS). Mr. Joustra holds an M.Sc. in Business Administration from the University of Groningen, and a B.Sc. in International Business and Management from this same university. We believe Mr. Joustra is qualified to serve on our Board due to his experience in the biotechnology industry and the venture capital industry.  Mr. Joustra is a resident of North Holland, Netherlands.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Paul Hastings, Director Nominee</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Paul Hastings, age 64, has served as the President, Chief Executive Officer, and a member of the board of directors of Nkarta, Inc. (NASDAQ: NKTX) since February 2018. Prior to that, Mr. Hastings served as President, Chief Executive Officer, and Director of the publicly traded, clinical-stage biopharmaceutical company OncoMed Pharmaceuticals, Inc. from January 2006 until January 2018. In August 2013, he was elected chairman of the board of directors of OncoMed and served in that role until January 2018. Prior to joining OncoMed, Mr. Hastings was President, Chief Executive Officer, and Director of QLT, Inc., a publicly traded biotechnology company dedicated to the development and commercialization of innovative ocular products, from February 2002 to September 2006. From 2000 to 2002, Mr. Hastings served as President, Chief Executive Officer, and Director of Axys Pharmaceuticals, Inc., which was acquired by Celera Corporation in 2001. Mr. Hastings was also previously the President of Chiron Biopharmaceuticals, a division of Chiron Corporation, President and Chief Executive Officer of LXR Biotechnology, and he held a variety of management positions of increasing responsibility at Genzyme Corporation, including President of Genzyme Therapeutics Europe and President of Worldwide Therapeutics. Mr. Hastings previously served on the board of directors of Relypsa, a publicly traded biotechnology company acquired by Galencia AG, as chairman of the board of directors of Proteolix, Inc., a privately held biopharmaceutical company acquired by Onyx Pharmaceuticals, Inc., on the board of directors of ViaCell, Inc., a publicly traded biotechnology company sold to Perkin Elmer, and as a director of ViaCyte, Inc., a privately held regenerative medicine company acquired by Vertex Pharmaceuticals, Inc. Mr. Hastings currently serves as Chair of the board of Pacira Biosciences, Inc. (NASDAQ: PCRX), a biotechnology company, and the immediate past Chair and Board Executive Committee member of the Biotechnology Innovation Organization. Mr. Hastings received a B.S. in pharmacy from the University of Rhode Island. We believe Mr. Hastings is qualified to serve on our Board of Directors due to his extensive experience in the pharmaceutical and biotechnology industries, including his leadership and management experience. Mr. Hastings is a resident of California, USA.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">27</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Remaining Members of the Board</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Biographical information regarding the remaining members of the Board and their qualifications is set forth below. Unless otherwise indicated, each director has held their principal occupation or other positions with the same or predecessor organizations for at least the last five years.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Jason D. Hanson, Chief Executive Officer and Director</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jason D. Hanson has served as Chief Executive Officer and as a Director of enGene since August 8, 2023. Mr. Hanson has served as Chief Executive Officer and as a Director of enGene Inc. since July 2018. He also served as President of enGene Inc. from July 2018 to December 2022. Mr. Hanson is also a member of the board of directors of Bullfrog AI Holdings, Inc. (NASDAQ: BFRG), where he has served as a director and chair of the nominating and corporate governance committee, and as a member of the audit committee and compensation committee since February 2023. From August 2016 to November 2017, Mr. Hanson served as President and Chief Executive Officer of Ohana Biosciences, a biotechnology company based in Cambridge, MA, and as member of the Ohana board of directors and consultant to Ohana from November 2017 to June 2018. Mr. Hanson previously served as Executive Vice President and Chief Strategy Officer for NuVasive, Inc. from November 2015 to August 2016. Mr. Hanson served as Corporate Vice President of General Electric Company and member of the senior executive team of GE Healthcare, a global pharmaceutical, medical device and healthcare services business from May 2014 to October 2015. In January 2013, Mr. Hanson served as Company Group Chairman and Executive Vice President of Valeant Pharmaceuticals International, Inc. (now Bausch Health Companies Inc.). Previously, he served in various roles at Medicis Pharmaceutical Corporation, including as Executive Vice President and Chief Operating Officer between July 2006 and December 2012. Mr. Hanson also served in numerous roles at GE Healthcare, including General Counsel roles, from April 1999 to July 2006. Mr. Hanson holds a B.S. from Cornell University and a J.D. from Duke University School of Law. On February 14, 2024 the Company announced Mr. Hanson&#x2019;s decision to resign from his position as Chief Executive Officer due to personal family and health reasons. Such decision was not the result of any dispute or disagreement with the Company or the Company&#x2019;s Board on any matter relating to the operations, policies or practices of the Company. The Board has engaged an executive search firm to assist in a comprehensive search for the Company&#x2019;s successor Chief Executive Officer. We believe Mr. Hanson is qualified to serve on our Board due to his extensive experience in the pharmaceutical and biotechnology industries, including in leadership and management roles, and his significant history with and knowledge of our company.  Mr. Hanson is a resident of Massachusetts, USA.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Jasper Bos, Ph.D., Director</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jasper Bos, Ph.D., has served as a member of the Board since August 8, 2023. Mr. Bos, the former Chief Executive Officer of FEAC, is a former Merck executive and joined Forbion Growth as a General Partner in May 2021. Before joining Forbion&#x2019;s Naarden-based headquarters, Mr. Bos was Senior Vice President and Managing Director at M Ventures, leading the venture capital arm of pharmaceutical company Merck, which he joined in 2009. At M Ventures, he led a team of 21 investment professionals and with a fund size of &#x20ac;400 million invested in over 50 portfolio companies spanning biotech, life sciences tools, and tech companies with investment activities ranging from seed-stage to cross-over and IPO. In addition, as Country Speaker Merck Netherlands, he assumed responsibility and liaised between all Merck activities in the Netherlands. His track record as an investor includes the successful exits of Prexton Therapeutics, Epitherapeutics, Galecto, ObsEva, Translate Bio, and F-Star, and has served on multiple boards of privately-owned biotech companies. He has experience in several operational roles in portfolio companies and played a key role in the creation of multiple successful spin-out companies out of Merck. Mr. Bos holds a Ph.D. in Pharmacy from the University of Groningen, the Netherlands. We believe Mr. Bos is qualified to serve on our Board due to his experience in the biotechnology industry and the venture capital industry.  Mr. Bos is a resident of North Holland, Netherlands.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Gerry Brunk, Director</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Gerry Brunk has served as a member of the Board since August 8, 2023 and as a member of the board of enGene Inc. since October 2017. He currently serves as chair of the Board&#x2019;s compensation committee. Mr. Brunk is a co-founder and Managing Director at Lumira Ventures, a healthcare venture capital firm. Prior to beginning his venture capital career in 2002, Mr. Brunk was an entrepreneur and co-founder of several venture-capital funded</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">28</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">healthcare companies and served as an Engagement Manager in the healthcare practice of The Boston Consulting Group from July 1994 to May 1999. Earlier, Mr. Brunk was a member of the investment banking group of Credit Suisse First Boston in New York from June 1990 to June 1992. Mr. Brunk received an MBA from Stanford University Graduate School of Business and a B.A. from the University of Virginia. We believe Mr. Brunk is qualified to serve on our Board due to his experience in the biotechnology industry and the venture capital industry. Mr. Brunk is a resident of Massachusetts, USA.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dr. Richard M. Glickman, Director</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dr. Richard M. Glickman has served as a member of enGene&#x2019;s Board since April 24, 2023, and as chair of the board of enGene Inc. since January 2015, where he also served as a member of that board since October 2011. He currently serves as chair of the Board&#x2019;s nominating and corporate governance committee. Dr. Glickman was a co-founder of Aurinia Pharma Corp. where he served as its Chairman and CEO since February 2017. He was also the founding and current Chairman of the Board of Essa Pharmaceuticals Inc. He is currently a director and Chairman of the compensation committee, and a member of the nominating and corporate governance committee of Eupraxia Pharmaceuticals Inc. (TSX: EPRX; NASDAQ: EPRX), a clinical-stage biotechnology company. Previously, Dr. Glickman was a co-founder of Apsreva Pharmaceuticals where he served as its Chairman and CEO from 2001 to 2006. Dr Glickman is the recipient of numerous awards including the Ernst and Young Entrepreneur of the Year and Canada&#x2019;s Top 40 under 40. Dr. Glickman holds a B.S. in Microbiology and Immunology from the McGill University. We believe Dr. Glickman is qualified to serve on our Board due to his extensive experience in the life science industry, including his broad leadership experience.  Dr. Glickman is a resident of British Columbia, Canada.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Staggered Board Provisions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Articles provide for a staggered board of directors consisting of three groups of directors with directors serving staggered three year terms.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At every annual general meeting and in every unanimous shareholder resolution in lieu thereof, all of the directors whose terms expire cease to hold office immediately before the election or appointment of directors, but are eligible for re-election or re-appointment. The shareholders entitled to vote at the annual general meeting for the election of directors may elect, or in a unanimous resolution appoint, the number of directors required to fill any vacancies created. The directors will hold office for the applicable terms contemplated in the staggered board provisions. Upon the resignation of a director, the remaining directors may fill the casual vacancy resulting from such resignation for the remainder of the unexpired term.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The terms of office for each of our directors are as follows:</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jason D. Hanson and Jasper Bos have terms expiring on the third annual general meeting following October 31, 2023 (i.e., the annual general meeting to be held in 2026);</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Gerry Brunk and Richard Glickman have terms expiring at the second annual general meeting following October 31, 2023 (i.e., the annual general meeting to be held in 2025);</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lota Zoth has a term expiring on the date of the Meeting, and if reelected at the Meeting will have a term expiring on the third annual general meeting following the Meeting (i.e., the annual general meeting to be held in 2027); and</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Wouter Joustra and Paul Hastings, if elected at the Meeting, will each have a term expiring on the third annual general meeting following the Meeting (i.e., the annual general meeting to be held in 2027).</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">29</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Replacement or Removal of Directors.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the BCBCA and the Articles, a director may be removed with or without cause by a special resolution passed by a special majority (being two-thirds) of the votes cast by shareholders present in person or by proxy at a duly convened meeting and who are entitled to vote.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To the extent directors are elected or appointed to fill casual vacancies or vacancies arising from the removal of directors, in both instances whether by shareholders or directors, the directors shall hold office until the remainder of the unexpired portion of the term of the departed director that was replaced.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Articles, the number of directors of enGene must be set at a minimum of three (3). The directors will be authorized to determine the actual number of directors to be elected from time to time.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Advance Notice Policy</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Articles include an advance notice policy for the nomination for election of directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Advance Notice Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Advance Notice Policy provides that any shareholder seeking to nominate a candidate for election as a director (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nominating Shareholder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) at any annual meeting of the shareholders, or at any special meeting of shareholders if one of the purposes for which the special meeting was called was the election of directors, must give timely notice thereof in proper written form to our Corporate Secretary.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To be timely, a Nominating Shareholder&#x2019;s notice must be made: (i) in the case of an annual meeting of shareholders (including an annual and special meeting), not later than the close of business on the thirtieth (30th) day prior to the date of the annual meeting of shareholders; provided, however, that in the event that the annual meeting of shareholders is to be held on a date that is less than fifty (50) days after the date on which the first public announcement of the meeting was made, notice by the Nominating Shareholder may be made not later than the close of business on the tenth (10th) day following the date of such first public announcement; and (ii) in the case of a special meeting of shareholders (which is not also an annual meeting) called for the purpose of electing directors (whether or not called for other purposes), not later than the close of business on the fifteenth (15th) day following the day on which the first public announcement of the date of the special meeting of shareholders was made. The Articles also prescribe the proper written form for a Nominating Shareholder&#x2019;s notice.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Chair of the meeting shall have the power and duty to determine whether a nomination was made in accordance with the notice procedures set forth in the Articles and, if any proposed nomination is not in compliance with such provisions, the discretion to declare that such defective nomination will be disregarded.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding the foregoing, the Board may, in its sole discretion, waive any requirement in the Advance Notice Policy.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to satisfying the foregoing requirements under the Articles with respect to advance notice of any nomination, shareholders who intend to solicit proxies in support of director nominees other than the Company&#x2019;s nominees for the 2025 annual meeting of shareholders in accordance with Exchange Act Rule 14a- 19 must provide notice in accordance with our Advance Notice Policy, which, in general, require that such notice be received within the time periods described above. Any such notice of intent to solicit proxies must comply with all the requirements of SEC Rule 14a-19.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cease Trade Orders and Bankruptcies</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No proposed director of the Company is, as of the date of this proxy statement, or has been, within the ten years prior to the date hereof, a director or chief executive officer or chief financial officer of any company (including the Company) that: (i) was subject to an order that was issued while the proposed director was acting as a director, chief executive officer or chief financial officer; or (ii) was subject to an order that was issued after the proposed director ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer. For the purposes hereof, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">order</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means: (i) a cease trade order; (ii) an order similar to a cease</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">trade order; or (iii) an order that denied the relevant company access to any exemption under securities legislation that was in effect for a period of more than 30 consecutive days.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No proposed director of the Company is, at the date of this proxy statement, or has been within ten years before the date of this proxy statement, a director or executive officer of any company (including the Company) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Penalties and Sanctions</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No proposed director of the Company has been subject to any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority, or has been subject to any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable securityholder in deciding whether to vote for a proposed director.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Individual Bankruptcies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No proposed director of the Company has, within the ten years before the date of this proxy statement, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the proposed director.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain Relationships and Related Transactions</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other than as discussed below and the compensation arrangements discussed under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Executive Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">,&#x201d; since November 1, 2022 (i.e. the first date of our last fiscal year), there have not been any transactions to which we are a party, nor are there any proposed transactions to which we would be a party, with related parties and which we are required to disclose pursuant to the rules of the SEC and the CSA.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 31, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Closing Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), enGene Holdings Inc. consummated the previously announced business combination (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Business Combination</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) with Forbion European Acquisition Corp., a Cayman Islands exempted company and a special purpose acquisition corporation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and enGene Inc., a corporation incorporated under the laws of Canada, pursuant to the Business Combination Agreement, dated as of May 16, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Business Combination Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  Throughout this subsection, unless otherwise noted, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our&#x201d; and similar words refer to, for periods prior to the Closing Date, enGene Inc. and its subsidiary, and for periods following the Closing Date, to enGene Holdings Inc. and its consolidated subsidiaries. Terms used herein but not otherwise defined herein shall have the definitions given in the Annual Report on Form 10-K for the year ended 2023.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As the Business Combination closed on October 31, 2023, the following discussion is being provided supplementally to give an understanding of FEAC&#x2019;s results of operations and financial position prior to the Business Combination.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">FEAC Class B Shares</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 12, 2021, Forbion European Sponsor LLP paid $25,000, or approximately $0.009 per share, in consideration for 2,875,000 FEAC Class B Shares. On November 23, 2021, Forbion European Sponsor LLP transferred 2,875,000 FEAC Class B Shares to the FEAC Sponsor in exchange for $25,000, or approximately $0.009 per share. On December 9, 2021, FEAC issued an additional 287,500 FEAC Class B Shares to the FEAC Sponsor resulting from a 1.1 for 1 share dividend. As a result, the FEAC Sponsor owned 3,162,500 FEAC Class B Shares as</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the date of the Business Combination Agreement. The FEAC Class B Shares will be exchanged for FEAC Class A Shares, on a one-for-one basis, on the day that is two business days prior to the Closing of the Business Combination. The number of FEAC Class B Shares issued was determined based on the expectation that the FEAC Class B Shares would represent 20% of the issued and outstanding ordinary shares of FEAC upon completion of the initial public offering (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IPO&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">). Such FEAC Class B Shares were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Private Placement Warrants</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Simultaneously with the closing of the IPO, the FEAC Sponsor purchased in a private placement 4,700,000 FEAC Private Placement Warrants (5,195,000 FEAC Private Placement Warrants when the underwriters&#x2019; over-allotment option was fully exercised on December 15, 2021), each exercisable to purchase one FEAC Class A Share at $11.50 per share, at a price of $1.50 per FEAC Private Placement Warrants. The sale of the FEAC Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500. Except as described below, the FEAC Private Placement Warrants had terms and provisions that are identical to those of the FEAC Warrants. The FEAC Private Placement Warrants were not transferable, assignable or salable (and the FEAC Class A Shares issuable upon exercise of the FEAC Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the Business Combination), except pursuant to limited exceptions, and they are not redeemable by FEAC. The FEAC Sponsor, or its permitted transferees, have the option to exercise the FEAC Private Placement Warrants on a cashless basis.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There were no redemption rights or liquidating distributions with respect to the FEAC Class B Shares or FEAC Private Placement Warrants.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Working Capital Loans</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In order to finance transaction costs in connection with the Business Combination, the FEAC Sponsor or an affiliate of the FEAC Sponsor, or certain of FEAC&#x2019;s officers and directors were permitted, but not obligated to, loan to FEAC funds as deemed required (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Working Capital Loans</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). FEAC repaid the Working Capital Loans out of the proceeds of the Trust Account released to FEAC in connection with the completion of the Business Combination. An aggregate amount of $1,500,000 in Working Capital Loans and Extension Loans was converted, at the election of the FEAC Sponsor, into additional FEAC Warrants at a price of $1.50 per warrant on terms identical to the FEAC Private Placement Warrants, concurrently with the consummation of the Business Combination.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 24, 2023, the FEAC Sponsor and FEAC entered into an unsecured promissory note (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">First Loan Note</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) under which the FEAC Sponsor agreed to extend to FEAC a loan of up to $900,000, to be used for FEAC&#x2019;s general corporate purposes. The FEAC Sponsor funded the initial principal amount of $450,000 under the First Loan Note on March 24, 2023 and an additional $450,000 under the First Loan Note on April 26, 2023. The First Loan Note bears no interest became due and payable on the date of the Business Combination (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loan Note Maturity Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). In connection with the completion of the Business Combination, the FEAC Sponsor elected to convert the total principal amount of the First Loan Note into additional warrants of FEAC at a price of $1.50 per warrant and on terms identical to the FEAC Private Placement Warrants. The issuance of the First Loan Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 6, 2023, FEAC issued an additional unsecured promissory note (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Second Loan Note</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) under which the FEAC Sponsor agreed to extend to FEAC a loan in the total principal amount of $300,000 to the FEAC Sponsor. The proceeds of the Second Loan Note were used by FEAC for general corporate purposes. The FEAC Sponsor funded the principal amount of $300,000 on June 6, 2023. The Second Loan Note bears no interest and became due and payable on the Loan Note Maturity Date. In connection with the completion of the Business Combination FEAC repaid the Second Loan Note out of the proceeds of the Trust Account released to FEAC.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On September 13, 2023, FEAC issued an additional unsecured promissory note (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Third Loan Note</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) under which the FEAC Sponsor agreed to extend to FEAC a loan in the total principal amount of $450,000 to the FEAC Sponsor. The proceeds of the Third Loan Note were used by FEAC for general corporate purposes. The FEAC Sponsor funded the principal amount of $450,000 on September 13, 2023. The Third Loan Note bears no interest and became due and payable on the Loan Note Maturity Date. In connection with the completion of the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">32</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Business Combination FEAC repaid the Third Loan Note out of the proceeds of the Trust Account released to FEAC.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Extension Loans; Business Combination Deadline Extensions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC was permitted to extend the period of time to consummate the business combination by up to two additional three-month periods (for a total of 24 months to complete the initial business combination). In order to extend the time available for FEAC to consummate an initial business combination, the FEAC Sponsor or its affiliates or designees were required to deposit into the Trust Account, for each additional three-month period, $1,265,000 ($0.10 per FEAC Class A Shares in either case), on or prior to the date of the applicable deadline, the first of which was on June 14, 2023. Any such payments were required to be made in the form of a non-interest bearing, unsecured promissory note (each such note, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Extension Loan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 6, 2023, FEAC extended the time available to consummate the initial business combination from June 14, 2023 to September 14, 2023 by borrowing from FEAC Sponsor, and having FEAC Sponsor deposit on FEAC&#x2019;s behalf an additional $1,265,000, or $0.10 per FEAC Class A Share, into the Trust Account (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">First Extension Funding</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), in accordance with FEAC&#x2019;s Current Articles and the Investment Management Trust Agreement by and between the Company and Continental Stock Transfer &amp; Trust Company, dated as of December 9, 2021. In connection with the First Extension Funding, on June 6, 2023, FEAC issued an unsecured promissory note (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">First Extension Loan Note</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) in the total principal amount of $1,265,000 to the FEAC Sponsor. The FEAC Sponsor funded the principal amount of $1,265,000 by depositing such amount into the Trust Account on June 6, 2023. The First Extension Loan Note did not bear interest and became due and payable on the Loan Note Maturity Date.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concurrently with the consummation of the initial business combination, the FEAC Sponsor elected to convert up to $600,000 total principal amount of the First Extension Loan Note into additional warrants of FEAC at a price of $1.50 per warrant, each warrant exercisable for one FEAC Class A Share. The warrants were to be identical to the FEAC Private Placement Warrants.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On September 13, 2023, FEAC further extended the time available to consummate the initial business combination from September 14, 2023 to December 14, 2023 by borrowing from FEAC Sponsor, and having FEAC Sponsor deposit on FEAC&#x2019;s behalf an additional $1,265,000, or $0.10 per FEAC Class A Share, into the Trust Account (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Second Extension Funding</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), in accordance with FEAC&#x2019;s then existing articles and the Investment Management Trust Agreement by and between the Company and Continental Stock Transfer &amp; Trust Company, dated as of December 9, 2021. In connection with the Second Extension Funding, on September 13, 2023, FEAC issued an unsecured promissory note (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Second Extension Loan Note</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) in the total principal amount of $1,265,000 to the FEAC Sponsor. The FEAC Sponsor funded the principal amount of $1,265,000 by depositing such amount into the Trust Account on September 13, 2023. The Second Extension Loan Note did not bear interest and became due and payable on the Loan Note Maturity Date.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sponsor and Insiders Letter Agreement; Surrender; Sponsor Loans Conversion</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 16, 2023, concurrently with the execution of the Business Combination Agreement, FEAC, the FEAC Sponsor, FGOF and the other holders of FEAC Class B Shares, enGene Inc., enGene Holdings Inc. and the other parties named therein (collectively, other than enGene Inc. and enGene Holdings Inc., the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC Sponsor Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) entered into the Sponsor and Insiders Letter Agreement, pursuant to which the FEAC Sponsor agreed to surrender, after giving effect to the conversion of all or part of the principal amount outstanding under loans made by the FEAC Sponsor to FEAC into FEAC Private Placement Warrants, 1,789,004 FEAC Class B Shares and 5,463,381 FEAC Private Placement Warrants, as a contribution to the capital of FEAC and for no consideration, effective immediately prior to the Class B Conversion on the date which was two business days prior to the Closing Date (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Surrender</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, the FEAC Sponsor Parties agreed to (i) be bound by certain other covenants and agreements related to the Business Combination, (ii) waive the anti-dilution protection with respect to the FEAC Class B Shares (whether resulting from the PIPE Financing or otherwise) and (iii) be bound by certain transfer restrictions with respect to the FEAC Shares and the FEAC Private Placement Warrants held by them (including the enGene</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">33</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Shares and Warrants received in exchange therefore in connection with the Business Combination and the Transactions), in each case, on the terms and subject to the conditions set forth in the Sponsor and Insiders Letter Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Also, FEAC, the FEAC Sponsor and each Insider that was a Lender under the Sponsor Loans (each such term as defined in the Sponsor and Insiders Letter Agreement), each on its own behalf and on behalf of its affiliates (including the officers and directors of FEAC and each Lender ), assuming that the aggregate principal amount outstanding under the Sponsor Loans exceeded $1,500,000 on the day which was two business days prior to the Closing Date, agreed to elect to convert, and to take such necessary or appropriate actions so as to ensure the conversion of, an amount equal to $1,500,000 of the aggregate principal amount outstanding under the Sponsor Loans, taken together, into additional FEAC Private Placement Warrants immediately prior to the Surrender on the date that was two business days prior to the Closing Date, in each case in accordance with the FEAC Warrant Agreement and the relevant promissory note governing each such Sponsor Loan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC Sponsor Loans Conversion</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">FEAC Voting Agreement</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concurrently with the execution and delivery of the Business Combination Agreement, enGene Inc., enGene Holdings Inc. and the FEAC Sponsor Parties entered into the FEAC Voting Agreement, pursuant to which the FEAC Sponsor Parties agreed to, among other things, (i) vote or cause to be voted all of their FEAC Shares in favor of the Transaction Proposals; (ii) be bound by certain other covenants and agreements related to the Business Combination, and (iii) be bound by certain transfer restrictions with respect to the FEAC Shares, in each case, on the terms and subject to the conditions set forth in the FEAC Voting Agreement.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Registration Rights Agreement</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Business Combination, on October 31, 2023, enGene Holdings Inc., FEAC, the Sponsor Holders and the enGene Holders (each as defined in the Registration Rights Agreement) entered into a Registration Rights Agreement. Pursuant to the terms of the Registration Rights Agreement, among other things, the Sponsor Holders and the enGene Holders were granted certain customary registration rights with respect to their respective equity securities of enGene Holdings Inc., in each case, on the terms and subject to the conditions therein.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Office Space, Secretarial and Administrative Services</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commencing on the date of the IPO and through the Closing Date, FEAC agreed to pay the FEAC Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support and to reimburse the FEAC Sponsor for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination. FEAC maintained its executive offices at 4001 Kennett Pike, Suite 302 Wilmington, Delaware 19807. The cost for the use of this space was included in the $10,000 per month fee FEAC paid to the FEAC Sponsor for office space, administrative and support services.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Additionally, the FEAC Sponsor agreed to pay an annual salary of $25,000 to each of the independent board members of FEAC for services rendered prior to or in connection with the completion of the Business Combination. Board members were also entitled to reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing the Business Combination as well.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FEAC&#x2019;s audit committee reviewed on a quarterly basis all payments that were made to the FEAC Sponsor, FEAC&#x2019;s officers, directors or its or their affiliates.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Throughout this subsection, unless otherwise noted, we, &#x201c;our&#x201d;, &#x201c;us,&#x201d; &#x201c;enGene&#x201d; and the &#x201c;Company&#x201d; refer to enGene Holdings Inc. and all of its subsidiaries post the consummation of the Business Combination, and &#x201c;Old enGene&#x201d; refers to enGene Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">34</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Closing Transactions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 31, 2023, upon the consummation of the Business Combination, all of Old enGene&#x2019;s redeemable convertible preferred shares outstanding immediately prior to the close were exchanged for enGene Common Shares, with no dividends or distributions being declared or paid on the redeemable convertible preferred shares. Further, certain of Old enGene&#x2019;s existing convertible notes were converted into enGene Common Shares at the conversion ratio in place at the time of conversion, and all of Old enGene&#x2019;s common shares were exchanged for enGene Common Shares at the Exchange Ratio established in the Business Combination Agreement. A total of 13,091,608 enGene Common Shares were issued to enGene&#x2019;s equity and convertible note holders upon the close of the Business Combination. Each of Old enGene&#x2019;s outstanding warrants to purchase Common Shares were exchanged for 2,679,432 Warrants based on the Exchange Ratio. All of Old enGene&#x2019;s existing outstanding Class C Warrants outstanding at the time of the Business Combination were terminated. Additionally, there were 3,670,927 enGene Common Shares issued to FEAC and its shareholders as part of the Business Combination, along with 5,029,444 Warrants to purchase enGene Common Shares.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2022 Convertible Notes</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 20, 2022, Old enGene entered into a note purchase agreement with, and issued the 2022 Convertible Notes to, existing shareholders, including the 2022 Noteholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prior to the execution and delivery of the Business Combination Agreement, Old enGene and the 2022 Noteholders entered into the Amended 2022 Convertible Notes to amend and restate the 2022 Convertible Notes, pursuant to which (i) the Amended 2022 Convertible Notes are, among other things, convertible into that number of Old enGene common shares that, when exchanged at the enGene Exchange Ratio, shall equal that number of FEAC Class A Shares (or after the Assumption, enGene Common Shares) that the holders of the Amended 2022 Convertible Notes would have received if they had subscribed for FEAC Class A Shares (or after the Assumption, enGene Common Shares) on the same terms as the PIPE Financing, and (ii) each 2022 Noteholder received warrants of enGene in consideration of certain amendments set forth in each Amended 2022 Convertible Note.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2023 Convertible Notes</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 4, 2023, Old enGene entered into a Note Purchase Agreement with, and issued the 2023 Subordinated Notes to, existing shareholders, including, the 2023 Noteholders.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concurrently with the execution and delivery of the Business Combination Agreement, Old enGene and the 2023 Noteholders entered into agreements, pursuant to which Old enGene repaid the 2023 Subordinated Notes by issuing to each 2023 Noteholder (i) an amount of convertible promissory notes of Old enGene substantially in the same form and on the same terms as certain convertible promissory notes issued concurrently to the FEAC Sponsor and Investissement Qu&eacute;bec (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IQ</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and (ii) a number of warrants to acquire Old enGene common shares substantially in the same form and on the same terms as certain warrants issued concurrently with the FEAC Sponsor and IQ, corresponding, in the aggregate, to the principal amount of 2023 Subordinated Notes held by such 2023 Noteholder.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 17, 2023 pursuant to the agreements described immediately above, Old enGene issued an aggregate amount of $38.0 million convertible debentures and warrants to the 2023 Noteholders, the FEAC Sponsor and IQ. This financing was completed in two tranches, with the second tranche closing on June 15, 2023.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Registration Rights Agreement</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Business Combination, on October 31, 2023, enGene, FEAC, the Sponsor Holders and the enGene Holders (each as defined in the Registration Rights Agreement) entered into a Registration Rights Agreement. Pursuant to the terms of the Registration Rights Agreement, among other things, the Sponsor Holders and the enGene Holders were granted certain customary registration rights with respect to their respective equity securities of enGene, in each case, on the terms and subject to the conditions therein.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">35</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Director Indemnification</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene has entered into indemnification agreements with each of its directors, which require enGene to indemnify these individuals and, in certain cases, affiliates of such individuals, to the fullest extent permissible under Canadian law and the BCBCA against liabilities that may arise by reason of their service to enGene or at enGene&#x2019;s direction, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene has entered into indemnification agreements with its directors and certain of its executive officers. The indemnification agreements require enGene to indemnify its directors and officers to the fullest extent permitted under Canadian law and the BCBCA.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indebtedness of Directors, Executive Officers and Employees</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None of our directors, executive officers, employees, former directors, former executive officers or former employees and none of their associates, is indebted to us or another entity whose indebtedness is the subject of a guarantee, support agreement, letter of credit or other similar agreement or understanding provided by us.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interests of Management and Others in Material Transactions</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other than as described above and elsewhere in this proxy statement, there are no material interests, direct or indirect, of any of our directors or executive officers, any shareholder that beneficially owns, or controls or directs (directly or indirectly), more than 10% of any class or series of our outstanding voting securities, or any associate or affiliate of any of the foregoing persons, in any transaction within the year ended October 31, 2023 that has materially affected or is reasonably expected to materially affect us or our subsidiaries.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Requirements under the </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Corporations Act</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (British Columbia)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the BCBCA, directors and officers are required to act honestly and in good faith with a view to the best interests of the Company. Under the BCBCA, subject to certain limited exceptions, a director who holds a disclosable interest in a material contract or transaction into which we have entered or propose to enter shall not vote on any directors&#x2019; resolution to approve the contract or transaction. A director or officer has a disclosable interest in a material contract or transaction if the director or officer:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">is a party to the contract or transaction; </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">is a director or officer, or an individual acting in a similar capacity, of a party to the contract or transaction; or </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">has a material interest in a party to the contract or transaction. </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Generally, as a matter of practice, directors or officers who have disclosed a material interest in any contract or transaction that our Board is considering will not take part in any board discussion respecting that contract or transaction. If such directors were to participate in the discussions, they would abstain from voting on any matters relating to matters in which they have disclosed a disclosable interest.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THE BOARD RECOMMENDS THAT YOU VOTE &#x201c;FOR&#x201d; THE ELECTION OF EACH OF THE DIRECTORS.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proposal_2"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROPOSAL 2 - APPROV</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AL OF THE PLAN AMENDMENT PROPOSAL</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Background</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company maintains the enGene Holdings Inc. 2023 Incentive Equity Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive Equity Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The Incentive Equity Plan was adopted on October 31, 2023 upon the completion of the Business Combination and superseded enGene Inc.&#x2019;s employee stock option plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ESOP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and equity incentive plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EIP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prior Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Upon completion of the Business Combination, the aggregate number of Common Shares that could be issued or transferred under the Incentive Equity Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Share Reserve</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) was 5,314,884, consisting of 2,706,941 Common Shares that had been subject to outstanding grants under the Prior Plans and 2,607,941 Common Shares for new grants.  Of such Common Shares, up to 2,607,941 were available for options (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive Stock Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) intended to qualify as incentive stock options under Section 422 of the Code (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ISO Sublimit</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The Incentive Equity Plan contains an evergreen provision (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Existing Evergreen Provision</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) pursuant to which, commencing with the first business day of each calendar year beginning in 2024, the Plan Share Reserve, and the ISO Sublimit, increase by a number of Common Shares equal to the lesser of (x) 1,946,226 million Common Shares and (y) such lesser number of Common Shares as may be determined by the Compensation Committee. Pursuant to this Existing Evergreen Provision, on January 2, 2024, the Plan Share Reserve was increased by 1,946,226 to 7,261,110 Common Shares.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 27, 2024, enGene filed a registration statement on Form S-8 registering the 7,262,110 Common Shares subject to the Incentive Equity Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Purpose</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The general purpose of the Incentive Equity Plan is to attract and retain employees, non-employee directors, and certain consultants and advisors of enGene.  The Incentive Equity Plan provides a means whereby our eligible employees, officers, non-employee directors and other individual service providers (including consultants, advisors and prospective employees, officers, non-employee directors, consultants and advisors) develop a sense of proprietorship and personal involvement in the development and the financial success of our Company and encourages them to devote their best efforts to the business of our Company, thereby advancing the interests of our Company and our shareholders. Through the issuance of incentive stock options, non-qualified stock options, stock appreciation rights, share awards, share units, and other share-based awards, the Incentive Equity Plan provides an incentive to participants to contribute to the growth of the Company by aligning the economic interests of participants with those of our shareholders.  We, by means of the Incentive Equity Plan, seek to retain the services of these eligible persons and to provide incentives for these persons to exert maximum efforts for the success of our Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board believes that the granting of such equity-based compensation promotes continuity of management and increases incentive and personal interest in the welfare of our Company by those who are primarily responsible for shaping and carrying out our long-term plans and securing our growth and financial success. On April 11, 2024, our Board approved an amendment to the Incentive Equity Plan&#x2019;s Existing Evergreen Provision to provide for annual increases on the first business day of each calendar year of (i) the Plan Share Reserve by such number of Common Shares as equals 5% of the aggregate number of Common Shares outstanding on the final day of the immediately preceding calendar year (or such smaller number of shares as is determined by the Committee), and (ii) the ISO Sublimit by the lesser of 2,500,000 Common Shares and the increase in the Plan Share Reserve (or such smaller number of shares may be determined by the Committee) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amended Evergreen Provision</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The Board directed that such amendment to the Incentive Equity Plan be submitted to the shareholders for approval at the Meeting (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Amendment Proposal</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The form of the Incentive Equity Plan reflecting the Amended Evergreen Provision (as so amended, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amended and Restated Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is included as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule B</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to this Proxy Statement with the revisions to the current Incentive Equity Plan to be effected with deletions indicated with strikethroughs of the text and with additions of text indicated with a double underline boldface type. Incentive Equity Plan.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">37</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If our shareholders do not approve this proposal, the Company will continue to operate the Incentive Equity Plan under its current provisions.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reasons for the Plan Amendment Proposal</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board unanimously recommends that you vote </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOR</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Plan Amendment Proposal, including for the following reasons:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our future success as a company depends on our continued ability to attract, recruit, motivate and retain high-quality talent. Being able to continue to provide equity-based incentives is critical to achieving this success as we compete for talent in an industry in which equity compensation is market practice and is expected by existing personnel and prospective candidates. Equity awards are intended to motivate high performance levels and to align the interests of our employees, non-employee directors and consultants with those of our shareholders by giving such individuals an equity stake in our Company and by providing a means of recognizing such individuals&#x2019; contributions to our success. Our Board and management believe equity awards are necessary to remain competitive in our industry and are essential in a competitive labor market and industry to attracting, recruiting, motivating and retaining the highly qualified employees who help us meet our goals.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Existing Evergreen Provision is unlikely to provide sufficient additional shares for grant under the Incentive Equity Plan to support the needs of our Company in light of our existing compensation structure, compensation strategy and business plans. The increase being sought in connection with the proposed Amended Evergreen Provision is necessary to help ensure we have a sufficient number of shares authorized, reserved for issuance, and available to appropriately compensate our employees, non-employee directors and consultants in 2025, and to issue appropriate awards going forward, under the Incentive Equity Plan.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In determining the appropriate evergreen percentage under the Incentive Equity Plan, the Board reviewed market, industry and compensation peer group practices and data. The Board determined that the Incentive Equity Plan does not provide sufficient share authorization to appropriately compensate our employees, non-employee directors and consultants for a duration comparable to that of the equity incentive plans of similarly situated companies. We believe the Plan Amendment Proposal will remedy this by positioning us to be in line with the equity incentive plan share authorization levels at similarly situated companies.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shareholders are being asked to approve the Plan Amendment Proposal to satisfy Incentive Equity Plan and the Nasdaq Stock Market LLC requirements and to qualify certain stock options authorized under the Incentive Equity Plan for treatment as incentive stock options under Section 422 of the Code.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Overview of Changes Implemented by the Amended Evergreen Provision</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Amended Evergreen Provision amends Section 4(a) of the Incentive Equity Plan as shown below (with deletions indicated with strikethroughs of the text and with additions of text indicated with a double underline boldface type), such that the Plan Share Reserve (i.e., the number of Common Shares authorized for issuance under the Incentive Equity Plan) increases on the first day of each calendar year, beginning on January 1, 2025, by 5% of the aggregate number of Common Shares issued and outstanding on December 31</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the preceding calendar year (or such lesser number of Common Shares as may be determined by the Committee) and the ISO Sublimit (i.e., the number of Common Shares in the Plan Share Reserve authorized for issuance under the Incentive Equity Plan pursuant to Incentive Stock Options) increases on the first day of each calendar year, beginning on January 1, 2025, by the lesser of 2,500,000 Common Shares and the increase in the Plan Share Reserve (or such smaller number of shares may be determined by the Committee).  The amended text of Section 4(a) of the Incentive Equity Plan will read as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">38</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 4. Shares Subject to the Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shares Authorized</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adjustment as</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the increases described in this Section 4(a), and the adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> described below in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sections 4(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> below, </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the aggregate number of Common Shares that may be issued or transferred under the Plan </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shall be 2,607,943 Common Shares, plus</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(the &#x201c;Plan Share Reserve&#x201d;) shall be 7,261,110 (consisting of</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> 2,706,941 Common Shares subject to outstanding grants under the Prior Plan as of the Effective Date</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, 2,607,943 additional Common Shares as of the Effective Date and 1,946,226 additional Common Shares added pursuant to this Section 4(a) as of January 2, 2024), and (ii) the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> aggregate number of Common Shares </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">in the Plan Share Reserve </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">that may be issued or transferred under the Plan pursuant to Incentive Stock Options </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(the &#x201c;ISO Sublimit&#x201d;) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shall not exceed </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,607,943</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,554,169</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Common Shares. Commencing with the first business day of each calendar year beginning in </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024, the aggregate number of Common Shares that may be issued or transferred under</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025, (i)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Plan </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Share Reserve </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shall be increased by a number equal to the lesser of (x) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,946,226 million</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5% of the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Common Shares </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the Company issued and outstanding on the final day of the immediately preceding calendar year </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and (y) such lesser number of Common Shares as may be determined by the Committee</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and (ii) the ISO Sublimit shall be increased by the lesser of (x) 2,500,000 Common Shares,  (y) the increase in the Plan Share Reserve pursuant to clause (i) of this sentence, and (z) such lesser number of Common Shares as may be determined by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other than as described above, the Incentive Equity Plan will continue in its current form.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024, 3,434,969 Common Shares are available for future issuance under the Incentive Equity Plan, including as Incentive Stock Options (not including future increases under the Incentive Equity Plan&#x2019;s Existing Evergreen Provision). This amount is insufficient for us to be able to attract, recruit, motivate and retain employees, non-employee directors and consultants or to appropriately compensate these individuals under the Incentive Equity Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the event that shareholders do not approve the Plan Amendment Proposal, the Amended Evergreen Provision will not become effective.  Awards will continue to be made under the Incentive Equity Plan to the extent that there are available Common Shares to do so.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Description of the Incentive Equity Plan</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following description of the material terms of the Incentive Equity Plan as amended by the Amended Evergreen Provision is intended to be a summary only, and is qualified in its entirety by the full text of the Amended and Restated Plan which is included as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule B</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to this Proxy Statement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Type of Awards</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Incentive Equity Plan provides for the issuance of stock options (including non-statutory stock options and incentive stock options), stock appreciation rights (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SARs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), restricted shares, restricted share units and other share-based awards to employees, non-employee directors, and certain consultants and advisors of the Company or its subsidiaries.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Administration</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Incentive Equity Plan is administered by the compensation committee of the Board or another committee appointed by the Board to administer the Incentive Equity Plan (and to the extent the Board does not appoint a committee, the Board will serve as the committee) (for purposes of this description of the Incentive Equity Plan, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;); provided that any grants to members of the Board must be authorized by a majority of the Board (counting all the Board members for purposes of a quorum, but only non-interested Board members for purposes of such majority approval). The Committee (if other than the full Board) must consist of directors who are &#x201c;non-employee directors&#x201d; as defined under Rule 16b-3 promulgated under the Exchange Act and &#x201c;independent directors,&#x201d; as determined in accordance with the independence standards established by the stock exchange on which the Company Common Shares is at the time primarily traded. The Committee may delegate authority under</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Incentive Equity Plan to one or more subcommittees as it deems appropriate. Subject to compliance with applicable law and stock exchange requirements, so long as the Chief Executive Officer is also a director on the Board, the Committee may delegate all or part of its authority to the Chief Executive Officer (or if there is none then appointed, the President), as it deems appropriate, with respect to grants to employees or consultants who are not executive officers under Section 16 of the Exchange Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee will have full power and express discretionary authority to administer and interpret the Incentive Equity Plan, to make factual determinations, and to adopt or amend such rules, regulations, agreements, and instruments for implementing the Incentive Equity Plan and for the conduct of its business as it deems necessary or advisable, in its sole discretion.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shares Subject to the Incentive Equity Plan</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The current Incentive Equity Plan contains the Existing Evergreen Provision described above. If the shareholders approve the Plan Amendment Proposal, the Existing Evergreen Provision will be replaced by the Amended Evergreen Provision described above.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If any options or SARs granted under the Incentive Equity Plan (including options or SARs granted under the Prior Plans) expire or are canceled, forfeited, exchanged, or surrendered without having been exercised, or if any share awards, share units, or other share-based awards granted under the Incentive Equity Plan (including options or SARs granted under the Prior Plans) are forfeited, terminated, or otherwise not paid in full, the Company Common Shares subject to such awards will again be available for purposes of the Incentive Equity Plan. If Company Common Shares are surrendered in payment of the exercise price of an option, the number of Company Common Shares available for issuance under the Incentive Equity Plan will be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as to which such option is exercised. Upon the exercise of any SAR under the Incentive Equity Plan, the number of Company Common Shares available for issuance will be reduced only by the net number of shares actually issued by the Company upon such exercise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If Company Common Shares are withheld by the Company in satisfaction of the withholding taxes incurred in connection with the issuance, vesting or exercise of any grant or the issuance of Company Common Shares under the Incentive Equity Plan, the number of Common Shares available for issuance will be reduced by the net number of shares issued, vested, or exercised under such grant, calculated in each instance after payment of such share withholding. If any awards are paid in cash, and not in Common Shares, any Common Shares subject to such awards will also be available for future awards. If the Company repurchases Common Shares on the open market with the proceeds from the exercise price the Company receives from options, the repurchased shares will not be available for issuance under the Incentive Equity Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Individual Limits for Non-Employee Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The maximum aggregate grant date value of Common Shares granted to any non-employee director in any one calendar year, taken together with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $500,000 in total value; provided, however, that with respect to the year during which a non-employee director is first appointed or elected to the Board, the maximum aggregate grant date value of Common Shares granted to such non-employee director, taken together with any cash fees earned by such non-employee director for services rendered during such period, shall not exceed $750,000 in total value during the initial annual period.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with stock splits, stock dividends, recapitalizations, and certain other events affecting Common Shares, the Committee will make adjustments as it deems appropriate in: the maximum number of Common Shares reserved for issuance as grants; the maximum amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding grants; the number and kind of shares that may be issued under the Incentive Equity Plan; the price per share or market value of</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any outstanding grants; the exercise price of options; the base amount of SARs; and the performance goals or other terms and conditions as the Committee deems appropriate.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Eligibility and Vesting</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All of the employees and non-employee directors of the Company will be eligible to receive grants under the Incentive Equity Plan. In addition, consultants who perform certain services for the Company may receive grants under the Incentive Equity Plan. The Committee will (i) select the employees, non-employee directors, and consultants to receive grants and (ii) determine the number of Common Shares subject to a particular grant and the vesting and exercisability terms of awards granted under the Incentive Equity Plan.  As of April 4, 2024, all 39 employees and four non-employee directors are eligible to participate in the Incentive Equity Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Options</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee will determine the exercise price of the options granted and may grant options to purchase Common Shares in such amounts as it determines. The Committee may grant options that are intended to qualify as incentive stock options under Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted to employees. Anyone eligible to participate in the Incentive Equity Plan may receive a grant of non-qualified stock options. The exercise price of a stock option granted under the Incentive Equity Plan cannot be less than the fair market value of a Common Share on the date the option is granted. If an incentive stock option is granted to a 10% shareholder of the total combined voting power of all classes of Company securities, the exercise price cannot be less than 110% of the fair market value of a Common Share on the date the option is granted.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The exercise price for any option is generally payable in cash. In certain circumstances as permitted by the Committee, the exercise price may be paid: by the surrender of Common Shares with an aggregate fair market value, on the date the option is exercised, equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by, solely with respect to non-qualified stock options, Common Shares subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate exercise price; or by such other method as the Committee approves.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The term of an option cannot exceed 10 years from the date of grant, except that if an incentive stock option is granted to a 10% shareholder of the total combined voting power of all class of Company securities, the term cannot exceed five years from the date of grant. In the event that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition on purchases or sales of Common Shares under the Company&#x2019;s insider trading policy, or pursuant to any restrictions on transfer imposed by the Committee, the term of the non-qualified option will be extended for a period of 30 days following the end of the legal prohibition, or until the expiration of such restrictions on transfer, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Except as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The Committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an option after termination of employment.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share Awards</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant share awards. A share award is an award of Common Shares that may be subject to restrictions as the Committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of pre-established criteria, in installments or otherwise, as the Committee may determine, including, but not limited to, restrictions based on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the share award, a participant will have all of the rights of a shareholder as to those shares, including the right to vote and the right to receive dividends or distributions on the shares. Dividends with respect to share awards that vest based on performance shall vest if and to the extent that the underlying share award vests, as determined by the Committee. All unvested share awards are forfeited if the participant&#x2019;s employment or service is terminated for any reason, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">41</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant share units to anyone eligible to participate in the Incentive Equity Plan. Share units represent hypothetical Common Shares. Share units become payable on terms and conditions determined by the Committee, including specified performance goals, and will be payable in cash, Common Shares, or a combination thereof, as determined by the Committee. All unvested share units are forfeited if the participant&#x2019;s employment or service is terminated for any reason, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Appreciation Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with a non-qualified stock option may be granted either at the time the non-qualified stock option is granted or any time thereafter while the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the incentive stock option is made. The Committee will establish the base amount of the SAR at the time the SAR is granted, which will be equal to or greater than the fair market value of a Common Share as of the date of grant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number of Common Shares that the participant may purchase upon exercising the related option during such period. Upon exercising the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent of an equal number of Common Shares. Generally, SARs may only be exercised while the participant is employed by, or providing services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying Common Shares over the base amount of the SAR. The appreciation of a SAR will be paid in Common Shares, cash, or both.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The term of a SAR cannot exceed 10 years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is prohibited by applicable law, including a prohibition on purchases or sales of Common Shares under the Company&#x2019;s insider trading policy, or pursuant to any restrictions on transfer imposed by the Committee, the term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, or until the expiration of such restrictions on transfer, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Share-Based Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant other types of awards that are based on, or measured by, Common Shares, and granted to anyone eligible to participate in the Incentive Equity Plan. The Committee will determine the terms and conditions of such awards. Other share-based awards may be payable in cash, Common Shares or a combination of the two, as determined by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividend Equivalents</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant dividend equivalents in connection with grants of share units or other share-based awards made under the Incentive Equity Plan. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the shares underlying a grant while the grant is outstanding. The Committee will determine whether dividend equivalents will be paid currently or accrued as contingent cash obligations. Dividend equivalents may be paid in cash or Common Shares. The Committee will determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of specific performance goals. Dividend equivalents with respect to share units or other share-based awards that vest based on performance shall vest and be paid only if and to the extent that the underlying share units or other share-based awards vest and are paid as determined by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If the Company experiences a change of control where the Company is not the surviving company (or survives only as a subsidiary of another company), unless the Committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control will be assumed, or replaced with grants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">42</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(with respect to cash, securities or a combination thereof) that have comparable terms, by the surviving company (or a parent or subsidiary of the surviving company).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If there is a change of control and all outstanding grants are not assumed, or replaced with grants that have comparable terms, by the surviving company, the Committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants, including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">determine that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding share awards, share units, and dividend equivalents immediately lapse; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">pay participants, in an amount and form determined by the Committee, in settlement of outstanding share units or dividend equivalents; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">require that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or Common Shares, equal to the difference between the exercise price and the fair market value of the underlying Common Shares; provided, however, if the per share fair market value of Common Shares does not exceed the per share stock option exercise price or SARs base amount, as applicable, the Company will not be required to make any payment to the participant upon surrender of the stock option or SAR and shall have the right to cancel any such option or SAR for no consideration; or </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">after giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options and SARs on the date determined by the Committee. </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In general terms, a change of control under the Incentive Equity Plan occurs if:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a person, entity or affiliated group, with certain exceptions, acquires more than 50% of the then-outstanding voting securities; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company merges into, or consummates an amalgamation or arrangement with, another entity unless the holders of voting shares immediately prior to such transaction have at least 50% of the combined voting power of the securities in the combined entity or its parent;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company merges into, or consummates an amalgamation or arrangement with, another entity and the members of the Board prior to such transaction would not constitute a majority of the board of the combined entity or its parent; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company sells or disposes of all or substantially all of the assets of the Company; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company consummates a complete liquidation or dissolution; or </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a majority of the members of the Board are replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the incumbent directors.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Deferrals</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may permit or require participants to defer receipt of the payment of cash or the delivery of Common Shares that would otherwise be due to the participant in connection with a grant under the Incentive Equity Plan. The Committee will establish the rules and procedures applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">43</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Withholding</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All grants under the Incentive Equity Plan are subject to applicable U.S. federal (including taxes under FICA), state, and local, foreign or other tax withholding requirements. The Company may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy such tax withholding requirements with respect to such grants, or the Company may deduct from other wages and compensation paid by New enGene the amount of any withholding taxes due with respect to such grant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may permit or require that tax withholding obligation with respect to grants paid in Common Shares be paid by having shares withheld up to an amount that does not exceed the participant&#x2019;s minimum applicable withholding tax rate for U.S. federal (including FICA), state, and local tax liabilities, or as otherwise determined by the Committee. In addition, the Committee may, in its discretion, and subject to such rules as the Committee may adopt, allow participants to elect to have such share withholding applied to all or a portion of the tax withholding obligation arising in connection with any particular grant.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Transferability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Except as permitted by the Committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during the participant&#x2019;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with respect to grants other than incentive stock options, pursuant to a domestic relations order. The Committee may provide in a grant instrument that a participant may transfer non-qualified stock options for no consideration to a permitted assign in compliance with applicable securities laws.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amendment; Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board may amend or terminate the Incentive Equity Plan at any time, except that the Company&#x2019;s shareholders must approve an amendment if such approval is required in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by the Board or extended with shareholder approval, the Incentive Equity Plan will terminate on the day immediately preceding the tenth anniversary of the effective date of the Incentive Equity Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shareholder Approval</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Except in connection with certain corporate transactions, including stock dividends, stock splits, a recapitalization, a change in control, a reorganization, a merger, an amalgamation, a consolidation, and a spin-off, shareholder approval is required (i) to reduce the exercise price or base price of outstanding stock options or SARs, (ii) to cancel outstanding stock options or SARs in exchange for the same type of grant with a lower exercise price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current price of a Common Share, in exchange for cash or other securities, each as applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Establishment of Sub-Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board may, from time to time, establish one or more sub-plans under the Incentive Equity Plan to satisfy applicable blue sky, securities or tax laws of various jurisdictions outside the United States or Canada. The Board may establish such sub-plans by adopting supplements to the Incentive Equity Plan setting forth limitations on the Committee&#x2019;s discretion and such additional terms and conditions not otherwise inconsistent with the Incentive Equity Plan as the Board deems necessary or desirable. All such supplements will be deemed part of the Incentive Equity Plan, but each supplement will only apply to participants within the affected jurisdiction, and the Company will not be required to provide copies of any supplement to such unaffected participants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">44</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Clawback</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All grants under the Incentive Equity Plan (including any proceeds, gains or other economic benefit actually or constructively received upon receipt of any grant or receipt or resale of any Common Shares underlying the grant) will be subject to any applicable policies implemented by the Board, now in effect or which may be adopted in future, in each case as amended from time to time, including any clawback or recoupment policies and share trading policies.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Performance Measures</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the grant, vesting, exercisability or payment of certain awards, or the receipt of Common Shares subject to certain awards, may be made subject to the satisfaction of performance measures. The performance goals applicable to a particular award will be determined by the Committee at the time of grant. One or more of the following business criteria for the Company may be used by the Committee in establishing performance measures under the Incentive Equity Plan: cash flow; free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation, amortization and charges for share-based compensation, earnings before interest, taxes, depreciation and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share; growth in earnings or earnings per share; book value growth; share price; return on equity or average shareholder equity; total shareholder return or growth in total shareholder return either directly or in relation to a comparative group; return on capital; return on assets or net assets; revenue, growth in revenue or return on sales; sales; expense reduction or expense control; expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution goals; other operational, regulatory or departmental objectives; budget comparisons; growth in shareholder value relative to established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting principles required to determine economic value added performance measures); measures of customer satisfaction, employee satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the completion of other similar transactions intended to enhance the Company&#x2019;s revenue or profitability or enhance its customer base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals may be established on an absolute or relative basis and may be established on a corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable indices.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Summary of U.S. Federal Income Tax Consequences</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following is a summary of certain U.S. federal income tax consequences of awards under the Incentive Equity Plan. It does not purport to be a complete description of all applicable rules, and those rules (including those summarized here) are subject to change.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">An optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market value of vested shares purchased over the exercise price. The Company generally will be entitled to a tax deduction at such time and in the same amount, if any, that the optionee recognizes as ordinary income. The optionee&#x2019;s tax basis in any shares received upon exercise of an option will be the exercise price paid plus the amount of compensation recognized by the participant as ordinary income (generally, fair market value of the shares on the date of exercise), and if the shares are later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such shares on</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">45</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the date of exercise will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending upon the length of time such shares were held by the optionee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock option must have an option price that is not less than the fair market value of the stock at the time the option is granted, and must not be exercisable after the expiration of 10 years from the date of grant; further restrictions apply to employees who are greater-than-10% shareholders. An employee granted an incentive stock option generally does not realize compensation income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual income. If the shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and one year after exercise, then (i) the excess (if any) of the amount realized on the disposition over the exercise price will be taxed as capital gain and (ii) the amount (if any) by which the exercise price exceeds the amount realized upon the disposition will be treated as capital loss. If the shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise, the optionee will realize taxable compensation income in the year of the disposition equal to the lesser of (i) the excess of the fair market value of the shares on the date of exercise over the option price or (ii) the excess of the amount realized on the disposition over the option price, and the Company generally will be entitled to a tax deduction in such amount. Any additional amount realized will be taxed as capital gain.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A participant generally will not be taxed upon the grant of share awards subject to restrictions, but rather will recognize ordinary income in an amount equal to the fair market value of the shares at the time the shares are no longer subject to a &#x201c;substantial risk of forfeiture&#x201d; (within the meaning of the Code). The Company generally will be entitled to a deduction at the time when, and in the amount that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&#x2019;s tax basis in the shares will equal their fair market value at the time the restrictions lapse, and the participant&#x2019;s holding period for capital gains purposes will begin at that time. Any cash dividends paid on the restricted shares before the restrictions lapse will be taxable to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect to recognize ordinary income at the time the shares are awarded in an amount equal to their fair market value at that time (less any amount paid by the participant for the shares), notwithstanding the fact that such shares are subject to restrictions and a substantial risk of forfeiture. If such an election is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will have a tax basis in the shares equal to their fair market value on the date of their award, and the participant&#x2019;s holding period for capital gains purposes will begin at that time. The Company generally will be entitled to a tax deduction at the time when, and to the extent that, ordinary income is recognized by such participant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In general, the grant of share units will not result in income for the participant or in a tax deduction for us. Upon the settlement of such an award in cash or shares, the participant will recognize ordinary compensation income equal to the aggregate value of the payment received, and the Company generally will be entitled to a tax deduction at the same time and in the same amount. A gain or loss recognized upon a subsequent sale or exchange of the shares (if settled in shares) is treated as capital gain or loss for which the Company will not be entitled to a deduction.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Appreciation Rights (SARs)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any cash received and the fair market value on the date of exercise of any shares received. The Company generally will be entitled to a tax deduction at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&#x2019;s tax basis in any shares received upon exercise of a SAR will be the fair market value of the shares on the date of exercise, and if the shares are later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">46</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">value of such shares on the date of exercise will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the participant) depending upon the length of time such shares were held by the participant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">With respect to other share-based awards granted under the Incentive Equity Plan (including, e.g., dividend equivalents), generally when the participant receives payment with respect to an award, the amount of cash and/or the fair market value of any shares or other property received in excess of the amount paid (if any) will be ordinary income to the participant, and the Company generally will be entitled to a tax deduction at the same time and in the same amount.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan Benefits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Future benefits under the Incentive Equity Plan generally will be granted at the discretion of the Committee and are therefore not currently determinable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vote Required</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The affirmative vote of the holders of shares of Common Stock having a majority in voting power of the votes cast by the holders of all of the Common Shares present or represented at the Meeting is required to approve this Proposal 2. As a result, abstentions, broker non-votes, if any, and any other failure to submit a proxy or vote in person at the meeting, will not affect the outcome of the vote of this Proposal 2.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Resolution to be Voted Upon</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The full text of the resolution to be passed is as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;RESOLVED, as an ordinary resolution, that the amendment to the enGene Holdings Inc. 2023 Incentive Equity Plan, as reflected in the form of amended and restated Incentive Equity Plan attached to this proxy statement as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Schedule B</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, be adopted and approved.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recommendation of the Board</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE &#x201c;FOR&#x201d; THE APPROVAL OF THE PLAN AMENDMENT PROPOSAL.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The existence of financial and personal interests of the Company&#x2019;s directors may result in a conflict of interest on the part of the directors between what they may believe is in the best interests of the Company and its shareholders and what they may believe is best for themselves in determining to recommend that shareholders vote for the Plan Amendment Proposal</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">47</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proposal_3"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROPOSAL 3 - APPOINTMENT </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AND REMUNERATION OF AUDITORS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The members of our audit committee and our Board believe the continued retention of KPMG as our independent registered accounting firm is in the best interests of the Company and our shareholders. Ratification requires the receipt of &#x201c;FOR&#x201d; votes constituting a majority of the shares cast by the shareholders who vote in respect of this proposal. Representatives of KPMG are expected to attend the Meeting and be available to answer appropriate questions from shareholders. They will also have the opportunity to make a statement if they desire to do so.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principal Independent Accountant Fees and Services</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">KPMG LLP has served as our independent registered public accounting firm since 2021.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents fees for professional audit services rendered by KPMG LLP for the services described in the table.  Fees disclosed below include fees actually billed or expected to be billed for services pertaining to the applicable fiscal year.  The amounts were billed in Canadian dollars and translated at an average rate of 1.3487 for fiscal 2023 and 1.2878 for fiscal 2022.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.967%;"></td>
    <td style="width:1.16%;"></td>
    <td style="width:1%;"></td>
    <td style="width:13.357%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.16%;"></td>
    <td style="width:1%;"></td>
    <td style="width:13.357%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023<br>($)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022<br>($)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit Fees</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,983,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">737,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit Related Fees</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tax Fees</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(3)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">744,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">64,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">All Other Fees</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Fees</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,727,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">801,000</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:73.333%;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Audit fees consisted of professional services rendered for the audit of our consolidated financial statements, reviews of interim financial statements, as well as work generally only the independent registered public accounting firm can reasonably be expected to provide, such as consents in connection with the filing of registration statements and related amendments, as well as other filings.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There were no audit-related or other fees incurred in 2023 or 2022. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tax fees consisted of services related to tax compliance, including the preparation of tax returns, tax planning, and advice. </font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-approval Policies and Procedures</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our audit committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent registered public accounting firm. This policy provides that we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in advance by our audit committee or the engagement is entered into pursuant to the pre-approval procedure described below.  In considering whether to pre-approve any non-audit services, our audit committee shall consider whether the provision of such services is compatible with maintaining the independence of the auditor.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, our audit committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next 12 months. Any such pre-approval details the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During our 2023 and 2022 fiscal years, no services were provided to us by KPMG LLP other than in accordance with the pre-approval policies and procedures described above.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THE BOARD RECOMMENDS THAT YOU VOTE &#x201c;FOR&#x201d; THE APPOINTMENT AND REMUNERATION OF KPMG AS THE COMPANY&#x2019;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">48</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="audit_committee_report"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AUDIT COMMIT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TEE REPORT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The material in this report is not &#x201c;soliciting material,&#x201d; is not deemed &#x201c;filed&#x201d; with the SEC, and is not to be incorporated by reference into any filing by enGene under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x201d;), or the Exchange Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The primary purpose of the audit committee is to oversee the Company&#x2019;s financial reporting processes on behalf of the Board. Management has the primary responsibility for the Company&#x2019;s financial statements and reporting processes, including the Company&#x2019;s systems of internal controls. In fulfilling its oversight responsibilities, the audit committee reviewed and discussed with management enGene&#x2019;s audited financial statements as of and for the year ended October 31, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The audit committee has discussed with KPMG LLP, the Company&#x2019;s independent registered public accounting firm, the matters required to be discussed under applicable requirements of the Public Company Accounting Oversight Board (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PCAOB</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and the SEC. In addition, the audit committee has received the written disclosures and the letter required by applicable requirements of the PCAOB regarding KPMG LLP&#x2019;s communications with the audit committee concerning independence, and has discussed with KPMG LLP its independence.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on these reviews and discussions, the audit committee recommended to the Board that such audited financial statements be included in the Company&#x2019;s Annual Report on Form 10-K for the year ended October 31, 2023, as filed with the SEC on January 29, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Audit Committee of the Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lota S. Zoth (Chair)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Richard Glickman</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Gerry Brunk</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">49</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="executive_officers"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXECUTIV</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">E OFFICERS</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth, as of April 4, 2024, certain information regarding our executive officers who are responsible for overseeing the management of our business.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.78%;"></td>
    <td style="width:1.96%;"></td>
    <td style="width:1%;"></td>
    <td style="width:2.36%;"></td>
    <td style="width:1%;"></td>
    <td style="width:2.28%;"></td>
    <td style="width:45.62%;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Age</font></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Position</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Named Executive Officers</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Executive Officer and Director</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ryan Daws</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. Alex Nichols</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">38</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President and Chief Operating Officer</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. Richard Bryce</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Medical Officer</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. Anthony T. Cheung</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">53</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Technology Officer</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dr. James C. Sullivan</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Scientific Officer</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:12pt;vertical-align:top;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lee Giguere</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Legal Officer and Corporate Secretary</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following is biographical information for our executive officers, other than Mr. Hanson, whose biographical information is included above.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Ryan Daws</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as Chief Financial Officer and Head of Business Development of enGene since November 27, 2023. Mr. Daws joined the Company from Obsidian Therapeutics, Inc., where he was Chief Financial Officer and Head of Business Development from July 2019 to November 2023. Prior to that, from June 2017 to March 2019, he served as a Managing Director in the Healthcare Investment Banking Group at Robert W. Baird &amp; Co. with a focus on life sciences companies. Prior to Baird, Mr. Daws was the Chief Financial Officer and Head of Business Development of Concert Pharmaceuticals, Inc. from January 2014 to June 2017, and a life-science-focused investment banker at Stifel, Nicolaus and Company from September 2010 to June 2013.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dr. Alex Nichols</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as President and Chief Operating Officer of enGene since November 1, 2023 and in the same capacity for enGene Inc. since December 2022. Prior to joining enGene Inc. Dr. Nichols served as President, CEO, and co-founder of Mythic Therapeutics, Inc., a clinical-stage product-platform company developing a pipeline of antibody-drug conjugates (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ADCs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). In this role, Dr. Nichols co-invented the company&#x2019;s technology platform and lead program, raised more than $130 million across several financing rounds and helped grow the company into an emerging ADC innovator. From November 2014 to September 2016, Dr. Nichols worked as an associate at Flagship Pioneering Inc., where he was part of the co-founding team of Cogen Therapeutics (now Repertoire Immune Medicines). Alex holds a B.A. in Biochemistry from Oberlin College and Ph.D. in Biophysics from Harvard University.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dr. Richard Bryce</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as Chief Medical Officer of enGene since November 1, 2023 and in the same capacity for enGene Inc. since September 2023. From April 2021 to June 2023 Dr. Bryce served as Chief Medical Officer at Rain Oncology, a late-stage company developing precision oncology therapeutics, where he built a clinical development team and oversaw multiple clinical studies. From August 2017 to April 2021, Dr. Bryce was Chief Medical &amp; Scientific Officer at Puma Biotechnology, where he led the development strategy for neratinib. Dr. Bryce also served as Senior Vice President, Clinical Research &amp; Development at Puma Biotechnology from June 2012 to July 2017. Earlier in Dr. Bryce&#x2019;s career, from August 2008 to June 2012, he served as Senior Director of Clinical Science for Onyx Pharmaceuticals, where he oversaw the Phase 3 registrational studies for carfilzomib. Dr. Bryce obtained his Bachelor of Medicine and Bachelor of Surgery (MBChB) Degrees from the University of Edinburgh and is certified in the EU in primary care/general practice and pharmaceutical medicine. He holds numerous postgraduate specialist clinical qualifications including those from the Royal College of Obstetricians &amp; Gynaecologists and the Royal College of Physicians. Dr. Bryce also served as a Surgeon Lieutenant Commander in the Royal Navy.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dr. Anthony T. Cheung</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> co-founded our Company and has served enGene and enGene Inc. in various capacities since the company&#x2019;s inception. Dr. Cheung has served as Chief Technology Officer of enGene since August 7, 2023 and in the same capacity for enGene Inc. since July 2018. From February 2013 to July 2018, Dr. Cheung served as the President and Chief Executive Officer of enGene Inc. From May 2011 to February 2013, Dr. Cheung served as Interim Chief Executive Officer. From March 2004 to May 2011, Dr. Cheung served as the Chief</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">50</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Scientific Officer of enGene Inc. From November 1999 to February 2015, Dr. Cheung served as the Corporate Secretary of enGene Inc. From November 1999 to March 2004, Dr. Cheung served as the President and Chief Executive Officer of enGene Inc. Dr. Cheung has co-authored numerous book chapters, review articles and peer-reviewed journals, and is named investor on numerous patents, in the areas of gene therapy and polymer chemistry. Dr. Cheung holds a B.Sc. from University of British Columbia and a Ph.D. in Physiology from the Tulane University School of Medicine.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dr. James C. Sullivan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as Chief Scientific Officer at enGene since November 1, 2023 and in the same capacity for enGene Inc. since February 2022. In this role, Dr. Sullivan oversees Research and Preclinical Development. From January 2021 to January 2022, Dr. Sullivan served as Vice President, Head of Pulmonary Discovery at Translate Bio, Inc. Before joining Translate Bio, Dr. Sullivan was Executive Director, Head of Translational Biology at Sana Biotechnology, Inc from August 2019 to January 2021. He also served at Vertex Pharmaceuticals, Inc. from January 2008 to August 2019, where he where he was an IND and/or s/NDA team member for several products, including, for cystic fibrosis, Kalydeco</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, Orkambi</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and Symdeko</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, as well as Incivek</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> for Hepatitis C. Dr. Sullivan was also an IND team member for multiple assets currently in clinical development to treat alpha-1-antitrypsin (AAT) deficiency and the first-ever CRISPR-based gene editing therapeutic product for the treatment of certain hemoglobinopathies (exagamglogene autotemcel). Dr. Sullivan holds a B.S. in Biology from Boston College, a M.Sc. from University College Dublin, and a Ph.D. from Boston University.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Lee Giguere</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">has served as Chief Legal Officer and Corporate Secretary of enGene since January 29, 2024. Prior to joining enGene, Mr. Giguere served as Chief Legal Officer of Obsidian Therapeutics, Inc. from November 2021 to January 2024. From September 2019 to November 2021, Mr. Giguere served as Vice President, General Counsel of Chiasma, Inc. (NASDAQ: CHMA), a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Prior to Chiasma, Mr. Giguere worked at Karyopharm Therapeutics Inc. (NASDAQ: KPTI), an oncology-focused pharmaceutical company from July 2018 to September 2019 as Deputy General Counsel and Assistant Secretary, and from September 2016 to July 2018 as Associate General Counsel and Assistant Secretary. From November 2013 to September 2016, Mr. Giguere served as Senior Securities and Governance Counsel at Boston Scientific Corporation (NYSE: BSX), a Fortune 500 medical device company. Mr. Giguere began his professional career in the business law department of Goodwin Procter LLP, where he concentrated his practice on representing public companies in connection with securities law, corporate governance matters and corporate finance transactions. Mr. Giguere holds a J.D. from Northeastern University School of Law and B.S. in Finance from Northeastern University.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">51</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="executive_compensation"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXECUTIVE CO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">MPENSATION</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Executive Compensation Overview</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following discussion contains forward-looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. The actual amount and form of compensation and the compensation policies and practices that we adopt in the future may differ materially from currently planned programs as summarized in this discussion.  We have opted to comply with the executive compensation disclosure rules applicable to emerging growth companies, as enGene is an emerging growth company. The scaled down disclosure rules are those applicable to &#x201c;smaller reporting companies,&#x201d; as such term is defined in the rules promulgated under the Securities Act of 1933, as amended.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The compensation </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to our named executive officers (each, a &#x201c;</font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">named executive officer</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">NEO</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) for the fiscal years ended October 31, 2023 and 2022 is detailed in the Summary Compensation Table and accompanying footnotes and narrative that follow this section.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For fiscal 2023, the &#x201c;named executive officers&#x201d; and their positions were as follows:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jason D. Hanson, our Chief Executive Officer;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Alexander Nichols, our President and Chief Operating Officer; and</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">James Sullivan, our Chief Scientific Officer.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Summary Compensation Table</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents information regarding the total compensation awarded to, earned by, and paid to our named executive officers for services rendered to us in all capacities for the fiscal years ended October 31, 2023 and 2022.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:29.68%;"></td>
    <td style="width:1.12%;"></td>
    <td style="width:9.8%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.72%;"></td>
    <td style="width:1%;"></td>
    <td style="width:2%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.32%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.32%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.32%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.72%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:4pt;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="margin-left:4pt;text-indent:0;font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name and Principal Position</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fiscal<br>Year</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Base<br>Salary<br>($)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option<br>Awards<br>($)</font><font style="color:#000000;top:1pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(3)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Nonequity<br>Incentive Plan<br>Compensation</font><font style="color:#000000;top:1pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(4)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">All Other<br>Compensation<br>($)</font><font style="color:#000000;top:1pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(5)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total<br>($)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">442,337</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,536,357</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">204,340</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,900</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,192,934</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Chief Executive Officer</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2022</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">446,419</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">193,638</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,150</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">649,207</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alexander Nichols</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">President and Chief Operating Officer</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">312,500</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(1)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">522,071</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">128,348</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,031</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">969,950</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">James Sullivan</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">379,500</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">371,956</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">132,936</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,850</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">896,242</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Chief Scientific Officer</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2022</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">279,250</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(2)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">57,517</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">97,737</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,362</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">439,866</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">_________________</font></p>
  <div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dr</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">. Nichols began employment on December 27, 2022, and, as such, this number represents his prorated base salary. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Dr. Sullivan began employment on February 15, 2022, and, as such, this number represents his prorated base salary. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Mr. Hanson and Dr. Nichols did not receive any option grants in 2022 but Dr. Sullivan did receive an option grant in connection with his hiring. Mr. Hanson, Dr. Nichols and Dr. Sullivan all received options granted in 2023. The amount reported represents the aggregate grant date fair value of the stock options awarded to Mr. Hanson, Dr. Nichols and Dr. Sullivan during the 2023 and 2022 fiscal years, calculated in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. Such grant date fair value does not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the stock option reported in this column are set forth in Note 12 to our consolidated financial statements as of and for the years ended October 31, 2023 and 2022 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Audited Financial Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The amount reported in this column reflects the grant date accounting cost for these stock option awards and does not correspond to the actual economic value that may be received by Mr. Hanson, Dr. Nichols and Dr. Sullivan upon the vesting of their stock options or any sale of the shares, which depends on the market value of our Common Shares on a date in the future.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The amounts in the &#x201c;Nonequity incentive plan compensation&#x201d; column represent annual bonus amounts awarded to the named executive officers by enGene&#x2019;s compensation committee, as detailed in &#x201c;- Cash Incentive Compensation&#x201d; below.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">This amount represents 401K employer contributions for each executive.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">52</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Narrative Disclosure to Summary Compensation Table</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Base Salaries</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We use base salaries to recognize the experience, skills, knowledge and responsibilities required of all our employees, including our named executive officers. Base salaries are reviewed annually, typically in connection with our annual performance review process, and adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance and experience. For fiscal year ended October 31, 2023, the base salary for each of Mr. Hanson, Dr. Nichols and Dr. Sullivan was $442,337, $312,500, and $379,500, respectively.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash Incentive Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We seek to motivate and reward our executives for achievements relative to our corporate goals and expectations. Cash bonuses are earned by our executives based on the achievement of overall company performance criteria over the course of each calendar year (not fiscal year). Accordingly, amounts set for the for each of the Company&#x2019;s named executive officers in the &#x201c;Nonequity incentive plan compensation&#x201d; column for 2023 and 2022 were awarded as a result of the achievement of certain performance measures over calendar years 2023 and 2022. The company performance criteria for calendar years 2023 and 2022 included operational goals in the areas of the clinical development of EG-70, technology advances in the DDX platform, financing activity and building the corporate organization and corporate brand. For 2023, the compensation committee determined that overall corporate performance was achieved based on an assessment of the pre-established 2023 corporate goals. The target cash bonus for 2023 subject to the achievement of overall company performance criteria for Mr. Hanson, Dr. Sullivan and Dr. Nichols was 46%, 35% and 35% of their base salaries, respectively.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity Compensation</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although we do not have a formal policy with respect to the grant of equity incentive awards to our executive officers, we believe that equity grants provide our executive officers with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executive officers and our shareholders. In addition, we believe that equity grants with a time-based vesting feature promote executive retention because this feature incentivizes our executive officers to remain in our employment during the vesting period. Executive grants are typically negotiated in connection with their hiring.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 31, 2023, upon completion of the Business Combination, the enGene Incentive Equity Plan (as defined below) became effective, which authorizes enGene to issue 2,607,943 Common Shares under the plan, plus 2,706,941 Common Shares that are subject to outstanding grants under the enGene Inc. employee share option and equity incentive plans. Additionally, as part of the Business Combination, the 2,706,941 Common Shares subject to outstanding grants under the enGene Inc. employee share option and equity incentive plans were modified to have the exercises price converted from the Canadian Dollar to the United States Dollar, at the exchange rate in effect on the date immediately prior to the close of the Business Combination.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employment Arrangements with our Named Executive Officers</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Jason D. Hanson</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 8, 2023, enGene USA, Inc., an indirect, wholly-owned subsidiary of the Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene USA</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and the Company&#x2019;s Chief Executive Officer, Jason Hanson, entered into an employment agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Hanson Employment Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to be effective as of November 1, 2023. The Hanson Employment Agreement replaced the prior employment agreement between Mr. Hanson and enGene Inc., dated as of July 9, 2018, which agreement governed Mr. Hanson&#x2019;s compensation arrangements for fiscal year 2022.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Hanson Employment Agreement has no fixed term and is terminable at will. Mr. Hanson is entitled under the Hanson Employment Agreement to an annual base salary of $590,000, to an annual 55% bonus opportunity, and to participate in enGene USA&#x2019;s employee benefit plans.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, pursuant to the Hanson Employment Agreement, Mr. Hanson has agreed to standard restrictive covenant obligations, including a noncompete and nonsolicit obligation which run while employed and for twelve months thereafter, or eighteen months, if such termination occurs during a change in control period.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 13, 2024, the Company (through its subsidiary, enGene USA) and Jason Hanson entered into a Transition and Modification Agreement, dated February 13, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transition Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), which amends and modifies the Hanson Employment Agreement (as so amended, the &#x201c;Amended Hanson Employment Agreement&#x201d;). Pursuant to the Transition Agreement, Mr. Hanson has agreed to continue his roles as Chief Executive Officer of the Company and as a member of the Company&#x2019;s Board, together with any roles held at the Company&#x2019;s subsidiaries, until the appointment of a successor Chief Executive Officer of the Company, at which time Mr. Hanson will resign from his positions as Chief Executive Officer of the Company and as a member of the Company&#x2019;s Board, as well as positions at the Company&#x2019;s subsidiaries. The Board has engaged an executive search firm to assist in a comprehensive search for the Company&#x2019;s successor Chief Executive Officer.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mr. Hanson&#x2019;s decision to resign is due to personal family and health reasons and was not the result of any dispute or disagreement with the Company or the Company&#x2019;s Board on any matter relating to the operations, policies or practices of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Transition Agreement, the Company shall make payment to Mr. Hanson of his 2023 cash bonus, in the amount of $204,339.55, no later than March 15, 2024, and, upon Mr. Hanson&#x2019;s voluntary resignation or death or disability and subject to execution and non-revocation of a customary release, Mr. Hanson will be entitled to (i) twelve months of continued health insurance benefits, (ii) payment of a prorated portion of his 2024 target annual bonus, (iii) acceleration and vesting of any then unvested time-based equity awards that would have vested in the twelve-month period following such termination; and (iv) extension of the period to exercise his vested equity awards to three years following the later of date of termination of his employment or the date of termination of the Consulting Period (as defined below), but in no event shall the post-termination exercise period of Mr. Hanson&#x2019;s vested equity awards extend beyond the respective applicable term thereof; provided, however, that if such voluntary resignation or death or disability occurs during a change of control period (as described in the Amended Hanson Employment Agreement), the continued health insurance benefits referred to above will extend to 18 months and the payment of his prorated 2024 target annual bonus referred to above will be increased to the full 2024 target annual bonus.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Transition Agreement further provides that, in the event Mr. Hanson resigns upon the appointment by the Company of a new chief executive officer, Mr. Hanson will be immediately engaged in a consulting role to provide transition services as a Senior Strategic Advisor to the Company for a period of at least six months following the effective date of his resignation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consulting Period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) in exchange for a monthly fee of $25,000 for the initial six-month Consulting Period, and $500 per hour thereafter, provided that Mr. Hanson need not devote more than fifteen (15) hours per week to providing such transition services.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Alex Nichols</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 8, 2023, enGene USA and the Company&#x2019;s President and Chief Operating Officer, Alex Nichols, entered into an employment agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nichols Employment Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to be effective as of November 1, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Nichols Employment Agreement has no fixed term and is terminable at will. Mr. Nichols is entitled to, under the Nichols Employment Agreement, an annual base salary of $475,000, an annual 40% bonus opportunity, and eligibility to participate in enGene USA&#x2019;s employee benefit plans.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Nichols Employment Agreement, (a) upon the termination of Mr. Nichols&#x2019;s employment by enGene USA without Cause (as defined in the Nichols Employment Agreement) or by Mr. Nichols for Good Reason (as defined in the Nichols Employment Agreement), Mr. Nichols is entitled to receive post-termination severance benefits from enGene USA consisting of (i) twelve months&#x2019; base salary, (ii) twelve months of continued health insurance benefits, (iii) a prorated portion of his annual bonus, if such termination occurs six months or more into the applicable performance period for such annual bonus, and (iv) acceleration and vesting of any then unvested time-based equity awards that would have vested in the twelve-month period following such termination; and (b)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">54</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">upon the termination of Mr. Nichols by enGene USA without Cause or by Mr. Nichols for Good Reason during a change in control period, which includes the ninety days prior to and twelve months following a change in control, Mr. Nichols is entitled to receive post-termination severance benefits from enGene USA consisting of (i) twelve months&#x2019; base salary, (ii) an amount equal to his annual bonus opportunity at the target level, (iii) twelve months of post-termination health insurance benefits; and (iv) acceleration and vesting of all then unvested time-based equity awards.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, pursuant to the Nichols Employment Agreement, Mr. Nichols has agreed to standard restrictive covenant obligations, including a noncompete and nonsolicit obligation which runs while employed and for twelve months thereafter.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">James Sullivan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 8, 2023, enGene USA and the Company&#x2019;s Chief Scientific Officer, James Sullivan, entered into an employment agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sullivan Employment Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to be effective as of November 1, 2023. The Sullivan Employment Agreement replaced the prior employment agreement between Mr. Sullivan and enGene Inc., dated as of February 14, 2022, which agreement governed Mr. Sullivan&#x2019;s compensation arrangements for fiscal year 2022.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Sullivan Employment Agreement has no fixed term and is terminable at will. Mr. Sullivan is entitled to, under the Sullivan Employment Agreement, an annual base salary of $485,000, an annual 40% bonus opportunity, and eligibility to participate in enGene USA&#x2019;s employee benefit plans.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Sullivan Employment Agreement, (a) upon the termination of Mr. Sullivan&#x2019;s employment by enGene USA without Cause (as defined in the Sullivan Employment Agreement) or by Mr. Sullivan for Good Reason (as defined in the Sullivan Employment Agreement), Mr. Sullivan is entitled to receive post-termination severance benefits from enGene USA consisting of (i) twelve months&#x2019; base salary, (ii) twelve months of continued health insurance benefits, (iii) a prorated portion of his annual bonus, if such termination occurs six months or more into the applicable performance period for such annual bonus, and (iv) acceleration and vesting of any then unvested time-based equity awards that would have vested in the twelve-month period following such termination; and (b) upon the termination of Mr. Sullivan by enGene USA without Cause or by Mr. Sullivan for Good Reason during a change in control period, which includes the ninety days prior to and twelve months following a change in control, Mr. Sullivan is entitled to receive post-termination severance benefits from enGene USA consisting of (i) twelve months&#x2019; base salary, (ii) an amount equal to his annual bonus opportunity at the target level, (iii) twelve months of post-termination health insurance benefits; and (iv) acceleration and vesting of all then unvested time-based equity awards.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, pursuant to the Sullivan Employment Agreement, Mr. Sullivan has agreed to standard restrictive covenant obligations, including a noncompete and nonsolicit obligation which run while employed and for twelve months thereafter.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">55</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Outstanding Equity Awards at Fiscal Year-End</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth information concerning outstanding equity awards held by each of our named executive officers for our fiscal year ended October 31, 2023:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:29.834%;"></td>
    <td style="width:1.26%;"></td>
    <td style="width:11.258%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:10.038%;"></td>
    <td style="width:1%;"></td>
    <td style="width:2.879%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:10.038%;"></td>
    <td style="width:1%;"></td>
    <td style="width:2.879%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:10.038%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.26%;"></td>
    <td style="width:11.518%;"></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:4pt;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="margin-left:4pt;text-indent:0;font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Grant<br>Date</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number Of<br>Securities Underlying<br>Unexercised Options<br>(#)<br>Exercisable</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number Of<br>Securities<br>Underlying<br>Unexercised<br>Options (#)<br>Unexercisable</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option<br>Exercise<br>Price<br>($)(1)</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option<br>Expiration<br>Date</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/9/2018</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">137,051</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(2)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.88</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/9/2028</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/30/2019</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30,939</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(3)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.88</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/30/2029</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8/20/2021</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">524,544</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(4)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.88</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8/20/2031</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8/20/2021</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,906</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(5)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.88</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8/20/2031</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/7/2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">512,826</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(6)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.25</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/7/2033</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alexander Nichols</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2/18/2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">177,935</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(7)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.52</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2/18/2033</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/7/2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17,835</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(8)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">84,089</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(8)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.25</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/7/2033</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">James Sullivan</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3/18/2022</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">88,901</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(9)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.88</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3/18/2032</font></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/7/2023</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40,736</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(10)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">77,773</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(10)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.25</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/7/2033</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">_____________________</font></p>
  <div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">The amounts in the &#x201c;Option Exercise Price&#x201d; column are denominated in United States Dollars. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option is fully vested and exercisable. This option was received in the Business Combination in exchange for an option to purchase 759,374 enGene Common Shares. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option is fully vested and exercisable. This option was received in the Business Combination in exchange for an option to purchase 171,429 enGene Common Shares.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option is fully vested and exercisable. This option was received in the Business Combination in exchange for an option to purchase 2,906,386 enGene Common Shares.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option is fully vested and exercisable. This option was received in the Business Combination in exchange for an option to purchase 60,429 enGene Common Shares.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option was granted on July 7, 2023 on the condition it is not exercisable unless and until (i) the Business Combination Agreement has been completed and (ii) an effective registration statement for the New enGene shares underlying such granted options has been filed. This option was received in the Business Combination in exchange for an option to purchase 2,841,461 enGene Common Shares. This option is fully vested.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option is fully vested and exercisable. This option was received in the Business Combination in exchange for an option to purchase 985,899 enGene Common Shares.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(8)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option was granted on July 7, 2023 on the condition it is not exercisable unless and until (i) the Business Combination Agreement has been completed and (ii) an effective registration statement for the New enGene shares underlying such granted options has been filed. This option was received in the Business Combination in exchange for an option to purchase 564,739 enGene Common Shares. At the grant date, 12% of the option vested immediately, with the remaining portion to vest equally over 48 months.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(9)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option is fully vested and exercisable. This option was received in the Business Combination in exchange for an option to purchase 492,582 enGene Common Shares.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(10)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">This option was granted on July 7, 2023 on the condition it is not exercisable unless and until (i) the Business Combination Agreement has been completed and (ii) an effective registration statement for the New enGene shares underlying such granted options has been filed. This option was received in the Business Combination in exchange for an option to purchase 656,637 enGene Common Shares. At the grant date, 30% of the option vested immediately, with the remaining portion to vest equally over 48 months.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employee Benefit and Equity Compensation Plans</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Summary of the Equity Plans</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For fiscal year ended October 31, 2023, executive compensation was under enGene Inc.&#x2019;s employee stock option plan </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> equity incentive plan (together, the &#x201c;</font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene Inc. Plans</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), Pursuant to the enGene Inc. Plans&#x2019; options to purchase non-voting common shares of enGene Inc. were granted to directors, officers, employees, consultants and members of the scientific advisory board. The enGene Inc. Plans provided for the issuance of common Share options up to a maximum of 15% of the aggregate issued and outstanding common shares and non-voting common shares of enGene Inc. calculated on an as converted and fully diluted basis. enGene Inc.&#x2019;s Board of Directors administered the enGene Inc. Plans. It was enGene Inc.&#x2019;s policy to establish the exercise price at an amount that approximates (and is no less than) the fair value of the underlying shares on the date of grant as determined by the Board.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Upon the </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Closing</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the Business Combination, the enGene Inc. Plans have been superseded by the enGene Holdings Inc. 2023 Incentive Equity Plan (the &#x201c;</font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive Equity Plan</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The following is a summary of the Incentive Equity Plan.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">56</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Type of Awards</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Equity Plan provides for the issuance of stock options (including non-statutory stock options and incentive stock options), stock appreciation rights (&#x201c;</font><font style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SARs</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), restricted shares, restricted share units and other share-based awards to employees, non-employee directors, and certain consultants and advisors of enGene or its subsidiaries.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Administration</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Incentive Equity Plan is administered by the compensation committee of the enGene Board or another committee appointed by the enGene Board to administer the Incentive Equity Plan; provided that any grants to members of the enGene Board must be authorized by a majority of the enGene Board (counting all the enGene Board members for purposes of a quorum, but only non-interested enGene Board members for purposes of such majority approval). The Committee (if other than the full enGene Board) must consist of directors who are &#x201c;non-employee directors&#x201d; as defined under Rule 16b-3 promulgated under the Exchange Act and &#x201c;independent directors,&#x201d; as determined in accordance with the independence standards established by the stock exchange on which the enGene Common Shares is at the time primarily traded. The Committee may delegate authority under the Incentive Equity Plan to one or more subcommittees as it deems appropriate. Subject to compliance with applicable law and stock exchange requirements, so long as the Chief Executive Officer is also a director on the enGene Board, the Committee may delegate all or part of its authority to the Chief Executive Officer (or if there is none then appointed, the President), as it deems appropriate, with respect to grants to employees or consultants who are not executive officers under Section 16 of the Exchange Act.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shares Subject </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">to</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> the Incentive Equity Plan</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Upon completion of the Business Combination, the number of enGene Common Shares subject to the Incentive Equity Plan was 5,314,884, inclusive of 2,607,943 Common Shares enGene is authorized to issue under the plan, plus 2,706,941 Common Shares that are subject to outstanding grants under the enGene Inc. employee share option and equity incentive plans. The Incentive Equity Plan contains an evergreen provision, pursuant to which, commencing with the first business day of each calendar year beginning in 2024, the aggregate number of enGene Common Shares that may be issued or transferred under the Incentive Equity Plan shall be increased by a number of enGene Common Shares equal to the lesser of (x) 1,946,226 million Common Shares and (y) such lesser number of Common Shares as may be determined by the Committee.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If any options or SARs granted under the Incentive Equity Plan (including options or SARs granted under the prior enGene Inc. Plans) expire or are canceled, forfeited, exchanged, or surrendered without having been exercised, or if any share awards, share units, or other share-based awards granted under the Incentive Equity Plan (including options or SARs granted under the prior enGene Inc. Plans) are forfeited, terminated, or otherwise not paid in full, the enGene Common Shares subject to such awards will again be available for purposes of the Incentive Equity Plan. If enGene Common Shares are surrendered in payment of the exercise price of an option, the number of enGene Common Shares available for issuance under the Incentive Equity Plan will be reduced only by the net number of shares actually issued by enGene upon such exercise and not by the gross number of shares as to which such option is exercised. Upon the exercise of any SAR under the Incentive Equity Plan, the number of enGene Common Shares available for issuance will be reduced only by the net number of shares actually issued by enGene upon such exercise.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If enGene Common Shares are withheld by enGene in satisfaction of the withholding taxes incurred in connection with the issuance, vesting or exercise of any grant or the issuance of enGene Common Shares under the Incentive Equity Plan, the number of enGene Common Shares available for issuance will be reduced by the net number of shares issued, vested, or exercised under such grant, calculated in each instance after payment of such share withholding. If any awards are paid in cash, and not in enGene Common Shares, any enGene Common Shares subject to such awards will also be available for future awards. If enGene repurchases enGene</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Shares on </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> open market with the proceeds from the exercise price enGene receives from options, the repurchased shares will not be available for issuance under the Incentive Equity Plan.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">57</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Individual Limits for Non-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Directors</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The maximum aggregate grant date value of enGene Common Shares granted to any non-employee director in any one </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">calendar</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> year, taken together with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $500,000 in total value; provided, however, that with respect to the year during which a non-employee director is first appointed or elected to the enGene Board, the maximum aggregate grant date value of enGene Common Shares granted to such non-employee director, taken together with any cash fees earned by such non-employee director for services rendered during such period, shall not exceed $750,000 in total value during the initial annual period.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Adjustments</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">with</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> stock splits, stock dividends, recapitalizations, and certain other events affecting enGene Common Shares, the Committee will make adjustments as it deems appropriate in: the maximum number of enGene Common Shares reserved for issuance as grants; the maximum amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding grants; the number and kind of shares that may be issued under the Incentive Equity Plan; the price per share or market value of any outstanding grants; the exercise price of options; the base amount of SARs; and the performance goals or other terms and conditions as the Committee deems appropriate.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Eligibility and Vesting</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All of the employees and non-employee directors of enGene will be eligible to receive grants under the Incentive Equity Plan. In addition, consultants who perform certain services for enGene may receive grants under the Incentive Equity Plan. The Committee will (i) select the employees, non-employee directors, and consultants to receive grants and (ii) determine the number of enGene Common Shares subject to a particular grant and the vesting and exercisability terms of awards granted under the Incentive Equity Plan. As of the Closing Date, all employees and non-employee directors would be eligible to participate in the Incentive Equity Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Options</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee will determine the exercise price of the options granted and may grant options to purchase enGene Common Shares in such amounts as it determines. The Committee may grant options that are intended to qualify as incentive stock options under Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted to employees. Anyone eligible to participate in the Incentive Equity Plan may receive a grant of non-qualified stock options. The exercise price of a stock option granted under the Incentive Equity Plan cannot be less than the fair market value of a enGene Common Share on the date the option is granted. If an incentive stock option is granted to a 10% shareholder of the total combined voting power of all classes of enGene securities, the exercise price cannot be less than 110% of the fair market value of a enGene Common Share on the date the option is granted.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The exercise price for any option is generally payable in cash. In certain circumstances as permitted by the Committee, the exercise price may be paid: by the surrender of enGene Common Shares with an aggregate fair market value, on the date the option is exercised, equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by, solely with respect to non-qualified stock options, enGene Common Shares subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate exercise price; or by such other method as the Committee approves.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The term of an option cannot exceed 10 years from the date of grant, except that if an incentive stock option is granted to a 10% shareholder of the total combined voting power of all class of enGene securities, the term cannot exceed five years from the date of grant. In the event that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition on purchases or sales of enGene Common Shares under the enGene insider trading policy, or pursuant to any restrictions on transfer imposed by the Committee, the term of the non-qualified option will be extended for a period of 30 days following the end of the legal prohibition, or until the expiration of such restrictions on transfer, unless the Committee determines otherwise.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">58</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Except as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The Committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an option after termination of employment.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Awards</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant share awards. A share award is an award of enGene Common Shares that may be subject to restrictions as the Committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of pre-established criteria, in installments or otherwise, as the Committee may determine, including, but not limited to, restrictions based on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the share award, a participant will have all of the rights of a shareholder as to those shares, including the right to vote and the right to receive dividends or distributions on the shares. Dividends with respect to share awards that vest based on performance shall vest if and to the extent that the underlying share award vests, as determined by the Committee. All unvested share awards are forfeited if the participant&#x2019;s employment or service is terminated for any reason, unless the Committee determines otherwise.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Share Units</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant share units to anyone eligible to participate in the Incentive Equity Plan. Share units represent hypothetical enGene Common Shares. Share units become payable on terms and conditions determined by the Committee, including specified performance goals, and will be payable in cash, enGene Common Shares, or a combination thereof, as determined by the Committee. All unvested share units are forfeited if the participant&#x2019;s employment or service is terminated for any reason, unless the Committee determines otherwise.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Appreciation Rights</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with a non-qualified stock option may be granted either at the time the non-qualified stock option is granted or any time thereafter while the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the incentive stock option is made. The Committee will establish the base amount of the SAR at the time the SAR is granted, which will be equal to or greater than the fair market value of a enGene Common Share as of the date of grant.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number of enGene Common Shares that the participant may purchase upon exercising the related option during such period. Upon exercising the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent of an equal number of enGene Common Shares. Generally, SARs may only be exercised while the participant is employed by, or providing services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying enGene Common Shares over the base amount of the SAR. The appreciation of a SAR will be paid in enGene Common Shares, cash, or both.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The term of a SAR cannot exceed 10 years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is prohibited by applicable law, including a prohibition on purchases or sales of enGene Common Shares under enGene&#x2019;s insider trading policy, or pursuant to any restrictions on transfer imposed by the Committee, the term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, or until the expiration of such restrictions on transfer, unless the Committee determines otherwise.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Share-Based Awards</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant other types of awards that are based on, or measured by, enGene Common Shares, and granted to anyone eligible to participate in the Incentive Equity Plan.</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">59</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee will determine the terms and conditions of such awards. Other share-based awards may be payable in cash, enGene Common Shares or a combination of the two, as determined by the Committee.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dividend Equivalents</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the Committee may grant dividend equivalents in connection with grants of share units or other share-based awards made under the Incentive Equity Plan. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the shares underlying a grant while the grant is outstanding. The Committee will determine whether dividend equivalents will be paid currently or accrued as contingent cash obligations. Dividend equivalents may be paid in cash enGene Common Shares. The Committee will determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of specific performance goals. Dividend equivalents with respect to share units or other share-based awards that vest based on performance shall vest and be paid only if and to the extent that the underlying share units or other share-based awards vest and are paid as determined by the Committee.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Change of Control</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If enGene experiences a change of control where enGene is not the surviving company (or survives only as a subsidiary of another company), unless the Committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control will be assumed, or replaced with grants (with respect to cash, securities or a combination thereof) that have comparable terms, by the surviving company (or a parent or subsidiary of the surviving company).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If there is a change of control and all outstanding grants are not assumed, or replaced with grants that have comparable terms, by the surviving company, the Committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants, including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">determine that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding share awards, share units, and dividend equivalents immediately lapse;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">pay participants, in an amount and form determined by the Committee, in settlement of outstanding share units or dividend equivalents;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">require that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or enGene Common Shares, equal to the difference between the exercise price and the fair market value of the underlying enGene Common Shares; provided, however, if the per share fair market value of enGene Common Shares does not exceed the per share stock option exercise price or SARs base amount, as applicable, enGene will not be required to make any payment to the participant upon surrender of the stock option or SAR and shall have the right to cancel any such option or SAR for no consideration; or</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">after giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options and SARs on the date determined by the Committee.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In general terms, a change of control under the Incentive Equity Plan occurs if:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a person, entity or affiliated group, with certain exceptions, acquires more than 50% of the then- outstanding voting securities;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene merges into, or consummates an amalgamation or arrangement with, another entity unless the holders of voting shares immediately prior to such transaction have at least 50% of the combined voting power of the securities in the combined entity or its parent;</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">60</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene merges into, or consummates an amalgamation or arrangement with, another entity and the members of the enGene Board prior to such transaction would not constitute a majority of the board of the combined entity or its parent;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene sells or disposes of all or substantially all of the assets of enGene;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene consummates a complete liquidation or dissolution; or</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a majority of the members of the enGene Board are replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the incumbent directors.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Deferrals</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may permit or require participants to defer receipt of the payment of cash or the delivery of enGene Common Shares that would otherwise be due to the participant in connection with a grant under the Incentive Equity Plan. The Committee will establish the rules and procedures applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Withholding</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All grants under the Incentive Equity Plan are subject to applicable U.S. federal (including taxes under FICA), state, and local, foreign or other tax withholding requirements. enGene may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy such tax withholding requirements with respect to such grants, or enGene may deduct from other wages and compensation paid by enGene the amount of any withholding taxes due with respect to such grant.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may permit or require that tax withholding obligation with respect to grants paid in enGene Common Shares be paid by having shares withheld up to an amount that does not exceed the participant&#x2019;s minimum applicable withholding tax rate for U.S. federal (including FICA), state, and local tax liabilities, or as otherwise determined by the Committee. In addition, the Committee may, in its discretion, and subject to such rules as the Committee may adopt, allow participants to elect to have such share withholding applied to all or a portion of the tax withholding obligation arising in connection with any particular grant.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Transferability</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Except as permitted by the Committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during the participant&#x2019;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with respect to grants other than incentive stock options, pursuant to a domestic relations order. The Committee may provide in a grant instrument that a participant may transfer non-qualified stock options for no consideration to a permitted assign in compliance with applicable securities laws.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Amendment; Termination</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The enGene Board may amend or terminate the Incentive Equity Plan at any time, except that enGene shareholders must approve an amendment if such approval is required in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by the enGene Board or extended with shareholder approval, the Incentive Equity Plan will terminate on the day immediately preceding the tenth anniversary of the effective date of the Incentive Equity Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shareholder Approval</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Except as otherwise set out in the Incentive Equity Plan, shareholder approval is required (i) to reduce the exercise price or base price of outstanding stock options or SARs, (ii) to cancel outstanding stock options or SARs</font><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">61</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">in exchange for the same type of grant with a lower exercise price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current price of a enGene Common Share, in exchange for cash or other securities, each as applicable.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Clawback</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All grants under the Incentive Equity Plan (including any proceeds, gains or other economic benefit actually or constructively received upon receipt of any grant or receipt or resale of any enGene Common Shares underlying the grant) will be subject to any applicable policies implemented by the enGene Board, which may be adopted in the future and be amended from time to time, including any clawback or recoupment policies and share trading policies. Additionally, on November 22, 2023, the enGene Board adopted a Clawback Policy consistent with Nasdaq Listing Rule 5608, which requires enGene to recoup incentive-based compensation from current and former executive officers in the event of an accounting restatement, subject to certain exceptions as provided by the Listing Rule.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Performance Measures</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Incentive Equity Plan, the grant, vesting, exercisability or payment of certain awards, or the receipt of enGene Common Shares subject to certain awards, may be made subject to the satisfaction of performance measures. The performance goals applicable to a particular award will be determined by the Committee at the time of grant. One or more of the following business criteria for enGene may be used by the Committee in establishing performance measures under the Incentive Equity Plan: cash flow; free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation, amortization and charges for share-based compensation, earnings before interest, taxes, depreciation and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share; growth in earnings or earnings per share; book value growth; share price; return on equity or average shareholder equity; total shareholder return or growth in total shareholder return either directly or in relation to a comparative group; return on capital; return on assets or net assets; revenue, growth in revenue or return on sales; sales; expense reduction or expense control; expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution goals; other operational, regulatory or departmental objectives; budget comparisons; growth in shareholder value relative to established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting principles required to determine economic value added performance measures); measures of customer satisfaction, employee satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the completion of other similar transactions intended to enhance the enGene&#x2019;s revenue or profitability or enhance its customer base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals may be established on an absolute or relative basis and may be established on a corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable indices.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Retirement Plans</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We maintain a US tax-qualified retirement plan that provides eligible employees with an opportunity to save for retirement on a US tax-advantaged basis. All participants&#x2019; interests in their contributions are 100% vested when contributed. Contributions are allocated to each participant&#x2019;s individual account and are then invested in selected investment alternatives according to the participants&#x2019; directions. The retirement plan is intended to qualify under Section 401(a) of the Code. We contribute 3% of an individual&#x2019;s eligible compensation to the 401(k) Plan irrespective of employee contribution.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">62</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We maintain a Canadian tax-qualified retirement plan that provides eligible employees with an opportunity to save for retirement on a Canadian tax-advantaged basis. All participants&#x2019; interests in their contributions are 100% vested when contributed. Contributions are allocated to each participant&#x2019;s individual account and are then invested in selected investment alternatives according to the participants&#x2019; directions. We contribute 1.5% to the Registered Retirement Savings Plan (RRSP) irrespective of employee contribution.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="director_compensation"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DIRECTOR C</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OMPENSATION</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enGene&#x2019;s non-employee directors did not receive any compensation, equity or non-equity awards for the fiscal year-ended October 31, 2023. We reimburse non-employee members of the Board for reasonable travel expenses incurred in attending meetings of the Board and committees of the Board. See the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Summary Compensation Table</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; above for a discussion of our Chief Executive Officer&#x2019;s compensation and awards granted in 2023.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">63</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="equity_compensation_plan_information"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EQUITY COMPENSATIO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">N PLAN INFORMATION</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth summary information relating to our 2023 Incentive Equity Plan as of October 31, 2023:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.42%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:11.24%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.4%;"></td>
    <td style="width:1%;"></td>
    <td style="width:10.700000000000001%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:11.24%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
    <td style="text-indent:5pt;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Plan Category</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of securities to be issued upon exercise of outstanding options, warrants and rights</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted-average exercise price of outstanding options, warrants and rights</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))</font></p></td>
    <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity compensation plans approved by securityholders</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,706,941</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.40</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,607,943</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity compensation plans not approved by securityholders</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,706,941</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.40</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,607,943</font></p></td>
    <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares initially reserved for issuance under the Incentive Equity Plan is 2,607,943 shares of common stock, plus 2,706,941 shares of common stock subject to the outstanding grants under the Old enGene&#x2019;s employee share option plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ESOP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and an equity incentive plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EIP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prior Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) which was adopted by the Board of Directors, and approved by the shareholders, effective July 5, 2018.    The 2023 Incentive Equity Plan includes an evergreen provision pursuant to which, commencing with the first business day of each calendar year beginning in 2024, the Plan Share Reserve, and the ISO Sublimit, increase by a number of Common Shares equal to the lesser of (x) 1,946,226 million Common Shares and (y) such lesser number of Common Shares as may be determined by the Compensation Committee. Pursuant to this Existing Evergreen Provision, on January 2, 2024, the Plan Share Reserve was increased by 1,946,226 to 7,261,110 Common Shares and the ISO Sublimit was increased by 1,946,226 to 4,554,167.  At the Annual Meeting, the shareholders will be asked to vote to adopt the Amended Evergreen Provision, as described in Proposal 2 herein.  If the Amended Evergreen Provision is not adopted by the shareholders at the Annual Meeting, the Existing Evergreen Provision will remain in effect.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">64</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="directors_approval"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DIRECTOR</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">S&#x2019; APPROVAL</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The contents of this proxy statement and its distribution to shareholders have been approved by the Board of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DATED</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> April 18, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">BY ORDER OF THE BOARD</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">/s/ </font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason D. Hanson</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Executive Officer and Director</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">65</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;" id="schedule_a"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SCHEDU</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LE A</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ENGENE HOLDINGS INC. MANDATE OF THE BOARD</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adopted October 31, 2023</font></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This Board Mandate (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mandate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) has been adopted by the board of directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of enGene Holdings Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">I.</font><div style="width:100%;display:inline;" id="i__purpose"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PURPOSE</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The purpose of this Mandate is to describe the principal duties and responsibilities of the Board, as well as some of the policies and procedures that apply to the Board in discharging its duties and responsibilities.</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">II.</font><div style="width:100%;display:inline;" id="ii__application"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">APPLICATION</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board will be granted unrestricted access to all information regarding the Company that is necessary or desirable to fulfill its duties. The Board shall have the authority to, at its sole discretion and at the Company&#x2019;s expense, retain and set the compensation of outside legal or other advisors, as necessary to assist in the performance of its duties and responsibilities.</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">III.</font><div style="width:100%;display:inline;" id="iii__composition_and_meetings"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">COMPOSITION AND MEETINGS</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board shall be comprised of that number of directors as shall be determined from time to time by the Board upon recommendation of the Nominating and Corporate Governance Committee of the Board, in accordance with the Company&#x2019;s constating documents and any agreements or other arrangements concerning the size of the Board. The Board will be comprised of a majority of &#x201c;independent&#x201d; directors within the meaning of the applicable listing standards of Nasdaq and National Instrument 58-101 &#x2013; </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Corporate Governance Guidelines </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adopted by the Canadian Securities Administrators; subject to any allowances permitted during the phase-in compliance periods under the Nasdaq Rule 5615(b)(1).</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At the appropriate time, and from time to time, the Board shall choose one of its members to be its Chair by majority vote, which Chair shall have the duties and responsibilities set out in Section V. The Chair should be an independent director. Where this is not appropriate, an independent director will be appointed to act as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lead Director</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board may delegate certain matters it is responsible for to the committees of the Board. The Board shall appoint from among its members the members of each committee of the Board, in consultation with the relevant committee of the Board. The Board will, however, retain its oversight function and ultimate responsibility for such matters and associated delegated responsibilities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board will meet at least quarterly, or more frequently as circumstances dictate. Each director has a responsibility to attend and participate in meetings of the Board. The Board and the Chair may invite any executive, employee or such other person or external advisor as it deems appropriate to attend and participate in any portion of any Board meeting, and may exclude from all or any portion of its meetings any person it deems appropriate in order to carry out its responsibilities. The independent members of the Board will also meet in camera, as required, without the non&#x2010;independent directors and members of management before or after each regularly scheduled meeting.</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">IV.</font><div style="width:100%;display:inline;" id="iv__responsibilities_and_duties_of_the_b"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RESPONSIBILITIES AND DUTIES OF THE BOARD</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board is responsible for the stewardship of the Company and providing oversight as to the management of the business and affairs of the Company. It is management&#x2019;s duty to run the Company&#x2019;s business on a day&#x2010;to-day basis. The Board is expected to focus on guidance and strategic oversight, with the goal of increasing long-term</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shareholder value. In discharging their duties, directors must act honestly and in good faith, with a view to the best interests of the Company. Directors must exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The responsibilities and duties of the Board shall include the following:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Chief Executive Officer and Officers</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Appointing the Chief Executive Officer (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CEO</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and, together with the CEO, developing the roles and responsibilities of the CEO.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delegate to the CEO and other senior executives the authority over the day-to-day management of the business and affairs of the Company.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Developing the corporate goals and objectives that the CEO is responsible for meeting and reviewing the performance of the CEO against such corporate goals and objectives.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taking steps to satisfy itself as to the integrity of the CEO and other executive officers and that the CEO and other executive officers create a culture of integrity throughout the organization.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Succession planning for the CEO and other key personnel.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Approving the compensation of the CEO upon recommendation of the Compensation Committee.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Reporting</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Approving:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the annual financial statements and related Management&#x2019;s Discussion and Analysis, and their filing and disclosure; and</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company&#x2019;s annual earnings press releases, including any pro forma or non- GAAP information included therein, and their filing and disclosure.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reviewing and monitoring, with the assistance of the Audit Committee:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the quality and integrity of the Company&#x2019;s financial statements;</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the external reporting of the Company&#x2019;s financial and operating performance in compliance with all regulatory and statutory requirements; and</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the appointment and performance of the external auditor.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Reporting Processes, Accounting Policies and Internal Controls</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reviewing and monitoring, with the assistance of the Audit Committee:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the adequacy and effectiveness of the Company&#x2019;s system of internal controls over financial reporting, including any significant deficiencies and significant changes in internal controls; and</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the quality and integrity of the Company&#x2019;s external financial reporting processes.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Ethical and Legal Compliance and Risk Management</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reviewing and approving the Company&#x2019;s Code of Business Conduct and Ethics.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reviewing and monitoring:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">compliance with the Code of Business Conduct and Ethics and other ethical standards adopted by the Company; and</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company&#x2019;s compliance with applicable legal and regulatory requirements, though notwithstanding the foregoing and subject to applicable law, nothing contained in this Mandate is intended to require the Board to ensure the Company&#x2019;s compliance with applicable laws or regulations.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In conjunction with management, identifying the principal risks of the Company&#x2019;s business and reviewing and monitoring management&#x2019;s implementation of appropriate systems to seek to effectively monitor, manage and mitigate the impact of such risks.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Responsibilities</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adopting a strategic planning process to establish objectives and goals for the Company&#x2019;s business and reviewing, approving and modifying, as appropriate, the strategies proposed by management to achieve such objectives and goals.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reviewing and approving the Company&#x2019;s financial objectives, plans and actions, including significant capital allocations and expenditures.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reviewing and approving material transactions not in the ordinary course of business.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In consultation with management, overseeing and reviewing the Company&#x2019;s procedures with respect to the Company&#x2019;s public disclosure, including the Disclosure Policy, to ensure that communications with the public are timely, factual, accurate and broadly disseminated in accordance with all applicable legal and regulatory requirements.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adopting appropriate procedures designed to permit the Board to receive feedback from shareholders on material issues.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In conjunction with the Nominating and Corporate Governance Committee, providing an orientation program for new directors to the Board and continuing education opportunities for all directors.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Overseeing the assessment by the Nominating and Corporate Governance Committee, each committee and each director.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Developing and overseeing a method for interested parties to communicate directly with the Board.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Performing any other activities consistent with this Mandate, the Company&#x2019;s constating documents, and governing laws that the Board determines are necessary or appropriate.</font></div></div>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">V.</font><div style="width:100%;display:inline;" id="v__responsibilities_and_duties_of_the_ch"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RESPONSIBILITIES AND DUTIES OF THE CHAIR</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The responsibilities and duties of the Chair shall include the following:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Providing overall leadership to enhance the effectiveness and performance of the Board, the committees of the Board, and individual directors of the Board.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chair meetings of the Board.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chair the annual general meeting, and any special meetings, of the shareholders.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In consultation with the Corporate Secretary, if any, determine the frequency, dates and locations of meetings of the Board and ensure that regular minutes of Board proceedings are kept and circulated on a timely basis for review and approval.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In consultation with the CEO, the Chief Financial Officer, the Corporate Secretary, if any, and others as required, review the annual work plan and the meeting agendas so as to bring all required business before the Board.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As appropriate, carry out any other or special assignments or any functions as may be requested by the Board or management.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If the Chair is not an independent director then the Lead Director should act as the effective leader of the Board and ensure the Board&#x2019;s agenda will enable it to successfully carry out its duties.</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">VI.</font><div style="width:100%;display:inline;" id="vi__limitation_on_the_board_s_duties"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LIMITATION ON THE BOARD&#x2019;S DUTIES</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board shall discharge its responsibilities, and shall assess the information provided by the Company&#x2019;s management and any external advisors, including the external auditor, in accordance with its business judgment. Members of the Board are entitled to rely, absent knowledge to the contrary, on the integrity of the persons and organizations from whom they receive information, the accuracy and completeness of the information provided and representations made by management as to any audit or non-audit services provided by the external auditor.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nothing in this Mandate is intended or may be construed as imposing on any member of the Board a standard of care or diligence that is in any way more onerous or extensive than the standard to which the directors are subject under applicable law. This Mandate is not intended to change or interpret the constating documents of the Company or any federal, provincial, state or exchange law, regulation or rule to which the Company is subject, and this Mandate should be interpreted in a manner consistent with all such applicable laws, regulations and rules. The Board may, from time to time, permit departures from the terms hereof, either prospectively or retrospectively, and no provision contained herein is intended to give rise to civil liability to shareholders, competitors, employees or other persons, or to any other liability whatsoever.</font></p>
  <div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">VII.</font><div style="width:100%;display:inline;" id="vii__review_of_mandate"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">REVIEW OF MANDATE</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Nominating and Corporate Governance Committee of the Board will review and reassess the adequacy of this Mandate from time to time and recommend any proposed changes to the Board for approval.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="schedule_b"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SCHED</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ULE B</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ENGENE HOLDINGS INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AMENDED AND RESTATED </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023 INCENTIVE EQUITY PLAN</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Effective as of the Effective Date (as defined below), the enGene Holdings Inc. 2023 Incentive Equity Plan (as </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">amended and restated May [&#x25cf;], 2024 and as </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">in effect from time to time, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is hereby established.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The purpose of the Plan is to provide employees, certain consultants and advisors, and the non-employee members of the Board of Directors, of enGene Holdings Inc., a company organized under the laws of Canada that that intends to continue as a company governed by the </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Business Corporations Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (British Columbia) (together with its successors, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and its subsidiaries, with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, share awards, share units, and other share-based awards.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company believes that the Plan will encourage the participants to contribute materially to the growth of the Company, thereby benefitting the Company&#x2019;s shareholders, and will align the economic interests of the participants with those of the shareholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the consummation of the transactions contemplated under the Business Combination Agreement, (i) the amended and restated equity incentive plan of enGene Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Corporation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) dated June 29, 2021 and as may be further amended and/or restated from time to time, and (ii) each other plan that provides for the award to any current or former director, manager, officer, employee, individual independent contractor or other individual service provider of the Company, the Corporation and any of their subsidiaries (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Group Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of rights of any kind to receive equity securities of any Group Company or benefits measured in whole or in part by reference to equity securities of any Group Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prior Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), will be converted and exchanged into rights to acquire shares of the Company as set forth in the Business Combination Agreement, with such equity security rights to be merged into and converted into grants under the Plan. No additional grants shall be made under the Prior Plans after the Effective Date.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 1. Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following terms has the meanings set forth below for purposes of the Plan:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">409A</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means Section 409A of the Code.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Board of Directors of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Business Combination Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means that certain Business Combination Agreement, dated as of May 16, 2023, by and among Forbion European Acquisition Corp., a Cayman Islands exempted company, enGene Inc., a corporation existing under the laws of Canada, the Company, and the other persons named therein and party thereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Canadian Employees</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means officers, employees, and non-employee members of the Board, or a corporation that does not deal at arm&#x2019;s length with the Company for purposes of the Tax Act, who are residents of Canada for purposes of the Tax Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning given to that term in any written employment agreement, offer letter or severance or termination agreement between the Employer and the Participant, or if no such agreement exists or if such term is not defined therein, and unless otherwise defined in the Grant Instrument, Cause means a finding by the Committee that the Participant (i) has breached his or her employment or service contract with the Employer, (ii) has engaged in disloyalty to the Employer, including, without limitation, fraud, embezzlement, theft, commission of a felony, indictable offence or proven dishonesty, (iii) has disclosed trade secrets or confidential information of the Employer to persons not entitled to receive such information, (iv) has breached any written non-competition,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">non-solicitation, invention assignment or confidentiality agreement between the Participant and the Employer or (v) has engaged in such other behavior detrimental to the interests of the Employer as the Committee determines.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CEO</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Chief Executive Officer of the Company (or if there is none then appointed, the President of the Company).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;, unless otherwise set forth in a Grant Instrument, shall be deemed to have occurred if:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) Any &#x201c;person&#x201d; (as such term is used in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">s 13(d) and 14(d) of the Exchange Act) becomes a &#x201c;beneficial owner&#x201d; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the voting power of the then outstanding securities of the Company; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that a Change of Control shall not be deemed to occur as a result of a transaction in which the Company becomes a direct or indirect subsidiary of another Person and in which the shareholders of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares of such other Person representing more than 50% of the voting power of the then outstanding securities of such other Person.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) The consummation of (A) an amalgamation, arrangement, merger, consolidation or other form of business combination of the Company with another Person where, immediately after such transaction, the shareholders of the Company, immediately prior to such transaction, will not beneficially own, in substantially the same proportion as ownership immediately prior to such transaction, shares entitling such shareholders to more than 50% of all votes to which all shareholders of the surviving Person would be entitled in the election of directors, or where the members of the Board, immediately prior to such transaction, will not, immediately after such transaction, constitute a majority of the board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all of the assets of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iii) A change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases, by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or nomination.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iv) The consummation of a complete dissolution or liquidation of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may modify the definition of Change of Control for a particular Grant as the Committee deems appropriate to comply with 409A or otherwise. Notwithstanding the foregoing, if a Grant constitutes deferred compensation subject to 409A and the Grant provides for payment upon a Change of Control, then, for purposes of such payment provisions, no Change of Control shall be deemed to have occurred upon an event described in items (i) &#x2013; (iv) above unless the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under 409A.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Share</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall mean the common shares of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan and to the extent the Board does not appoint a committee, the Board can serve as the Committee. The Committee shall consist of Directors who are &#x201c;non-employee directors&#x201d; as defined under Rule 16b-3 promulgated under the Exchange Act and &#x201c;independent directors,&#x201d; as determined in accordance with the independence standards established by the stock exchange on which the Common Shares are at the time primarily traded.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consultant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a person other than an Employee, officer or Director of the Company or of any of its subsidiaries that:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) is engaged to provide bona fide services to the Company or a Related Entity of the Company, other than services provided in relation to a distribution, the offer and sale of securities in a capital-raising transaction, or, directly or indirectly, to promote or maintain a market for the Company&#x2019;s securities;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) provides the services under a written contract with the Company or a Related Entity of the Company; and</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iii) spends or will spend a significant amount of time and attention on the affairs and business of the Company or a Related Entity of the Company; and includes</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iv) for an individual consultant, a corporation of which the individual consultant is an employee or shareholder, and a partnership of which the individual consultant is an employee or partner; and</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(v) for a consultant that is not an individual, an employee, executive officer, or director of the consultant, provided that the individual employee, executive officer, or director spends or will spend a significant amount of time and attention on the affairs and business of the Company or a Related Entity of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Director</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a member of the Board of the Company or any of its subsidiaries.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Disabled</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, unless otherwise set forth in the Grant Instrument, a Participant&#x2019;s becoming disabled within the meaning of the Employer&#x2019;s long-term disability plan applicable to the Participant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dividend Equivalent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an amount determined by multiplying the number of Common Shares subject to a Share Unit or Other Share-Based Award by the per-share cash dividend paid by the Company on its outstanding Common Shares, or the per-share Fair Market Value of any dividend paid on its outstanding Common Shares in consideration other than cash. If interest is credited on accumulated divided equivalents, the term &#x201c;Dividend Equivalent&#x201d; shall include the accrued interest.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the effective date of the consummation of the merger contemplated by the Business Combination Agreement, subject to approval of the Plan by the shareholders of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employed by, or providing service to, the Employer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means employment or service as an Employee, Consultant or member of the Board (so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Share Awards, Share Units, and Other Share-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be an Employee, Consultant or member of the Board), unless the Committee determines otherwise. If a Participant&#x2019;s relationship is with a subsidiary of the Company and that entity ceases to be a subsidiary of the Company, the Participant will be deemed to cease employment or service when the entity ceases to be a subsidiary of the Company, unless the Participant transfers employment or service to an Employer.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(j) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an employee of the Employer (including an officer or Director who is also an employee), but excluding any person who is classified by the Employer as a &#x201c;contractor&#x201d; or &#x201c;consultant,&#x201d; no matter how characterized by the Internal Revenue Service, other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(k) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employer</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Company and its subsidiaries.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(l) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Securities Exchange Act of 1934, as amended.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(m) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the per share price at which Common Shares may be purchased under an Option, as designated by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(n) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fair Market Value</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) For so long as the Common Shares are publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market for the Common Shares is a national securities exchange, the closing sales price during regular trading hours on the relevant date or, if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Common Shares are not principally traded on any such exchange, the last reported sale price of a share of Common Shares during regular trading hours on the relevant date, as reported by the OTC Bulletin Board.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) If the Common Shares are not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair Market Value per share shall be determined in good faith by the Committee through any reasonable valuation method authorized under the Code or Tax Act, if applicable, and commonly used to value privately held stock.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(o) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GAAP</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means United States generally accepted accounting principles.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(p) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an Option, SAR, Share Award, Share Unit or Other Share-Based Award granted under the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(q) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grant Instrument</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the written agreement that sets forth the terms and conditions of a Grant, including all amendments thereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(r) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Incentive Stock Option</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an Option that is intended to meet the requirements of an incentive stock option under Section 422 of the Code.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(s) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-Employee Director</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a Director who is not an Employee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(t) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonqualified Stock Option</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an Option that is not intended to be taxed as an incentive stock option under Section 422 of the Code.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(u) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an option to purchase Common Shares, as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(v) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Share-Based Award</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any Grant based on, measured by or payable in Common Shares (other than an Option, Share Unit, Share Award, or SAR), as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(w) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Participant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an Employee, Consultant or Non-Employee Director designated by the Committee to participate in the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(x) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Performance Goals</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means performance goals that may include, but are not limited to, one or more of the following criteria: cash flow; free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation, amortization and charges for share-based compensation, earnings before interest, taxes, depreciation and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share; growth in earnings or earnings per share; book value growth; share price; return on equity or average shareholder equity; total shareholder return or growth in total shareholder return either directly or in relation to a comparative group; return on capital; return on assets or net assets; revenue, growth in revenue or return on sales; sales; expense reduction or expense control; expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution goals; other operational, regulatory or departmental objectives; budget comparisons; growth in shareholder value relative to established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or organizational restructuring goals; development and</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">implementation of risk and crisis management programs; improvement in workforce diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting principles required to determine economic value added performance measures); measures of customer satisfaction, employee satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the completion of other similar transactions intended to enhance the Company&#x2019;s revenue or profitability or enhance its customer base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance Goals applicable to a Grant shall be determined by the Committee, and may be established on an absolute or relative basis and may be established on a corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable indices.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(y) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated association, joint venture, governmental authority or other legal entity of any nature whatsoever.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(z) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Related Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, for the Company, a person that controls or is controlled by the Company or that is controlled by the same person that controls the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(aa) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restriction Period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning given that term in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 7(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(bb) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SAR</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a stock appreciation right, as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(cc) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Share Award</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an award of Common Shares, as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 7</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(dd) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Share Unit</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an award of a phantom unit representing a Common Share, as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ee) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Substitute Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; has the meaning given that term in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 4(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ff) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tax Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Income Tax Act (Canada), as amended, including any applicable regulations and guidance thereunder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(gg) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Termination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, in respect of a Canadian Employee, the date that an Employee ceases to provide services to, or otherwise ceases its relationship with, the Employer on a permanent basis, for any reason, whether lawful or otherwise (including, without limitation by reason of termination for Cause, termination without Cause, resignation, death or disability), without regard to any applicable period of notice, payment in lieu of notice, severance pay, termination pay, benefits continuation, or similar compensation and/or benefits to which the Employee may then be entitled, subject only to the express minimum requirements of applicable employment or labour standards legislation (if applicable).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 2. Administration</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Plan shall be administered and interpreted by the Committee; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, however, that any Grants to members of the Board must be authorized by a majority of the Board (counting all Board members for purposes of a quorum, but only non-interested Board members for purposes of such majority approval). The Committee may delegate authority to one or more subcommittees, as it deems appropriate. Subject to compliance with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder in any individual instance (without any need for any formal assumption of authority from the Committee). To the extent that the Board, a subcommittee or the CEO, as described below administers the Plan, references in the Plan to the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; shall be deemed to refer to the Board or such subcommittee or the CEO.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delegation to CEO</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to compliance with applicable law and applicable stock exchange requirements, so long as the CEO is also a Director, the Committee may delegate all or part of its authority and</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">power to the CEO, as it deems appropriate, with respect to Grants to Employees or Consultants who are not executive officers under Section 16 of the Exchange Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee Authority</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee shall have the sole authority to (i) determine the individuals to whom Grants shall be made under the Plan, (ii) determine the type, size, terms and conditions of the Grants to be made to each such individual, (iii) determine the time when the Grants will be made and the duration of any applicable exercise or Restriction Period, including the criteria for exercisability and the acceleration of exercisability, (iv) amend the terms of any previously issued Grant, subject to the provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 17</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> below, (v) determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply to individuals residing outside of the United States who receive Grants under the Plan, and (vi) deal with any other matters arising under the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee Determinations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&#x2019;s interpretations of the Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all Persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform as to similarly situated individuals.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No member of the Committee or the Board, and no employee of the Company shall be liable for any act or failure to act with respect to the Plan, except in circumstances involving his or her bad faith or willful misconduct, or for any act or failure to act hereunder by any other member of the Committee or employee or by any agent to whom duties in connection with the administration of this Plan have been delegated. The Company shall indemnify members of the Committee and the Board and any agent of the Committee or the Board who is an employee of the Company or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such Person&#x2019;s bad faith or willful misconduct.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 3. Grants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants under the Plan may consist of Options as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, Share Awards as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 7</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, Share Units as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, SARs as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and Other Share-Based Awards as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All Grants shall be subject to the terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate and as are specified in writing by the Committee to the individual in the Grant Instrument. All Grants shall be made conditional upon the Participant&#x2019;s acknowledgement, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 4. Shares Subject to the Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shares Authorized</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adjustment as</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the increases described in this Section 4(a), and the adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> described below in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sections 4(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> below, </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the aggregate number of Common Shares that may be issued or transferred under the Plan </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shall be 2,607,943 Common Shares, plus</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(the &#x201c;Plan Share Reserve&#x201d;) shall be 7,261,110 (consisting of</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> 2,706,941 Common Shares subject to outstanding grants under the Prior Plan as of the Effective Date</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, 2,607,943 additional Common Shares as of the Effective Date and 1,946,226 additional Common Shares added pursuant to this Section 4(a) as of January 2, 2024), and (ii) the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> aggregate number of Common Shares </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">in the Plan Share Reserve </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">that may be issued or transferred under the Plan pursuant to Incentive Stock Options </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(the &#x201c;ISO Sublimit&#x201d;) </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shall not exceed </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,607,943</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,554,169</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Common Shares. Commencing with the first business day of each calendar year beginning in </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024, the aggregate number of Common Shares that may be issued or transferred under</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025, (i)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Plan </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Share Reserve </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shall be increased by a number equal to the lesser of (x) </font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,946,226 million</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5% of the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Common Shares </font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the Company issued and outstanding on the final day of the immediately preceding calendar year </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and (y) such lesser number of Common Shares as may be determined by the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Committee</font><font style="color:#ff0000;white-space:pre-wrap;text-decoration:line-through;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and (ii) the ISO Sublimit shall be increased by the lesser of (x) 2,500,000 Common Shares,  (y) the increase in the Plan Share Reserve pursuant to clause (i) of this sentence, and (z) such lesser number of Common Shares as may be determined by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Source of Shares; Share Counting</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Shares issued or transferred under the Plan may be authorized but unissued Common Shares or reacquired Common Shares, including shares purchased by the Company on the open market for purposes of the Plan. If and to the extent Options or SARs granted under the Plan (including options or SARs granted under the Prior Plan, if any), expire or are canceled, forfeited, exchanged or surrendered without having been exercised, or if any Share Awards, Share Units or Other Share-Based Awards (including options or SARs granted under the Prior Plan, if any) are forfeited, terminated or otherwise not paid in full, the shares subject to such Grants shall again be available for purposes of the Plan. If Common Shares otherwise issuable under the Plan are surrendered in payment of the Exercise Price of an Option, then the number of Common Shares available for issuance under the Plan shall be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of Common Shares available for issuance under the Plan shall be reduced by only by the net number of shares actually issued by the Company upon such exercise. If Common Shares otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with the issuance, vesting or exercise of any Grant or the issuance of Common Shares thereunder, then the number of Common Shares available for issuance under the Plan shall be reduced by the net number of shares issued, vested or exercised under such Grant, calculated in each instance after payment of such share withholding. To the extent any Grants are paid in cash, and not in Common Shares, any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. For the avoidance of doubt, if shares are repurchased by the Company on the open market with the proceeds of the Exercise Price of Options, such shares may not again be made available for issuance under the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Substitute Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted awards of a company acquired by the Company in a transaction (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Substitute Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) shall not reduce the number of Common Shares available under the Plan and available shares under a shareholder approved plan of an acquired company (as appropriately adjusted to reflect the transaction) may be used for Grants under the Plan and shall not reduce the Plan&#x2019;s share reserve (subject to applicable stock exchange listing and Code or Tax Act requirements).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Individual Limits for Non-Employee Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to adjustment as described below in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the maximum aggregate grant date value of Common Shares subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash fees earned by such Non-Employee Director for services rendered during the calendar year, shall not exceed $500,000 in total value; provided, however, that with respect to the year during which the Non-Employee Director is first appointed or elected to the Board, the maximum aggregate grant date value of Common Shares granted to such Non-Employee Director during the initial annual period, taken together with any cash fees earned by such Non-Employee Director for services rendered during such period, shall not exceed $750,000 in total value during the initial annual period. For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial reporting purposes.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If there is any change in the number or kind of Common Shares outstanding by reason of (i) a stock dividend, spinoff, recapitalization, stock split, or combination or exchange of shares, (ii) a merger, amalgamation, reorganization or consolidation, (iii) a reclassification or change in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Common Shares as a class without the Company&#x2019;s receipt of consideration, or if the value of outstanding Common Shares is substantially reduced as a result of a spinoff or the Company&#x2019;s payment of an extraordinary dividend or distribution, the maximum number and kind of Common Shares available for issuance under the Plan, the maximum amount of Grants which a Non-Employee Director may receive in any year, the number and kind of shares covered by outstanding Grants, the number and kind of shares issued and to be issued under the Plan, and the price per share or the applicable market value of such Grants shall be equitably adjusted by the Committee to reflect any increase or decrease in the number of, or change in the kind or value of, the issued Common Shares to preclude, to the extent practicable, the enlargement or dilution of rights and benefits under the Plan and such outstanding Grants; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, however, that any fractional shares resulting from such adjustment shall be eliminated. In addition, in the event of a Change of Control, the provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 12</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shall apply. Any adjustments to outstanding Grants to individuals subject to U.S. income tax shall be consistent with</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 409A or Section 424 of the Code, to the extent applicable. The adjustments of Grants under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 4(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shall include adjustment of shares, Exercise Price of Stock Options, base amount of SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final, binding and conclusive.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 5. Eligibility for Participation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Eligible Persons</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All Employees, Non-Employee Directors and Consultants shall be eligible to participate in the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Selection of Participants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee shall select the Employees, Non-Employee Directors and Consultants to receive Grants and shall determine the number of Common Shares subject to a particular Grant in such manner as the Committee determines.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Voluntary Participation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Participation in the Plan will be entirely voluntary and any decision not to participate will not affect any Employee&#x2019;s, Non-Employee Director&#x2019;s or Consultant&#x2019;s employment or other service relationship with the Company or any of its subsidiaries.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 6. Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may grant Options to an Employee, Non-Employee Director or Consultant upon such terms as the Committee deems appropriate. The following provisions are applicable to Options:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee shall determine the number of Common Shares that will be subject to each Grant of Options to Employees, Non-Employee Directors and Consultants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Type of Option and Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) The Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Company or its parent or subsidiary corporations, as defined in Section 424 of the Code, who are subject to U.S. income tax. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and Consultants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) The Exercise Price of Common Shares subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair Market Value of the Common Shares on the date the Option is granted. However, an Incentive Stock Option may not be granted to an Employee who, at the time of grant, owns securities possessing more than 10% of the total combined voting power of all classes of securities of the Company, or any parent or subsidiary corporation of the Company, as defined in Section 424 of the Code, unless the Exercise Price per share is not less than 110% of the Fair Market Value of the Common Shares on the date of grant. Notwithstanding the foregoing, the Exercise Price of any Option granted to a Canadian Employee shall under no circumstances be less than 100% of the Fair Market Value on the date the Option is granted.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option Term</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant. However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns securities possessing more than 10% of the total combined voting power of all classes of securities of the Company, or any parent or subsidiary corporation of the Company, as defined in Section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited by applicable law, including a prohibition on purchases or sales of Common Shares under the Company&#x2019;s insider trading policy, the term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercisability of Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Options shall become exercisable in accordance with such terms and conditions, consistent with the Plan, as may be determined by the Committee and specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options at any time for any reason.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants to Non-Exempt Employees</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may become exercisable, as determined by the Committee, upon the Participant&#x2019;s death, Disability or retirement, or upon a Change of Control or other circumstances permitted by applicable regulations).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Termination of Employment or Service</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Except as provided in the Grant Instrument, an Option may only be exercised while the Participant is employed by, or providing services to, the Employer (and in the case of a Canadian Employee, prior to a Termination Date). The Committee shall determine in the Grant Instrument under what circumstances and during what time periods a Participant may exercise an Option after termination of employment or service.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise of Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise to the Company. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash, (ii) unless the Committee determines otherwise, by delivering Common Shares owned by the Participant and having a Fair Market Value on the date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of Common Shares having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, and solely with respect to Nonqualified Stock Options, by withholding Common Shares subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise Price, or (v) by such other method as the Committee may approve. Common Shares used to exercise an Option shall have been held by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes, must be received by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance or transfer of such shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Limits on Incentive Stock Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Common Shares on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option, as to the excess, shall be treated as a Nonqualified Stock Option.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 7. Share Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may issue or transfer Common Shares to an Employee, Non-Employee Director or Consultant under a Share Award, upon such terms as the Committee deems appropriate. The following provisions are applicable to Share Awards:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Common Shares issued or transferred pursuant to Share Awards may be issued or transferred subject to restrictions or no restrictions, as determined by the Committee. The Committee may, but shall not be required to, establish conditions under which restrictions on Share Awards shall lapse over a period of time or according to such other criteria as the Committee deems appropriate, including, without limitation, restrictions based on the achievement of specific Performance Goals. The period of time during which the Share Awards will remain subject to restrictions will be designated in the Grant Instrument as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restriction Period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee shall determine the number of Common Shares to be issued or transferred pursuant to a Share Award and the restrictions applicable to such shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Requirement of Employment or Service</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If the Participant ceases to be employed by, or provide service to, the Employer (or in the case of a Canadian Employee, a Termination Date occurs) during a period designated in</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Share Award shall terminate as to all shares covered by the Grant as to which the restrictions have not lapsed, and those Common Shares must be immediately returned to the Company. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restrictions on Transfer and Legend on Share Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. During the Restriction Period, a Participant may not sell, assign, transfer, pledge or otherwise dispose of the shares of a Share Award except under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 15</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Unless otherwise determined by the Committee, the Company will retain possession of certificates for shares of Share Awards until all restrictions on such shares have lapsed. Each certificate for a Share Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Participant shall be entitled to have the legend removed from the share certificate covering the shares subject to restrictions when all restrictions on such shares have lapsed. The Committee may determine that the Company will not issue certificates for Share Awards until all restrictions on such shares have lapsed.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Right to Vote and to Receive Dividends</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall have the right to vote shares of Share Awards and to receive any dividends or other distributions paid on such shares, subject to any restrictions deemed appropriate by the Committee, including, without limitation, the achievement of specific Performance Goals.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dividends with respect to Share Awards that vest based on performance shall vest if and to the extent that the underlying Share Award vests, as determined by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lapse of Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All restrictions imposed on Share Awards shall lapse upon the expiration of the applicable Restriction Period and the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Share Awards, that the restrictions shall lapse without regard to any Restriction Period.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 8. Share Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may grant Share Units, each of which shall represent one hypothetical Common Share, to an Employee, Non-Employee Director or Consultant upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to Share Units:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Crediting of Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Each Share Unit shall represent the right of the Participant to receive a Common Share or an amount of cash based on the value of a Common Share, if and when specified conditions are met. All Share Units shall be credited to bookkeeping accounts established on the Company&#x2019;s records for purposes of the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Terms of Share Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee may grant Share Units that vest and are payable if specified Performance Goals or other conditions are met, or under other circumstances. Share Units may be paid at the end of a specified performance period or other period, or payment may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any or all Share Units at any time for any reason, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> such acceleration complies with 409A. The Committee shall determine the number of Share Units to be granted and the requirements applicable to such Share Units. Notwithstanding anything to the contrary, the vesting period for Share Units granted to a Canadian Employee shall, in all cases, be in compliance with the requirements pertaining to the exception to the application of the salary deferral arrangement rules in paragraph (k) of the definition of &#x201c;salary deferral arrangement&#x201d; in subsection 248(1) of the Tax Act, as such subsection may be amended or enacted from time to time.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Requirement of Employment or Service</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If the Participant ceases to be employed by, or provide service to, the Employer (or in the case of a Canadian Employee, a Termination Date occurs) prior to the vesting of Share Units, or if other conditions established by the Committee are not met, the Participant&#x2019;s Share Units shall be forfeited. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Payment With Respect to Share Units</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Payments with respect to Share Units shall be made in cash, Common Shares or any combination of the foregoing, as the Committee shall determine.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Canadian Employees</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All Share Units granted to Canadian Employees shall be in compliance with the requirements pertaining to the exception to the application of the salary deferral arrangement rules in paragraph (k) of the definition of &#x201c;salary deferral arrangement&#x201d; in subsection 248(1) of the Tax Act, as such subsection may be amended or enacted from time to time.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 9. Stock Appreciation Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may grant SARs to an Employee, Non-Employee Director or Consultant separately or in tandem with any Option. The following provisions are applicable to SARs:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee may grant SARs to an Employee, Non-Employee Director or Consultant separately or in tandem with any Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any time thereafter while the Option remains outstanding; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, however, that, in the case of an Incentive Stock Option, SARs may be granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR at the time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a Common Share as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the foregoing, in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a prohibition on purchases or sales of Common Shares under the Company&#x2019;s insider trading policy, the term shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tandem SARs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period shall not exceed the number of Common Shares that the Participant may purchase upon the exercise of the related Option during such period. Upon the exercise of an Option, the SARs relating to the Common Shares covered by such Option shall terminate. Upon the exercise of SARs, the related Option shall terminate to the extent of an equal number of Common Shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercisability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting and other restrictions as may be specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding SARs at any time for any reason. SARs may only be exercised while the Participant is employed by, or providing service to, the Employer (and in the case of a Canadian Employee, prior to a Termination Date) or during the applicable period after termination of employment or service (or in the case of a Canadian Employee, after Termination Date) as specified by the Committee. A tandem SAR shall be exercisable only during the period when the Option to which it is related is also exercisable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants to Non-Exempt Employees</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may become exercisable, as determined by the Committee, upon the Participant&#x2019;s death, Disability or retirement, or upon a Change of Control or other circumstances permitted by applicable regulations).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Value of SARs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value of the underlying Common Shares on the date of exercise of the SAR exceeds the base amount of the SAR as described in subsection (a).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Form of Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The appreciation in a SAR shall be paid in Common Shares, cash or any combination of the foregoing, as the Committee shall determine. For purposes of calculating the number of Common Shares to be received, Common Shares shall be valued at their Fair Market Value on the date of exercise of the SAR.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 10. Other Share-Based Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may grant Other Share-Based Awards, which are awards (other than those described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sections 6</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> through </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) that are based on or measured by Common Shares, to any Employee, Non-Employee Director or Consultant, on such terms and conditions as the Committee shall determine. Other Share-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria or other conditions and may be payable in cash, Common Shares or any combination of the foregoing, as the Committee shall determine.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 11. Dividend Equivalents</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may grant Dividend Equivalents in connection with Share Units or Other Share-Based Awards. Dividend Equivalents may be paid currently or accrued as contingent cash obligations and may be payable in cash or Common Shares, and upon such terms and conditions as the Committee shall determine. Dividend Equivalents with respect to Share Units or Other Share-Based Awards that vest based on performance shall vest and be paid only if and to the extent the underlying Share Units or Other Share-Based Awards vest and are paid, as determined by the Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 12. Consequences of a Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assumption of Outstanding Grants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised or paid at the time of the Change of Control shall be assumed by, or replaced with grants (with respect to cash, securities, or a combination thereof) that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). An assumption or substitution of any Grants shall be done in a manner consistent with the provisions of Sections 409A and, if applicable, 424 of the Code, for individuals subject to U.S. income tax. After a Change of Control, references to the &#x201c;Company&#x201d; or &#x201c;Employer&#x201d; as they relate to employment matters shall include the successor employer in the transaction, subject to applicable law.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Alternatives</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee may determine that outstanding Stock Options and SARs shall automatically accelerate and become fully exercisable and the restrictions and conditions on outstanding Share Awards, Share Units and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine that Participants shall receive a payment in settlement of outstanding Share Units or Dividend Equivalents, in such amount and form as may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Stock Options and SARs in exchange for a payment by the Company, in cash or Common Shares as determined by the Committee, in an amount equal to the amount, if any, by which the then Fair Market Value of the Common Shares subject to the Participant&#x2019;s unexercised Stock Options and SARs exceeds the Stock Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all of their outstanding Stock Options and SARs, the Committee may terminate any or all unexercised Stock Options and SARs at such time as the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Common Shares does not exceed the per share Stock Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any payment to the Participant upon surrender of the Stock Option or SAR and shall have the right to cancel any such Stock Option or SAR for no consideration.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 13. Deferrals</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise be due to such Participant in connection with any Grant. If any such deferral election is permitted or required, the Committee shall establish rules and procedures for such deferrals and may provide for</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">interest or other earnings to be paid on such deferrals. The rules and procedures for any such deferrals shall be consistent with applicable requirements of 409A.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 14. Withholding of Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Required Withholding</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All Grants under the Plan shall be subject to applicable United States federal (including taxes under FICA), state and local, foreign country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Grants or exercising Grants pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Grants, or the Employer may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Grants.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Share Withholding</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Committee may permit or require the Employer&#x2019;s tax withholding obligation with respect to Grants paid in Common Shares to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#x2019;s applicable withholding tax rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines otherwise, share withholding for taxes shall not exceed the Participant&#x2019;s minimum applicable tax withholding amount.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 15. Transferability of Grants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nontransferability of Grants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant&#x2019;s lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect to Grants other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Grant under the Participant&#x2019;s will or under the applicable laws of descent and distribution.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transfer of Nonqualified Stock Options</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument, that a Participant may transfer Nonqualified Stock Options to a permitted assign in compliance with the applicable securities laws, according to such terms as the Committee may determine; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that the Participant receives no consideration for the transfer of an Option and the transferred Option shall continue to be subject to the same terms and conditions as were applicable to the Option immediately before the transfer.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 16. Requirements for Issuance or Transfer of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No Common Shares shall be issued or transferred in connection with any Grant hereunder unless and until all legal requirements applicable to the issuance or transfer of such Common Shares have been complied with to the satisfaction of the Committee. The Committee shall have the right to condition any Grant on the Participant&#x2019;s undertaking in writing to comply with such restrictions on his or her subsequent disposition of the Common Shares as the Committee shall deem necessary or advisable, and certificates representing such shares may be legended to reflect any such restrictions. Certificates representing Common Shares issued or transferred under the Plan may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 17. Amendment and Termination of the Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Board may amend or terminate the Plan at any time; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, however, that the Board shall not amend the Plan without shareholder approval if such approval is required in order to comply with the Code, the Tax Act or other applicable law, or to comply with applicable stock exchange requirements.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No Repricing of Options or SARs</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Except in connection with a corporate transaction involving the Company (including, without limitation, any stock dividend, distribution (whether in the form of cash, Common Shares, other securities or property), stock split, extraordinary cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Shares or other securities, or similar transactions), the Company may not, without obtaining shareholder approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options or base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise Price or base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel outstanding Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Termination of Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is terminated earlier by the Board or is extended by the Board with the approval of the shareholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Termination and Amendment of Outstanding Grants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. A termination or amendment of the Plan that occurs after a Grant is made shall not materially impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 18(f)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant. Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 18(f)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> or may be amended by agreement of the Company and the Participant consistent with the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Section 18. Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants in Connection with Corporate Transactions and Otherwise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Nothing contained in the Plan shall be construed to (i) limit the right of the Committee to make Grants under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or (ii) limit the right of the Company to grant stock options or make other awards outside of the Plan. The Committee may make a Grant to an employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of securities or property, reorganization or liquidation involving the Company, in substitution for a stock option or Share Awards grant made by such corporation. Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Grants as it deems appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant the same economic value as the prior options or rights.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Governing Document</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Plan shall be the controlling document. No other statements, representations, explanatory materials or examples, oral or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and assigns.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Funding of the Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any other segregation of assets to assure the payment of any Grants under the Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rights of Participants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Consultant or other person to any claim or right to receive a Grant under the Plan. Any Grant under the Plan shall be a one-time award that does not constitute a promise of future grants nor will it form part of a Participant&#x2019;s standard compensation or be considered for the purpose of calculating any entitlements to vacation, benefits, notice of termination or payment in lieu of notice or as otherwise required by any other contract or applicable law. The Company, in its sole discretion, maintains the right to make available future Grants under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual any rights to be retained by or in the employ of the Employer or any other employment rights.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No Fractional Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No fractional Common Shares shall be issued or delivered pursuant to the Plan or any Grant. Except as otherwise provided under the Plan, the Committee shall determine whether cash, other awards</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compliance with Law</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) The Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer Common Shares under Grants shall be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required. With respect to persons subject to Section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent of the Company that Incentive Stock Options comply with the applicable provisions of Section 422 of the Code, and that, to the extent applicable, Grants comply with the requirements of 409A, to the extent applicable. To the extent that any legal requirement of Section 16 of the Exchange Act, 409A or Section 422 of the Code as set forth in the Plan ceases to be required under Section 16 of the Exchange Act, 409A or Section 422 of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority under this Section.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) The Plan is intended to comply with the requirements of 409A, to the extent applicable. Each Grant shall be construed and administered such that the Grant either (A) qualifies for an exemption from the requirements of 409A or (B) satisfies the requirements of 409A. If a Grant is subject to 409A, (I) distributions shall only be made in a manner and upon an event permitted under 409A, (II) payments to be made upon a termination of employment or service shall only be made upon a &#x201c;separation from service&#x201d; under 409A, (III) unless the Grant specifies otherwise, each installment payment shall be treated as a separate payment for purposes of 409A, and (IV) in no event shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with 409A.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iii) Any Grant that is subject to 409A and that is to be distributed to a Key Employee (as defined below) upon separation from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the date of the Participant&#x2019;s separation from service, if required by 409A. If a distribution is delayed pursuant to 409A, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&#x2019;s death. The determination of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by the Committee or its delegate each year in accordance with Section 416(i) of the Code and the &#x201c;specified employee&#x201d; requirements of 409A.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:10%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iv) Notwithstanding anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences of Grants under the Plan, and in no event shall the Company or any subsidiary or affiliate of the Company have any responsibility or liability if a Grant does not meet any applicable requirements of 409A. Although the Company intends to administer the Plan to prevent taxation under 409A, the Company does not represent or warrant that the Plan or any Grant complies with any provision of federal, state, local or other tax law.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(g) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Establishment of Subplans</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable blue sky, securities or tax laws of various jurisdictions outside the United States or Canada. The Board shall establish such sub-plans by adopting supplements to the Plan setting forth (i) such limitations on the Committee&#x2019;s discretion under the Plan as the Board deems necessary or desirable and (ii) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not affected.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Clawback Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All Grants (including any proceeds, gains or other economic benefit actually or constructively received by the Participant upon any receipt of any Grant or upon the receipt or resale of any Common Shares underlying the Grant) under the Plan shall be subject to the provisions of any applicable policies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">implemented by the Board from time to time, including, any clawback or recoupment policies, share trading policies and other policies that may be implemented by the Board from time to time.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Tax Act Elections</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In the sole discretion of the Committee, the Company may make an election under subsection 110(1.1) of the Tax Act where applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(j) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Waiver of Damages</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. A grantee, who is a Canadian Employee, waives any and all rights to any Grants and to any compensation or damages in respect or in lieu thereof as a consequence of termination of the Participant&#x2019;s employment or service to the Employer for any reason, or otherwise for any reason whatsoever insofar as those rights arise or may arise from the Participant ceasing to have rights with respect to such Grants upon a termination such Participant&#x2019;s employment or service to the Employer.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(k) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The validity, construction, interpretation and effect of the Plan and Grant Instruments issued under the Plan shall be governed and construed by and determined in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, without giving effect to the conflict of laws provisions thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/// end</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">QUESTIONS MAY BE DIRECTED TO BROADRIDGE:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email: Proxy.request@broadridge.com</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">North America Proxy Line:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-916-0609</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9305</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">French Canadian Proxy Line (voicemail):</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Toll Free: 844-973-0593</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">International &amp; Direct Dial: 303-562-9306</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.2in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><img src="img18171159_1.jpg" alt="img18171159_1.jpg" style="width:624px;height:808px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.2in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><img src="img18171159_2.jpg" alt="img18171159_2.jpg" style="width:615px;height:796px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Calibri',sans-serif;min-width:fit-content;">BROKER ADDRESS  123 ANY STREET  ANY CITY/PROVINCE A1A 1A1   LOGO HERE   1 OF 2S91970 81 010 E: CS:3 E:2 1/1 MA:A V: 1  JOHN A. SAMPLE   123 ANY STREET  ANYCITY PR A1A 1A1  XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX  XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX  XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX   PROXY FORM   Annual General Meeting   enGene Holdings Inc.   WHEN:   Wednesday, May 15, 2024 at 10:00 am EDT   WHERE:   www.virtualshareholdermeeting.com/ENGN2024   REVIEW YOUR VOTING OPTIONSSTEP 1  ONLINE: VOTE AT PROXYVOTE.COM USING YOUR COMPUTER  OR MOBILE DATA DEVICE. YOUR CONTROL NUMBER IS LOCATED BELOW.    SCAN TO VIEW  MATERIAL AND VOTE NOW    BY TELEPHONE: YOU MAY ENTER YOUR VOTING INSTRUCTIONS BY TELEPHONE AT: ENGLISH: 1-800-474-7493 OR FRENCH: 1-800-474-7501   BY MAIL: THIS PROXY FORM MAY BE RETURNED BY MAIL IN THE ENVELOPE  PROVIDED.  REMINDER: PLEASE REVIEW THE INFORMATION / PROXY CIRCULAR  BEFORE VOTING.   G-V502122020  CONTROL NO.:</font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#x2794;</font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Calibri',sans-serif;min-width:fit-content;">  PROXY DEPOSIT DATE: May 13, 2024 at 10:00 am EDT   The control number has been assigned to you to identify your shares for voting.   You must keep your control number confidential and not disclose it to others other than when you vote using one of the voting options set out on this form. Should you send this form  or provide your control number to others, you are responsible for any subsequent voting of, or subsequent inability to vote, your shares.   INSTRUCTIONS:  1. This Form of Proxy is solicited by and on behalf of management of the issuer.  2. You have the right to appoint a person, who need not be a shareholder, other than the person(s) specified on the other side of this form to attend and act on your behalf at the  Meeting. If you wish to appoint a person:  &#149; Write the name of your designate on the &#x201c;Appointee&#x201d; line and provide a unique APPOINTEE IDENTIFICATION NUMBER for your Appointee to access the Virtual Meeting in the space provided on the other side of this form, sign and date the form, and return it by mail, or  &#149; Go to ProxyVote.com and insert the name of your designate in the &#x201c;Change Appointee(s)&#x201d; section and provide a unique APPOINTEE IDENTIFICATION NUMBER on the voting  site for your Appointee to access the Virtual Meeting.  You MUST provide your Appointee the EXACT NAME and EIGHT CHARACTER APPOINTEE IDENTIFICATION NUMBER to access the Virtual Meeting. Appointees can only be  validated at the Virtual Meeting using the EXACT NAME and EIGHT CHARACTER APPOINTEE IDENTIFICATION NUMBER you enter.   IF YOU DO NOT CREATE AN EIGHT CHARACTER APPOINTEE IDENTIFICATION NUMBER AND PROVIDE IT TO YOUR APPOINTEE, YOUR APPOINTEE WILL NOT BE ABLE  TO ACCESS THE VIRTUAL MEETING.   3. This Form of Proxy confers discretionary authority to vote on amendments or variations to the matters identified in the notice of the Meeting and with respect to other matters that may  properly be brought before the Meeting or any adjournment or postponement thereof.  This Form of Proxy will not be valid and not be acted upon or voted unless it is completed and delivered as outlined herein.   4. If the shares are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this Form of Proxy.  If you are voting on behalf of a corporation or another individual, documentation evidencing your power to sign this Form of Proxy with signing capacity stated may be required.  5. In order to expedite your vote, you may use the Internet or a touch-tone telephone, and entering the control number noted above. The Internet or telephone voting service is not  available on the day of the Meeting. The telephone system cannot be used if you designate another person to attend on your behalf.  If you vote by Internet or telephone, do not mail back this Form of Proxy.  6. If the Form of Proxy is not dated, it will be deemed to bear the date on which it was mailed to the shareholder.  7. This Form of Proxy will be voted as directed by the shareholder. If no voting preferences are indicated on the reverse, this Form of Proxy will be voted as recommended  on the reverse of this form or as stated in the management proxy circular, except in the case of your appointment of an Appointee.  8. Unless prohibited by law or you instruct otherwise, your Appointee(s) will have full authority to attend and otherwise act at, and present matters to the Meeting and any  adjournment or postponement thereof, and vote on all matters that are brought before the Meeting or any adjournment or postponement thereof, even if these matters are not  set out in this form or in the management proxy circular.  9. If these voting instructions are given on behalf of a body corporate, set out the full legal name of the body corporate, and the name and position of the person giving voting instructions  on behalf of the body corporate.  10. If the items listed in the management proxy circular are different from the items listed on the other side of this form, the management proxy circular will be considered correct.  11. This Form of Proxy should be read in conjunction with the accompanying management proxy circular.  PLEASE SEE OVER   <br> PROXY FORM   enGene Holdings Inc. 90   MEETING TYPE: Annual General Meeting  MEETING DATE: Wednesday, May 15, 2024 at 10:00 am EDT  RECORD DATE: April 10, 2024  PROXY DEPOSIT DATE: May 13, 2024 at 10:00 am EDT CUID:  ACCOUNT NO: CUSIP:   CONTROL NO.: </font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#x2794;</font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Calibri',sans-serif;min-width:fit-content;">    APPOINT A PROXY (OPTIONAL)STEP 2  APPOINTEE(S): Jason D Hanson, or failing this person, Ryan Daws, or failing this person, Lee Giguere  Change Appointee   If you wish to designate another person to attend, vote and act on your behalf at the Meeting, or any adjournment or postponement thereof, other than the person(s) specified above, go  to www.proxyvote.com or print your name or the name of the other person attending the Meeting in the space provided herein and provide a unique APPOINTEE IDENTIFICATION NUMBER  USING ALL BOXES for your Appointee to access the Virtual Meeting. You may choose to direct how your Appointee shall vote on matters that may come before the Meeting or any adjournment or postponement thereof. Unless you instruct otherwise your Appointee will have full authority to attend, vote, and otherwise act in respect of all matters that may come  before the Meeting or any adjournment or postponement thereof, even if these matters are not set out in the proxy form or the circular for the Meeting. You can also change your  Appointee online at www.proxyvote.com.   You MUST provide your Appointee the EXACT NAME and an EIGHT (8) CHARACTER APPOINTEE IDENTIFICATION NUMBER to access the Virtual Meeting. Appointees can only be  validated at the Virtual Meeting using the EXACT NAME and EIGHT (8) CHARACTER APPOINTEE IDENTIFICATION NUMBER you enter below.   PLEASE PRINT APPOINTEE NAME INSIDE THE BOX  CREATE AN EIGHT (8) CHARACTER IDENTIFICATION NUMBER  FOR YOUR APPOINTEE  </font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#x2794;&#x2794;</font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> MAXIMUM 22 CHARACTERS - PLEASE PRINT CLEARLY MUST BE EIGHT CHARACTERS IN LENGTH - PLEASE PRINT CLEARLY   E-R2    COMPLETE YOUR VOTING DIRECTIONSSTEP 3  ITEM(S): VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES (FILL IN ONLY ONE BOX &#x201c;    &#x201d; PER ITEM IN BLACK OR BLUE INK)   To elect three directors to each hold office for a three year term expiring  on the 2027 annual general meeting of shareholders:   FOR  WITHHOLD   1AElection of Director: Paul Hastings    1B Election of Director: Wouter Joustra  WITHHOLD  FOR  1C Election of Director: Lota Zoth  WITHHOLD  FOR  02 To consider, and if deemed advisable, pass an ordinary resolution approving  and adopting the amendment to the enGene Holdings Inc. Incentive Equity   FOR  AGAINST ABSTAIN   Plan described in the Proxy Statement.    03 To appoint KPMG LLP as the Company&#x2019;s auditor for the ensuing year and  authorize the directors to approve the renumeration to be paid to the auditor.   FOR  WITHHOLD   THIS DOCUMENT MUST BE SIGNED AND DATED STEP 4  SIGNATURE(S) *INVALID IF NOT SIGNED*  MMDD YY</font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> <br> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.2in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">ENGENE HOLDINGS INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Corporation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Request for Financial Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In accordance with National Instrument </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">51-102 &#x2013; Continuous Disclosure Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, registered and beneficial shareholders may elect annually to receive interim (quarterly) financial statements and corresponding management discussion and analysis (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">MD&amp;A</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and/or annual financial statements and MD&amp;A for the current financial year. These instructions will remain on file for the current financial year, after which we will ask you again to confirm your instructions for interim and annual financial statements and corresponding MD&amp;A, unless you have sold all your holdings in the Corporation.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you wish to receive these documents by mail, please return this completed form to:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ENGENE HOLDINGS INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4868 RUE LEVY, SUITE 220</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SAINT-LAURENT, QUEBEC H4R 2P1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CANADA</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rather than receiving financial statements by mail, you may choose to view these documents on the SEDAR+ website at www.sedarplus.ca</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I HEREBY CERTIFY that I am a registered and/or beneficial holder of the Corporation, and as such, request that my name be placed on the Corporation&#x2019;s Mailing List in respect to its annual and/or interim financial statements and the corresponding MD&amp;A for the current financial year.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:34.793%;"></td>
    <td style="width:31.874%;"></td>
    <td style="width:33.333%;"></td>
   </tr>
   <tr style="height:10pt;background-color:#eeece1;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-top:1.5pt solid #000000;border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">SHAREHOLDER REGISTRATION (PLEASE PRINT CLEAR IN BLOCK LETTERS)</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#eeece1;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">STREET ADDRESS</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#eeece1;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">CITY</font></p></td>
    <td style="border-right:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">PROV/STATE</font></p></td>
    <td style="border-right:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">POSTAL/ZIP CODE</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="border-right:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td style="border-right:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#eeece1;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">COUNTRY (IF NOT CANADA OR USA)</font></p></td>
    <td colspan="2" style="border-right:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">EMAIL</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="border-right:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#eeece1;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">IF THIS IS AN ADDRESS CHANGE, PLEASE CHECK THE BOX AND PROVIDE YOUR FORMER ADDRESS BELOW</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#eeece1;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">PLEASE SEND ME THE FOLLOWING:</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Annual Financial Statements with MD&amp;A</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="border-right:1.5pt solid #000000;border-left:1.5pt solid #000000;padding-left:0.08in;vertical-align:top;border-bottom:1.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;">Interim Financial Statements with MD&amp;A</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNED:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">					</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">	DATE:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">					</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">              (Signature of Shareholder)</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img18171159_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img18171159_0.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M93P01P0:^.?BA_P2U^%GCS5+N^\,WVJ>!KF1M[VUF5N+,%N25B?YEY[!PH[
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..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img18171159_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img18171159_1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" <[!98# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWAR'P%\4M.\<:9;V%\%\0KN\0Z;JUC>:;=3)/:K:B1HITCD5'AMQ$'0!28'
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M7TW7S)+_ ,I*;?\ [)2W_IV% CZ;HHHH&%%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
MC^U$,_LS_%O/_0HZM_Z1RUZ=7F7[47_)L_Q;_P"Q1U;_ -(Y:!',?\,-_ ;_
M *)AH?\ WP__ ,52_P###?P&_P"B8:'_ -\/_P#%5[G10,\,_P"&&_@-_P!$
MPT/_ +X?_P"*H_X8;^ W_1,-#_[X?_XJO<Z* /#/^&&_@-_T3#0_^^'_ /BJ
M/^&&_@-_T3#0_P#OA_\ XJO<Z* /#/\ AAOX#?\ 1,-#_P"^'_\ BJ/^&&_@
M-_T3#0_^^'_^*KW.B@#PS_AAOX#?]$PT/_OA_P#XJC_AAOX#?]$PT/\ [X?_
M .*KW.B@#PS_ (8;^ W_ $3#0_\ OA__ (JC_AAOX#?]$PT/_OA__BJ]SHH
M\,_X8;^ W_1,-#_[X?\ ^*H_X8;^ W_1,-#_ .^'_P#BJ]SHH \,_P"&&_@-
M_P!$PT/_ +X?_P"*H_X8;^ W_1,-#_[X?_XJO<Z* /#/^&&_@-_T3#0_^^'_
M /BJ/^&&_@-_T3#0_P#OA_\ XJO<Z* /#/\ AAOX#?\ 1,-#_P"^'_\ BJ/^
M&&_@-_T3#0_^^'_^*KW.B@#PS_AAOX#?]$PT/_OA_P#XJC_AAOX#?]$PT/\
M[X?_ .*KW.B@#PS_ (8;^ W_ $3#0_\ OA__ (JC_AAOX#?]$PT/_OA__BJ]
MSHH \,_X8;^ W_1,-#_[X?\ ^*H_X8;^ W_1,-#_ .^'_P#BJ]SHH \,_P"&
M&_@-_P!$PT/_ +X?_P"*H_X8;^ W_1,-#_[X?_XJO<Z* /#/^&&_@-_T3#0_
M^^'_ /BJ/^&&_@-_T3#0_P#OA_\ XJO<Z* /#/\ AAOX#?\ 1,-#_P"^'_\
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MH \,_P"&&_@-_P!$PT/_ +X?_P"*H_X8;^ W_1,-#_[X?_XJO<Z* /$OV;_
M^A_#;6OB[X<\,Z9;Z-H=GXLB^SV-L"$CWZ+IDCXR>[NS?B:]MKS#X1_\E"^-
M?_8V6_\ Z8M*KT^@04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU6W\+W?A6&VMM:DLI5LIY!'IP,:3%=C,#&_R@Y^1O0U]ET44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F7[47_)L
M_P 6_P#L4=6_](Y:]-KS+]J+_DV?XM_]BCJW_I'+0(]-HHHH&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'F'PC_ .2A?&O_ +&RW_\ 3%I5>GUYA\(_^2A?&O\ [&RW_P#3%I5>GT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU/Q%9+IOB&]TNUN=1LTB:,07+PJTL85B67:Y9<,21CFNHHHH&%%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M110!YA\(_P#DH7QK_P"QLM__ $Q:57I]>8?"/_DH7QK_ .QLM_\ TQ:57I]
M!1110 4444 %%%% !1110 5S'B;QL/#=]]E_L36=4?\ LR\U,/IMJ)4/V<Q?
MZ.&+ >?+YO[M/XO+DY&WGIZ\.L_BQXQU3Q*W@^&V@CU[5[G5KG2->724ETNQ
ML;"]%M(EU$=02>:;YHANC"*3=1D+B.3 (];\+ZX?%'AK2=8.GWVD_P!H6L5W
M]@U.'R;JV\Q%?RIH\G9(N=K+DX((K6KB_@WXRO?B'\(_!/BG4(H(=1UO1++4
MKF.U5EB22:".1P@+,0H+' +$XQR>M=I0 4444#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,KPW^SCX[_:B_;-^)7CS6
MCXO^%NB6+M'HGB"QM;G2KJ=5 MH#!YZ!MKV\;M)MQ@R 8 ?%?IK10!^8_P )
M_@UX]_9W_:G^+/A2WTGQMXN\'^)?#]W;KXGN-/G:WNKQK07*2S2@;)9 [30
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M)\,_#OA71-6NM5T^STEM:T.U#1736\5D0\;PDAI"DJQ?N@K-N53MRF1]YT4
M?D?9_"7Q=?\ [4GP.U_2/V>]<^&'A>Q.EB6*WMY+U=JW3,US=RI$/+EP=K>>
M?-VQJSX#"O8OV1/A;XS\.?\ !0KXU>)=7\)ZYI7AV_\ [:^R:M>Z;-#:W/F:
MG \?ERLH5]R*S#:>0">17Z'44 ?&G_!4SP+XF^(7[/>AZ;X7\/:MXEU&/Q-;
MW#V>CV,MW*D2VUTI<K&I(4%U&2.K#VKS;XH?LT^+M8_X*+>%]7MHM9'@35KK
M3/$U_>V=C*=/M[JPA=8HYG!\HRLT3 ,3N NVP.3G]%** /S\^!_P)\5>)O&7
M[9^BZCX?U#1;?QA>7$.BWVKVD]K:W;/+J'ERI(4^>-6DB8L@;AAP<\_/'@7X
M$R> +%/"'CS]C[Q-X\\8P3K&->T[6K^"QN?-?<F^: M;H$5U4R*VWY3NVE6)
M_8JB@#\S?VP/V1+WPS\>M%^(]A\-]2^*OP\N+*"QU+PKI5W<+>6[06RVT*J8
MLR^6%6*0,-Q+)('*@JQ]=_9H^#-AX@^"?Q9L/#_P7OO@=<>+--FT>)=<U6ZO
M);S,$T<<TD4_SPJC3M\N/F#9!; K[5HH _,']DSP_P#$[X?? GXZ_!C7OA1X
MDT^6XT77=2@UN2UE,-U=&UBM4LX L129G*LRLDC;@#M##FO)H?@1\2U_8!N/
M#9^'GBH>(&^):Z@-)_L6Y^U_9O[+,?G^5LW>7O\ EW8QGBOV7HJK@?E5X^^#
M/Q NOCI^R-J%OX(\17-CH?AOPK;ZK=0Z5.\5A)#=LTR3L$VQ-&IRP8@J.M:=
MI\*?BK^S+\=/C*NB^!+;5/ OCBSU%+?Q!)J#)I^D6A+2"XN)MK,JP1ROOB91
M)(8V\MGP"_ZA5\D>//\ @G7X<\<:IXHE_P"%D?$#2]&\4:M-K.L>'[358AI]
MQ/)(LA(A\G;E65<,X<C8G7:*+@<7_P $?_\ DWGQ9RI_XJRX.5Z?\>EK7W77
M!?!;X*^$_@#X!L_"7@_3_L6FPDR2S2$-/=S, 'GF< ;Y&P.<  !54*JJH[VI
M$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJEC;:EIUU&T,]G>0K+#,C#!1T8%64C.01S6'X,^%/@KX=S74OA/PAH/AB2Z
M6=M&TR"T,H4G 8QJ-P!)Z^IKK:* "LG_ (1C1O\ A)/^$B_LFQ_X2'[)_9_]
MJ_9D^U?9M_F>1YN-WE[_ )MF<9YQFM:B@#(U'POHVJ:WI6LWND65YK&D^;_9
M^H7%LCSV?FJ$E\F0C='O4!6VD9'!XK \7?!;X?\ Q U1=2\4>!?#7B345C$*
MW>KZ1;W4PC!)"!Y$+!068XSU)]:[:B@#E=#^%_@[POX:U#P[HOA'0])T#4?,
M^VZ58Z;#!:W/F($D\R)5"ON0!3N!R  >*W=/TVUTC3[;3[&UAL["VB6""UMX
MPD44:KM5%48"J    ,  5=HH XZ^^#W@/5/"EGX7O?!/AZ[\,V,OGVNBSZ3
M]G#)\WSI"4V*WSOR!_&WJ:9X/^#?@#X>ZD^H^%O WAOPUJ$D1@>ZT?2+>TE:
M,D,4+QH"5)53C.,J/2NTHH ****!A1110 4444 %%%% !1110 4444 %%%%
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MSDYK?\U.1N [<\4 8WA#P]<^%]!@TZ[US4?$=PCRNVI:L8C<2EY&?#>5''&
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M<9(I:D HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5YE^U%_R;/\6_^Q1U;_TCEKTV
MO,OVHO\ DV?XM_\ 8HZM_P"D<M CTVBBB@84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6ESK8M\Y !L;>+&__IIN^X-N/FSWGBBQU'4O#VJ6>D:G_8FK7%K+#9ZGY"W
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M\_\ "_UW_P"3*]3HH \L_P"&;_"W_08\>?\ A?Z[_P#)E'_#-_A;_H,>//\
MPO\ 7?\ Y,KU.B@#RS_AF_PM_P!!CQY_X7^N_P#R91_PS?X6_P"@QX\_\+_7
M?_DRO4Z* /+/^&;_  M_T&/'G_A?Z[_\F4?\,W^%O^@QX\_\+_7?_DRO4Z*
M/+/^&;_"W_08\>?^%_KO_P F4?\ #-_A;_H,>//_  O]=_\ DRO4Z* /+/\
MAF_PM_T&/'G_ (7^N_\ R91_PS?X6_Z#'CS_ ,+_ %W_ .3*]3HH \L_X9O\
M+?\ 08\>?^%_KO\ \F4?\,W^%O\ H,>//_"_UW_Y,KU.B@#RS_AF_P +?]!C
MQY_X7^N__)E'_#-_A;_H,>//_"_UW_Y,KU.B@#RS_AF_PM_T&/'G_A?Z[_\
M)E'_  S?X6_Z#'CS_P +_7?_ ),KU.B@#RS_ (9O\+?]!CQY_P"%_KO_ ,F4
M?\,W^%O^@QX\_P#"_P!=_P#DRO4Z* /+/^&;_"W_ $&/'G_A?Z[_ /)E'_#-
M_A;_ *#'CS_PO]=_^3*]3HH \L_X9O\ "W_08\>?^%_KO_R91_PS?X6_Z#'C
MS_PO]=_^3*]3HH \L_X9O\+?]!CQY_X7^N__ "91_P ,W^%O^@QX\_\ "_UW
M_P"3*]3HH \L_P"&;_"W_08\>?\ A?Z[_P#)E'_#-_A;_H,>//\ PO\ 7?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ7D+ZC;Q1W$UJL@,L<<C.L<C+U"L8I &(P3&X'W3B]0 4444#"BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_B';Z_>>
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M)A?VTMIJ&B1W3P-:B.X%Q'*+J";YS(;8KM3HLF2. ?J2'=Y2[S\VWYN]/HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\LC& "0#V^BOF3XY?\-'?\-*^ /^%<_\DCQI_P#PD?\ R#<_\?DGVK_7?O\
M_CW\O_5_\!^;-?3= PHHHH _.3Q'X:\+? ?Q9\7K#XY?!R36_"/B_P 17VK6
MGQ,TG38M1&FV=_+'&D<DA3S;7RF?(*DMYA;RT;Y6;[E^#?A/2/ _PM\,Z)X>
MUNZ\1>'[6RC73=2NKA+AY;4C,.)(U5601E54@?=5>3UKYZN8_P!IKPA_PE?@
M>Z\(Z'\8M UJYFCTKQ1KFK6MO%8V4Q:)8M0M1#&;D(@#R+$GS!V +9POLO[,
MWPAG^ ?P&\)^!I[E=0O=)MG^TR0MN1IY97FE",57*!Y&"EE!P!D YH$?G_\
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MX7Z#9ZM,+/4'EAOIIM/DNWB5FB5E16C,8<KE@0VU?NU7\3?L\^);[]GSX/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!S'C/X8^#OB.UF/%GA71/
M% L]_P!F&M:=#=^1OV[]GF*=N[8N<==H]*T/#?A?1_!NCPZ1H&DV.AZ5;[O)
ML=-MDMX(MS%FVQH HRQ).!R2:UZ*!!1110,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG@]:I>&?"^C^"]%M]'\/Z18Z%I%ON\C3]-MDMH(MS%FVQH HRS,QP.22>]?
MWC3X^>._V4=8^(_P<FO?$7C3Q1XBEAN/AOK%_<_:IV6\80&&2621R&@DW; Z
M_.T;$[5=*^U/@GX%U?X:_"SP[X=U_P 1:CXKUNSMO]/U?4[M[J:>X<EY,2.
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M+%0[,%#$D*%&3B@#<3PAH4/BB3Q*FB:?'XCDMOL3ZPMI&+MK?<'\HS8W>7N
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M_$%W:V(MKO6KV\G:[NY64^;,9&E:1&9V9@!)\F0%("C ([*BOSA\8_'CXD?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME\6M,^.7PK\-^.='1HK'6;;S3#)NW0RJ2DL1)5=VR573<!AMN1P17=*H5<*
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M?#G5(SX+TV3?';ZAIEF2=0E8%86\J4%G)5RS!9K=@2J8_0?X7?$C1_BW\/\
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MF\S2-7LTO(=[H6CW#+1R%&91(C!D=0QVLC \BNJ557.% R<G _#/Y8I0H7@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6OO+X6_#.S^%_P ,=#\&0W,^KV^GV@MYKK4)7F>[=LF:5][-]]V=MN<#=@8
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M9\+?B5!\2/A7H?C.6UFT..^LOM-U:7RO$]G(H(FC<R(A^1U==Q4 A=PX(-#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOA^%X=)TBU6WA\S;O<@9>1RJA2[N6=B ,L['% SKZ*_,+XQ0^+_V;/%'B_\
M9R\%6:_\(W\7[RW;PO?W,Q\G1UNY!;W]N_\ H[;D*KLVH<Q1.CAB[5^A_P *
M_AOH_P (?A[H'@W0(6@TC2+9;>'>$\QR!EY'VJ%+NY9V( RSL<"@#KJ*_,3X
MP0^+OV;_ !3XP_9N\$VB_P#"/?%R[MW\+WUQ,3%HT=W)Y%_;N# VY"%*[4.8
MHG63)<U^AGPL^'.C_"'X>Z!X-\/PM!I.D6JV\(D"!W(&7D<JH4R.Y9V( RS,
M<"@#KZ*_,7XO1^+_ -G'Q-XO_9J\$6BMX?\ BU=V\GA>^N)F:+1H;N3R+^W<
M&!MT>$9=J',4;B3)=J_0SX6_#G1_A'\/M!\'>'X6@TG1[1;:+>%$CD#+R/L4
M*9'<L[$ 99V..:!'745^8OQ<B\7_ +.GB3Q=^S-X(M5DT+XL74$OA:^N)W9-
M%M[N3R+^WD!@;,>$9<(<QQN)-Q=C7Z&_"WX;Z/\ "/X>Z!X/\/P^1I6CVJ6T
M*LJ!W(&7D?8%4R.Y9V8 99V/>@#K:*_,?XM1^+_V=_$7BW]F/P/:K+HGQ6NH
M)?"U[/.[IHMO=R&&^MY 87S$!&XPG,<;F3<7:OT+^%_PXT?X2?#W0/!V@0?9
M])T>U6VAW(@>0@9>5]BA3([EG9@!EF8XYH ZVBOS'^*R>+_V>?$'BO\ 9?\
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M7[.?BK]JC2?BQ\7]7TO7O"GC2.:./X<V-W'-:7^GP6+>:DBIYJ;)+I\K\_\
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MX=U+PKJ5];[[K1=6@>&XM9E)1T*L V-RDJQ4;E*M@9KM:* /SA\5? /X@?M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BLCQ-XHT;P7HMQK'B#5K'0])MMOGZAJ5REO;Q;F"+ND
M<A1EF51D]6 [UQ/_  U!\&O^BM^!?_"DL_\ X[0(]-HKS+_AJ#X-?]%;\"_^
M%)9__':/^&H/@U_T5OP+_P"%)9__ !V@#TVBO,O^&H/@U_T5OP+_ .%)9_\
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M$A[L>$_%NA^)_L83[2NC:E#=^3OW;"_EL=N[:V,]=IQT-=10 4444#"BBB@
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MYS^PWXH\:3?LA_'WQ':22W_Q$?Q)KVH0O:VJ2O-JAL+>12D*KM8M-C"!<'(
M':E<1^6/C'P#XF^'>I1:?XJ\.ZIX:OYH1<1VNKV4EK*T99E#A9%!VEE89QU4
MUA5^OO[1<OB3QS_P3,N=9^,6CPV'C>"WM+N19;5(YH)_MR1P2[ &\F:2%U#@
M!2#-(I6,$JOY7_"6Z\)V?Q,\,S>.[2YO_!RWT1U6"TE,3M;E@&.0K-M .2JX
M9@"%9"0X8RE!\/?%-UX1N?%<'AO5I_"]K((I];CL96LH7+*H1YPNQ26=!@M_
M&OJ*Y^OV*_:L\?>%_B7_ ,$U_%>O^";1;'PG,UM:Z; ELMLODP:U#;AEC'"*
MWE%E7 .",@'('XZT ?7O[!_[<=]^SIXBM_"WBN[GNOAI?3'S5VM*^DR-_P M
MXE')CW8+QKDD9906^5_L7]O']C71?VA? _\ PM#X?Q)>^,H;2.Y232=DL6O6
M9"E3D-AW2,[HW4DNH"?-^[V?C[7V/^PA^WAJ'[/.J0>#?%TTVH_#:\E8H3N>
M7197))EC !8PLQS)&,G)+H-V]9%YH1\=S0R6\TD,R-%+&Q5XW4AE8'!!'8@C
MO3*_53]O;]ANS^+FDR?&#X30P:CJ]Q;)>7VFZ8RO'K$) 9;JU*\/*5(RJG]\
M-I7YQB7\J_8\&F,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBG+]X?6@!M%?OW\3M4\<7'Q8T30+SPAX=U?X%W.DS7/BC6
M-8$;O;2QK,ZKL>8 IN2W))B;&YCD8RO@_P"P)_PA@_:$_:<_X5XJ+X1&IZ7]
MB$)B\C(^V^:8#$=GD&7S/+V\>64^E*XC\?**_23XD_'CX\^#_P!I#X!Z]\;O
M"7A7P/8VNLW5O:75K.K0-;7 AMKZ65EO)=@CBF5U9BH!.2& (KV32?@7=2?\
M%2M=\:7<,S64/AB/7[&:SR8EFDB&FK%<$I@%UCNY%56R0@.3AE# _'>BOUL^
M"OQ'/Q:_9 _:R\8++>2V^L:MXGN;7^T&)G2V.E0B"-AO;&R((NT,0H4 < 5Z
MCH_B#XL^&?V,?@U=?!KPQI/BOQ.VBZ-'<66L2+'"EH=/!>0$SP_,'$0^\>&/
MRGJ 9^(5%?K/\-/&GQ2^(O@G]L'PG\0O"]AI?C6/2([V32=!5IF-S=:,T"1)
MMEF#YBL[8A58G=(_7(5=CXJ:;K'B#]A'6_A?_9::9JOAOX:>&M>NGU!V1LH\
MCSP-%LW(Z+ICXW'EI #M"DT"/R HK[L_X*O7\?A_QO\ "[X=:9;06OAKPSX8
M22PBCW%X_-D: HS%CE5CLX<9&>6))R,>A?L:^*%_:R_8W\?? +6-3;_A)=(M
M0=',UPL;2VPD6:URQ+NR17,:QN1& D4D*CD\ S\T:*_7;XQ6?A?QK\9O@I^R
M;;W%Y?\ A#1;-+OQ$(;Q$GECM+-_LEK*Z8;+")7D4*IQ+$R%3AEA\-?M.:%X
MR_:WU']F>+X>>%+SX3I/=Z7#;KIOD&&YMH'GG+1',3+Y\5PHVHGWE?=Q\RN!
M^1]%?KI^R/\ ".S^!OQ=_:Q\%Z<ZR:78QZ9-9J-W[NWGM[R>.(EF))1)50L3
MSMR>M?.GPA)_X=._&X_]39!_Z-TJF(^%J*_;WP3JGQ*A^"7[-ND^$/!VC^*_
M!6K>'=/M?&,FK,@:UL6M;5=T:-,N_*/<$KLDSL P,\_F9^WQ_P *W7]H[65^
M&$=G%H:6MK'<II*VZZ=]J$0#_91#\OE[/+W9&?-$WM0,^=:*_1>*X7]H#_@D
M_,LL>I:OKGP\OTC5@I)7R)4 8 $DQ16-T02P&/+8]%R?6OC%\/M&U;7/V5_V
M8=:FL;S3XXO[2UZ*U5XYI?L-@ZQX(8;([AUNPQ^_\N001\P!^1U%?K_IO[16
ME:M^V!/^S#'\//"-S\+,26BVO]G!0MQ%;?;G9H2/)9!,D@"B,?,5DW'&#QG[
M/'CC5/V:_P!MS6OV:_#EII,W@+5->N]9$\D$YO+59=+6YBMXW,Y4K&L44>YU
M9FVLW!8!0#\LZ.?2OV'\3?M'>)/$G_!1_P *_!RZL-)C\->']1;4[6\CBE%\
M\CZ!<,RNYD*%<W3\*@^ZO/7/8?#'7H/"?[6?[7&N74<DMMI=CX<O9DA4%V2/
M2Y78*"0-Q"GJ?2E<1^)%%?L5X'^&]KX%\9_M;ZGI5Y%J7A_QAX<M?%.FWD5R
MEPL\5U!J3NZN@"[#,)MF,_)LY/6O&?@M9^%/V+_V+=(^-EYX0M==^)?B6YV:
M5-JJ+*MM))YPM]KC)BC,"/,VPJ[E]C,!MV,9^;=%?<7[>/B+]HOQ=\-_#]_\
M8_AWX<\*:%::EY5EJ&CRV\LCS2Q.WE,1<S2!"L1;"E5)0;MQ";<7_@F3^SIH
M7QP^*^N:QXKTRVUCP]X7M89CI]RV4FO)7;R!)'MQ)$%BG+*3C(0$,I(H ^-Z
M*_4K]G[XV>&O^"@VK>+OA-X^^'^AZ7H^FZ6UUX9ET6U\NXTNU29(BJ3.QV2*
M'M<>7&J,(Y R[2$I/V/]0^(7P!_8O^,'_"+>&5\0?$'PYXWFL$T(6TM^'F4V
M$$Z!(&#2;%,K91L?+GH#0!^6U%?J9^UK\1I/V.O%'PQ^)_@GX=^&?"7CKQ9H
M=]IVO:1)$9;:-M]E<,&^S/$DDL<K.OG#[X/.0%V]Y_P4X_:2\3?!/P+H7AG0
MK+2KFP\=:?JVFZC)J$,KRPQ"*"/= 4D4*VVX?EE89"\=<@'X[T5^OG_!0#X1
M_P#"\OC5^S5X&\Y+:UU.\U;[2Y;81:Q1VDTX0[6^?RHW"Y&-Q4' R1@^(/VB
MO#7PB_:JTO\ 9ELOACX7@^%,UUI^EWT(TX7$]Y<W%O$\4SJS+&0)9+8.TBR.
M1$[[BQ4* ?E#17ZT?LQ_ NS_ &>?^"B7Q$\-Z):3V7A:Z\)'4](AGNEG;R9+
MBU##.=VU)A/&OF?/M09+9W-T7P$^'=EX;_;X\6^,?#NZ7P9\0?!Q\3Z9=(DX
MCF::XM6G),H'SF1FEV#[BSH,+P*5P/QVVGT]J2OUN_8;\*C0_P!BV;Q9\(=!
M\*ZE\8II+U;F35FWO+(EVV+65U=7CW6\<12,O&FYD=L;F8_G3^U5XA\;>*OC
MWXKU7XB^'H?"WC":6..^TNUA:*&,Q0QQ(R;G?<K)&K;PQ5]VY3@BF!Y/1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'Z7?\$7_^/SXO?]<]*_G>5^G5
M?F+_ ,$7_P#C\^+W_7/2OYWE?IU4L HHHI %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ?,O\ P4G_ .3*?B-_W#?_ $XVM?AC7[G_ /!2
MC_DRKXB_]PW_ -.5K7X852$>G_LX?"/1_CA\4+/PEK7C"U\#VUW"YBU6\1'0
MS J$A"M)'EG)V@!LY(ZU^KOP[UMOV%?@OJK_ !M^+G_"8ZO-))?66GS73W%V
MRJ$C$%H)G\R8$A&(PJ(78G #.?Q3I<DX[]J8S[>_X)&ZA:Z?^TEXDENKB&UB
M/A*Y4--($&?MEF<9)ZXS^M>9M=0_\/(C<^=']G_X6QYGG;ALV_VQG=G/3'?-
M?-E% '[@?M(? ?Q-\;?'-EKGA;]HO5OAAI]OIL=E)I&CSRF*65997,Y\N[B&
MYED5?NYQ&.>P\P_8NF'P8_9O^/\ IEOXF@N]8\.>+/$$5KJDI17N9+>S@5+@
M1LS#YFC#;26')&3SG\CJ*5A'JOQC_:C^*7Q^T^PL?'GBVXURQL9#-!:K!#;0
MB0@KO:.%$5F + ,P) 9L'DUY5113&?I3_:EE_P .9?L7VRW^V?\ /OYH\S_D
M8MWW<YZ<]*_-:BEVGTH 2OL;]A/]@Z^_:(U&#QCXPBN-.^&MK,0@4F.;69$;
M#11MU6%6!5Y1SD%$^;<T>]^PU_P3SU7XO7VF^./B)8RZ9\/]BW5G8NP6?6,D
M[1MSNC@( ;<<%U9=G#;Q[/\ MX?MWV?PNTNX^$'P?EM].U2UB&GZCJNE*L4>
MCQHNS[):A1A9E4!"R@>1MVK^\YB7H O[>'[=MC\+]'N/A!\(+B'3]3M85L-0
MU72\11:1"HV?9+0H-JRJJ[69?]2/E7]X#Y/Y9T44P"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I4_U@^M)10!^OGCC_ (*-
M?"^'X[?#"[T'QTUSX*6UU>S\3L=.OUC@WQV[VD@B,8,DGFPE RJ^U9).F[->
M9_LM_M,? OX$_'3X^7[^-8[;PEXHO["^T.XBT:[".I%U+-$L4<):-8GN!&-Z
MKD*,5^9]%*P'U=^UK+\$M1\$Z/>_#[XR>./B9XEM]2$;6/BZ6XEBM[5XW,DD
M9EM8L,7C@4X8Y!Z'&1]-^/?V_/AAKW[(>KVW]MPZO\8-;\'V^AZG"^E3VTL\
M[Q&*<F=8/*VQM<74JJ&VY9@,;S7Y;44P/N7]E7]I+X=?#G]B'XP> ?$7B+^S
M_%NO_P!KG3M/^PW,OG^?ID,,7[Q(VC7=(C+\S#&,G YKVG3OVG/V??''[,?P
MS\!^(OC)XF\#:GH>EZ8+N7PK;7UM<K/!9B%X6E%JZM&&9LA>"44@^OY8T4K
M?=O[.OQ\^$_P%_;8\7Z\WCW7_$7P]U+0Q86GBC6HI[N[EF*VDI:X7RED(5XI
M8E(BR,)_#EJ]8TG]O+X<ZQ^V#X]OO$?B6Q;X/7WA.UTFUFDTBYE747B=9 DT
M)B:0D->7ZX**A4#(/!/Y=446 ][_ &Y?BMHGQG_:6\3^)_#.J2ZOX;FCLXM/
MN)$FC'EI:Q*X6.4!D'F^9QM'4G'.3;_8,^+VA_!']HS2/$WBC6YM!\-BTN[:
M_N(XYI5=7B;8CQQ*S.IE6-L;2 54]LU\\T4P/I*T_:9C\"_MS:I\7;*ZN/$>
MB?\ "27MPK2>9ON--F:6)0BNRL&6VD'EH^ I5 1@8KZ<T_XO_LK:#^T5=?M"
MV/CW58=;EL9;U/!<.@3JPU"6!XY2)?+$99U=LJ7V^:[OYNTX'YHT4K ??7[+
MO[?'AZQ^/7Q:U_XG++I>C_$-HF^V1HUP--2W65(+9UAB#.@AE$?F*FXM&I8?
M.S+A?$_XQ?!GX1_L>ZM\%OACXEU#XAZAXJU07^H:M/936$5H8YK=PVR6,$EE
MMHHPJYZ2.67Y5;XBHI@?IO;_ +>'@CP;X _9IT_P_P",)7G\.MIMAXNT\6U[
M'#%:_81;7!<! L_E,S.JH7^:-2 >_P D?MT>*?A]X^_:$U?Q;\-];CUC1-<@
MAO+CRM-FL5M[L QRIME1&=F\M9C)MY:9ADD$GY_HI6 ^QO\ @GK^T=X%^$?_
M  L3PE\3[D6G@OQ1IJ*\TD5Q<)O4O&\'E0QN<2QW#DOQ@0@<DC#/BU^V9;0_
MMY6?Q=\-SR>)_"^AO#9Z=#>QO#NLS:F&X6-3ADW--<2(6'WG4E<?+7QY13 _
M2RW^,W[+T/[2G_#1D?Q%UJTUMM.-W_PA4>@S+)]N:T,#J9A'Y>6C)!7?@RDO
MYVPXKP3X0?M3:9KW[?EE\:/'EROAW1I[F[DE98I+@6D)L)K>VBQ%&6<JOE(6
M"9)RQ YKY.HI6 ^YYOVDOARW_!3Y?BR/$7_%OQ@G6/L-S_T!?LW^I\OS?]=\
MOW/?IS7IUC^V%\(8_BW^U'K+^+L:;XVTC2[309_[-O/]-DATV:"1=OE;H]LC
MJO[P*#G(R,FOS*HHL!^F?[/W[=7P]L?V,[GP%XW\23Z=XQL='O\ 1;2":QN)
MOM,7E.MKM>&(HBJCI#AV!_=9/!S7EO[/_P"TA\)/&G[,+_ 7XUSWGAO3;"=[
MO2_$6GV1N&C'VCS\ [)62?=),NY8]OE,RY!^]\/44P/O3]L;X\_#'Q5^R;X-
M^''A/XH:O\3/$FD:['>W>I:[;7BW=RAAN]\C23Q*-H>=55=S$(%'S;2:\B_8
M+_:DLOV8?BM=W&O)=2^$==MELM1%JH8P.K[HKDIC<X3=(I52#ME8@,5"'YHH
MI6 _1WX8?%S]EW]D?4?B!X^\!^*]2\;>*-66:'1-%33[RU2RMG=66T\R=-KK
MYBH6G<L^R)=JD[A)Y;\%?VG-$^&O[#?Q+\*6GC&^\/\ Q/U;7_[1TJ/3Q<QW
M)B)L@[BXB4+&2L4XPSJ2 1CYAGXTHI@;_C#Q]XE^(FJPZEXJ\0:IXDOXXA;I
M=:M>27,JQAF8(&=B=H9F; /5F/<Y^Q_^"FG[2'PZ_: C^&T?@+Q&-=;1O[2%
M\/L5Q;"'S1:B/F:--P/E/]W/W><9%?#-% 'Z.?MD?MQ>"=6^)WP.\;?"[Q#_
M ,))=>#+V^GU"W6UGM,Q2K:JT.Z>$<2Q)/'N56*YSP=M:6N?%;]DSX@?M$Z)
M\>-4\>:MIFK6]O;WTOA671;W>^H0!1#+)-&K)E$1%\M&V%HT)<KO5_S1HI6
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M HHHH **** "BBB@ HHHH _2[_@B_P#\?GQ>_P"N>E?SO*_3JOS%_P""+_\
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M ";1_=%&T?W12T4 )M']T4;1_=%+10 FT?W11M']T4M% ";1_=%&T?W12T4
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M $VC^Z*-H_NBEHH 3:/[HHVC^Z*6B@!-H_NBC:/[HI:* $VC^Z*-H_NBEHH
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MLXQVR:]S_P"%D>(_^&WO^%?_ -H?\4E_PKS^W?[/\B/_ (_?[2\CS?,V[_\
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M7\S(<A<&M=>%](NO^"FUM>OIEJ;RW^&9U&*<1*'%R=1:V,V>[F!VCW'G;@=
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MYJ,T?PW&E:A-H>F26UL,M9WEM8R7*RH#(5>=;S:KMTP<?=QYCX7^/?Q=T?\
M9%\'?'Z[\>7'BBX6_9=7\(7]A8P6VHPG4)+)8K:2"V6:*4#8^2SC*DX(^4^C
M?!_X:VWP>_:F\"^#;3R2-(^$#03201>4L\XU. S3;<G!DE+N<D\N>M8'_!/_
M . _@GQ?^SG\)_'&N:5<:QXATBXU"XTYK_4KJ>ULY1?3H)(;5Y3!$P"(VY(P
M=R*_WAFC49[C^S1\0O$/Q!N/BVNO:B;]-#\=ZAHVG#RHXQ!9Q16[1QC8HW8,
MC_,Q+<\G@5Q_P.USQQ\;_P#A:OV[XBZYX?/ACXAZWH5BVC66F\V40@\B*3S[
M27/EY?###'>VXM\N,SX-_$CPQ\!OBA\</"'C_P 0:7X2OK[Q9)XJTZZUF]CL
MK:_L[Z&,1F!YBAD:-K=TDVC:K8 9N<;W[#VDW;?#_P =>,)K>>TT[Q[XUU7Q
M9I,%U&T=P+&X:-86D0C@L(RXVEE*.C D-4B/-/'WQ%^)G@7]A1OC%;_$[6[_
M ,5WF@Z3>)#>:=I?V.VFNKFT$CQHEFK$A))$ =V&')QD*1[C\0-)\5_"OX3_
M !"\4P_$OQ'K]_IOAC4;JSAUBUTORH+B.!I(YP(+*(LRE,8<LA#'*G@CY[^.
M2EO^"2-@ "2?#'AT #K_ ,?-E72:OX/_ &<_#OP=^+MQ\(KCP=/XE;P+JZ7'
M_"/ZO%=W'V7[,Q8LBR,0F\19..NT56H%=_BA\1_!?@[]FOQG-\2;_P 0/X^U
M71;#6?#^KZ?IZP.E_;AY)(&M[>&5/*9N,LPRR;B<$-]JU^<^@_";PE^SUX#_
M &9OCUX=TD:5*(=*M/%UQ%+(+=[34+-8I+V?YBJ^5-(&X7YC* ?NKC]%U8,H
M8'(/(J0%HHHH&%>9?M$?\D_TO_L;?#'_ *?;"O3:\R_:(_Y)_I?_ &-OAC_T
M^V% 'IM%%% !1110!^<?QD^//QXUS]O75?@M\/OB%;>%],G\DV0O-*M+B*#&
MF)=R;F:!I#N8/U)^\.U9/PE_:(_:)^*'PW^.6EZ9XUM-;\6^ 9HKW3_$6B6%
MG-!J$:M.DULB>25E21(&EA9(@Q8 %L.%KR_]IH_#K_AYUX@_X6N?^+?XM_[2
M_P"/G_H#1>5_Q[_O?]=Y7W?QXS7L'_!*3Q!K5SXJ^*.C^'X;Z3X/1W;7.FSZ
MLJBZBN'?$49*?*7:W53*%)"M''C&_P":N@CCM5_X*$_$?Q)^SK\-],\*:U<2
M?&75?$5QI=_=PV-D_P!H\LIY<:P%&4>8+RV"N$7+6\H''7[X\9>%?BO+^SZN
MB^%_%]C%\6/L=HG_  D>H6\:VS7"R1&Y?RQ ZJK()54"+C<O0\C\]OV.?A/X
M9U;_ (*0?$:Q;38XM.\(7NLWVDV4:*889(;];>(%6!X192R]"&1"#Q7ZR4F,
M_*/X7?&;]KWXM_'#Q=\*]&^*^AP>(?#/VPWEQ>:7:+:R?9KE+:01LMDSG+N"
M-R#@'..E=)\8/VA/VAO^&R+OX-^$OB5I'AL_9[18YM6LK06<<HTN.ZG9I6M7
M?#N)",KU=1@#I)^Q+_RDP^/7_<?_ /3Q!7CO[7D?@2;_ (*1>*5^)DE]#X((
MM/[0?3<_:!_Q*(?*V[03_K?+S@=,T]0/H;X__%O]H7]G?]D^RU_7?B7HFN>,
M[SQFEK%K7A^UM;B#^SVLI6\@JUJB;Q-"S;@F>1\W:OIJ+XD^)&_8?'Q .H_\
M5;_PKS^W?[0\F+_C]_LWS_-\O;Y?^L^;;MV]L8XKX+_:>U3X77W[ .@VGPAN
M-3N/"6F^/TM6;5E83?:&LKF9QR!E<2ICCN:]9\(_MH?#+Q=^R#+\*-.U"^?Q
MC#\-+S3G@DL76+SK;1I6F'F8VX A?![X%&HCS_X _%S]K']H;P?=>(M%^-_@
M_0[6VOWT][7Q!;6=M<,RQQR%U5;)@5(E SGJK>E=9\;_ (^_M!ZU^W1J_P %
M_AKX]LO#UO*L/V"+4M/M7@B*Z9'=R[I#;22?,1(1G/) X'3Y*_9OM?V:KCP3
M?'XR7GB2W\3?V@XMET</Y7V3RHMA.$/S>9YO4YX%>W_&3X6Z?\:O^"JVJ>"M
M4U#4]*TW5XXHI[K1YUAN55="20JK,K+AMFULJ<JS#O1J,Z[X>?MY?%+Q9^Q]
M\8M7N=1AA\<^"9M,-KXFCM( T\=W?B,I);F,Q;T1)%W*N"KK\H92[WO'G[9W
MQ)TG]@+X<>/M.\<6Z?$;4_$$UGJ-RMI9/*]N)+\*&@,91!B&#Y@@/'7YCGN_
MVF/V8O!/[,7[ _Q0T;P?!=2->OITU[J>HNDMY=LNHVX0.ZJJ[4#$*JJ ,L<9
M9BWQ/XZ_9^\*>'_V"_AW\6K1+P>+-=U^73KQGF#0>2KWZC:FW@XMX^_KZ\&@
MC['^+G[8_P 2(O"_P#^'G@FX@@^)GQ"T#1]2O/$VH6L;0P-<[%#)&JLH+2)*
M9,Q%40C:I)RDGA_]H_XR_LX_M1>%_A9\9O$%A\1+'QBEF+'4-)LXK:2PDGN)
M+>-BJQQ*P,BD.IW84(ZG(,;>!^.HM0_9P^(/[,?QVCT2ZN_"DWA#0HM3NT3S
ME,ZV(MYXD7>@20VA0QAV 9D8_,$<#JOB%XTTG]M3_@H'\*[KX9RW&JZ)X<2Q
MFOM3ELYH81%;73W<L@W)N52'6%3(B RD+]TJQ-1E3Q)_P4!^*7PY_;"UO1-;
M\6P2?#;2/%L^G7EA/I=NPATX7+1,P:*,3LT:?,"&8DHNX/DJ?JCX>_'3QKK_
M /P4,^(WPUO-:\[P/I7AV&_L=+^RPKY4S16#%_-""1N;B7AF(^?IP,?'OP_^
M$R_&_P#;"_:I\#(Z1W&JZ7KD=I)-(R(MU'JMI+;EV"D[!+''NP"< U>_X)=^
M*[WQE^UGK%]J$<*3VO@5-,7[.K*ICM/[/M(V(8D[C' A//4G@9Q1J!L_ /XM
M?M9_M#>%+_Q#HGQN\':#:6FH/I[6WB&VL[:=G6..0LJI8N-A$JC.<Y5J^UO
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ME(9? /B*SU&[ECMXYKJ339V^RWEO"7& TB3J<%@#Y8.0RH1(CE_C1^T=XO\
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MFMZ5HUXESI>FZD;A8TDA=-RQO(@<>2I4;5SRJ1HO7_ O_D]S]I[_ *Y>%_\
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MU_"OPATK]GM=8\;:E\2OB!KVE:7HDWVZ#Q3KTVI6J11[9I+ORMF[S@L1^YP
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M!3(()L!+@$[B6VG" ! ?8.KZ+I_B"RELM3L+74K*3;YEM=Q++&V"",JP(."
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MH9E*@YKW^@"AJ6CV&L?9OM]C;7OV69;FW^TPK)Y4JYVR)D?*PR<,.1FK]%%
MPVCIBBBB@0GEKR-HPW)XZTM%% !1110,*\R_:(_Y)_I?_8V^&/\ T^V%>FUY
ME^T1_P D_P!+_P"QM\,?^GVPH ]-HHHH **** .:U;X;^$]=U"6^U/PMHVI7
MTN-]Q=:?#+*^ %&69<G  '7H!6U8V-OIMK%:V=M%:6T*+''#"@1$11A550,
M    =*^?_P!L77?%.K:-X3^&'@+Q&GACQKXXU"2*#4BUU"]K9VD#7-Q+'/!_
MJVW);Q_,?F$[#&,E<SP;HK_ME? 'X:>+I?B%XZ\%WRV#B]D\':F-*^V78*PW
M!E78VY5F@DV8P '8]^ 1]":?X/T+2]8N=5LM%TZTU2XW>??6]I&D\NY@S;G
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MXIT :WI,WBF8WFH6MVAD5X?M&1F)H[>=^5 !"!0#O:3[$DD6.-G9E55&26(
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M6*Y2-V1I(9-ZE26V.KCJ#0!]3V-C;Z=9P6EK;Q6MK BQ100H%CC11A551P
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M]E;PWUYM%U=1Q*LL^P;4WL!EMHX&3Q7S5^QC\1O%-YXJ^+?PM\6ZGJ'B"[\
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MC[X%^ ?VU/C\WQMLM$N4O1X?.CG6O#SZH/DTX"?R]L$FS[T63QG ZXX_0Q5
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MO"ZZA=_%74K72-*O/#O]FW2R:/-;W%FUR]V6A'E11%2#(1CN,C)'Z TFT>E
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MEC;W4L+P7%W]N96M3;AM[HRRMN#1@[0Q99_''PE\3_ 6Z^"GCSPAI%WXSN/
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M$L=(\%^"_P!G&Q\$7\@\-3_$O0Q:SV^IRW:W-M,MS+_KW=VEC?<&!+,"-N.
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M(7,\8Z;X]_9)_;P^'OCKXD>+(?$Y\2>7%J?B&.V&FVCP,@LI%=4&T^1'Y$I
M4#(0G!YK]9%QCCI1\K G@CO57 _,G]B4_P#&R[X\MNX;^W\>_P#Q-X#Q^%>)
M?L!_M=>$/V4+OQ__ ,)=I>O:@==:R6V&C6T4NSR&N=^_S)8\9\]<8ST/3O\
MM'M'I0<;3G&.A]*D9\Q_"+]M2U^+W[0LGPWL/"$]A8CP]:^(H-8NKU3*T=Q:
MVUPL;VXCPC 704D2MRAZYX]2_:<_Y-K^+/\ V*6K#_R2EKTD*O&%''3CUIU
MCX:^/Y(_X))Z5V/_  B/AG_T;8UJ_M6?!_P%\/YO@/J?A7P3X=\-ZC/\4M @
MDN](TFWM99(BTS%&>- 2NY5.#QE0?>OM#V/(Z4<>E 'RI\)=8M_#O[7G[6&K
M7OF"RL;3PU<S&&!YG\M-,E9BL:*6<X!PJ@D] ,FN+^'?BGP?\3/VPO#7C'X$
M:;/)HDUKJ47Q!UJUTN6TL;C>B/;(WG(H-Q]H^<M&N]@Q)++NQ]N;%VX"C!Y(
MQZGG\Z<JA>@ ^@Q0!Y#^U/H]CX@^$?\ 9>IVT=YIE]XB\.VUU;3#*2POK=DK
MHP_NE21^)KK/AW\(O!/PHM;B'P=X5TGPVEQM$[Z?:1Q/,%+%?,<#<^W>^-Q.
M-QQP:[.B@#\Q?AGX8TSX4?L9_"/X[Z+I=KI7B/PKKSW&O:E96R+>ZCI4NI36
MEQ;,#A9F*O$$\TY0(=CH>OT)=^*--_9N_:8\??$'Q3)<1_#KXCZ3I=Y'XI@M
MI;BTL;RT3[.+20PK)@21RB99G\M.JC<5)'UJ5##!&1TQ1@=,<4#/B&\^,FG0
M_$[X@?M+_9;I/!.D^$;?PKX5:Z@FMW\47$LOVK,"2()47SBD(;RG4@N^<(X&
M!9^ ?%G['-UX)^-FNZG<W[^(I/LWQ7C>4^4LEW.9(+Q8HPZ9MI)C"6C."JJ(
MHU\UZ^_0H]!Z4M 'R[^W)##?67P'+I'/'+\5-!0AE#*R-YV1TZ' S7U%3=J\
M':..!Q_*G4"/C[X=_"_PA\1OVTOVDAXM\)Z)XH%D/#1M?[:TV&[\C?I[;S'Y
MB';NV)G;C.Q?2M7Q[KUM^S/^U5J/C_6;:\L/AQXXT&"WUC6K>SEN8;/5+.01
M6[W+(I\B)H)1&O\ ><G@!68?584+T &>M+UX/- 'RW\);P?&[]JS5OC%X<AN
M?^$"L?!Z>%;+5+RVDMQJMP;PW,DMLLBJQACQY9=E +@[=P!-?-'PG\%V?@/]
MB#X7?&[PYH\-GXK\):W+J6K7NFVH2_U;3?[2FAN+6210-ZF,I\TFX(D1QMK]
M.@H48 P.F*7 QC% 'R)\2_ ^F_'[X[>.O#L4UI>6/B'X2V:VEYGS;<2O?W<E
MO."I^8*XCD&#SM%>!>/+CQ%\1/V#?C'\5O%RWL6O^(_[#TH0W%R'1(-.NK6W
M=DB"CR-]V;^0Q@#!DZ=2?TWVC.<4OMB@9#&1]E4D\; ?TK\Q_A_=^*/A_P#L
M2? WXH>#+;5-1U_0;O7=%&GZ?EHYDU*ZN8(VFC"DS*EW'9,L>/F8J.N"/T^V
MCTXZ44"/CWP9X7T7X ?'[P9I4]Q:VNC>%_@_>&\U"&U%O$_E7UL]Q<F-2<%V
M#RM@DY<G))R>&^$O[./Q@^,'PCU[Q&/BZO@'1_BI->:]J7A>/PS;:BOEWH*@
M+<O.9 KVPBPH(*!@,!@:^^MHXXI:!GPU+KEK\6/V$_#]KXMTZTU#Q%X8U_1]
M U6SU-5NIK:[M]6M[20R^8"5ED@8E@>=L[ \$Y^XHL>2F.F/Z4[:/0>O2EH
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M#;NR2W2QZE=?:;,%(W<B> R1[%'S.8\\5]W4W:&SD YX/'Z4 ?,W_!-AF?\
M8U\",PVDRZD2/3_B8W-7[S_E(9IG_9,;C_TZ15]&44 > :W\-O!_Q(_:F\21
M>+/"NA^*4L_!VD&W76=.AO! 6OM3W;!(IVD@+G'7"UPVK>&M$\&_"7]K?1_#
MVE6&A:1;Q70AL--MTMX(RWARS9@L: *"79B<#J3WKZWV_-G'/KWHVCK@9^E
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M,=#_ .3F/&7_ &*&A_\ I;J]>G4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'S-_P %)/\ DRSXB?\ <-_].5K7TS7S-_P4D_Y,
ML^(G_<-_].5K7TS0(****!A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'DO[1G[2'AK]F'P-9>*O%5AJVH:?=ZBFF1PZ1#'+-YKQ2R
M D22(-NV)OXL\CCKCYT_X>_?!W_H6/'7_@!9?_)=._X*^_\ )MOAG_L;;;_T
MBO:^;OV%/V%? ?[3WPFUCQ3XIU?Q'87]IK<VF)%I%Q!'$8DM[>0,1) YW%I6
MZ'& .,U2$?1Y_P""OWP=_P"A8\=?^ -E_P#)='_#W_X._P#0L>.O_ "R_P#D
MNE_X=!_!W_H9?''_ ('6?_R)1_PZ#^#O_0R^-_\ P.L__D2C0!/^'OGP=_Z%
M?QU_X V?_P EUZG^SC^W=X#_ &GO&]YX6\+Z/XDT[4+33GU.236+>WBB,22Q
M1D QSR'=NE7C&, \UY9_PZ#^#W)_X2;QQ_X'6?\ \B5\T_\ !(?'_#3'B7 Q
M_P 4I=?^EEE1H!]N?'[_ (*!?#W]G+X@OX.\3:)XFO=26VCNO.TFVMY8-DF=
MHS).C9X.1MKW_P ">,+/XA>"/#WBG3HYXM/US3[?4[:.X4+*(YHED0. 2 P5
MAG!(SWKP'X_?\$__ (>_M'?$!_&/B76O$UEJ;6T=J8M*N;>.'9'D*<20.V>3
MGYORKXR\2_\ !1KXE?L]^)=5^%OAO1/"M]X?\#W4WAG3KC4[2Y>ZFMK)S;1/
M,R7"(TC)$I8JBC.< #BI _0/]I3]J;PM^RWHNCZKXJT[6=1MM5N'MH%T:&*5
MU=5W9822QC!'H3TKQSP+_P %3/A7\0?''A[PMIWAWQE!?ZYJ-OIMM-=6=HL*
MR32K&A<K=%@H9ADA2?8UXA\'O%][_P %2M2U#PM\5HX/#VG^%8EU.RE\'*UM
M++)(?+99#<&<%<#HH4Y[U[?X%_X)9_"KX>^-O#_BC3?$/C&?4=#U&WU.WCNK
MRU:)I895D57"VP.TE1G!!QWI^H'T=\;?B]H_P%^&.L>.?$%M?WND:5Y/GPZ:
MB/.WFSQPKM5W53AI%)RPX!ZG@X7[./[1WAO]J#P3>^*/"UAJVGZ?9ZB^FO'K
M$44<ID2*.0D".1QMQ*O).<@\=#6[\;OA#H_QX^&.L>!=?N+ZTTC5?),TVFNB
M3KY4\<R[6=&49:-0<J>">G6L+]G']G+PW^S!X)OO"OA:^U:_T^\U%]2DEU>6
M*242/'%&0#'&@VXB7J,Y)Y]$!Y7)_P %'/ANGQN_X5:=$\5-K_\ PD/_  C7
MV@6MM]D^T_:OLVXM]HW>7OYSLSCMVKN?VFOVOO"'[*1\.?\ "6Z7KNHC7A<_
M9O[%@@EV>1Y6_?YDT>,^<N,9Z'I7X_?&3Q?=_#[]LKQQXHT^.">_T/Q[?:E;
M172LT3RP:B\J*X# E2R#."#C/(K[$^##'_@JLVL#XL8\/#P)Y)TW_A#/]&\[
M[=O\WS_M'G[MOV*+;MV_>?.>,58#[T^"/Q@T;X\_#'2/'?A^UO[/2-4\[R(-
M21$G7RII(6#*CNHRT;8PQXQTZ5X=\%?^"CGPX^/7Q.T;P)H&A>++36-4\X0W
M&H6MJENOE023-N9+AFY6-@,+U(Z=1\K_ !(_:\\8?L&>,]1^!?P_TW0]7\(^
M%?+-E>>)()I[^3[5&MY)YCPS11G$ERZC;&/E"YR<D_5'P3_X)S?#;X#_ !,T
M3QYH.M^*KO6-+\[R8=1NK:2!O-@DA;<$MU8X61L88<@=>AD#=_:._;N\"?LP
M^.+/PMXIT;Q)J%_>:<FIQ2Z/;6\D7EM++&%)DGC.[,+$\8P1S7EO_#WWX/?]
M"QXZ_P# "R_^2Z^:?^"O0_XR4\,_]BG:_P#I;>U[+\'?^"6OPK^('PC\$^*=
M2\0>,(=0US0[+4KF.TO+185EFMTD<(&MF(4,Q RQ.,9)ZU6@'8_\/?O@[_T+
M'CG_ , ;+_Y+I/\ A[]\'?\ H6/'7_@#9?\ R72_\.@_@[_T,WCC_P #K/\
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M:2FJ>'? GB;7],=F1;W3-'N;F%F4_, Z(5R#Z&M7_AFGXO?]$J\;?^$[=_\
MQJOU=_X);X'[(^D'&?\ B97O;_IK7L5G^U)\*;[QQ_PAL'C;2Y/$_P!M?3O[
M+#-YOVA&*M'C;]X,I&,]JDU]$?EOIG[,L&C:#=-8>'?C-9:G=^"&-S#:^'[R
M*.;7FP39OBU^:T) ZGM]ZO._C!^RWXFTWX@:E;_#CX=_$G5?!Z+";.ZUCPW=
MK<L3$AD# 6Z<"0N!\HX K]F/B5^T;\-?@_KEOH_C+Q?IWA_4[BW6[BMKMF#/
M$S.H<  \%D<?\!-:^O?&#P9X7\ 6GC?5?$%E8^$[R*&>WU69B(9(Y@&B8'&<
M,&!''>IM;J'-Y'X._P##-/Q>_P"B5>-O_"=N_P#XU7K/_!/#3KO1_P!N'P+I
M]_:SV-_:2ZG!<6MS&T<L,BZ?=*R.IY5E((*D<$&OV,^'/Q6\(_%[1[C5?!NN
MV?B'3K>X-K+<V;$JLJJK%"2.H5U/_ A7Y9_LY_\ *6#4O^QL\3_^BKZCYB^1
M^O\ 1116A 5^4G[?/Q<UKQ!^UM%\,?'7BS6O!'P=MUM%F?1;>4_:K>6*.:2X
MDC#?Z1^^!C#881^42J,P</\ JW7PY^UI\3_V6O&WCOQ/X#^,EI<:3XJ\.P6\
M4.NQZ?,;AA- 94%O/;*[,L8GSY<ZB/>X.UN2&@.V_9Q^%/A/]D[X=?$+QKX;
M^(VH?$#X8S68U:RMUEBN_LB6<4HN3%+&XBE9RH4[4CQY**2=N:^)?@_X*^*/
M_!33Q7XXG\4?%"ZT#PYI4EO<G3(X9I[*.60R+;I#:><D:JJ1RYD9R_*YWEV8
M6/\ @F7\,_%/Q&_X7-I-I+>:=X&U[PI=Z!/J3KO@6^F*K WE[E\UXXGN&PI^
M4/@E?,7-;]BGX_6W["WQ2^('@OXJ:#JFD?VA-:6]U<QQAVL)8C)L9XQG?$\<
MY</&S9"J55PX(>HC]"OV>_A1)^QS\$/$-CXL\>77BS1]+GNM:;5+JVE3[%9K
M!&TD:Q;Y6VJT<LF$)R9&(7).?R=\-_$CQMX;\>Z#^T9?7=U_95[XZNC?6FD2
MSQQAU,-U<6X+$JB2Q73QHK,20DF> :^U/VROVVO#'Q&_9#\2S> KB_"ZUXB/
MA-+BXE^Q330Q)'<7%Q%'DR26[QE(65PA_P!(.X#[K?-WCK]G7]H2Q_8OT2[U
M'5]'U+X3:9;V_B:TT&PB#7T"W +F5B+<2'8MU(S[I"%7=V48$!]<_P#!7'4)
M[/\ 9I\,7%G<2P,_BNU DA<H2IL[PXR#G' _(5\Q> _C9>:Y_P $X_C+X U#
M4ICK_A&_L)+63<JL;.?4[<D(P;>Y683[B1@"6,9.<"]\??BHOQ8_X)?_  IN
M'DMCJ.A^*+?0+R&TB=%A:VLKQ(@0QP6:W-NY*G;F0XQ]T<7^VWX/O/AQIOPX
M\4:3*L%A\1/A_I>GZI&?WC326B63GAE_=KB*QP4(),;YP"0P@/T/_P"";]U-
M>?L9?#V:XEDGE;^T,R2,68XU&Y R3[ ?E7R3_P %2OV?]1\%ZQ??&B#QG=/#
MXBU>STI?#\=NT2VNVQ8&03>:=V3:D[?+7F3KQS]9_P#!-<$?L5_#OC'_ "$?
M_3E=5YG_ ,%@?^3:?#7_ &-MK_Z17M'4#Q[]C[P?=?L\?LYZY^U!>>,)-5>\
M\-WVGVGAV]LI'AANS?I!;L\HFRRM+ @.$7 E;YOER>4^!/[+OCK]N[P'XE^*
M_B3XFZO'XRM;Z:QT+[8&\A9HQ'.&WJ?W4):5T"PH ARP!P4/OOP)^%=U\:O^
M"4MKX.L%DDU.^L-1DLH8F13-=0:I/<01%G(4*\D2(2Q& QY'6O(/V)_VT/"/
M[,/P)\;^#/'"ZAI_C/1M4NKFPT2YLI4^U2&)$-L75&\IUFB??YJC:)%QNP0I
MJ,]@_P""7/[4GB/XP:3XG\$^-M<DUO6]%2&]TZ\O)-]U-:M^[D5VQE_+<1G<
MY+'S\= *X[_@KMX-U?1I/ /Q+T6[O+ Q2-HEW<VUZT11P6GM2J \$$7)+C_8
M]JK?\$@_@O?63^,/BCJ6GW%G:WL*Z-HUPY*I<Q^:7NF5<?,JR10*''&Y9%ZJ
M0/J?]OKX8VWQ0_94\<VTWDQW.CVAUZUN)D+>2]J#*Y49^\T(FC'IYE'41\D?
M\%(/B]JGQ9\,? +P_P"$;FYBU#QA:1ZZWA^WF'GE[E($L0S#&26DN4&#@D'V
MJE^U%H\OP\_;H_9D\)6&HWTNGZ7I_AG3E,\OSS+%J<L0:3;A2S*HS@#OP*\I
M_8;M]9_:2_:D^&,/B8KJFG?#S1-T/F2M$\=O:.[69!4C<8[FX@P/[J '(!S[
M;^W(I;_@I5\ < GCP_\ ^GFXIC/+?^"@D#Z]^W9;>'[GQ(WA?2M3&E6EUJ<D
MVV"RCD"H\[@NJ[44ECEA]T\CK7K.E?LSZ)X+_92_:"M/!WQTTGXH7-QIECJ4
MTVER)G3UL99+HH3%<S$&94=1G;DIWYQY+^WT/#C?\%!-,/C#'_"(^9HYUG_6
M_P#'D"GV@?NOWG,8?[GS>G-?8_[*]Q^RGKUUXR\#?!E!='Q!I9;7M/D35"ES
M9QDPD%KL8 _TIEPA!._VX6HCXLUCXE-\0OV$?@I\--%O[R3QG>^.+G3U97?E
ME>1MC-U.?[3M<8##@]QBHM-^,^OV/_!,77-&DU%[QKGQZNAQO/(WG6EKY$=_
M\A!SEIXI/O9XD<=ACA_V7].U_6OV@/A)\,)-*&FZGX7\<WFM7/VN0I*K(MHU
MS"PQPR)I;8]6<CBN?\9^%[O7?VEO$GP<TG4IM$\+ZI\19K"VM'DDEMK>3[;+
M:0S;"WS,B2,NXG)'&>],9^U'[./A.;P-\ _A[H=W9'3M0M-"LQ>VKX+)=-"K
M7&XCJQE9R3W)->DTV-3'&JD[L#K3J@04444#"LCQ-XHT;P7HMQK'B#5K'0]'
MM]OGZAJ5REO;Q;F"+ND<A5RS*HR>2P%:]4=6TNRU[3;O3M2LX=0TZ\B:"YM+
MJ(2PS1L"K(Z,"&5@2"",$&@1Y\W[47P;5<GXM>!NN/\ D8[,]\?\]:]+CD$B
MAAW]00?R]:_&/]O#]@Z]_9YU2?QEX-AN-0^&MY+\ZDF271)'8!896/+0LQ 2
M4Y(R$?YMK2^A_P#!/O\ X*"GP+_9WPP^)VI_\4Q\MOHGB"[?_D&=EM[AR?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM56#!F#<'EZ@?%5O\0/!/CCP#^T!XD\9)9)\3?%%_9WOAZ-;29_*:34#/?\
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MS5\7M0D_9Y\-_'?X0WQFBT+QK::1XH\.@Q/#;B1KRVF>&"%04 "&:,R94'[
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MZ<;:OIBOF?\ X*3?\F6_$/ZZ=_Z<;:@1SG_!+?/_  R/I&/^@E??^C:ETO\
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M[(?@D3Z8=,U#51<:K<[UP]QYL[F"9O7=;K!C_9"T6$?35%%%(84444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?PO\'>%O#5_X=T7PEH>E>']1\S[9I-CIT,-I<^8@23S(E4*^Y%"G<#D  \4
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MW?%[Q+XY_LO^Q#K5PL_V'[1Y_DX14V^9L7=]W^Z.M?=H^,Q_X*I_\6E_L?\
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MJM^V+^PN?V3O#?A_5CXW_P"$K_M>[DM?)_LG['Y6U-^[=Y\F[Z8%>N?L0?\
M!/\ _P"$^T'X8_&L>/!8"#5DU3^P_P"QO,+?8[]E\OS_ +0/O^1U\OY=_0XY
M-!F=^R9XD^/?@K]H#POK/Q=U?XC:'\.[4W7]J7_C6ZU"#28]UK,D/G/<L(AF
M8Q*NX_?* <D"ONCQ?X^_9?\ B%J<>H^*O$/PF\2ZC'"+:.ZU>[TR[E6(,6"!
MY"Q"@NQVYQEB>]=E^TC\&#^T'\&/$7@#^V?[ _M;[/\ \3'[+]I\KRKF*?\
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M+6DM8+FYC!9=L""=M["0)'\Q4;YHAGYJ /J2BOD74/\ @I3X#TKX:Z1X]N?
MOC^/PQJE_/IUO>-I=L TL2(Y.3<A=K;F"D'DQ2_W#77_ !L_;I^'?P+\)^!O
M$FJVFO:QI/C*V>\TJ32;.,N8E2)P\BSR1%-RS)@8)ZYQ0!]%T50T?4)=3TFS
MNY[&?3)[B%)&LKIHVE@) )C<QLR%ES@[&9<@X8CFOF?XU_\ !1SX0_!/QC/X
M8NIM7\2ZQ:R-#>P^'[5)192*%)CD>62-2XW$%4+%2K*VTC% 'U/17S%\3/\
M@H5\+/AKX%\%^,-FN^)/#_BTWBZ;=:/8H#FV=8Y=Z7$D++\[X'R\[3[9L?M%
M?MX> OV9_&NG>&?$^C>)=0U"]T^/4HGT>UMY8_+>1T )DG1MVZ-N-N.1SGH
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M\?> _@G^V+\*H_A]XAN-8T37M'L= \3_ &.TE6%]4E3R'$8NHXY!&;A+:<L
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M##]@OXF?#?Q'X4NA^TOXKO\ P]H-W:RCP[Y%U%:3VT#H?LNW[<RK&R)LQL(
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MO".J> +S2?@_J7A^XDN/M.@^'8MUQ(6B:%SY4L.UHVC8@G)^?MCDT \ _;J
M_P"'CGP" '&="_\ 3Q-4W_!: ?Z/\'P!@;]6_E95](_'+]BP_&?]HSX??%0^
M,O[(/A,6 _LG^R_/-U]FNWN?];YR[-^_;]QL8SSTJ7]L[]C(?M>1>$5/B_\
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M2^#/#/PZN?B+?^+]1U*R>WM;:2Z-@B7TN+DPI&Q8HTB,K$J$D$9SVKH_C=\
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M7U[47TNVM8;:W-XDJM< LZ&<(%S;2=')Y7CKCR7XT?-_P21TXGDCPIH&,_\
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MIN4N'\M5B5AAT &YVP"<YZU[O10 4444#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /,=#_Y.8\9?]BAH?_I;J]>G5YCH?_)S'C+_ +%#0_\ TMU>
MO3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YF
M_P""DG_)EGQ$_P"X;_Z<K6OIFOF;_@I)_P F6?$3_N&_^G*UKZ9H$%%%% PH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X<_X*^_\
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MPY8:?9ZE)IDD6L75Q%*9$BBD+*(X'&TK*O4]0:^N/^'-NA<_\70U'_P41_\
MQVOJO]D_]FNU_97^'NI>%+/7IO$$=YJLFJ&ZGME@92\,,13:&/3R0<Y_BH]
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MIM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F.A_\G,>,
MO^Q0T/\ ]+=7KTZO,=#_ .3F/&7_ &*&A_\ I;J]>G4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'S-_P %)/\ DRSXB?\ <-_]
M.5K7TS7S-_P4D_Y,L^(G_<-_].5K7TS0(****!A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7%_%;P?>^.O#-GIUA+!#/#KFC
MZDS7#,J^7::G;74H! /S%('"C&"Q7) Y':44 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPJ7Q7_T6OQQ_X Z#_P#*R@#TVBO,O^%2^*_^BU^./_ '0?\ Y64?\*E\5_\
M1:_''_@#H/\ \K* /3:*\R_X5+XK_P"BU^./_ '0?_E91_PJ7Q7_ -%K\<?^
M .@__*R@#TVBO,O^%2^*_P#HM?CC_P  =!_^5E'_  J7Q7_T6OQQ_P" .@__
M "LH ]-HKS+_ (5+XK_Z+7XX_P# '0?_ )64?\*E\5_]%K\<?^ .@_\ RLH
M]-HKS+_A4OBO_HM?CC_P!T'_ .5E'_"I?%?_ $6OQQ_X Z#_ /*R@#TVBO,O
M^%2^*_\ HM?CC_P!T'_Y64?\*E\5_P#1:_''_@#H/_RLH ]-HKS+_A4OBO\
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M4OBO_HM?CC_P!T'_ .5E'_"I?%?_ $6OQQ_X Z#_ /*R@#TVBO,O^%2^*_\
MHM?CC_P!T'_Y64?\*E\5_P#1:_''_@#H/_RLH ]-HKS+_A4OBO\ Z+7XX_\
M '0?_E91_P *E\5_]%K\<?\ @#H/_P K* /3:*\R_P"%2^*_^BU^./\ P!T'
M_P"5E'_"I?%?_1:_''_@#H/_ ,K* /3:*\R_X5+XK_Z+7XX_\ =!_P#E91_P
MJ7Q7_P!%K\<?^ .@_P#RLH ]-HKS+_A4OBO_ *+7XX_\ =!_^5E'_"I?%?\
MT6OQQ_X Z#_\K* /3:*\R_X5+XK_ .BU^./_  !T'_Y64?\ "I?%?_1:_''_
M ( Z#_\ *R@#TVBO,O\ A4OBO_HM?CC_ , =!_\ E91_PJ7Q7_T6OQQ_X Z#
M_P#*R@#TVBO,O^%2^*_^BU^./_ '0?\ Y64?\*E\5_\ 1:_''_@#H/\ \K*
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MK\<?^ .@_P#RLH ]-HKS+_A4OBO_ *+7XX_\ =!_^5E'_"I?%?\ T6OQQ_X
MZ#_\K* /3:*\R_X5+XK_ .BU^./_  !T'_Y64?\ "I?%?_1:_''_ ( Z#_\
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MU^./_ '0?_E91_PJ7Q7_ -%K\<?^ .@__*R@#TVBO,O^%2^*_P#HM?CC_P
M=!_^5E'_  J7Q7_T6OQQ_P" .@__ "LH ]-HKS+_ (5+XK_Z+7XX_P# '0?_
M )64?\*E\5_]%K\<?^ .@_\ RLH ]-HKS+_A4OBO_HM?CC_P!T'_ .5E'_"I
M?%?_ $6OQQ_X Z#_ /*R@#TVBO,O^%2^*_\ HM?CC_P!T'_Y64?\*E\5_P#1
M:_''_@#H/_RLH ]-HKS+_A4OBO\ Z+7XX_\  '0?_E91_P *E\5_]%K\<?\
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MTQK&^AU+3]3T:[-M=V5U$3LFB?! 8!F'S*0,Y&&"LL'_  J7Q7_T6OQQ_P"
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MER[M(2LH)8*#E551G?\ "I?%?_1:_''_ ( Z#_\ *RC_ (5+XK_Z+7XX_P#
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M\3;WQ8(/!.L7C:?8ZH-.NV\V=3*"GE"(R+@P2\L@'R^XS\^?\%@O^39_#/\
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M0KV!NY+=0J[8UCND50JX*^4$]<^"?L9>'_B/KTWC+_A7WP>\#_%<Q&T^W?\
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MNLVGB'1['5;";[187T"W-O-M9=\;J&5L$ C((X(SS7)_%SXV^"_@/X9M]?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&D9AQG.%P>,;]G[]BWQ_\$O'WAK5;_X_^)/%GA?18I+=?"EQ!<163Q&W>&)
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M$GBIIO$/@V#[-I7BBUTY8\1!1&L;VYD.5,:0J<2 EH5;<.5/UC10!\5>&_\
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MK1K:RLS;-<D+;*\KN(V%P#M9F.\2,"!((X_&_P#@GW\-]+\+V?Q3\0Z,9Y-
MU'Q5>:9X>F^W-=6KZ/:3RK;&W8LV4\R:X&[<=V,^Y^J]4TNTUK3;O3M0M8;Z
MPNHFAN+6YC62.:-AM9'4@AE()!!'.33=%T6P\.Z7:Z9I=E;Z9IEG&L-M9VD2
MQ0PQJ %1$4 *H Q@<4 5/&6@'Q9X1US1!/\ 96U*QN+(3[-_E^9&R;MN1G&[
M.,C.*Y#0_AOK_@WX(^&?!'AKQ-!INM:%I^G6$.MW6F>?%(MMY2R![?S1\LL<
M;H0) 5$A*ME0:]*HH \*T/X%^*_$7Q;\,_$7XD>*-+UG4O"]K=0:+I.@:7)8
MVEK-<#RYKAGDGE>5WB"IM.$7&0N[).Y^S;X@\8>,OA]=>)/&D6K:=?ZOJ]_<
MV>B:U8)9W.DV0N7CM[9E5$9L1HK[W!8^9U(Q7K-% 'SS??LZ^,_^%^:W\4[/
MQKX=FU:YM5TS38-9\,W-V-)LP=QBA*:C$-SM\S.5SDMMV*Q4])\5/@OKWCZ;
MX?\ B73]?TS3/B+X-N)+BVU:72Y);*<36YANH#;?: 4CE^0Y+NZ! %;)+'V*
MB@#P"Y_9O\1S?#OXD68\>1VGQ!\>W EU3Q9::+&B00A4A6V@M_,W")+=#$I>
M5G!=Y-^XUT7PF^#VL?#WPO!X.U"Y\'7W@2"P>P30M(\+SV896.&$CS7UP)58
M-)O#H6<N69B<[O7:* /G7XK?L0_#;X@+X171O"?A7PDVC^(;/6;PV/ANU/\
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MTWP-<:BS65KX=TGPS-=Q--=2E_.CN&EW#*(/,'EY!$<@W?=-(#ZUHKY%T_\
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M?C;XF?#CXF_MD>*/AQ8^&+T:-XFGU'6!XC>X+"UAN-3<BWCB*AW(#L2\B@!
M &+?+]8?$K]H+QE_PKOX:>*O"6N_"SP4OBK1XM5DM?B5J\T)8R0Q2"*V,>SS
M-@EPS'^\GRC- 'TW17P]KW[=7C"\^#/P9\2Z-HWA?PQ?^/+F^M+O7/%=U<-H
MFES6LC1!9'A4,//9&*EFPFT[MP#.OUO\-?\ A,6\%Z?_ ,)^VAGQ;^\^W?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP#E>H->V44"/D/P7^R-XQ\.S_M4R7.I:))_PM9+E=$\J>8_9_,6^"_:<Q#:
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M'OP[NM1DCLM:MVOO#^HPWET\DL4ZO#O^YY9#!,JRL!R5D3[GHH&?'>L?L?\
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M:2:>9@J(JC+,Q)X  )R3VK(M? 'AFQ\7W?BNV\.:3!XIO(?L]SK<=C$M[/&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6&&%!U9W8@*!ZDU@:;\6O!.L0Z_-I_C#0[Z+P^K2:P]MJ4,@TU5W[C<$-^Z
M\N3[^/\ 5MZ&N&_;,Y_91^*..?\ B0W'_H->3?M#^#K:'XA>(-)\.:)#'/+\
M$/$>EV-EIEJ%9T66T6WMXT0#*J9"%C'3?P.:D#Z?M_'WAJ:;P]!%XBTN2;Q%
M"UQHL:WD9;4HEC$K26XW?O5$;*Y*9 4@]"*YZ#]H+X8WDD"6WQ&\*7#36TU[
M$L6M6SEX(5D:650'Y1!#*68< 1ODC::^2? _B32-9^)/[!MI8:K8WUW9^%-3
M^T6]M=)))#_Q)HX3O4'(Q+;SQ\_Q0R+U4@>>?#?3[>U_8Q_9*DCM8HIKGXO6
M+7#+&H:1OM]^F6..3M1%Y[*!T% 'VE\1OV@M/@\,^%=9\ ZYH7BBSU3QAI7A
MRZNK*Y2]AC2YN$CE :)\"54<,,GC<I((KT7P;\1/"OQ&M9[OPKXETCQ-:V[^
M7--I%_%=)&Q&=K&-C@D$'![8KXA^.\V@Z7XM^*UMKZV<7A"W^*/@^[U&UNHU
M-H(7L[1[IY(\;2'56+Y'S '.:S_VPM4UOQ!XT^,^I_#74_MVC?\ "JM-.LSZ
M%.DL):35!(&EV$Y)TW[4P/\ SQ=B.&!(!]O^'_C)X \5:;J^HZ)XW\.ZS8:1
M#]IU&[L-5@GBLHL,=\SJY$:X1SN8@?(Q[&MS0O%6C>*O[0_L;5['5CI]W)87
MGV&Y2;[-<QX\R"3:3LD7<,H>1D9%?(WQ*\+VMUX-\?\ BVX\?>!]?U-OA)K6
MGV.F^$=.:R-QIS(&BGP;^X\R&)XWC0HH&9V^;H*^F?@OX6TGP3\)O"&BZ%I]
MOI>EVNEVXBMK=-JC*!F8^K,S,S,>69B22230!/:_%SP+?>,/^$4M_&?AZ?Q2
M&9#H::I U[N12[+Y ??E55F/R\ $]*7PS\6_ WC37KG1?#WC'P_KNL6R-+/I
M^FZI!<7$2*RJS-&C%@H9E!)'!8>M?-7PGU;1=+_87N=!\)7TUI\0)-!UBT&F
M^>5UMO$<=K,]Y$J'$WVE9B[!0-X38>F*@7Q+X2UK1?V38/AI=^'UUN/4;::S
ML[B6.6]ATEM+O8]0&$8OG$3HS!B//B0,25H ^E=%^-'P]\2:Y::-I'COPUJN
ML7F\VVGV6KV\T\VS=OV1JY8[=CYP.-K9Z&O![G]I;5?%OBSXH-X,^*/POMM,
M\+Q11:5:ZU.#:W2R1V+R7US=1W&[RHI)9K<"-%7>X#,2 !XIX)T>PL_V4?V?
M;F"QM8+F\^,=I<7$T<*J\LO]KW<0D9L9+^4B)N/.U5&< 5V7[4FW_A3O[8(&
M,C5]'./^X?I/^'Z56H'U]KGQ0\(>%=?TW0=;\5:+I&NZD8Q9:7>ZA#%=7)=]
MB".)F#.6?*C:#D\=:Y+PC\>M @^#/P^\8^/?$.@^$[OQ-HMEJ#?;;Q+2!II;
M:.618O-?[JE^[' QD]Z\:U#Q-\.?!_Q._:A/Q&MVMH[C3=.N[E;^3R3J>BG3
MDM]EH&D4O_I)N(RT8'[V>-=V[ 7D/A&_B%O''P5T[3];TW0I;_X-:3!I!\2:
M3<7]E<2+\]_!;HM[;I]H,:63N LC>7"I.Q5^:0/L#6?BCX.\.Z3;ZKJGBS1-
M.TNXM?MT%]=ZC#%!+;[XD\Y79@K)NN(%W XS-&/XAGAOBA^UE\-/A.OA%]5\
M2V%XOB:[M8+(Z??6TFVWGWA;^0M*H%HNP[IAD#WKSOX-_"VR\"^,O@3H=YXA
MMOB"-$\)^)+G2_$)B4J5DO=,$+0?/)M5;>=HE*N1L! P#BO-/B)IMGH?PM^!
MECI5M!I^GVO[0$EO;6MH@BBBA76]658T51@(% 4*!@ #% 'TQX=^,%K)XF\>
MWVL^-O 9\":7#I=QIUU8:H/M5M%<P[_,OW9_+1969# RX#H<\\5/XR^-VCM\
M$/'GCOP'KNA^*_\ A'=)OKR*:SNEO+3[1!;&812-$_H4R P.&[5\GZU\6+?P
M3\<OVEM=TS2-+\5PZQ?>![73;S4F5]$M)9K0M;:A>3+D);1N$D\Q?XA&%92P
M8==XMN#<6_[6QN-?\+>(]57X>01:C=>%M/-FL=Q'#K,9AN5-S.6N$5(U+,X(
M41KM7:,UJ!]D:AJ=IHFEW%_J-W#96-K"T]Q>74BQQ11H"S.[' 50 22< 5S/
MA_XR> ?%FFZMJ6B>.?#FM:?I$7VC4;K3]6@GBLH]KMOF97(C7:CG+$#",>QK
ME/VK/B9%\'_V>?&?BN71K/Q#':VL=O\ V;J'-K/]HFCMP)5Q\T8,H++_ !*"
MN1G(^9OBMXD?7?&7Q!BU+Q?X2\6^(+?X)>(Y+F3POI,EKY%O+]CDMUEE-U.L
MH8,[H%*E5?<1B5#4@?8WA3XP>!/'FK3:7X:\:>'_ !!J<41GDL]+U2"YF2,%
M07*(Y.T%T&>F6'K7E'QR_:GTWP7X@\ :#X.\0^&=>UW5?'.G>&-:TQ;Q+FYL
M[:9Y(YV,<<@:.1'55RXP"<$9.*\;\/QR1>,_V"H[<+#*_A'5> -HW'0K8Y(
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M$2'>C$>8S21J%SDF10!R*L>#_B%X6^(EK<77A;Q+I'B2WMI!%--H]]%=)&Q
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MB+Q/\;_@I\6OB?I@7^W-%^'EEX4N&FDVP-<&,7FN@6Y'[MTCDCB&1D/"P[4
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M.\;<9XKS[X??M1?#SXG_ !&U[P7H/B"SN]6THP[&CO('BU 21&5C:E)"THC
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M<<=CZ]^S/IMIHOPWU#3;"UAL+&T\3^(H+:TMXUCBAB36;Q41$ PJJH "@8
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M&>35_P#:4_??LV_% [>6\)ZH0,?].<IX_*N%77/#GA?]K'Q)>^++[1]*NIO
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MC_93LO!=Q'I'B&_\!ZS96EQG:AE&DVSP"8X.Y%F"/A@W(SC(KEO$FH^"+[X
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MW1?"5UK5WXEO;7SKB]U;4&W37EU//)<3RMG)PTLKD;B3C&68Y)Z'PGX%\-^
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MKS!\*-(M=4\[[?C^U/.L);OR\>5^YV^7LW9?.[..U8UA^U-XE\77&AZ7X/\
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M=Y,WF[/WGE;>* /7](^#O@/P[;ZQ!I7@GPYIL&LQM#J<=GI-O"M]&P8,DX5
M)%(9LALYW'UKJ[6TBLK:*WMXE@@B41QQ1J%5% P% '0 8''I7'_&/XDGX2_#
MW4?$D6C77B.]ADM[6RTFS=4EN[JXN([>WBW-PH:65 6P2!DA6(P>0L/B]XZ;
MQEJ7@K4?!6AV?C#^R(];TA4\07+Z;?P"X$-RK71T]6BDBW1ML$4F?-3)4'-
M'H</P\\+6OB^;Q7#X9T>+Q3,GERZW'81+>R+M5-K3A=Y&U$7!;HJCH*?X?\
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M\0I_%&D:SI,'AWQ;X8U$V&J:1#J4=\@5T66WN(Y%56,,T3JREXXVR)%*Y0T
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M&+"8(/G+\R]P#UCPGX%\-_#_ $V73_"WA[2_#5A),;A[32+**UB>0A5+E(U
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MVVGU7P7H/A_2[;6TCNY;[0+."%;]2&:.1GB4"4$2,RL2?ODCK7CW[>O]M2_
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M+K_PP^"NM>,_^$6AUO6M'L5OKO0[34Q'%M4J;@I<O$"4C3S'!,89A'@*"0*
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MJ-7P5WA9%(#8)&0.A-:+Z79-J%K?/:0-?6\4EO#<F%3+''(R&2-6QD*QCC+
M<$QJ3]T5?HH H:;I-EHT,D-A9P6,4DTEP\=O$L:M+([222$ <L[,S,W4EB3R
M:YO6O@[X"\2:IJFI:MX'\.:KJ&JQ)!J%W>Z3;S2W<:-&429V0F15,41 8G!B
M3'W1CLZ* ,#4/ _AO6+^YO;[0-+O[VYL&TF>YN+*.266R<EFM68J286)),9^
M4YZ5G/\ "7P--JFCZA)X,\/R:CHL$=MIEVVE0&6QACSY<4#[-T2+D[54@#)Q
M7844 4=4TNSUS3;K3]1M(+^PNHVAN+2YB66*:-@59'1@0RD$@@CD5F>*_ ?A
MGQYI\6G^)O#VE>(=/BE$T=GJMC%=1*X4J'"R*0&"LRY'9B.]=#10!D7WA?1M
M4UC2]5O-)L;O5-*\S^S[Z>U1Y[/S%"R>2Y&Z/>H ;:1D  YJK>?#WPMJ6F:O
MIMWX:TBZT_5Y_M6I6D]A$\-[-\G[R9"NV1_W<?S,"?D7T%=#10!S^I>!O#FL
M:A=7NH:!I=]?W6GMI,]U=64<LLMD[%GMF8KDPL228R=I)/%6?^$5T?\ X1H>
M'1H^GCP^+;["-*^RI]E^SA=@A\K&WR]OR[,8QQTK7HH Y?0_ACX/\*^';[0-
M$\):'I.A:AO%YIEAIT,-M<[T"/YD2J%?<@"G<#D  \5JMX>TMK_3[UM-LWO=
M/AD@M+AH$,EM&^SS$C;&55MD>57 .Q<]!6G10!SUGX!\,:?XLNO%%IX<TFU\
M2W<7D7.LPV,27LT?R_(\P7>R_(G!/\"^@JK<_"WP;=>)+KQ#-X1T*77KH0K/
MJLFFPFZE$3QO$'EV[FV-#"RY/RF)"/NC'5T4 8TGA/19K?5[>31]/>VUC=_:
M436L92]W1K$WGC&),QJB'=G*JHZ#%5O#/@#POX*54\.^&])T%5A%L%TRQBM@
M(1(\HC 11\@DEE?;TW2.>K'/144 >.^)/A%J_CC]HCPGXWUJXL[/P]X)@NCH
M-O83.]U>7-W"L5PUT&C"I&B+A$C+$G+,X'R5Z%KW@/PUXLU32]0UOP[I.L:A
MI,OGZ?=ZA8Q3RV<F0V^%V4F-LJIRI!RH/85T%% '/^(/ ?AKQ9J6DZAKGA[2
M]:OM(F^T:==:A913RV4FY6WPLZEHVRB'*D'*+Z"K/AWPOH_A/18='T32;'1]
M)A#>58:?;I!;Q[B68+&@"@%B3P.YK7HH YWPCX \,?#ZSGL_"WAO2/#5I/*9
MYK?1[&*TCDD*A2[+&H!8@*,GG 'I533_ (4^"-);7&L?!V@63:^KIJYM]+@C
M.HJ^[>MQA/WP;>^0^<[V]376T4 82^"_#R76C3IH6FI<:)&T.ES"SC#6".JH
MR0-MS$K*JJ0F 0H':LE/@[X#BU2YU%/!'AU-0N[^/5;B\72K<2RWD;.T=R[[
M,M*K2.1(3N!=L'DUV=% &3XB\,Z1XRT6YT?7M+LM:TFYVB?3]1MTN+>7:P90
MT;@J<,JL,CJH-9FF_#/P?H]OJ-M8>$]$LK?4;2+3[V*VTZ&-;JVBC,4<$JA<
M/&D9**C9 4D  5U-% '-V?P[\*Z?=07-KX9T>VN+?31HT,T-A$CQV .1:*P7
M(ASR(Q\OM4GA/P+X;\ Z?)8>&/#VE^'+"24SO:Z3916L3R$ %RD:@;B%49Z_
M*/2N@HH H+I-E%JDVI+8VZ:C/"EO+>+$HFDB1G9(V?&2JF1R%)P"[8^\:S-#
M\ >%_"^J:GJ>C>&])TG4M4E\[4+S3[&*"6[DW,VZ5U4&1MSL<L2<LWJ:Z*B@
M#FK/X>^%+'0K'0[7PUH]OHVGW"W5IIL-A$MM;S))YBRQQA=JNLA+!E (;)ZU
M--X'\.7%UKMQ)X?TN2?78%MM7E:RB+ZC$J%%CN"5_>J$9E"OD!21T-;]% %'
M2=*LM#TVTTW3K2#3].M8E@MK2TC6.*"-0%5$0 !54  *!@ "KU%% !1110,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \I_: \*^+=<T7
MPWK?@>.UO/$OA36H]<M]+O)!$FI1BWN+>>T$IXA>2&YD"R,K -MS@'<OS[^T
M3\#_ (E?'KX:?%O7!X)32_%/B'3-)T+0?#[:M ]TEG9ZL]R\ER_F"W2217$F
MQ9'"A N\L6!^V**!!7PM^S=X?^)WCK]F_P"!WA.TTZRM_"]I=V/B'4/%%Q<Q
MLL]E:WJ7,-A';A?,6X,BA=Y'EB.!6WLTIC3[IKG_  1X'T;X<^$],\,^'++^
MS=#TR$6]I:^:\OEQ@Y W.68]3]XF@#Y^OOV?/&/BG]G_ .*/@^.>#PSXCUCQ
MGJ6OZ-=712>(J-6%[:.^PMM#^6F<@E=V2A(VG<\-^%?&/QB^,/@GQ]XW\!_\
M(':^#K#48;&SN-<CO+N:\O(+1))"D"F,0HHNHU+2;V.UC&G0?0M% 'Q1\,/V
M;?B7H/P9^..A^(B-8U:?PW<^!?!D4B6R37&E6T5Y]BD:592J^:UYMV2;"GDK
MN]NO^&_@3XL?!VX^'NH:=X7T_P 0V4_@'1/">MZ0VI1VUUINH64=PT=PTI#(
M]LKW#QR>67D 8.B2;=C?5%% SX7\"_LG:_X%\&_#?4?$_P -/#OQ/UK0(-9T
M?7-&O+BWE:>"XU@W,%Y9"X7[.72-II KF%BLY4E3\H^J_@KX9M_#/@.V6+P#
MI'PTNKR5[NZ\.Z+Y#102$[06>&-$>0QI'N*@@$;0S!0Q[VB@1\?_  -\$*_[
M9GQ6LWFCO])\#W,NIZ6E\K3SVMUK\5M<W(B=AMA1&M9\+&.1>2 L<M6QX?\
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M7?#\.@Z?\--1TK5]0\3QZG%=6VH/I\!BAAM(@!,3*6!=IDB\O#A?-X+?7%%
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M'X9C\">&_!/VZXN(#J,&H#6KVXAEM4^SM'AT@CB9GWRB-F,RJ81MWKY_X*^
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M:D[C]A44 ?(O[06F_$;P)X9_:)-MX6TS7/ _B[0[S48-3M]1$$^E21Z/!:W
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MLDS(&>'S5&V38Q*[EX.W(ZUKT44 %%%% PHHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(D0Y*X^=?44 =%14>X!@N1N(R!WXQD_R_.I*!A1110 4444 %%)N'3(STI:
M"BBB@ HK!USQMX=\+ZEI.GZSK^F:/?ZM+Y&G6M]>1P2WL@*@I"C,#(V7484$
M_,/45NA@W0YH$+12%@.IQ2T#"BBJ6J:E::+IMWJ.H74%AI]I$T]Q=74JQQ01
MHI9W=R0%50"22<  F@"[16?HNN:?XDTJVU32;^UU33;I!+;WEE,LT,J'HR.I
M(8'U!JKX7\7:%XYT=-6\-ZUI_B#2Y&9$OM+NH[F!F4X8!T)4D'@C/:@1M444
M4#"BBB@ HJEJNJ6>AZ;=:EJ-W!8:?:1-/<W5U*L44$2*6>1W) 55 )))P ":
MJ^&_$VD>,-%@U?0-5LM;TFY+>1?Z;<I<02[6*MMD0E3AE93@]5/>@1KT444#
M"BBL'PKXTT#QYIK:AX:UW3/$6GK*T#7>DWD=U")%P60O&Q 89'';(H WJ**P
M+GQUX<L?%EIX7NO$&EV_B6]B-Q:Z++>Q+>3Q .2Z0EM[* CY8#'R-Z&@1OT4
M5D^)/$VC^#=%N-8U_5;'0])MMOG7^I7*6\$6Y@B[I'(499E49/)8#J:!FM17
M,:]\2O"/A+0;#6]=\5Z)H^CWY1;34M1U&&"WN"Z%T$<CL%<LH+#:>0"1Q73T
M""BBL'0_''ASQ1JFJZ;HOB#2]7U+1Y1!J5G87L<\UE(2P"3(I)C8E'&& /RM
MZ&@#>HHHH&%%%% !1110 4444 %%%% !1110 4444 %%4M4U.ST/3;O4M1NX
M;"PM8FGN;JZD6.*&-%+/([D@*JJ"22<  FJOACQ1HWC31+?6/#^K6.N:1<;O
M(U#3;E+BWEVL4;;(A*G#*RG!X*D=J!&O163XF\4:-X,T2YUC7]5L=#TBVV^?
MJ&I7*6\$6Y@J[I'(499E49/)8#O5FPU"TUC3[6]L;F&\L;J)9H+FWD#QRQL
MRNK#@J0000>XQ0!=HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/X,^+/CM:VGAG3?A]X>UF)XY9=,\9W^OR65QX>N@@R[11P&1T<JF%1V!9 9
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MH?$.N2:Y%;BVDN;>166"(1N96BC\UV5F0YMI4X;RP_9_\$U_^3*OAW]=1_\
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MN3Q/I/B.[U5O+E\Z]M9O(,"0,Z^7%;MN=B/WC*JJRYDKO=8_9-UCQ1J'[/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-WB8-%/&CLS".:WD@F4;F $N-S8R>OO]>TW2[RQM+V_M;2YOI?)M89YU1YY
MK.4C4G+,%5FP.RDT :5%8UUXKT2RO+6UN-8T^"ZO+EK.W@DND5YIU4N8D4G+
M.%5FVCD $XI->\9:!X6^PC6]<T[1C?W265J+^[C@-Q</RD,>XC?(W95R3VH
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MJ&(7NF:3!;S!" "@=$#;3@<9QQ3M/^#'@#2/%C^*+'P-X<LO$SS2W+:U;Z5
MEX99 PD<S!-^YP[[CGG<V<Y- ')_M->-M+\*^#-&TG4/"VE^,IO%NN67A^PT
MC7)8H]/>ZD8R1O<M(K_NT\HMA4=BRHJKELCRC]CG1==\(_'3XZ^'=:3PU87-
MNF@W<VE^#8Y8-*@GF@N=SQP.Q\N1XXX"^ -VU3[U].^*?!N@^.M)?2O$NAZ=
MX@TQV5VLM4M8[F%F4Y4E'4@D'OBH?"_@/PUX'C$'ASP]I>@0^2MN(]+LH[91
M$LDLBH BCY1)/,X'0-+(>KG(!\Q_'[1;;X)_$SQ'\>;^PT3XA>&[>/3;?5M-
MUIXWU'P])!/$(GTEG4HI(N/.:!S&3($99,O@9_QF^$G@WQAX1_:U\3:WX;L=
M3UZT1_LM_<IYDMK]G\.Z?<1>4Q/[LB4[B4P7VJ&W!5 ^F=2^#?@'5_%G_"47
M_@?P[?>)EEBN!K5SI,$MX)8@HC<3%"^Y B;3G(VC'2MRY\*Z+>6>LVD^D64U
MMK6[^TX9+=&2^W1+"WGC'[S,2)&=V?D15Z "@#Y!_:HG?XL77Q8T30_ O@&Y
MF\"Z#'%K?B?QE$LUX(9K26Z6*R6)?-C"*P=9G=5\TN%0[689'P-MH_'G[2GP
ME/B6)=??_A1FC:UNU1?M)_M".\'EWF7!_P!(0S2XE^\/-?!^8U]>ZQ\(? WB
M+Q);^(M4\&>']3U^W:-XM5O-+@FNHVC.8V65D+ J<$$'C'%7]-\!>&=&U*TU
M'3O#VEV&HV>G+H]M=VME%'+#8HP9+5&5<K"K $1CY00.* /@_P#9[^#OC#XC
M?#WX1>,=.TWP?IE[IOB=-;U?QC-JEW'XBO6%W*FH6T_^A*6:0M)"8WE92$1=
MS#!KM)?A_P"&X/AAXI\9#0K"7Q7'\7BT.M3VZRW4&WQ;'$%BD8%HDV%AM0A2
M9)"1EW+?4UG\%?A[IWBM_%%KX%\-VWB9YWN6UF'2+=+PROD/)YP3?N;<V6SD
M[CZUN-X.T Z9+IYT/3CI\MY_:$EJ;6,Q/<^>+CSV7&#)YP$N\\[P&SGF@#X>
MU7PWX?\ $7PK_; \1_$/P]HEQXNT[Q!K=OI^I:YIL O(+==/ACTP1.Z[E#*8
M_*93EBX(R6R8OCUJ'CB[_9Y^)=W=)J<?C6?X5>"GUA8(#%<AGO\ 4OMXD2-1
MM41FX\P !0N_.%S7V?K/P@\">(O%$'B35?!7A[4?$,#QRPZQ=:5!+=QO&08V
M65D+@J0,'/&!BMR^\+Z/J3:D;S2;&\.I6BV%]]HMT?[5;+YFV&7(^>,>=+\K
M9'[U^/F.0#Y5^*O@CPW\-OBY<7'PKT/3M \=O\+?$4L=CX;M8TN&>*2Q^P/]
ME08),GFJA*?/L*G<$ 7 _9;^%NM0Z?\  3Q?!X>\ >$K*'1UBFU30M6GCU/7
M()M,=C;W%N+6..:0S)%<L&D<HUO(5)^8GZS\*?"OP7X#D1_#7A'0_#SH9=IT
MK38;;;YOE^;C8HQO\B'=CKY4>?NC%'P_\#_AUX4UZ/6]%\ ^&='UF-G=-1L=
M'MX+A"X97*R*@8%@[ X/1B.YH \S_8L\(^&/ ?P)^'BVC6Q\3>(O#=IJ=W=7
M)B_M&^C6.-L.X4/+#;_:DB3.1$C1IGD9@^*6BV7C;]K?P#X=\;Z9H^I^"5\-
M:C?Z)9ZG(KB[UI)X%ES;L^V5HK4EDS&2OF3,#\N5]0T?X+>%?#_Q)A\;:?8_
M8]4M_#\/ABTM[?\ =6EI8Q3-,(XHE 5<LR#G.!$@7;\V[<\6^!/#7Q!TZ&P\
M4^'],\1Z?#*MQ':ZM9QW42R@,H<)(I&X!F&<9^8T ?&$/PU\!ZIX)\:Z5:Z5
M8>(_#^A_&6QT_1HM3TY'BTV"?4-*.H65JCQA8K<7$MU$5C78RCG=G)Q?%GPX
M\(W7Q _;:\SPQHLP\/\ @W2UT;=I\+#3570Y]HMQM_= >5%C9C'EIZ"ON$?"
MWP6O@K_A#O\ A$="_P"$1_Z ']FP_8/]9YO^HV^7_K/G^[][GK3=/^%_@W1[
M75+:R\):'9VNJVD5AJ,5OIL,:7EM'$88H)5"XDC2(F-4;("G:!CB@#XL^'GA
MS4/'VL?#.P7PUX)\;W%A\(_#EQ9:5XXU66)(4F$Z75Q;VXMIU=F,=NDDA52H
M6%<G?BNN^'_[/K-XP^"'@;XO6.@^-]0\,>"]9V1K$;BP/E7MC#;'9(B"39;2
M*OSI]X9Y(#5]/:_\'_ 7BG2](TS6_!'AW5].TB/R--M+[28)H;*/"KLA1D(C
M7:B#"@#"J.PK9TWPCHNDS:?+8Z18VDFFVAT^R>&W1&MK4E"8(R!\L?[J/Y!@
M?NTX^44 ?.G_  4LTNQOOV-?&\UQ9074]C+83VDDL2LUO(;V",O&2/E;RY)%
MRO.UV'0FN8F^%'@>X_;]T_PQ)X/T"3PW:?"EIK?1FTR V<+MJ[[F2$IL4GS9
M.0,_O&]37UUK&BV/B/2;O2]4LX-1TVZC,5Q:7<2R0S1G[R.A&&4C@@@@@UB>
M&OA?X-\%WD%WX>\)Z)H=U;VK6$,^G:=# \5LTIF:!6505C,K-(4'!9BV,G-
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M1I>L7:7Q;9+;V]PLDL8 5LLR@@ @ YY(%=%X7^$O@GP/:ZC;>'?!^@Z!;:B
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M>A^)/%_[)F@"5_%/@J:_\<V-HFLJ;E+S3K:9S8K(DH^942WMV164!3%&0!M
M'W#XB^#O@+Q=8:98Z[X)\/:U9:5'Y.GV^H:5!.EG&512L2LA\L;8T&%QPB^@
MK2A\!^&8)?#\T/AW2DF\.QM!HTBV48;3(VC$;);G;F%6C55(3&5 !XH ^&?
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MJAFQ<*.F*^M&^%O@UO%4_B=_">B-XDGC\B76#IL)NY(]@CV--MWE=@"X)^Z
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MVEQ\3]'M[B&VTN!(Y(9E=)HW4)@I(L,*N#PPB0'.T8]-_;#AU7P9^R'X]MO
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'QA^P?\
M$CQ->^)/%7ASQ?XJU'Q&VM)<^)-"743-.\$$.IW>GW,(G<D;4:WM6$8(QYY(
M')-6O@I\<+S1;OXN?%'QUXAU8^$[S0]/\4Z;I>J3+$EA8R7NK06D5O$7\M9)
M[>ULVP"#))* <DYK#U3]FGXE2? GP!8:-;2:3XSL=4\1:3J$1U!5C@TC6+B\
M66X;RWQ*8@]G<J@;.8AP6 %=K\?/V9]5\?>#?BGX6\-6$>F:7>>"_#^F:"D7
ME^7)<:;>W]R+15,@\M2KVT>]B%'FY^;8PH$>@?\ #4&D>']0\16/CKPYK7P\
MNM&T:3Q$%UG[/.EWIZ2")Y(I+666,R+(T:F$L'S+'M#;LB?2?V@-2U#5[O0[
MSX9>+M(\2?8?[5T_2;IK#S-2M%GCAE>*47/V=9(C+&TD4DJ,!(F-V<5X?XZ^
M!D7Q^^&_COP_IO@#XC>$_$$FDS6%IK'CWQ%)J$!GCNK2Y^RPK+J%P=DTEM%F
M=$"XC/S'[I].^!_AO3]4\9IK5S\-OB+X;US2;:XL5U7QKXDFU*VC9VA\^&V6
M74)F97*H1*L01A%][( H R?A_P#&:3XA7G[/.J>*K?Q;X:\1>);2XGM+*PN+
M:/2=5?\ LI9Y9[B..>1FMR'9H5;$BN@+JHKJ[K]J:SAU*V2#P+XNN]#?Q,WA
M&?7TMH%M(-0%]]B&=TPD:$R?\MD1E!94_P!9N1/-OAIX#\;:O??LPRWG@O5-
M B^&]O?:-KS:I+:J0RZ.MJL\(29C+"\V55E&3C=@+@GT3_A6_B/_ (5(-%&F
M_P#$R_X6-_;I@\Z/_CR_X2PZAYN[=M_X]?WFW.[^'&[Y:!E;Q+^V)X:\-6?C
MK63X<\0ZCX0\%7UQI6L^)+)+9K=+Z)8B;9(FG6=V,DJ0[_*"!V!+; TB^_J2
MR@D8/IUKXK^)Q^(WP\^!OQ^\$S>#VN+?4'\2:UIOBB-HCI2Z3<AKJ=9SY_G"
M[43W$:(L.TN(^J"20?6]GJVKS>++VPET40Z'%9P3V^LB[5OM$[R2B2#R<;EV
M*D3;R<-YP ^Z:!'BGQ?^(/B+P/K/QPO]'EU&ZFT?P!INHV%K;R1NMI<--K :
MZ6.9Q'\HBB=^[+ !AR%4VOV08ET3]F'PWJ-EX,U#3M2O-,AU6[B>6U:ZU^\E
MMHI9;T2>>RLT['"F=T88 8(H&+/Q2^'?B+Q!>_&R33].:Y7Q%\/;;1-+Q*B_
M:+Q#J^Z+EOE(^UV_S-A?GZ_*V.Z^ _AO4?!OP1^'OA_6+;['J^D^'=/L;RWW
MJ_E31VT:2)N4E3AE(RI(..": ,KPS^T1X/\ &&C_  UU#2[QK@>/PYTJU$D)
MF01VTL\_FJKG'D^48I-I;9*R*>N:Y72_VNM%OI/"=]=^$?$^C>#_ !;JD>CZ
M!XIU"WMTMK^XE,OV=A;B8W213"+='(\*@AU+;%^8^._"SX36OC+XW?&+X6:F
M--MO"'@?3]0TS2X]+TT6]Q%#XE(O)3&S.Z1M;I&T";(P"KG@#Y3U&BZ5\5;O
MX>_"SX3_ /"O9M(G\+ZEH8USQ%=7L$ND3:?IMPLBRVDBRB=I9FL82(W@R@F(
MDVY62@#W<_&+2!X/'B+[+?&Q_P"$B_X1DQ[$\W[3_:W]E;P-V/+^T?-G.?+Y
MVY^6M/X@>/(/AYI^E7EUIU[?P7^KV6D&2S,7^C/=3K!%+)O=28Q+)&IV!V&\
M':0&(^=H['XF36$_P^7X7:C';V_Q*3Q WB*34[,6,FDOXC;4Q.@\SS#,%4@P
M;00HW%@S+&WLW[27PT_X6]\"/&_A%+0:A>ZAIDOV"!IC$#>QCS;5BV1@+.D3
M<G''S9!- $%M^T5X6/Q/\9^![Z/4-)N_"MB=1O-6OX533I($AMYIVCGW$9A2
M[MRX<*0)%/(YKBKCX[>#=,FU7XN7VL^*[/2K/P!I6LOH<]S$-/:WOY[A[8I!
MOV_;F>!H2Q<+AXU#')(\E\7_  $^*_B/X8V^KZ3X?DTSXA^+=2\2:=XHTC4]
M8AN8+;3=7+QK*\Y9MPM8[32@JVY!*P%=AR17O.K>!I= \7>.+N'P*/$GA*Z\
M)Z'H-MH-E]DC2Z6"ZU(3VZ13/'&J)#=1':Y5"#@'@X ,WXT^.+V]^#:ZQKGA
M/6_"IL?%_AYVL;Q8+RYEB37-/<21I9RS;RRD@(I+EE8!3P6[OX>?%:;QOXFU
M[P]J7A'7/!^MZ/;6M[+;:P]I()8+F2X2%XWMIY5/-K(&!(P1QGK7@'PU^'?C
M'5/">N6^E>'/%'AWP)_PDGA6X\-^%O&&I">_L(+'4+26_D42.[0V_EP+Y<+3
M.?W#E57S%4_0>B^&]2MOCEXN\02VQ32;[P[HUA;W)=3OF@NM4>5-N=PVK<P'
M) !W\$X. #G_ !)\6O$>D_'SPYX+MO!6L7>AWVFWUS+J4,EAY<ACFT]!.FZZ
M6010BZD613'YA9D\M7 )K"T_]KO0;ZSM=>;PUKL'P_NM6;1[?QN9+)],:474
MEJ)7"7#31P-*BJLKQ@?O%+;003O_ !$FU?0OCA\/?$%IX9U;Q!I3:=J>@W4^
MDI$_V&6[N=-DBFF#R*1"%M)RS*&QA>,L ?G-/@IX]U?]F.W_ &;;OP9J\/DW
MT5I=>-!)9)IO]FIJSSK<QK]I:9Y&AA'[G8"&==VT$$@'V/XT\33^#_#TVIVV
M@ZIXEN$FAA33-&2-KF8R3)$"OF.B!5W[F9W4*JL2<"O*-8_:VT?P7X-\8ZWX
MT\)^(O"=UX3&GRZII5U'!--Y-[-Y-O<0R12M%+&7$@.U]P,4@VY !T/VJK'Q
MQ??#K31X)BU*Z$&NV-UKEIH=V]KJ5SI,4GF7,-I(DD;"9@JC D0LN]0<D _(
MG[27@.^\/_LV_'SQ(O@W7_"'AS7-)\*I81>)];?4M1FDBU61YC,))YF@8?:(
M_P!WO88(/#%T0 ^MYOVG+70I/$T7BKP/XI\)W&C>'KKQ1%#J$5K-_:-C;*/M
M!@D@N)(O-1B@,;R*<2Q-P&XL>"_VD;3QAKWA"TG\&>)M!TGQA;-<>']=OXK:
M2SO]L!N0A,$TC0L\ :1%F5"P208#+BO%?VAK/Q/\5+'QMXGU7P+K'@S0O!/P
M\\36L5QK-W:&6_O;VSCRJ1V\DJF%(8B?,\SEY-N!L;-?X<Z#XA^//PP_9Z\(
MW7@77- \)Z!I%CJ^H^)KN\LT2=5TB6VMDM$CDE9S(\Q<^8J-&B+N7,@P >P:
M-^UCI6J?\(QJ-QX,\5:5X.\4:E%I>B^*KZW@6UNY96D6W<P"8W,44Q1/+DDA
M4'S4+;003RG@_P#:,\(?#S3_ !9<)<>._%$M_P#%&^\(QVVL3P7,D6JM'N6U
MLRTJK%9$QA(@[#:TGS;5RPR_#ND_$Z\^'/PS^$LOPZNM*F\,ZAH::OXENKZV
M?29+'3;E)5GM723SWDF-A'B)X%*>> ^T88\4_P"SC\1O+X\.-_R<1_PG7_'Y
M;_\ (%)_X^O]9[_ZO_6?[- 'KWC+]JB]C^&'Q1OM%\&:S:>-_!-K(=1T.^FL
M'DTW?8M=6]Y-MNMCVQ4#(C=I258",X->Z>%]9NO$&AV]]>Z)?^'KF3<'TW4G
M@:>+#$#<8)98SN ##:YX89P<@?,^N?!+QK>>,/VO[V+1&>U\>^';&Q\.2?:8
M1]NFCTF>W=,;\QXE=5S(%'.0<<U[SIWB37_&OPON=5T31+KPIXDN[*<Z?IWB
MR)4:WN K+";E(7?"%@K$*Q;:>S9  .6\*_M 7>M>)/#6FZU\-_%W@RV\3,8]
M(OM:6SQ+*ML]RT,T4-Q));R>7%(=LB@_(P.""*Z?XG_%:Q^%L.@&\TO4M8N=
M>U,:18V>DQ))))<M;S3(IW,H56$#+O8A5+ N50,Z_,GP:\ ^*]1\:?"75M7\
M!^/[;Q!X:N9U\5^)/%WB1KFWDN/[+NH7^R6K7<JR1/<7 VR1QK@8QD%ROL_[
M1VJ:OHNO?!R\T+1F\0:E#XR8C34GCADFB_L;4Q,(VD94\P1;V4.RJ6"@LH.X
M %>W_:QT"/3]>AU;0M6T7Q?H^K:;H<WA&YN+(ZA/=WRQ-:K"PN#"XD$C$9D&
M!#*6"[34<W[6^@>'?#/C+4_&GA_6O!=[X/N-/CUO3+Z..>2WAOI4CMKI'A=X
MY8B6;=Y;,Z^5(-N0H;PCQQ^SWXY^-'B7Q;\3)O#.L:%!=>*?">MZ;X6DN(+;
M6;NTT^WDBN098[H):RD7LK(3*K@VX!$9(8>@0^ Y?&_P_P!:NO#7PY\=^'M5
MU#5/#<KR^/-<:[N[JWLM82=PHGOIVB6%!/)M8IO\T;0W% 'INH?'_4;?Q!I_
MAVP^&/BS5/$LE@-6O=)BFTY'T^T:>6&-I)FNQ;L\C0N5CCE8[58G;C%/\7?M
M"?V#XB\1Z/H?@'Q9XWD\,112ZW<:##;>7:M) TP@C$\\37$PC\MS'"KX$T?\
M3!:X?]K#P7>:]>QZCX1\!>,+CXE1Z7):Z#XV\)ZA:V2VLQ+S):W;274;/;EX
M0662)X\3,$(D>M*YUCQ_\)?&WQ$DL?AIJ7CJU\4WMOJVC7>B7]K%&+E=,AMG
MMKS[1)&UNH:Q5A*JR B< _.-K &[/^U%H-]XDTCP]X4T+6O&NM:MX>L_%=E:
MZ6MO )M,N)'3SP]U-$JE"B9C8JW[Z/ ($ACV/"'Q\TCQW:_#B\T'1M<UC2O&
MUI/=0ZO86J3V6E&&(.\5],CE89"VZ( ;LR(Z\8KR3X*_ 'Q?\-_C]X(U/4+2
M.?0-&^$-GX2N-5MYT,3:E%>+(\:H<2;2H+!B@&, \Y%:'['_ (7^(OP3^#/P
MD^'^L^!&ZZQ_PD.H'5K<?V+_ *3--:_NU+?:/.WA?W;?)U;TH ^G****!A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%)N&2,\TM !117'_%;XCVGPA^'>N^,K_3-2UC3]&@^U
M7-KI$227/E!AO=5=T7"*2[98856/M0(["BO,OB9\?/#_ ,*O&W@7PQK-KJ<E
MQXPN)+6RO+.W$MO;R+)!$OV@[MR*\ES"@8*PRXSM'-=%IGQ"TK5OB'K_ (.M
M&:74]#L;.^OI%=#%#]I:<11'#;A)MMV<@J/E=#D[J .+\2?LP^"_&'B">_UQ
M_$6KZ5<3?:KCPU?>(KZ;1YI_/$XD>S:8QD;P/W17RL$Y2O7ZP6UG4$\8)I0T
M2X.D-8M='7//A\D3"0*+;R]WF%MI+[MNW QG.!5/X<_$CPY\6O!NG^*_"FI_
MVKH.H>9]FN_)DA+^7(T3_)(JL,.C#E>V1QB@#JJ*16#9P0<'G%<'X[^+6G>$
MO _Q&UZR3^U[KP397-S?:?N:',T5FMVL.\J<;HI(CN4,!Y@[@B@"W\-_A=HW
MPNTNXL])DU*\GO;@7=]J.L:C/?W=Y<>5%"99)9G9MWEP1+A<* @  %=E2*VX
M9!R*8LB,WEAU+XSM!Y^OYT 244UI$C^\P7ZG'^>M+N&W.X8]: %HIOF*<@,#
M@X//MG%(94P277 Z\B@!]%-:158 L 3T!/-.H&%%)N'K7G?PF^(6N?$3_A);
MS4-!M-&T>QUF^TG39HM3-S->BTO)[6662/R4$(+P_*H=\Y/3 W 'HM<K\2OA
MMX=^,'@O4O"7BW3?[7\/:B8_M5GY\D/F>7*LJ?/&RL,.BGAAT^HKJ0ZMR&!'
M3K1O7=@,"?3/- C)\4>&=-\9>&=6\/ZU;_;=(U6TFL;RW\QT\V"5"DB;E(89
M5B,J0>>,4OA?PSIW@OPWI.@:/;?9-(TJTAL;.V\QG\J") D:;F)8X50,L23C
MDUJ^8O/S#CKS2>8O_/1?S% #J*#@=3BN"^&'Q/\ ^%D7_CNV.F_V>/"_B*;0
M-_VCS?M/EP6\WG?=79GS\;<M]S.><  [VBDW#!.1CUKG]6U[4['Q5H6F6OA^
MXU'3;X3F]U:.YA2+3MB!H]Z.XDD\QLJ/+5MI&6P.: .AK(U;PSINO7VB7U];
M>?<Z+=M?6#^8R^3.T$UN7P" V8KB5<,"/GSC(!&MYB]-PX]Q1N7U'IUH 6BF
M[AG!(S_C7,?\+,\.+\2AX _M(?\ "6G2?[<_L_R9/^/,3>29?,V[/]9\NW=N
M[XQS0!U-%)YB[MNX;O3/-!8+U.._- "T4FY?44*P8 @Y'J*!BT5R[?$KPVOQ
M(_X0$ZCCQ9_9/]N_V?Y$G_'D)O),OF;?+_UGR[=V[OC'-<Q^S;\:/^&A/@QX
M>\?_ -C_ -@?VO\ :?\ B7?:OM/E>5<RP?ZS8F[/E[ONC&['.,T"/3Z*;YBY
MV[AGIC(S7!_&CXBWWPM^']SKVE:$OB;6/MEEI]CHS7RV?VN>YNX;9$$S*RIS
M,#R,<8..H .^HKQO2?VCM-N/@_K?Q(N[ W'A^UU>[TW2X_#\S:G/JR1WS6,#
M1*L:@R3S*-B*SKAT)DY.WT/P-XPLO'_@GP_XHT])[?3];TZWU.VBN@JRK'-$
MLBAP&(# ,,X)&<\F@#H:*;N4]&'KUI0P;."#0 M%)O7=C(SZ9YK$\-ZY?ZPN
MH-J&C3:(8+Z6WMQ<3Q2_:H5;"7"^6QVJXY"MAA_$ >* -RBN5^)7Q*\-_"7P
M;J7BSQ9J7]DZ!IXC^U7GDR3&/S)$C3Y(U9CEW0<*>O/%=/YR*H)=1GU(% #Z
M*0L%Y) '7K7F_P 9/C)#\(_^$5,MK:7::SJC6MR]U?BU%E916L]U=7GW&,@B
MBMV.P 9+*-PR,@'I-%<C\)_&TWQ(^&GA;Q9<:<NDR:[IMOJ8L8[@W A6:-9%
M3S"B;B%89^4<YQGJ>!^ ?[0FJ?';X=^ ?&-IX%N;'3/$AU#[=-%J<,T>D_9Y
MI(H]^X1R2^:T9QY<9VY^; Y(![912!US@,"?3-&X<C(R.M "T4C,%!).!UR:
M-PQD$$4#%HHW ]\]Z\Y\=?%[_A"_BM\,_!0TK[;_ ,)I-J$7V[[3L^Q_9;4W
M&=FP^9OQM^\N,YYZ4"/1J*1G5>I ^IQ2;AZB@!U%)O7&=PQZYI%D21=RLK#U
M!!% #J*P/[=U/_A-O[(_X1ZX_L;^S_M7]O\ VB'R/M'F%/LOE;_-W[!OW;-F
M.-V>*J>+_&__  BOB#P5I?V/[5_PDFK/I?F^;L^S[+&[N_,QM._/V39MR/\
M69SQ@@'544@(]:"P'4XH&+12!@W0Y[4;ASSTZT"%HIGF+R=PP.O/YUA_V]JG
M_":#2O\ A'[C^P_[/^U_\)#]IA\C[1YFW[+Y6[S=VS]YOV[,<;L\4 ;]%)O4
M=6'KUHW#L<T#%HI-PZ9&:&;:I;T&:!"T5XG^S]^UCX+_ &F-4\7V?@Z#5C%X
M:FABFO-1MT@BNUE,P22$;R^TB!C^\5#AER,Y X?6O^"@W@KP]KWB2UOO!7Q
M&A>&]<DT#5_%<.B)-I%G<1SK"[/,DQ;:&=&P$WD.N$)(% 'U)17S'XX_;T\(
M>#/BCK?@*Q\%^.O&NMZ1:1:A<2>%=+AOH#;2013+,I$X;RPL\8+%0,MU.03T
MNM?ME?#S2O@WX9^(ULVJZY8>*+E++1='TVQ,FIWUR93$T$<#%<LCJX)+;25
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M&TY4<59\2>)--\(^'=5U[5KG[+I.EVLU[>7&UG\J&)#)(^U06.%4G"@DXX%
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M#Z***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMJ\7\<^#M)\7_%7]KZ]UF"6^E\-^&M*U72$>YE5;*\326E6XC57"K,KV\>)
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MQ7M'P!\7&W\-^$/A]<:1J5OK6B>"]'OM2FG6-([9I8WA2W=2_FB;-M,2ICP
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MSXI\ ^(FM],LO%&DZCMT6YN+W1I;J^2>VF:TCB>XPZ6SQ[E3 $XRP# -[_\
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MORK&1)?*D(VR%&(5MI."0#BOHV@ HHHH&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%(S!5RQ 'J>*  *%Z#%+7BEU^
MV%\*;?3]8U*'7[_5-&T>9H+_ %C2-!U&_P!/MW"JS!KJ"!X>%=2</QD5[70
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MT7FG1:7X8\2Z2E[H<>OB;6+6*%8K>2YG@@5P)6;?+]FED0J"K1A6W<@5Z]0
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M1@X- '84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX6\!DG11'-F/;'(-OSDU%XB_8=\(:YX=U3PG!XG\7:1\/=2OH[Z;P38WT/\
M9:,DJS%(@\+30QO*#(8XY57<Q("X&.N\9?LT:%XK\2>*-9M-=UWPQ/XMM([#
MQ)#H\L&S5X4C:)%D,T,C1D1NZ;H3&V&SG(! !<^&MQ>?&O\ 9O\ !UYKE_J6
MG:CX@\/V%W>WNESO87(F>*.1WC>,JR!FS]W&5;'>OAS]E(:C%\-_V;O!-GXE
M\1Z9H_Q'NM<N=9_L_5YX7ACTR2XDCM[5@W^BQS.09C#L=]GWAEL_I'X9\-Z=
MX-\.:3H.CVWV32-+M(K&SM][/Y4,2!(TW,2QPJ@98DG')KQ+P[^QGX7\)^&=
M'T/1_$OB:P@\/7S7_AFZBFM1=>'W>622>.VE^S[I(I1*R21W)F5E"C'&: #]
MG;Q=J=G\5OC#\*[O5-4U^Q\%7>FSZ=JFM7?VF[-O?6@F^SO)M#.(I$EVN[.Y
M6159ODR?$]4\,>./'W[0W[8GA'P59^'Y)/$&F:#I=W?:]J$]L+1)M)DC#QI%
M!)YK%7DZLFTJOWLD#ZV^%_PMLOA?IVK10:KJVNZEJ^H2:GJ6KZU<":ZN[AU1
M 6VJL:JD<<<:I&BHJQJ .N8O"/P?T;P7\4/'WCRRNKZ75_&GV#^T8;AT,$7V
M.!H8O) 0,,JQW;F;)QC'2@#YW\1^%=4^%OB#45@\:>)G\'_"'X;:/JR>&=/O
MFLTUJZM?[36-IY%!*1M':%9(U7;*6C+Y$2J<B/Q%XI^'/@W]G+XF1>,_$NO:
M_P#$+7-&TSQ!9ZUJ#3:;-#JEN))/+M%VQ6[0N@,30JA +!_,!Q7US:>#+*S\
M<:OXI22<ZAJ>G6>F31LP\I8K:6ZDC*C&0Q:[ESR>B8 P<^9>%?V3_#OAO4?"
MYN/$?B;Q)H7A.22?PWX<UV]CGL-)E)_=2(!$LDS0)F.$SR2^4K';@X( /&O#
M3:]\2/BKK/P,_P"$\\06?A_PMJ6L:B/$FF7U\FHZA \%N;>R6_\ M+[GLI=4
M/F"0G/V>R!C(:3%[X4>-/$?Q6U3X*_#WQ-.]K=Z7X=UJ;QUX?U"8WKZI]D=M
M%07$N=LJRS&YF*L74F,?>*J]>R:'^S)X7\-:7X'BL;_5O[7\(ZI<:O;>(+AX
MKG4KR:Y$HO%N99(FWK<"5O,VA2=J%2I12.>_9G\!PVOQ&^,OQ&MM"U3PQ9^,
M=;@6RTW5+#["\L%K $:\^SL!)&9[B6[?]X%9AM8J"QR#/$?!SZQXR\)?"W]G
MO53J=]<>'O&5YIOB"\O-$B^R7>D:(4N;=)(B<K#,L^D(KD?,6;+,&'FTM&^)
MGBJT_92L?VFM1\6>);SQ6^LQWUWX?L=39='FLVU2.R;3H[-P\<:"!3MD"^=Y
MCLYD:OKC0O@/X7\/_&CQ)\4+9+Q_%.NVL5G.TERQ@BC1(T8QQ] SK!;AB<_Z
MA,;?FW<QIG[*/AS1=1M8=/U_Q%8^#K37%\0VW@>VNXH]'ANU82(%41><(5G
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M>%?B-H%Y=ZC%9^.IO.U&2WD020M]CMK3$)*$ >7:QGY@WS%CW %S_A3NC_\
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M+\8^)M&\7Z9JNH:C;:#XFO6M]-BL[6_N+;^S+C3XQY>YK==O(\[SPA$JUL_
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M^C,%Q]G(*$G)&:^C?%7[*>C^*K[QV/\ A+_%6B:+XV4_VUH.CW5O!9SRFW6
MS+F R([!$+[7"RE )%="R'<N/V?=+_X6-X=\<Z=KNLZ+X@T?1X_#SR6AMGCU
M#3TF6803I+"^ 77[T1C?#'YNF) ^>_V>/$WCO7]2^%'B2&P^*US)K47VCQ7J
M/B*[MIM"OH;BUEF$UO")F^SA+AK?RO)BA_<@JX)KU#XV>*-8TG]K?]F_1K'5
MKZSTC5CXD_M#3X+ET@O/*T^-XO-C!VR;&)9=P."21S77?#_]G]?AO<:%;Z7X
M^\92^&=#FFDL/#%U=VTEE%$Z2QI;M)]G%S+#$LO[M))F"^5%UV+6[XP^#^C>
M-/BAX!\=7MU?1:OX+^W_ -GPV[H()?MD"PR^<I0L<*H*[67GKD<4 ?$/PA^(
M'C?2_@W^S?\ $^Z\>>)M=USQ1XVA\*:G8ZMJ4DUA-8RS7-K@P @&5!;+(LS9
M<N[[V<;57Z7_ &TO =OXP^&>F7<^K:[IKV6NZ/ L6DZK-:12BXU:QB9I$C8!
MW0?-&S#,;?,N#5S1?V/_  ?H?PQ^'/@.#5-<?2/ GB.+Q+IDTDT)GEN8YYIE
M29O*VM&7G<855. HW9!)]%^+GPPL/C)X!U'PEJ6HZGI-K>26\WV_1IQ!=P20
M7$<\;Q2%6"L'B0YQ0!\;:U\/I[/XD_M5?8/%_BS39/#'A31;FTNK'6YX;J>X
MBTRY:&:XN%(EF9=C JS[6\QBRLRH5UKWQYXO^)UOX#M]6;XF:U!<?#;1M:N&
M^&MQ!I\PU*_6X$EU</Y\/W?LX:.)5:/)?<N H/T38?LXZ+;3_$BZO==US5=0
M\?:1:Z/K5Y=/;JY2"VEMEEB6.%421EE9C\I7=C"@<543]E_0]+'@^Z\/>)/$
MGA;7O#&A6_AJWUO3+F!I[K3X$(CAN(IH9() &)?/E [CD$#BJU W/V<]:\<^
M(O@MX7O/B3IC:5XW,#P:I;R*BLSQRO&LK*GR@R(JR$+@#?P .*ZSPWX$\-^!
M[<0>'?#^EZ%"L0@6/3;..W41AY) F$4?+OEE;'3=*YZL<W?#^DR:#H>GZ;)?
MWNJM9V\=NU]J#J]Q<%%"F21@%4NV-S$* 23@#I6IMW9!Z=*D#P/]AO\ LFY_
M9?\ !.H:9J5QK,NI02:AJ6HWQ+7%QJ,LSM>-([*&D9;CS4WMDD(/F;[Q\X^(
MWA?7H5_:B\::=XUUS0W\.74>IZ/8Z1/]F2"^M- L+AI9L';<QRA88FAF5D"H
MY W/E?4?$'[*NE7FN>)-0\,>-O&GP[B\2N9]8L?">I1P07-TS;GNU$L4C03O
MA TD)0L$&>Y/::Q\']&USP_\2-'GNM02V\>"1=39)$WP^9806#>22AV_NH$8
M;PWS%CT.  >-_'K5(/&/Q U;PYX5U7XC:GXUTSP_NDM?!>J);6.@RLY:WN;M
M9+JVBEFEWY$$DC%HH&.Q1\QP_ >D^*/VB-6T677/B!XFT2QN?A;X=U6ZM?#E
M_)I[/J=X=0S>H\3+L*!&S&%V2$Q;P1"HKU;Q=^R_H?BOQAXGUR/7_$&B0^+;
M>TM?$VF:9/"D&LQ6RLB+([1--$&B8Q-Y$D>Y?0Y8]3\._@WHWPR>R.E7-].+
M7P[IGAE5O'1LVMC]H\ESM5?WC?:7WD<'"X5><@'S?X.\8>+/C]X[^%W@_P 0
M>*]8TO2IOA;9^,[ZX\.W;Z7=7^I3L("TLL)4^4@+2"*/8I<C<&4!1G6_C/Q[
M!X9^'_A+5=2\8>///U?Q;+XBN_".VVU;4AI^KFVA5)/M4/V2W+3JQ6)]P$<<
M:X0M7I/CCX9^$?AS=_#^UL)OB#H>L^'?#W]B67B?PCH+ZG-/81K%&+.\9+.>
M-MQ02*&C 5E=E*;OFB^#O[.]EKGP6\%?;+'7OAYKFB:QJVK>'[B.6/\ M?2;
M:[OKF6.&1IA,IWVTD:RQRA\G[XWKD '6?LGW_CZ;X=ZK9^/[#6K6?3-8N+/1
MI_$1C.IWFEJJ-;2W;1L4:<!F1F4\F/)R26;Y.NOC?X&M_$%G\9I;H)XG/Q!_
MM5[RZ\':E&(?#DD7]E+&MR(MK$V?E7GWP-YP$+?*WW9#\.YG^&NI^$-0\5Z]
MJ,FH6]U;RZ_+-%'J2^>7)='CC6-&3>0FU %"+QQ4#_"'1V^"A^&'GW:Z WA_
M_A&_M".HN1;_ &;[/N#%2OF;><E2,]CTH \&C\,^*_C'\>?CYHD?Q'\3>&[+
M0#I9\/0Z9?/%!8WEQIT$C3NBD&:,-$O^CLWE'S9CMWOO%+P+I_B_]HCQ!HDN
ML_$+Q'H&D7/PP\/ZK?6?AN]>PDEU.[-]BZ22,YC*!')C7Y9"(=X98PIB\%_L
MSZEK7Q:^-^FWWB7QSHNCWMGHFCC6UEC\S7[5-*BAE,DTT#++)N5]TL05PSN-
MR[B*[6Y_9UM[WXTWG]B7_B/P)8:)X(T?0-)U?P_(JXMQ/J2S6:M/'+&Q51:-
MNQYB%8R&7<=P!YA\+/'7C7]HKX@>%/ _C#Q9?:98:1X8O]2U"X\*WDNDW>KW
M\.K76EI+(\3!A$J6QF\N,HOFR#(9=J+2\#_&/Q7K7[07P:\)W'B'7I[31_%O
MCCPQ?W%Y<!!KD-E;JUI+,D2I'*T:.B[BOWXW;J37T''^REX0T.'P@_@ZZU+P
M#JGA>SDTZRU;P_\ 9_M$UI(2TEO<">&6.9&E8S?.A(D)<$%F)GT7]E_PMH.K
M?#35(-2UN>_\ G4I;*>\O!</?3WZ$7<]V[J6DD=V>7*L@#.>-N% !\C?"'Q]
MXVT?X)_LX?$JY\=^)];UWQ1XXB\+:C:ZKJ<D]E)837-S 5,/"M(@MPZS/F3<
M[99E"JN]IFDWOPE\,_&W5?#VN>/+O59?B#;^%8OL6I/?3K#<-I@DG5+A_+-V
MR.\27$G(9XUR!T^A]'_8_P#"&A_##X<^!8=4UPZ1X$\11>)M-FDGA-Q+<QSS
M3*D[>5M:/=.^0JJ<!?FZDZ&L?LN^']<F\>1SZ[X@CT;QE<IJ%]HUO=1Q007R
M>1LO+>18Q/'*K6T3<RE"0<IC  !\Y>(OB)\2/A_#XIL='\,_%O1_!^NC2+:S
MO?$%Q;ZCJ6G7TM_#;7,=I)+<3$":W=?+\V0JL^<! U<_\;_&GQ%\%_!WXUP:
M7X:^(6E>!]1\.VOD3?$"ZCU">TNI;J*TO((7,T\GE2VTP?YY#L=)2H7(KZYO
M/V?8/$7A'7O#OBGQQXN\6V6K06D*2:A=6UO+8-;2M-#-;M:00[9?,V,7;<6\
MJ,$D#!L-\"SJ7@_Q=X;\1^.O%/BZR\1:3_8[MJSV:M:1;)E+P+!;1H)3YQ)=
MU<GRX\Y"XH \F^-_B&_\#_%J'6_'M[XNTCX26^G6T6DZOX0O)H;#3[HNS3RZ
MHEN?.8DQP1Q[E:W E(*AF9E[70+F73_VSO%5E8:/%_9FJ^!=*U#4=4C*HWVF
M*]O8H%=<9=GB9_F)R!;J/2I)O@)KWQ"\$Z?IGQ \>^(E>\T^UM/$NCZ'>01:
M=JDD2JLQ5_LRSPQ3A3O2%X@5=A@98GK?AWX%U+2/'?C[Q=KI4:AKMY#:64$=
MTTZ6^F6B%+=.54*SR27$Y51P;C;EMN2 =3X?\#^'?"=Q--H>@:9HTTT%O:R2
M6%G' 7A@4I!$2JC*1H2J+T4$@8KYV_::U+7=#^)$-]XF/CZU^#O]@&&36/ E
M])"^D:D9)FDO+F.U(N6B2!4;>V^%"H!C8OQ]3UYE\4?@I_PM:6\@O?&OBC2=
M!U&RCT_4- TJ>VCM+R%7D9U8O \J&19#&[12(615';- 'S3\1/''C?QYXL^+
M*^'M*^+4^M:%?QZ=X5G\.SV]KI=E-#:6\Z/<1-<*+E)YI"S&:.8&WECV;23C
MTOX03>)OV@O%GBGQ)XKOO%/@VV\.:C:Z78>$(;F73FL[A;.TNKF6Y:&0"[61
MYE5%E!01*2!F4X[?Q%^SG!J&O^(=6\/>.?%W@2?Q!;16^IV_AZZMQ#.T<(@2
M=%G@E,$HB5$WP&,XC0_>7-2^*/V>[+6/$WB/7M"\7^*/ NJ>)((X-9G\/7%N
M#>^7%Y4<F;B"4PR)&2JO"8ST/)4$ 'RY\8?!]W\'/A'^TWXB\->-?&D.L:9J
MUCI]O=7'B6[E<+):Z+*TQ)DR9L2&,2_>$>$SMXKW5_"/B;XO?$#XG>9X^UCP
M[;>&KRUTOPY;Z--) ME<'3K2\DN[A$=5O=TEPB^3.#&%C<8S(QK:^('[*6B_
M$?\ X6);:EXK\40Z/XY%JVIZ1;3VPMHIK=;9(YX-T#.DA2UC5LLP8$Y&0A6_
MXP_9GT#Q1XB\4ZQ:ZWKGAN;Q=:16'B2#2I+<Q:Q!'$T*)+YT,C1XB=TW0-&V
M&)SD @ ^??"_B3Q9\??C5X%\.ZMXX\2^']*USX/6/BB^A\.WIL"^H-<21><C
M*-T>/M!?"$!S%")!(B[#[;^Q;\2=;^*W[+O@GQ/XCN4FUB:WN+:YO,G,IM[F
M:W$KEF/SLL2LQZ;BV !@#H_"_P"SOX5\&_$C1O&6CM?65UI'A./P9::<)@]K
M'I\<PE7[P,AD!4#<TAX'()YJ[\)/@;X=^#_P@LOAKI_VC6/#=O%=0E-:$5PT
M\<\LDLB2@(J.I,KKMVXV\'/4@'S_ /#'Q'=-\0_A;JVA:M\3M3TCQ%JM_:7?
MB#Q=>(NF:_!)8W5ZDD%@\N^W D@B,+16\""(.I+;AN\C^%OC/QM8? ;]FWXC
M3_$#Q7JGB#Q!\08?#]\M_JLDUK-83WEW$\+P'Y)#B/(DD#2J6.'"I$L?USX!
M_9EL/ G_  A$3^-?%GB"S\&.SZ)9ZM=6YBMU:VGMF1A%!'YJ^7/\IDW/'Y:A
M&5&D5Z.E_L@^#]&^&'P[\#6^I:T=&\#>(XO$VG2230F>:XCGFF6.9O*"F/=.
MXPJJ<!?FZD@'S7^U-X=UWQ)^R3\9_'>L>,]>O[F;Q+<V-MI)F*6%MI]MKBVD
M5L;;)CR# LOGJJRD@*6*[Q)]!?MZ>*]:\$?LB^-M;\/ZM>Z'K%J-/,%_I\[0
M31;KZV5MKJ00"K,IYY#$=ZG\8?L:>%O&=CXNTBX\3^*[/PIXHU&?5]0\-6EY
M"+(WLH!:=6:%IAB55G$9E,7F '9M^6H?V^?"^L^+OV1?'6C>'M)O]<U><6(@
ML=.MGN+B7;?V[MMC0%CA59C@<!2>@H \_P#CA=:O\!M4UBVT_P :>-]7C\6?
M#_Q)<R&\U%KD66HV-M%-'?1M\ILRRS3 K!LC#M"%C0!=MO0;7Q7XL@^"_ANY
M^(&L06OCJPN_&/B6Z&I26]].8H;%DL+"6/#6T'F7*DQQ[6\J)_GR7+^I_P##
M,>DZK#KYUOQ9XL\02:MX<G\+0OJE]&YTVPG!$R0 1 -*^(MT\XEE;R(]S'!W
M:NM?L\^']6\.^!=/M=0U31M3\$1)%H7B"Q:#^T+51"('&98GC99(U"NK1E6P
M..!@ \"GU[QCX!^*EA:+K?C/Q-H/@?QY8Z!-)?7H2VN=-UC3X$07,@&;R6UN
MIXB-X+@3(23NW+T/PY\6>(/%?B'P[XR/BB34M'\6?$[5+72X;&^G:T_LFTTO
M5+>"/RR_EX>6S%P=@PS,C'D#;ZI_PS9X:NOA?XO\%ZG?ZQK,?BRYFOM6UB^N
M5:^FNW*;9U*H(XWB\J'RU2,(HA3Y.#G=T7X.:-H'AOX<:+;W-_):^ _*.F-(
MZ%YO+L)K$>>=GS9BN';Y OS!>WRD ^5/#-OXI^*7P-\"_%_6?&FJG6/$'C+1
M;G4M#\]VTG['_;EI#!:VUJ6V0>4T<$GG &1B)0[,)/E@\9>./BQK6I>*_$O@
M_1/B+K'C'2/%=W:Z*NGRPIX7DL;2]DM7M9[=KK,V^-)F:4Q"02[=C(J"O>U_
M9%\*6KV-M!K?B"T\-Z9KL7B/2O#-O/ FG:;>I<K<;H%$(?8S>8OE.[(!-)L5
M6V,FY:_L]V6B>--4U_PWXL\2>%8=8U.+6-4T/2I;86%]=*ZM)(RR0/(AEV@2
MB*1-XSGDDFM0+WQ^\6Z+X4^%]Y+K^NZQH"7\L%E;_P#".,?[5O+AY%V6MFJ@
MNTTN&3]W\P4LP9-N]>#_ &<+[Q!8_$SQ[X?U!?&%AH4.GZ5JVFZ/XUOH+^\M
M#</>QR[+A+BXD:)C;)A992RD-\J@Y;TWXL_!_1OC%H>DV&K7%]I]UH^JVVMZ
M9J6FR(+BRO(&)CE42(\;\,RE9$=2&/&0"*_P[^#5E\/?$^O^(SX@USQ'K^O0
M6UOJ-]K4T3&7[.\YB94BCC2+"SE-L:JF(T.W>79Y \_;Q-K"_&#X_6/]K7QL
M]+\+:3<6-O\ :'V6LKQ7Y>2)<X1F,:$E0,[%]!7B?PUO/%'Q:^*_PS\(:IX^
M\7:?H^H_!/3M>OAI>L2V\UQ?&?ROM#2@EQ(3+O+JP+F- ^],H?I3X@?LY:/\
M0?&6H:_+X@U[1EUC2X]%UO2])GABM-7LT=V$=P&B9\E99(_,C=) CL%9:3P+
M^S;X;^'OCCP[XHTZ_P!5FO\ 0_!\'@BUANI(FB>QBD619'"Q@F8L@RP(7&<(
M.M 'S1\*?VCO%FI?#OX'^-]=O;[573PKXPO=2L;6X=!J9TZ2%(&D4DJ\I6,_
M,P.&D<@#.*;KC>*/#?PN_9M\<Q?$7QI<ZQXX\9>')->AN=:D:UNA>+)-)$L(
M 6&%2[1B&()&4V[U=D1D^C/AG^RKX2^%>G^ K+3+[5[V#P9;ZK:V*W\L+^>F
MH3++/Y^V)=Q#( NW:,9R&->-_'+]F^^\&P_!6S\*:AXR\4Z)HOQ&TF6VT6:4
MWEMH6G"65Y"#'&',,0$<:R7+R&)%"JRAFW %#0?B#XIF_9G^#VJR>)=7?5+[
MXH6^GW=X]]*9KBU.NW$1@D<MN>,QJJ;&)&U0,8XK*\7>-/BMJFI^*O$OA#1O
MB7KGC'2?%MW;Z0ME/!'X6EL;2]EM7M);<W/[P/$DC-*81()MNQE517NT?['O
MAA=2M&?Q'XFGT.P\1_\ "5Z7X=-Q;KI^FZA]J6Y+0*L(?9GS4\MG90L\I4!R
M'7H;/]GNRT'QEJ>N>'/%OB?PK:ZMJB:QJ>AZ;<6[6-[="022.PF@>2/S2 )!
M%(@8<=S0!8_:6^*DGP:^ /C;QC&[0W^G::XLW6(2[+N4B*!BIX*B:2/.>, ]
M>E?!/[(_QB^'/@;XZ?!73O!^NV\@\0>$/^$;\3:>T=Q;+;:MO-TLSO(@6YDD
MGDD@3:2%!P&VE0?T"^-7P-\/_'G1]!T?Q-+>G2])U>WU@VMK(@2[>$,!!.&1
MM\+!VW*,$\<BHOC5\#=+^-VA^'=-U+6-7T.30=9M]<L;[1)(4FCN8%D6-CYL
M4BE09"V"O51SZ@'P[I'A7XF_&#0_VCOA7X1\#Z?<Z#K_ ,2M8:X\::IK:6\&
MGS)/#(8FM5C:9R1%'AT&,RC/"G.#X1T/QG\(?V]/'/A'X<^%[7X@:MI_@73M
M ']K7T=I!#"ECID0NYU8?O45DCW0H0S!S@\5^AWPH^#ND?"'_A+O[)N[Z[/B
M?Q!=^)+TWKHVRZN-GF)'M5<1C8,!MS<G+&L3P_\ LW^&O#?[17B7XR6M_JLG
MB?7M.73+JTFEB-DD2K;J"BB,.&Q;1]7(^9N.F #XQ\(_"7Q+\%_VI?V5OACX
MEFAUS1=&T;5[N.ZBLR+1M0N!?3SI&[#+^6%M0,X^ZC;4W8KV37_[2T;_ (*@
M>'CH.D6KVFJ?#]VU^X5%6181<S*DYP06?S8K2+)#'8<8PN5]R^.W[/?A;]H#
M1-.M->^VZ=J>DW27VE:_HT_V?4=-F5E8O!-@[=VQ<@@@[5/#(C+F?!/]E_PO
M\$-;U[Q!:ZGKGBWQ=K>R.[\3>*[T7VHF%$14@$NU?W8V*<8R<+N)"(%JX'PW
MHOAW3_&'[ _[,&@ZO;"[TK5/BC;V-Y;EV02P2W^HQR)N4AAE6(RI!&>#79?#
M3Q/J+?'C]EWP%XBMH['Q7\.[WQ1X6U"")&2.6*#3(OLMS$KG>8I;<Q,LC*N\
MARJA<5]/:3^Q_P"#]%^%OP]\!P:EKC:3X'\11>)=-FDN(3/-<QSS3JDS"+:T
M9:=P0JJ< <\9.CJG[*O@W5/VD-)^-GFZC9^+=.MV@,-K)$MI=$PR0>9,IC+L
MXBD" AQQ&G'',@> _"W"_P#!6?XO*.!_PB$!Q_VRTL9_("O-OV;_ /A<C?M*
M?M-_\*F_X0; \6RC4O\ A-/MN?\ C[OC%Y'V?MS)NW?[..]?:^@_LX^&O#_[
M1'B+XRVU]JK>)]=TU-*N;266,V2QJ( &1!&'#8MH^2Y'+<=,>97/[ GAV/QQ
MXL\4Z+\3?B=X1O\ Q-J4VJ:E#X;UZ*QADDDD>3:0D&XJID<+N8D!CSR30!X-
M<+\3/^'FWQ<'PM_X1,:^/#UF+@>+A<_9/L_V;3]VS[/\WF;_ "\9XQN]J_0;
MPJ-:7POI(\2&Q/B+[+%_:7]E;_LGVG8/-\G?\WE[]VW=SC&>:\#\??L.>'O'
M'Q=UWXDVWQ \?^#O$VL0PV]U)X6UB*Q4QQ0QQ! 1"7VD1(Q4N1N&?3'O?A70
M3X6\,:3HQU*_U<Z?:16G]H:I-YUW<^6@3S9I,#?(V-S-@9))H _*/]GO_DV7
MX2?]E_TK_P!$K7U3^TAI]G:_MV?LXWV@+8OXRN!J$&H1S73;O[.2)F5C$&PI
MVR7I1L#<RD$L%P.JL_\ @GYX$TSX0V/P\L?$OB[3]/LO$J^*K?5+.^@BOXKU
M8S&I600;550=PVJ&#*#NKO\ X0?LN^$O@]X@NO$<-YKGBSQA=1?9YO%'BS47
MO]1>'C$7F$!0H"J!M4'"@'-5<#YE_8[_ .%QGQ=\3O\ A"AX&_X00?$W4?[7
M_MW[9_:9_>0^=]G\K]U_J=NS?_'G/%<-KT-[X,_:[^.'Q=TRR>_NOA]KNB7.
MHV\2RRRRZ1<VD\%\(XD(5Y%4QS NRJOD%B< @_2UK^PCHND^)-9U;0OBK\4O
M#<>K:M+K%WINB^(4M+-[B5PSGRT@&0<*N22=J@9.*]'T']G/PKHOBSXG:[,;
MW57^(D-O;ZW8WTB-;&.**2()&JHK*&65\[F;M@BC4#YM^%UW%J'[.?[9UU"Z
MRP3>)_%\B21MN5U-DI!4]""#Q7FUO_RA?G/?YA_Y<%?7OPG_ &0?!WP?^"_C
M#X8Z/J6N76@>)S=&\N+Z>%KF/[1;);OY;+$JC"("-R'G.<CBE7]C_P (+^S(
MWP+&J:W_ ,(DQ)-YYT/V_P#X_/M?W_*\O_6<?ZO[OOS1<#YLC_X63_PU!\-O
M^%6?\(O_ ,)%_P *8LO._P"$O^T_9?LWVT;MOD?-YF_R\9XQO]JM>./[;7_@
MII^SY_PDAT\>(O\ A"W_ +1.E!_L@N?(U/S/)#_-Y>_=MW<XQGFOJWPU\ /#
M_A7XEZ/XXM+S5)=6TOPI'X/AAEDC,#6:3+*)&41AO-W+C<&"X)^4=:@\3?LW
M^&O%7[0?A;XPW5]JD?B;P[8/IUK:Q2QBS>)Q.I+J8RY;_27Z.!PO'%2!XG_P
M2_M=$F_9TN==MKO^T/%&K:S>3>(KN>3S9_M0D(19'/S?ZGRI,$GF5CU8US/[
M:WQ8^&\W[0OP\\#?$[4H;/P#HUA=:[JUO-#/=0WUQ-&]O:P%+=6DCD0>;-N.
M!M8=R*]B\:?L4^%_$7C[6O%V@>,?''PUU+7&2358_!&LC3XK^=2Y\^5?+;+G
MS&S@@$DG&YF+=M\,?@!H_P +_''BKQ5::MJ^K:KXCM["VNCJ<D+)$EI$8HA&
M$B4C*D;MQ;)4'.: /B_P%\4O^%B?\$M_'FG37;W][X7AGT22Z8@":)94D@,:
MX#",0R1QC<H/[MN.*S/VUO\ E&7\!_KH/_IIN*^P-8_8]\$:O<?%J19M2T]/
MB7';)K,%BT$21-"&_>P#ROE>1G=W9]^YF)XR:;\3_P!C[P=\6/@7X2^%.K:G
MKEOX>\,_9#:75C-"EU)]FMWMX_,9HF4Y5R3M0<XQ@<4 ><?LUV<NI?MK?M)Z
MEK6EVL6JVL>AVMK,$5W2U>W?;M?)($L<4#LH/)5<@;0!\N^.KB[A^%/[<>F6
MCS'PK!XJL9K6,P[85NY-4 N0C;1D@)"-H/ ">N3]V?%C]DCPQ\3_ !I;>,+3
MQ!XH\ ^+$M/L%SK?@S4_[/N;VW!4K',=K!@I5<'&<*H)(5 K;C]C[P$W[/>I
M?!^V.HV'A_5'CFU#4;>9#J%W<++'*UQ)*Z,K2.T29)7 4!5"A5 K4#XR^/T[
M?"GQ)H7P9N5BM[!/B=HWBWPM#$(XHAIEVUR9H(H(UQ%'!=%U&YLMYHPH4"OO
M?]I?_DVWXI_]BIJG_I)+61\;/V7_  E\>-=\#ZSK]QJ=I?\ A"\%Y8R:;)$G
MFMOC;9+OC;<F8E^[M/+8/->A>./!]I\0?!&O^%K^6>WT_6M/GTVXDMBHF6*:
M-HV*%@0& 8XRI&1T-2!^5WB9E^#O['?BSP-)9+9:'XZ\)^'O&6A7"JY66\WZ
M=%J4#2R-\TN\1S".,$*DCG*C:H^A_A2IC_X*M_%9F4JK>#K=@Q& 0(=+&0?3
MK^1KVCXJ?L4^ _B_\(_!/P^UNYUB*P\(0PVVFZG9RPK?>7'"(BCNT3+M<+&S
M!5&6C0\ 8K8^+O[+>@_%KQ?IWBI?%7C#P3XFL[ Z6=5\(:N;&>XM/,\P0R91
MP5$A9OE"Y+?-NPN*U ^./B!E?V//VQSC'_%TKPC_ ,#["M/PG=06.J:!^RC-
M+#I]K#\0KB<Z;+:)>K<>'(5_M6&*Z+N<M/(Z*"H&%1MXX*O]3R_L;_#^/]G6
M_P#@U8KJ.F>&M0,3WM_:RQB_NIEFCE,\DC1LK2,T: DI@* JA550O66/P#\,
M:7\=KKXL6GVJ#Q+>:*-$N8D9!;S('C83,NS?YVV*./=OQL11MXS1J!\!:,FJ
M_P##!?[,R^'_ +&NN?\ "T;<:?\ VB'-K]H^WZAY7F[/F\O?MW;><9QS7<Z#
MK][%>_MB:1X^>R@^+UYX5>YU"WT3=_9,EC!I96"2W\S,FX";]YYA_CCP!\P'
MT-??L3>#KSX&^$_A=#XB\5:;I7AC6/[=TW5K&\ABU&.Y$D\BMYOD[1M:X<@J
MBD;4YR#G8\)?LE>%/"'A+QWHXUGQ/KFH>-[$Z=KGB+7-3-YJ5S#Y4D48WLOE
M@QI(RJ?+Z8!W8%&H'&?L5_\ "XV^%O@IO%P\#_\ "O#X4M#I']B_;/[6YBA,
M'VCS?W7^JW[]G\6,<9KXJ^&]KKGC3X*_LZ> ?'=OING?![6/%MS-;:S96]U<
MW4MY'>7*K97.QD$(F:66-60L<%7R-CX^]_A+^R#9_!_7-&O=/^*?Q-UC3M*A
M:VMO#^L>(%FTOR_*,:(;=8E7:BD;0, %5XXQ3F_8O\$/\"-!^%*ZIXB@TK0-
M1_M?2]9M[Y(=3M+OSY)A,DJ1A-P,SJ"8^ 01\P# U ZW]I#Q1X@\$?!G5[[P
MIJ-AH^O23V6GVFH:FNZWM&N;R&V\Y\\8C$Q?)! VC*L,@^'?&"WUO]GBWU#2
M-$\8>.M?M=>\ >(IVFU'4Y;]["_L;6!X[\7#GS+?=YCJ=C!/,>+:BYX^G_'W
M@+0_B9X-U7PIXCLTU'1]2@\B>&90V>05<9'#*P5E;LRJ1R*\[_X9BTN_M]:'
MB'QCXK\6WFH^'+CPM'>:M=6XDLK*<$3B%(8(XS*Y$9,LB.Y\M 6P"#('A'PM
M\4>*O"7C;]E>>3QCXB\0?\+)\.W;Z_#K>H/<PN\.GQ7,4D4?"1.I?865<NJ@
MOO<M(W3_ /!07PC#XB@^"DDFI:M9&3XBZ3II6PU&6V4+,TA:50C#$R;!LD'S
M(&;:1DUZ[9?LU^&K#4?A#>QZAJIE^&%E-8:.&EBVW"26J6S&X'EY9MB C84&
MXDX(XKH/B]\']'^,VA:5IVK75_IT^DZM;:YINHZ:\:SVEY;L3'*HD1XVP"RE
M9$92&/&<$ 'QYK_@&]T_XA?M4:GIOCCQ9H]UX/T'2KS3YK#5GBEFN+?2%E26
MZD.3<EA"$99<@AY"1N*LLTGQJ\5_&?XD:QIUSIWQ'FBT/PQH\UK%\,[Z*WBB
MO;ZV6Z>ZN5DGB,A'R)'&[21823*Y?-?3UO\ LYZ+Y/Q*-[K6M:E>?$#3(=+U
MF\N'@63;'9_9?,C"0JJ.R$L<J5W'A0/EJ+_AG.PTNZT2_P##?B[Q-X1U;3M&
MAT"6^TF2U?\ M"UAQY/VF*XMY8F>,[]LBHK 2.,[3@ $LVA^,_B!^S$FG:I=
M76C?$/4?#*>9<6]U)82VVJ&W!#>9 =R!9P,A<@@$$,I(/S]KWQ^\3^.O#^C^
M--&N;I!X7^%]UXIU&7P]J*O9/J]VAAMX)[;>?-2!K:\?#[MA7G!'S?8OA?0S
MX5\,:3HYU'4-7-A;1VO]H:I-YUW<[%"^;-)@;Y&QN9L<DDXKS7P/^RQX$\"0
M_$J*VM+B\C^(-U<3ZT+B0+F.4.IMHS$$V1*))=H^\-[?,>, '"ZCX%\0_#WQ
M?\.[&'XC>(-9L?&CW>A^)$U'4YGEFF-C=7*7EE\_^A.CQ.I$!5 'C&W*AJ\"
M\-V.H_"_X*_"C4O#_BOQ3;2ZY\8+?2;V&77+F2%[9-4U!&C6,OM590 9 !B1
M@"V2*^N?!_[-FC>%_$GAK6=0\0:[XLG\+VKVGAZ+6WMRNE1NBQOY;0PQO(QC
M5$+S-(Q"]<DDXW_#(?AR2UT_3Y/$WB:;1M-\61>,=-TMIK8P65XD\TYC1OL_
MF&%WF8LKNS?*NUERVX ^6_&7C3QGI_P>_:,^(MOX]\5QZUX)^)%U:Z';?VM+
M]CMX5N[5#$T/W98BDNWRI=Z+L&P)ODW^P^.+KQ#XZT?X^^,H_&GBK0+CP3;W
M%CH>GZ;=&U@@DM],AN9)GB V3F221@#*K;4*E-K;2OHVK?LB^#]:^&_Q*\$W
M&I:XNE^/]>E\0ZG,DT(FAN7EAE*0'RMJH&@3 96."WS'J/,OV@O"MG>:A\5M
M/\.VOQ2A\2^)-/ATB72-'TF=]&UJY:T6*VN?M?DF.%$$D<<I%Q I%LXD5U^_
M6H'NO[->K7VO?L[_  RU+5+VXU#4;SPWI\]S=W4K2S32/;1LSN['<S$DDL3D
MY)->G5PWP1\&WWPY^#O@CPIJ;PS:CHFBV>G7,EJS-$TL4*HY0D E=RG&0#CJ
M!7<U(!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *HZKJUGH6EW>IZC=PV.GV<3W%S=7$@CBAB12SN[$X55 )
M))P #5ZN.^+5CHFI_"GQE9^*+J6R\-7&C7D6J74.=\5JT#B9UPI^8(6(PIY
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MS[#X=U;XE>*-<TKXSO\ %G6/[(L+.^:W%C]FMX!-=/;#=9Q)&7#FZX)+ -R
M&6@">\_:X\/V7[2P^$DNEZAN.FI<?VPMG=N/MCW0@6V,8M\"(@AOM1?R@?E)
MSFNL\(_M)_#GQUXIM?#VB>)H[[4;T7)L9!;3I:ZA]G*^>+6Y9!#<L@8,5A=R
M!DG@$UX7\75GL?VWKQ%UVW\(7OB/X27&@>']:OY!#&VJOJ9\N.)FQYDJF2-_
M+3+8(XYYY.U\4Z)\3?A9^S%\/O#I_MSQWX<UO0KO6=&0/#=Z(NEH(]0DO(V
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M\&/'FD^,-+UOX=^%]>NH/$,FES+=V=G<75C+#97-Q)'NCB6*3<I=V&S[2AR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\:P75+Z^CM(OM(4L83YQ0K)M!8(P#%<, 5() /3=BYSM&?7%&T+T %<5X/\
MC-X!^(FJ/IOA7QOX=\3:C'";B2UT?5K>[E2,,JF1EC<D*"RC<1C+ =ZTO$GQ
M"\+^#]6TG3-<\1:7H^I:O*(-.LKZ]BAFO9-RKLA1F!D;+H,*"<LOJ* .DIFU
M=P.!GIT_SZ#\JS/^$IT4>)AX;_M>Q_X2(VG]H?V3]H3[5]EW^7Y_E9W>7O\
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MP*U/#/Q&\,^,/!,'C'1]=L;[PM-;-=KJR3J+<1)G>S,3\FPJP8-@J58-@@@
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M<+D@;LQSQ-E<CYL9R"!L4#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*<%>=W7?&OX,^(=/^&_Q3\7^,/'3^-'TSP'KVFZ#:MHMO9M913VS-/+*\?\
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M:SN"EL(S"708:...49/[ST]&_P"&,>N/& Y^+)^*7S:9GD_\N/\ KOK^^_\
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MR<G< =M<WX/_ &$]/\&?"7X<>#+'Q)&L_A3QI;^,[S5!IC ZG-"\FV,Q^?\
MNCY;1Q[MS<1 [<FBX'SWXOT_4=0_X*'?&I=.^"FC_&Z5=,TTOI>LWEE;)9K]
MCL_WRFZC=2Q/RX49^;TK]#? L4MOX&\/)<:!;^$9H].MU?0+62-X=,81*#:H
MT8"%8S\@* *0HP,5\]>+_P!D7QS/^T!XP^*?@/XQMX"U#Q-!:VUS:#PQ;ZCB
M.&"*(#?-+C!,0;A%/..<5[ZO@UM=^&O_  BGBZ_;Q*UYI/\ 9>KWRQ_8S?EX
M?*GD"Q$>5YF6.$/R[OE/ -2!\\?#OXLZG+\1OAU;:9\5M;^)>D:Y>WVC:K/?
M>$Q::1++%:7,_P!HTZ^AMHHSMELGC\OSK@,DK$']WNK"\+?%#XG0^ _ 7Q O
M_'LFIIK'Q"_X1RXT*72K5+1M/DU2>QPS(@E\],!UD5U3"(K1L=SMZ7X"_9I\
M1^$[[X=QZC\3+C6M \!S.NCZ2='B@5K?[)=6L8N)%<F2>.*X1!*NQ=L39CWR
M%Q>L_P!F4V?PO\)>#1XE+C0/%R>*1>-8#,^W4Y+_ .SE/,^7/F>7OR>F[;VH
M \D^)FO?$'XI_ []HGQ(GBG^S-*T:;Q!H5GX;^S0/8SV%K ]O/)+)Y/VCSW
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M'?#GQ&U:RU>XTV72Y+R.PFB;S;EXMUTJ[YYUB<MM 58]FTC84-0/F?\ 9O\
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M!%\+GPQX_339K#PK8^$M2>YT2.X^U0VA;R+FWS*/L]POG7&-YFB/F)NB;9R
M>,_!OXL:M\;O%?[*WC#750:Q?:;XJBN6B4*LCPM;P&3   +^5NP. 6(' KK/
M^"BWA>R\<>"/A/X;U,.=-UCXD:1I]R(FVOY4T=S&^TXX;:QQUKK?A/\ LD0?
M"I?A9%:^)I+ZV\!KK<<8FL@LEX-0F64;F$F$,87:?E._.?DZ5W'QP^# ^,L?
M@13K!TC_ (1?Q58>)^+;SOM/V8R8@^^NS=O^_P#-C'W3FGU ^2?C)XTU7XQ?
MLMZ-X$U9KE->TW1==O?&$0OX6F5]$@D@Q-M+;O,OS:2#:2"J-SCFNJ^'_P 1
M-9A\&_";PG#XE\4>%=$LOAIHVJ23>$/#$NM75S<7"-%&LA6RN5BBC6U<X(1G
M,O#80BO7/^&2=&M_$/QQU:SU"WLI_B=IO]GE(M.4#3M]M)%-*,.#*TLDC3/R
MFX@9Y&ZG:3^S3JO@N/X?ZAX/\:_V3XH\,>';;PO>75]IC7>G:Q8PQD*);03Q
MM&ZRDR(\<H*[G0[U8X0'DWA_]I/Q[XXOO!^@^*K7Q=\+=0;PQ)JVKMH/AB?4
M]1DNOMLMI"#;-I]Q]GA9;:6;YUR?.C56(4LW):E>>.OB?\5OV2-1\5:IX@\&
M^*[U/$EG<[-/M[>>&6WMV0W20W-J=C7"*C%9$*A"NQ4.6;Z6U?X"Z_-XF\(^
M-]*\:QVGQ*TG1QH>J:U>:0)[+6K;&]EFLTFC\LB?,J&*1=NYE.]< 5?'G[/?
MB/QE'\,M=C\?K#\1?!'VCRO$EWHJ3079N;?R;@M:)+&J;L(RX<A=N#NR35:@
M?/VM?M"?$V;2=8M['Q:VG7S_ !Z_X02"^73;21H-+92!$$:+:Q5B&WL-YQ]Z
MNBUKX^>/?!7C;XM?#@>*WU/4;/6O#&B>'_$6K:;;RW%I+JR*)9)8X5AAD6(+
M))&-GWL!]Z\#NY/V+UD64?\ "7L&D^*J_$YC_9N<$9_T(?O>G3][]?DI/BW\
M"](\-R?&OXA:WXVU#0K'Q4NAWANM-TIKB;1)M,*&&<!?,,RF1(W?Y%"HKY(&
M74U D\&>*/'7A7]LE_AMK'CN]\7^%Y/!#^((5U+3[.&XCN/MD4 #R6\,8? 6
M0C"KQ)@ABH:O??&7B>R\$^$=;\1ZB9!I^D6,^H7)C7<_E11M(^T9&3M4XYKX
M]^%&B>+/B3^TUK?BW1O'O_"76EM\.I?#(^(%CHT4.G0:HUWNC%M$6*7!14\U
M]LDB>8[J3&K)&OT1\1?@WJ/Q5^"]GX!\1^)OMLDXL4US5EL3"^II#+')<*J1
M2J(#,8R#M+!%=@ >,2!\O?LK^-O#7A[XB?#;5=/\7:1XD\2_$[2[YO%UMH]S
M8JUOJ;S2:E;27,".9E=$GO;8L21\D2[4X%=MJGBWXP2?#/XH_$2R\<Q0OX0U
M_6CI6@M9V_V*]T^QO)M\=VWD&;S3'')&OE2(NU(B?F+M7O/QI^$,?Q9\)Z7I
MT%[#I.KZ-J]CK>D:E<6SW*6MU;3!U9HEEC\Q63?&5+CB0GJ!7S_\/_V>/^%L
M>'?'NF7'BJYL/"&M^/M:N?$N@PVRL^HF#4;A$CCN-P>W1Q'!YBJ"6$*A#'OD
M+@';77_"U_B-XZ^+^G^'_'B^%[+P_-:P>'HHK.V?==R:9;3O'=M+;R'[,))$
M8&/$G[V;)(6,#F_AW\6O&O[3VN7>E:#XSNOAS-HOA#1]3NVTW3+2Z,^IZE;F
MX4DW"R;K>)%3]VHC=FD?+X5*L2_!F_\ B1\5/CS#HOC"[\(C5M0T[1=:\BUC
MNFNM.&E63$0[S^XF*R3QK, P E<E&98V3OIOV<[CPA=3WGPJ\2Q> ;^XT&U\
M/3"ZTF/4X&AM5D6VN-I>.1KF)9"H=Y60JJAXWPI !R_[/W[0/B'XU?\ "I-6
MOXH=,CUS0_$$VHV-J0\,MW8WMG:I*A8;U4^9.P3<0!( 2Y4-6/\ "GQ1\5;[
M2?@/XM\2^/?MB>-)6MM4T&WT^U%JT;Z9<W-M/')Y*RQR[;9&E7<R&25]FQ%5
M3ZA\.?V<]&^%+>!(/#=[-!I?A72=2TQ(+I3--=/>3VL\EP\FX;6\RW=BH7:?
M-.T(% JYX?\ @J^@^%/A)H@UD3CP#)"_GFTV_;A'IT]D!M\S]T2+C?U?[N.^
M0 ?)OPCU3Q+\-/ O[1&OZ1XSU9;]?B==: AN-+M[]1-<7ME;OJ/V:"!9)KI4
ME9EA0^4Q50(CFNX\2?M#?$#P2GBS3-&A\8^*]*?1K672O&'BWPK<:7)9ZG<7
MT5E]G,2:=%]H51<1W"(D)D;RY$_>9&STN']E-5O_ (FV!\4S6O@GQQJ0UYM+
MT^V>WU'3=5#0R&\@O_./)EA$@1HL A ,*K!]>X^!/B/Q]X U_P '_%'QW'XO
MTO4M/M;.*32-&&CSP30NTAO"XFEW3,_DM@!8E,*XCPS @'B_B+XN?&+18O'^
ME?#ZU\<>.S_PC$>IZ7KWBOPFVFO9WRW2Q7,$4365JMR_V>3SHUVGYHBH63<5
M'T-\!O%NF>,_"=Y>Z5X[U+Q[''?RV\\^L6D-I=V,T>U'MI(8[>W,95E+;9(P
M^'!R5*U0TOX=_%%?#.JZ?JOQ7M;G5)+&UM=.U33_  O%;-;31,S27$T;S2K,
MTP**Z+Y:!4.P(6W"_P#"+X.R?#S5O%?B76-:_P"$D\9>*;I+C5=4CM?L<'EQ
M*8[>"&WWOLCCCPH+.[L=S,YR  #E;&?QW\4OBI\1+>R\<7/@_P ,>&KFUTG3
M[?1[.TEGGNFM(;F>6Y-S;RY7-Q&BB-DR%;H<,?*?VDOVC;KX:Z?X\\3^%OB1
MKFNZCX8U"TA?PU9^'4FT.W8/;1SVEU?K9MMD(>5N;E&5I$3;E<-[3XN^"7B6
M;Q]JOB?P-\0[SP2=>CB36[-]/34HII8O*1+FV25]D%QY,?E,Q21&4(3'N0-7
M'?$']D?5_B!X)\;>!I/B/-9^"?$>I7&L+9KHL+7L%Q-.+EHVN=^)+?[27E"B
M-9>53SMJD, <K\0/B5\1]3\3?M#II/C:Z\,V'P[TNVU;2HK&RLY3.SZ6MS)#
M/Y\#YC#QL5*%&!F?<6545??O^%K16OP+;XD7EA(+>'P\VORV,,@=]BVYG:-6
M( +8&,D 5RM]^SE]LOOC9<CQ#Y9^)6EPZ:5-EN_L[R[ V>__ %G[W.=^/D]/
M>N]\-_#^RT?X9Z=X)U'R]:TVWTI-(N!-$%2ZA$0B8,F3\K+D%23U[T ?->E_
M&#X@>"_"?P2^(VN^,9/$FE_$75;'3K_PS_9EM!;6 U)#+;M:R(OG#R-H1O-D
ME\Q68_(P%,T+XC?$Z+P9X;\?7/CU[Z*\^('_  CLGA^32;1+1K!]4EL<,Z()
MO.7Y7619%7$:*T;?.S^B>'?V6;JT?P-HVO>,Y/$?@7P+/%=Z#HDVE107'VB%
M2EM)=7*M^]\A&94$<<6<(7\P@YU8?V;S!\,]%\(#Q%D:;XJ7Q/\ ;/L/^LVZ
MFU]Y&SS.#EO+W[CTW;?X: /(]/\ '&O_  W\3^//$6F-NT./XO0V'B"%YH88
MA8W6GVENLK-(I8>7<2V[80@D Y^7)'MWP1\9:]X^UWXDZEJ1O8-$L_$D^C:+
M:7$<*Q^3:)'#--&R(&8/<K<<NS8V@ +@UYU\>/ OA_X:_ OXW#Q#J-OJ_P#P
MG][<3Z7ITMEN=M2FM(H+.UAC!=IIC-;HZLJ@@Y;"A"U>J_L[> 9_AA\$_!WA
MN^M_L^K6FG1'4OWQF,EZXWW,A<D[BTS2-G/)8XH \AUS2/'EQXH_:$UCPMXT
MD\)Q:5>QW5G!;6=O+]JO4T2Q<BY:>&7]P%2%1Y01OFER6^3'#6/[57B7XQ:O
MJ&F:9K7B+P#<:;X4TK4XO^$:\+2Z_P#:=0O[,7*_:'2RN?+MXP44*$C>0M(0
MQP OK?C3]E[7O$7B[XBZIIGQ+OM!TWQZL%GK6EKID5PJV<=O# XMV=OW5PZ)
M,IF*LNV88BW1J]7&_9ENO!6O2:K\)O%$'P]FN='M-#O;>\TE=6@FBM(VBM)1
MOE2031(^W<TC*P5-R-C) /3OA;KVL^*/AKX5UCQ%8-I>OZAIEM<W]BT#PF"X
M>)6DCV/\R[6)&UN1C!YKK*S="T^XTO1[&SN]1FU:Z@A6.:_N$1)+APH#2.J*
MJ!F.6(50 3P .*TJ "BBB@84444 %%%% !1110 4444 %%%% !1110 4444
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ME7OPN_:<^'WAB*W5/"?C7XE:#XTT]HH8XDM]0CD-KJ$602TC2&6VG+':!N(
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M5J]"\6?M-/X9_:U\$_!4>'?M">)-'DU4ZU]MVFWVI=MY?D^6=V?LH^;>/O\
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MU^U!HO\ :>HZS_9^LV-M_:.KW'GW=SLEOQYDTF!OD;&2V.237JG[#'7X_?\
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M?AC\/M0L_&MSXX\3P:/<?V7,7A:UMQ#=W,D=VD<D:>6'MBT@60*K2?*Q1@)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M,BQ\+Z-I>LZIK%GI-C:ZMJGE_P!H7\-LB3WGEKLC\V0#=)L7Y5W$X' K/T/X
M;>$/"JQ#1?">BZ0D5X^HQBPTZ& )=/&T3SC:HQ(T;NA<<E78$X)JK)\7O D.
M@W>MOXU\.IHMI=FPN-1;5;<6\-R "8'DW;5D (^0G/(XJWX/^)7A'XA-=_\
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M=I<S?O2Q&=_S9SS6!K7QW^&OAG5[O2]7^(?A72M3MFV3V=]K5M#-$V <.C2
MJ<$=0.HI-1^.WPVT>&QFO_B%X5LHKZ#[5:27.MVT:W,6XKYD9+_,FY6&Y>,J
M?2@#5\4_#7PEXXN+"?Q)X6T;Q#/8,SVDFJ:?#<M;,Q4LT9=24)*KG;_='I1X
MP^&/@_XA26;^*O"FA^)39[Q:_P!L:=#=&#?MW[/,4[=VQ<XZ[5]*TO#?B72/
M&&C6^K:#JMCK6DW&[R;[3KE+B"3:Q1MKH2IPRLIP>"".U1ZMXQT'P_J^EZ9J
MFM:=INIZJS)I]G>7<<4UVRXW+$C,&D(W+G:#C</6@"'7O ?AKQ5?Z3?ZUX=T
MO6+[1YO/TVZO[**>6RDW*V^%F4F-LHARN#E%]!2Z;X%\-Z*='&G>'M*L#HT,
MEOIOV6RBB^PQ2;?,C@PO[M6V)N5< [5ST%&O^./#?A/4M+L-<\0:7HU[JTOD
M:?:ZA>Q02WDF579$KL#(VYT&%!.77U%6O^$FT<>)!X?_ +6LO[?-K]O&E?:4
M^U?9]^SSO*SN\O?\N_&,\9H XCXG?#R?4O ]SH_A7PMX,U&*^U);W5-$\3V1
M%AJ*M+YD[,8T?9.TFV42O%+EEY7)#+A_L^_ NY^%M]XH\1ZX^B_\)7XI&GB]
MM?#-G)::78PV=HEO!:V\;R,2B 2?/\N0X&Q  *])\6>-O#O@'38]0\2Z_IGA
MRPDE$"76K7D5K$\A#,$#R, 6(5CC.<*?2LK2OC+X!U[2M5U33/'/AO4=,TI%
MDO[VUU>WEALU;.UI75]L8.UL;B,X/I0!<U_X:^$O%6LIJNM>%]&U?4EM9+!;
MR_L(IYA;R*Z20AF4GRW61U9<X(8@@YJ%?A/X*CU71]5'A#05U/1K:.RTR\_L
MV$2V-O&"$BA;;F-%#, JD  UL-XHT=?#@\0MJ]B- -K]N&JFY06OV?9O\[S<
M[?+V?-OSC'/2L;PO\6O!'CBQU&\\.>,O#^OVNFH'OKC2]4@N8[52&(:5D8A
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M;V;1+MB,,94K&47Y5V@;1TQ6QIFEV6CV[P6%I#90/-+<-';QK&IEED:260@
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M'"JJC)X"@5MZ;X"\-:+J5IJ&G^'M)L-1L].32+>[M;&*.:&R1@R6J.%RL*D
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M@C(XX/I6OX<\3:1XQT>WU;0=5L]:TJ?=Y-]IUPEQ!)M8HVUT)!PRLIP>"I%
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M45BZ'XOT'Q+H US1]:T_5=$8.RZE8W<<]L0A(<B125PI5@>>"I':LGPK\7/
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MP2[\9^)?$&B:;?\ B?PAJ%MX<TK7[BW$M]%8K>V<J1+,Y+*J"[EC54VJ$PH
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MCO;ZQX:T?3&TZRT:7P7;11H$MFAMBTJS>8RQ-Y;XW@N$P6^8FL[PC^P%\/\
MP[^SW/\ #R^TGP_K7B633KVR7QK=>'K<WR33F4QS@G+[HO,7;^\SB-1N'8U
M\3_;P\$^$+W]HO\ 9@U&ST#1IH_%GB;_ (FMQ'9PN-6A:YTY5$[ ?OEV2,!N
M+##G'!KG_P!J;2_"7P^_;Z^%%A+\.9/%OA.S\(LH\&>']$BOC."VI[1%:'"$
M(Y$AZ8",W:OH+5_V*-5\26?[/D>J_$".ZN?A+=K*MPNB^7_:D,<ULT,17S_W
M16.U1"_S[B=V.U:?QT_9*\3?$[]H+PU\6?"7Q+7P%K^@Z0-+M=V@QZEU:YWO
MB255^9+IEP5.,9SG&#4#U[X(WNCZI\,-'N- \$:A\.M(<S>1X;U+2TTR>TQ/
M(&W6R'$>]MT@QU#ANIK\]?VM/B%H?C?XZ?$_QG;^(]-C\2_!^/1;?PGI<E]&
MBZA>)>BXOI?+D8>8\.V2-HT!^ZO?%?H]\-=!\2>&/!>GZ;XM\4_\)IX@A:3[
M3K8T^.P%QF1B@$$9*IM0JO!YVY[XKQSX4_L0?#[P?X3U.S\:Z/HWQ+\4ZQJ%
MWJ6J^)M8TB'[3<33N2VPL7>)0,<*_P![<W!:I \._;6T<_M'>./V9SX3OKZR
MO-?TK7M9T"\M9?LLZW2:?;WEBQ<@^6/-2+<1R 6P01D=)\!?BM:?&_\ ;+\)
M^.+,*O\ :_P626>)$=5AN5UDI<1+O 8A)ED3=C!VY&00:[_X7_L<WWP_N_@C
M->>.%UD?#!M:2'_B5F)K^*_BV*C,9V\LQ9." 0P"C"XR=+X8?L?Z?\+?VI?'
M/Q?TO6PMKXGLYH&\/_96)AFFE@FGG^T-*Q;?+%(VS8 /-P,!0* //?\ @I_)
M$GPC^'+7-A)JMK_PG^FF;3XXQ*URGV>[+1!"<,6 V[2<$G'%<S\5-<\&ZU^R
M+\;_ /A$?@IKWP>$6FV?VG^V_"\.B?VAF<[-GEL?-\O#9S]WS1_>KZ'_ &IO
MV>[O]HWP=X>T:Q\3_P#")7FBZ_;Z]!J!L!>YDACF14\LR(.LH;))^[C!SQS>
MJ_LX_$GQQ\(?'O@?Q]\8T\8'Q);06UC?#PO;V(TS9(6D;9#(/.WC9PS#&SCJ
M: /F1M%M?CO\0_V4O@YXKEAE\!0?#6R\1W6EF[EMGU*X:S>-4!1QO=/LX9=H
M5E1KCYL$BO7&\9?"O3]<^-?P^\)?"C5/AQXLM/!FJ37-S+HD.F6.IV=L\D*3
MP+')^]1I)&*2F,;E!YX"UVGBW]C>34?#_P );CPQXT;PE\1/AUI<&CV?BR#2
M8IS=VZ6XA=)8&?E6P[*I<A/-DX.XFLOPC^S5\4/%7Q \9^//BGXJ\,KK^M>$
M;KP7::9X5LIVL[2UD=)4F\R9E=G$AERA4Y# [_X0 ?%?_"[&;_@F&?A\/ ?C
M8[>3XL.D :%C^VA-@76_D\B+[O\ K./>OKG]NGX7>#[K6/@UK4_A319M7UOX
MG:#I^J7\FG0M/?6S)*C03OMW21E412K9&$48XKJO^&+6_P"&*_\ A0'_  F(
MSU_X2'^S/^HC]M_X]_._X!_K/?VKTSXY?!4_&9?A^/[9_L<>$_%NG^*?^/7S
M_M7V7S/W'WUV;M_W_FQC[IJM1G=>&/"^C^"="MM'\/:39:'I%MN\BPTVV2W@
MBW.6;:B  99F8X'))/>OC;]E'X>^'/VE_&WQ?^*'Q'T*3Q/JT?BN\\-:;I'B
MZSCD71]/@\N2.#[*P*1RCS=K<$AD;G+R%_N&OE?Q%^S;\3?AC\2/$'C+X$^,
M])T^W\37_P#:.M>#/&$4LVES73K*);J.:/=-&S,T;%$VY8$E]BI$$A'A7QZU
MC3_@1_P4+^"K:1X9U[7M*\/^!TLK/0?#=LVH7[PJFIP(L:.^Z0HA#$EL[58D
MFM3]@OXA:=:_%3]K7QOK$%]X;TI-4AU>\MM6M&CN[&(2ZE(Z30KN82*!RB[C
MD$#)KWZ;]EG5-2_:/^&?Q?UCQNNJ:MX3\/+HE];_ -DK$=3F\F[22Z#++MAW
M/=%O+"$#:0#R,<G-^PS?K8_M!6]C\19M,E^*]_!=&XM]-96TZ%+F6:6$XG'G
M++'.\+<H-I.00=M/4#YC_9;^(WA[PG\;OAG\3WUFRN?%'Q9O]>T[Q;IL,Z3+
MI,]Q?!["*&!"981-*D6&F9QM9CQG<+W[2GBGP9X8^-O[6?\ PE?P[OO%MQ>Z
M3I-IIFO0:)#>0:!<R:2(HI))W8-;F262+!09)B]0*^K_ (H?L)_#KQ5\.+70
M?!>CZ5\-_$FFRVL^D^+-)TQ1J%I+ ZXD:5'CDE8J&&YY/O,'Y95-;NH?LPOJ
M.O\ Q\U-O$_EM\5-*M-,"+8G.EF"PDM/,!\W]]N,F_;\F-N,G.0: >,_&'4-
M3^"_[ /@OP+=>--+U#5_$]OI_A"V\4H8AI4<%R/F9Y"N/LJ6:R1_: A8@))M
MR21Q_P -?C-IGP'^&/[37@OP#KZ^)[+P>7USPE=Z'=KJ/V:UOXAM2&-G<-!8
MS,K2R;F'SNS*"2&]ETO]BJXU"Z^"UMXZ\3:3X[T#X;Z?>:<FEW_AR-4U%9HV
MBC\P&5XPL4<=H%4H26A9BQ+#;KWW[%?AN'XW'Q=X?&D^%O"%_P"%[CPKKW@[
M2-$CM8M4MYC*SN9X70Q.6:'YD3?B #< W!J!D?LK_LM?#:3X)^ _%6J^';?Q
M#XRUB*P\77OB751YVI'49/*O-XN.'15DVC8I 8 [PQ=RWC'QA^%?@RX_X*B_
M"S0I?"6B2:-K'AZZO]2TY]-A,%[<E-3<S3)MVR2%HT;<V3E5]*]J^%_P$^.?
MP;UO2?"FA_%/3-;^$EK/ T;:_IQDUS3K2*9Y#8PLH\N59(Q'"99&^16/E1Q^
M6H;L/%_[,S^*OVMO!/QK_P"$C%JOAO29-+_L/[#O-QN2[7?YWF#9C[7G&QON
M=>>#4#XWU^;P;X-_X*$?%FTUSX1:E\3]#MM%TVULM!T#PW%JWV+;96(200.0
ML<:HI3<.FX#O3OVB]4\-V?[;WP/OKWX7ZIK_ (9_X0*!E^']OH,5S>)$R:B(
M[?["QV!H"4+(#\GE,1]VOI/Q;^R#XXE_:(\8?%CP+\7U\#:EXDMK>TFM6\,0
MZCLCBA@C*[I9MIW- &R$!&<9]>@E_97U35OVD/AK\7]9\;KJ6J^$_#JZ+>6X
MTE8CJEP8;I)+K<LNV$,UT6\M48#;C/H7 Y/_ ()GZ&MC^SWJ.NV5I'I7AWQ+
MXFU'5M%T=+N2Z;3;+>L"VS2. 697MY/FR=P*L?F8@>:?MUZMH'QB^.6E?"G5
M_%&@Z%I/A[POJFNSG6M>6TMIM6G@:#3X9%W )+$S1W WMEHY7^7:?G^F_P!G
M']GYOV>X_&^G66K6=WX>UW7[C7-/TVUTUK4Z8)<*;<-YK*\:I'"%PB8(?J&
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M=-X3_9GD\+?M9^,OC4/$2W2^(M(CTHZ+]B*FW*+:*'\[S#OS]EZ;%^_UXR9
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MR2)H$BB(9LMY8+%@\B/6H'%_$[X3^&_AS^U9\,?#OA?3;7P[X3^)^BZYX?\
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MY>]=Q/EX^\.N>U>)^,_V +?Q)^REX.^"MAXVFTU/#^I?VF^MS::)VN)6%P9
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MVAJLFK>*-0\#?#&^\=_#GPC/);^(?&$&M6UFD#P*9+L6T$HW7(BCP00RAVR
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MHA%]GT(7T=D;C=(BN/.D&U-JLS?,.=F.,YKYV_9\_;*\<?';XJ:]X0E^#?\
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MNN+BU_:(_99EM?'UG\+IU^$^E[?%>H0V\T-CFTO@=RSL(SO&8QN/60$<XJK
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M6&YLK#_A)[:^_M/>[+(OF0QGR=F$Y93G?P.*?\'_ -H#XL_%'PW<Z_=? O\
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M1PB*&*--JF1V,C!!N8Y(R<5]/U(!1110,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/P\\1> QX*OO!.B2>$XV=H=(CL8XK>V=Q(&D@5 /)?\ >R$/'M8&1B""2:/
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MNH;V%)I;=GMY5D42Q2-'+&2.-R.CHPZAE8'D5=H$%%%&X#&3CM0,**,^^:*
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MR3/=KF,".(1H3YO&^U:_M=6L&BV7B#7=-L]*T/3_ !1?^#O%MY#=SW$6@:A
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M  O\<Z_X\^">@>,)=(L(M=UK28]4M=*2_?[/F:/S((WG\G<N59-["-MI+8#
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M*J=P! /RCD'BNNIMO$(84C7[JJ%!^E.H ****!A1110 4444 %%%% !1110
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M9Z3JOG>3!J<:)<+Y4\D+;U1V49:-NC'@CITKO%8, 0<@\@BORL_9RNKKQ_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '.^+_ ?AKXA:=%8>*/#NE^)=/AE$Z6NL6<=U$L@
M!7>$D4@, S#=C.&8=S3O"/@;PW\/].DT[POH&F>'-/DE,S6FDV<=K$9" "Y1
M !DA5&<=A7044""BBB@84444 %%%% !1110 4444 9NJ:#INN26+W]A:W[V-
MP+NT:YA60P3!6021D@[7"NZ[ASAV'<UI444""BBB@84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<]?> O#.I>+;+Q1>>'M*NO$]
MA&8+36IK*)KRWC(8%$F*[U4B1_E!Q\[>IKH:* "BBB@ HHHH **** "BBB@
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MGV'Q[KG_  A&H>)]5\6'3WUBSTO46@NK]K-D6V>-I;F*.%H0 ^Y'C)V9^9L
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MD5QI$T$^EZE>:M8WVGZC=6=[:W%Y)+)=M'<PRI,JRM-)N0/L/RC;A% ](HH
MX"W^"7A*'6O!NKS6E_J.K^#_ +8=%U#4]7O+RX@-VNRXW/-*S3;E^4>:7V@
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M% !1110 4444 %%%!/K0 4444 %%%)N&[&1GIUH 6BDWC=MR,^G>EH ****
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M%7 #JWU3\<O#>H^,_@G\0-!TB#[5JVK>'=0L;.W+JGF32VTB1J68A1EF RQ
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MN\06>JW\>IV-[&&:_P!1M-/LYR+<KNCN%2VOV\[# B]<9RSJ<WX1_!SXFP_
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MD7PY)+%/J\6FPQ+'I,K*GF,KL99&VHB[-G+%WC &[W7X=VOBG0_C;\5+6_\
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M>FVMY:ZKX>\/Q6<-^^(+ZXL-2O;R6UD"NKJKJ\,9;*C$Q()VG!J(==?M>?\
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M7B[P=<VT>H6EO??;K9XKF(RV\L4_EQE@Z*25:-2O&>:^;O\ AF[XC?O@/#9
M;]H1/&Z_Z9;_ /(&'_+U_K/_ "'_ *S_ &:].T_PK\1OAC\;OVB?B#HW@;_A
M*QKZ>'1H&G_VM;V?]I&WMS#<_O&+>3Y>\M^\4;MN%SG- 'TY121L7121M/7%
M+0 4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR1R,R?"_QM_PLCX:^$?%AM!IQU_2+35?L7F^:8//A27R]^%W;=^-VT9QG H
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MQU'Y4 /HKE?AO\2O#GQ<\&V'BKPGJ)U70+XR"WO/(DA\PQRM$_R2*K##HPY
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M'?@?Q)9:WH.@/IES8SSW-C:PZA=?8+*69&CE>WLS+]GA+*[+^[C7AC0!X_\
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MT/A?3;;Q-?>(8[;;K%]:6]A<7'F.=\$#SO$FW.T;6N9SD#)W\YP,<?J_[/\
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M0!\N<9)) /D[]I7^S/'6K?%M]+^%&E:[K/A'PT]I?>-?$=X+4V$BVDEU"-.
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M-*UZ/3/CAJFJW_AO7+N6WL]:MH50FT=HQ@DR&*15E#1;XDWJR@@]O)\$=?\
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M\=K),_B7PCHB2Z%=/(7739Y- C:6X@0G:DTGE0JT@7<5B5<[2P.7=_#'QO\
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M@W4+>)8(IK::VADMI85)C:-)D9E3H#'&<#&VN;\+Z2-2N/AS\)Y]$-[\+/\
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M8Y'124D9A\HXQ7J.CZ/8^'=)L]+TRTAT_3;.);>VM+6,)%!&J[5C10,*J@
M    4 ?F_P#!32/C'X1_8;O/'7AKXDS7'AFWTC5FA\&6^DVUK+;@S3QR7":D
M&\U6B)>Y&!DF/8,9!KZ(OOA[X,^!/QW^!]MX"M[7PA/X@%_H^HZ7I]N NKV<
M-B\ZR3,0=TL4J1?O2?-;SF!9AD5[WX/^%?A3P)X!C\$:+HD$/A2..:$:7<%K
MF)HY6=I$?S2Q=6+OD,3G<1TK&\ ? 'P'\+-<EU?PWH36>HR68TY)Y[VXNC;6
MHD:06\ FD?R(=[%O+B"KG!(^48 /B?Q%\&_#OAK]F/\ 9PNH$O)M5\7>-O"M
MSJVK3W4@O9@\$@CB6X4K)''#&WEQ*C#RU V_,2QM^*O@]X*N?&_[8>DMX8TU
M-)\*>'++4] L8;=8X-+NI-*:66>V1<+%([VT!9E +"-0<CBOMB^^"?@K5O"_
MA#P[=:*9=&\(WEI?Z);&ZF'V2:U4K;ONW[GV D8<L#_$":6X^"?@RZU3QWJ$
MNC;[WQS9Q:?XAD^U3C[;#' T")@/B/$;LN8]I.<DYYH Y&\\;:Y_PQY=^+H[
MUE\2?\(-)JJ7RJBD77V$R"4*!M!W_-@+CV[5Y-)\*/!'A&V^ FI^#]+MM?F\
M17G]DZI>@I;OXETVZTRXDN9;[('VD9C2?;(&Y! P7KZMT/PYIWAOP_9:'IUN
M+?2K*V2T@M]S,$A10JIEB2<* ,DD\5Q'@_\ 9S^'7@+Q%'K>A^&8K748#-]D
M9[B::.P$KL\BVD<CLEJK%VRL*HI#$8QQ0!YG^Q5X3T+PW#\77TC1=/THKX^U
M>Q#6-K'"1;PSD0PG:H^1 S!%/"ACC&:X/3?"'BWQU^UI^T]HWA;Q78>$TO;'
MP_;7MW=:0U_/L>P8 PG[1&L; ;^723.Y<;<<_67A'P'H?@6/5ET.Q^PC5M1G
MU:]_?22>;=3-NED^=CC<?X1@#L!4.C?#GPYX<\;>)?%VG:;]G\0^(EMDU2\\
MZ1OM(MT*0_(6*KM5B/D49[Y- 'ROIOPDT#1?VX/ '@^XBFU?2O"?PMMI=/6_
M?<3/:W[103R*H".Z*[D$KA6(90&52.#\/Z/;7W['^D?'+3]-'BKXT2^(;75$
MUY=\&H7=X^JI:-9^8A!6%HG>V\D#R=IX3H:^Y6^&WAM_B0OCTZ;GQ8NE'1!J
M'GR<69E\TQ>7N\O_ %GS;MN[MG'%<K_PS9\-O^$X;Q8WA:%]9;43JV'N)VM!
M?%54W8M"_D"<^6A,PC#DKNW9R: /F74&TY/VM9/!$E]<K\*=2\10:SJ \N9;
M3_A*1;M.-.-P)%4HY\N[,3;QYT:H%&6%1:7'#I_CS3/V<HKK[#!IOQ%DUZ+3
M](M7,::"D(U6)+@MD;/M<\46[@'RL#D<_5,OP \!S>#[KPPVAN-+N=3_ +9E
M=+VY6[:^,PF^T_:A()_-W@'S!)N  7.T8KD]%^%UYXU^/7C/QMXG\.2:5I::
M#'X/TF.XU!9);^U\Z66YN6CB)$:.7C5,OYF(V+!"P% 'N=%8_A?POIO@OPSI
M6@:);_8M(TRVCL[2W\QW\J*-0J)N8ECA5 RQ)XYS6Q0 4444#"BBB@ HHHH
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ME0M;F*7S%E9&8*OE"1I%4@'UC9_%+1+CX2P?$>X-Q8>&I-$7Q#(]Q'NF@M#
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M#PG>:?!XD^,=WXQ72I;1C<:=82Z;=1Q2WL8!$$I=49LGY6E0$[N* /5]0_;
MT#3[[Q-8#P7XTNM1\+6EK?Z]9P:;"S:9;S6L5R))6\[82JRE3&C-)F*4JC(A
M>M[6OVF/#5K_ ,([!X=T[6O'6KZ]HZ>(;+1_#]JAN3I;+N%XXG>)40DJ@5F\
MQF=0J$[L>'>&/B;%\,?VN/VI;V3P_P"(/$4TEOX>DM[70-*GOVDECTQV2%O)
M5C&9"2%=P$^5MS#@'=^$=CXB_9WU;P@/%?AC6;K1YOASHNBW6JZ78SZM-8ZE
M92W+/:-#:),^PK=\2_<_< 9.10!Z%JG[77@:UTWPA>:3#K7BH>+H+Z;1(-%T
M\O/>26DL4<T CD*,L@,I/S *HAE+,@6M'XE_M*:/\);K4YO$/A?Q5;^%]*DM
MXM0\61Z>C:;;-* 5/,@FE4%E5FBB=0S!<[L@>!^#_!'C>Y^,/[-WB'6/!^KZ
M1G5_'6M:M;2(;F/1UU!I9K:.:5!LC++(H&X@EBPP#D5C?&1?'WC32_CI9>)/
M#GQ$UCQ9+<7NC^$_#_AUM1M-"&CBV+17K20$6]S*ZR2L\4SR/(R) L:9V  ^
M@?#O[0FKZU^T5K?P^E\ >)+32+.RMY(M6FLX1&KF:]5KAW%P3]FE%M&(2$W;
MA)N"C%1:7^T=H&@^$/AWI^EV7BWQ[X@\1>'H=;L]+MH;>?5S8"W#F[O#YD<,
M9+%4SN >5PL8;G%^WU2XT']K34X)]"UQ]/USP?ID%KK5MIDTVG)/;7>I/)!+
M<*I6*0I<(R[R 1QG)0-XI\-?"WB#X0^/O@K\0-<\-:]/H#?";3_!M_'I6D7-
M[>Z5?Q[+G%S:Q(9EC8(T>Y4;;( KA P) />=0_:5\-6W@?PWXGL=*\1ZS!XA
MU&?2++3;#29#J'VV&*Z>2"2W?:R,KV<T1+856P6*QAI%Z3X6_%73OBMI>KW%
MEINJ:/?:-J<VCZGI>L0+%<6EU%M+(Q1WC<%'CD5XW=2LBX.<@?/GP6^%^OZ*
MWA#Q'>Z-JEB_BGXJZUXTN=,O;'RY](M;K2=2B@6Y"NX1B/LY.XC:\XC(W#GW
M3X8Z7>Z?XX^+UQ=6EQ:P7WBB">UDFB*K<1#1=+C+QDCYEWQR)D<;D8=0: ,+
MQ_\ M/>'_A_K7B"SE\/>*M9L/#/E'Q%K6DZ49;+1UD$3[I69E:79%,DSB!92
MD>68#&*M:A^TIX6M?B9H?@;3[75O$.M:UIUGK-G)HMH+JU:PN)I(OM;3*VQ(
M8S&&9V(R)8]GF%L#P36O#NM?"_PG^TA\.8O"?BKQ'JOQ U?4=3\/7FEZ')+9
M77]K6Z0['N5<Q6_V>82"1IWB_=JL@SNVCUSX!_#;4_A[XNM[#5;,--I/PX\+
M:%_:<<+&"6>WDU);B.*1E&<$PL5X.'C) R* /3O'WC:3P/IMC<0>&]<\4W-Y
M=I9PZ?H-O'+-N968N[22)''& IR\CJN2HSE@#YA>?ME>!K'P?I7B&:P\1'[7
MXJ7P7<Z7#IIEOM/U0HSM!-"K$N5"8_<^:274*&).(OVGK[Q8OB+X<:=:?\)-
M:_#N^O[EO%>H^#;:YFU.,11"6T@4VH:XCAFD1EDDB3< %7S(P_S?/-UX!\5:
MQI'AFYM/ OB_3[=OCYH^NI;ZRUWJ-['I2:?;HM[<2REY A51O\QCY+%HF.8R
M* /J.Q_:D\&+X=\::EXA34O!UQX-N(;?7=+U>!7N[-IBOV=MMN\JR++O788V
M;=GBJ$G[4-DVE^(K7_A#?%%CXUTK3TU5/"%Y;6_]HW5G(ZHEW$%G,3Q*[$/B
M4,AC<%0=H;Q'Q=X!\<1_&3]I/Q#H_@_5]79=7\#:SI-LJFUCUE=/:*:YBAF<
M;)"HC;.TDA@HP6P#ZS9ZMJ?Q:^-O]N:1X8U6Q\,:5X-U+2_[6UC3KG39KJ_N
M[FU<6Z07,4<A2-+/=YF-I,V.H- '$0?M):_XM\-_ 'QE>^&O%&D3:IJ$HO\
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M6&L6MS;(LEH4M=T0D26.6#;<>7^Z\CDH<@ ^EY?V@?#]GX;^)6M7UEJ>FP^
M9YX=2MKI85FF$=NEPDD"B4ADFCE3R]Y0DG!"FN$L_P!HOPOX3\4?&+5-;N?&
M5L_ABVT.?4M%U&*WN8+*2\A_T>WL4MF<M([NJR;F9?,(*MLYKSKXP? O5/\
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M$JLS?ZSGG!';6/[4/AU;'Q=_;>BZ_P"%=<\-Z))XDN?#NL6\*7T^G)&9/M,
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MLUC0=,\1P&YU.RLFGL]%LY-/TY06+NI*B2661H[=9'4;W9%#*6\R^ ^GZ_\
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M8H\>U'++(A1E4XS'X7_:.\/:QJNLZ5K^GZIX!UO2M+_MZ?3?$RP13'3L?-=
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M$W+(,IM:1'169D8#:OOVCM.T_P 4'3[CPCXOCT,:XGAW_A*GTU%TW[:S*B*
M9//,33,L G$/E&0@!\?-7RGX!^&7C*T_9-_9LTBY\)ZY%JVD?$VWO]0T^;39
MEN+.V%[?,9YD*[HXPKHVY@!AEYY%=;/9^)_%T\\_B/2?B5=^.H_'5CG2H%OD
M\.Z=I\&MPE9H=L<%M=0BW5?G9))B?WA4(K.@!]"7'[16@V?PXMO%UWI>J6<E
MWK9\.VV@W#VB:A/J(O6L_LZ?O_)9O,1VR)2-B,V< UPO[;7CC5/ ?A_X2W^F
MZIJNE)-\1='M[Y=),YEN;5O.:6W*0@O,KA1^Z ;>0 %)P*\[C\%ZI;_MS_\
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MI-_96E7T=PUP9K6VW;(B[L<J!M"EE0('?=JWG[.FA-X\/B?2=<\2^%Q<W_\
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MIWB#4_\ A"]9ET:"%;B- )+AEO+.W\R647&R,$MB*7Y0H%>8_ _]HCQAX;\
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M37L?PU^!WAKX6>(O$VO:.=2N-8\1BU_M2^U34I[V6X-NCI$Q:5F((61A@'
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MP6KZ0M_@IX9M=7^'^HK!.;CP/8S:?HQ,Q(CAEACAD#C^,E(DY/3!]:YKP_\
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M%8]Q^RSX2O+Z6:\O=<OK;_A*H_&-K8W.I.]O9:BLCRY@3HB-++)(R="SGM@
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M9G\"7OPQU[P)?6%]J>B:],MUJLM_J=S/=WEPIC*S27#R&0N##'_%CY ,;>*
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M^HZ--'#J.FZA8W%A>6;2()(S);W"1RJKH=RL5VMAMI.TXXC4/VF+#3?VEO\
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MR*\G^,O[1FB:A\);>_\ !VOZY!-J>NV.C-J.BZ!<W5S89U*U@O(I(VMI!;W
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M+XD\51:'\0+""?Q!<)"NA:CJ+^';329+J6[6&6U!N5>-&?=%YGEB%!ND-QD
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M8^BT44##CTHHHH **** "C;[444 ''I1110 FT=<#\J7'M[444".5\7^"?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$,E72/#FE^'_  3)K$>H7]NKFZ6\D^R3!/,D!AC(FB &URO!WS0^.)YOVZ/
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M1_\ 3C=5Z%X7_9[T?PE\3]%\<V^HWTVIZ7X0A\&QV\FSR7M8YA,)2 N[S"P
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MW7/%T7A[XF>)_!O@WQQ>3WWBOPU8&.9;Z:55W-;S2 M:AW!,H 82*WEG"!5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB+Q%8Z;::E?&RU.[_L[2_$$NEW,>CZE>!YU:VMKXQ^3+(#;MC#[9"RB,N<@
M'L5%>&_"7]I2#XH?%SQSX231M8L+317M$L9KS0;^U=_,MA/*;DS0JL!RP5$D
MVLX&Y=P88ZSXB?';PM\,_$%AH5__ &KJOB&\A^V)H_A_2KC4KM+03)$]U)'
MC&.%"^2S8W;'"!W&V@#T:BO!?A;\:K*S^!<_C:0Z_P"-;.]\0>(#IW]A:?<Z
MM<W<(U2^-LD:QJQ6/R8T1&<I&H"+E<@4[QM^U9X9T[P/8Z_X8>_UO[1X@M=#
MG6'0-0G:S?\ M"VMKN*XBCB\RWN$CG8QQ3!'D;8$63(!!GO%%>0_$+]I[PE\
M-ULS?:=XHU#?9VVJ7PTWP[>2G2-/F\[;>WH,:^1&OV>;<C?O1L/[LX.)?&'[
M3G@7P;JNGV4UQJFLBZTZ/6FNO#^D76IV]MITB3-'>226\;J(F,#*"I)^96QL
MW.H(]9HKYV_X)^^*-8\9?LD^!-9U_5[[7=7N?M_GW^I7+W$\NV_N47=(Y+'"
MJJC)Z*!VKKOBEX\C\'_%CX<6LWC:XT2VOHM7EE\*VF@OJ,WB%8+42$))&K20
MM!S(%0%I2VP G H ];HKR7X _&]/C-8^(Y6T^_L9M,UJ_L4^T:->V<;6\-U+
M#$=\\:JTI6/+QJ=T;$JRJ>*V/$GQT\&>$?#'BKQ#J^IW%CI7A?4%TO599-.N
M0\%PYA"*L?E[I WVF$JZ!E(D!!(YH ]"HKROQM\9/#4WP[EOM/\ %;:%_;7A
M6]\1:5KJ:7+=K;6<4$;M>F'9\PC%Q _E/@OG !^;'S5XF^)OB.;XDZJ+'Q[J
MNMZ8W[.TNOV^HVIDT^&[O?.;;J26H(6"9UPPP R A0>*!GW317F_[..J7NM_
ML^?#+4M3O+C4-1O/#&EW%Q=W4C2RSRO:1,\CN22S,Q)+'DDFO+_V=?VG?#%U
M\-?A?I'B#5M7DU;5-&TRU7Q'J=G<OIVHZF]N3):KJ#*8I+D-$P92^3(VP;I
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M(&:*0!T#;0P# '#+D \4 ;-%%% PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH/'- !
M17S<_P#P48_9UC=D;XC1!E."/[)O_P#XQ3?^'C?[.G_11XO_  4W_P#\8H$?
M2=%?-G_#QO\ 9T_Z*/%_X*;_ /\ C%'_  \;_9T_Z*/%_P""F_\ _C% 'TG1
M7S9_P\;_ &=/^BCQ?^"F_P#_ (Q1_P /&_V=/^BCQ?\ @IO_ /XQ0!])T5\V
M?\/&_P!G3_HH\7_@IO\ _P",5](QR+)&KJ<JPR#[4#'4444 %%%% !1110 4
M444 %%%% !1110!\]_MF^!)/&WA/X?W#^'W\3Z-H/C;3-6UC3(;62[>2Q E@
MD86\:.TX4SJS1A3N17!XS63X%\11:+\2/CE\5-.\ >+AH5Y9:-&J+I5Q%J&N
MW=M%<":2VLK@1R@+%-;1?=16,3D%CN-?35% A%;<H(Z'FEHHH&?!LWP[\5M\
M ?V>].'AG63?Z5\8X]3U"U^P2^;9V@U749#<2KMS'$$DC;S& 7#J<\BOJO\
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M.-9TZVFO;?PCX]T7Q#J-M:6L]U<O9Q3-%*8H84=Y&3SA(5"_<1R,D 'Z!HH
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MC^!O$=DF@MJ.JZOJ?B'0KK3'TJ-[!K<6V^:()*\DL\>5AD8?Z/GYEPP^G:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDF)#+N0E6\_()!!H$?0E([B-2QR0/3DTM% 'S*O_  4F_9S=@H^(1R?71=1
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M%?&/Q2_:4\6_ WXJ?'G1?$>J-+I5MX-A\5>#)I;:*5+-BXM/)D$4>]O,O94
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MFR^ ]>T,0KH1O)H%,L6I.(R)CY\1813LJ^7',3L1LL#/O&O*O%O[1WA/P/\
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MB^%X;>'1M%!MX;O&J2SF$7HF0Y1$:0@)-^Y8!T9V&??=%?"$GCKXQ_M >/\
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M'@FP\4^*K'5K_3[S48],CCT>&*642O'+("1)(@VXB;H<Y(X].Y\=>,K3X?\
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MK>4VR/\ :8HT4.^;M,$\*(?E4.QD!8#]6**^0;'5/&_[1W[3GQ,\*GQ]X@\
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MYQ\Q9'WLNX^8 Q8KN8L!]N45\N_M;:J?&'B+0OAMH/BSQYI7B^XLKC4HM)\
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M"F1(VD4Q+)N^_NZW7/CQ\:M#^'&G:+8W6N:)K ^)]GX7T/Q)XQ\/M!)JVCW
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M)/ARS_\ C=)_PS'\'?\ HD_@?_PG+/\ ^-T >8?\/*/V<O\ HHG_ )1=1_\
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M9N/"VE7.D^'!K-_!<)HJ3JRF6!/("-(J-M7SED4*J*581QA)]#_8I\%>'8/
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MC'X^^)_B/Q+\5=#A\,:/=ZE#9>#!#:(+73X'@9-4:[R)&A",Z%F&PEBV1@
M'H&A_L0^ M'\#^*- >]UJ_U/Q!KB^(I_%5Q+;IK-OJ"L&CG@N(X4\MHW,C)A
M>//E[.17IOPZ^&-UX NKR>Z\;>)O&3W%K:V<8\0S6[+;I 92"BPPQ#>YE^>1
M@S-LCR?E%5/AE^T-\./C-J&J6'@KQCIGB#4--EDCN+6WD*RXC95:5%8 R0Y=
M )D#1DL,,:I6_P"U%\(KNXN8X/B3X8N$M;-M0N+B'5(7AMX!-%#ODD#%8\R3
MQ* Q!8N-N>< &9\<_P!E?P=^T)XC\+ZQXHDU!&T%F!L[)XE@U&%I8I?(N@T;
M-)$'@4A59?O-W/$OQ,_9KTGXB?$33_'-IXH\3>"O%-KI<VC/J'AF[CB:YM)&
M9O*E6:*5"%9W884$,5;.8XRLDG[6/PB6Z\8P#Q[I$DOA*V6\U<1S%A%&VT Q
ML!B8[G2,K$7(=T3&]@I[SP)X\T#XG>$M,\3^%]3AUC0M1B\VVO(#\KC)!!!P
M58$$%6 92"" 010!XKJG["OPRU7]GRR^#_DW]IX=MKM=174+>2-=0>[!(-P\
MACVM(49HR60@(0H"[5QO:U^R_8:IXP\/>,+?QUXQTKQGI&FR:2_B"SNK9I[^
MW>5I2EQ'+;O RJ[NP58E )7C]W'LV_&W[3WPK^&_C2T\)>)?'FBZ/X@N2P%G
M<7('V?"+(/M#_=M]R.I7SF3?GY<UN^-OC%X(^&JZF?$WBG2]'FTW3?[8NK:X
MN5^T)9^9Y8F$(^=E,A$8VJ=SD*,L0* //O$'[)ND>(]-\"F[\<>-?^$E\&WM
MU>Z7XN_M.-]5_P!)8M-#(SQ-%)$P*IL,7W$5/NEPUW]GW]E?PU^SEJGBW4M#
MUOQ#K>H>*'MYM2N?$%XES))+$93Y@81JQ9VGD9RQ;)/&*]<U/5+30],N]2U"
M[AT_3[2)I[BZNI%BBAB5=S.[D@*J@$DDX !KSCX;_M/?"KXN6^JS>%?'&E:@
MFEK++>))(UM)#%%M,DY28(WDCS$S,!LR<;LT >>>,_V#_!WC5?'%H?%OC71O
M#OC+5/[:U?PYIVI0BPEON6,ZK)"[J6D(D*[]I9(\KB-%7H_BA^R;I'Q>L[K2
M?$/C7Q?+X4NKRSO)O#,5Y EBQ@CCC$8/D><L;^4&9%E"[V9P QS72_##]I3X
M9?&;Q+KGA_P7XNLM?U?1B?MEM;K(ORARADB9E"S1A@!YD19?F3GYUR[XQ?M)
M?#7X!QVK>._%MEH4UT1Y%GB2XNG4A\2>1"KR>7E&'F;=H( SD@4 6?C?\#?#
M/[07P[N_!GBJ.<Z;</%*MS:E!<V[QNK!XG=7VL0"I..5=AWKSM/V,= O/%/B
MKQ)K7CCQEXEUGQ)X:N?"=S<ZI<VF(;&954B%(K9%C==N1QMW,Q926-5O''[<
MG@'P/\<O!WP_DU+29=/UNQDU"_\ $TFL0Q6FF1F!IK8-P0YF 4C+)\LL3#=O
MKN?&'[4_PF\ _$2'P1XB\=:3H_B:2/S&M;N4I' -A<":;'E0LR@$+(ZEMR8!
MW+EZ@8'P^_8]\'_#=OA/_9NIZY./AK_:QT@74T+&?^T=_G_:-L0W;=YV[-F,
M#.ZK/BS]EG2]>^)'B;QQH_C/Q?X'UOQ/IR:;K'_".WL"17BH@C20K-!*8Y5C
M5562)D*A25VL[EJ$W[8'@Z']I>+X2'4-(WOIOFMK#:O$,:E]J-N--\G;_KS@
M-M+AN<!>03W&H?M!?#C2?BA'\.K[QEI=GXRDBCE72IYMC?O'58X]Y&SSG+KM
MAW>80P(7!!I <UK?[+^FZGXI\(^*;+QMXQT/Q?X=T-= &OV=]#)<:C:C! O$
MGADBF;?ND+>6,N^X\JFV=OV9](_X3[P'XW3Q3XJ@\5^%='BT%]134%=M:LT(
M/EWZR1L)=S[W9E",6?=G*(5S?VGOVEO"?P9\):_H[^,++0_']WX?U&^T*U<+
M(_G0VTCQ,P96C3<Z;4$N!(RE5#$$4S]B+XD^)/B_^S#X/\6^+-2;5_$&H->F
MYN_(BAW^7>SQ)\D2*HPB*.%[>O- %K2?V6M+\+^--?USP]XU\9Z!I^O:Q#KN
MH>'+/4(&TZ:Y2599"HE@>6-9F4^:L<B[U8K]T*JXWBO]BOPQXDUWXD:A8^*O
M%/A2W^(7DCQ#IOAZ2RM[>Y\M&7@M:M(N_?(TF'_>&1]VX,176^ OBVJMXB_X
M3+Q?X*9?^$MN-!T=]$OF"@#:8+&Y,IQ]O W[XT/I@5O_  Q^-W@7XS_VW_PA
M/B6RU\Z->-87WV4L#%*,D$9 WQMAMLB91]K;6.TX &#X.Z.OP.'PL^TWW_"/
M_P#"/?\ "-&XWH;K[-]F^SEMVS;YA3G.S&?X<<5Y5X7_ &$_!OA,^"K6#Q1X
MRO?#?A#4(]7TOPS>ZG&^G+>HJ_Z0RK$'+&13-MW[ \DNU%61T;8^*W[8'@OX
M3_&?P9X U/4]'0ZNUX-7U"ZUB*W_ +!\JW2:#[1&1_RWW@+N9.Q&[.*XKP_^
MUEIG@O\ :,^-?ASXE>.M.T7PWI%WHEKX=M=0,,)5KB!C/M*H)'4.\)=G++&"
M"2BT]0,K1_AB/B+_ ,%%;OXC6OA'7-%T/PGH'V277+NP-C!JVJMYEN&C\U=U
MS&+>1T\Q  #;Q_.4*;_HCXV?!_1OCS\,]:\#:_<WMII6J&'SIK!U29?*GCF7
M:65EQNC4'CH3T/-0^/\ ]H#X=_"WPKI_B/Q-XMTVPT?4H5N=/FCE^TO?1G8=
M]O'$&>=0)$8M&K *P8D#FNO\.^)=*\7:/;:QH>IVFLZ3=*7@OK"=)H95!()5
MU)! ((X[@T@/)]!_99T32OBMX4^(U_XI\3>(O%?AW1FT."ZU:XMF%S 6G8-.
M(X$WR 7##<",A$SD[BV!=?L-^!KKP+K/A@:QXFMDU'Q:_C2+5+6_2"]T[4F"
MKOMW2-0 %4@;U<C<Q!W;67N?&'[4'PI\!K:'7/'NBV0N=7?05'VD.8KV/;YL
M4H7/E>7O3S&DVK'O3>5W#.IX1^.O@#QYXZ\0>#?#WBK3]6\3:"JOJ&GV\A+1
MJP&2C8VRA255S&6V,P5]K$"@"?X>_#NZ\"76M7%YXR\2>+[K5'CD9]?F@*6^
MQ-N(8H(8HX@PY(5.2,G)S7%^(/V8;3Q9XHT35=:\>^,=5L-%\0?\))8Z%=7-
MJ;*&Z$SS(,BW$[1QLY"(TI"J HX&*V?!?[3GPK^(_C.Z\*^&O'>BZSKUOM)M
M;:Y4^<"C29@?[L^U48MY3-LQ\V*JZM^UE\&M#UF#2KWXF^&8-0FGDMC#_:4;
M>3)&K,XF8'$( 1AF0J-V%'S$ @&)J_[(/@W6?AC\2O UUJ.N?V3X^\13>)=3
MFCGB$\-U)-#,R0-Y6U8PUNF ZL<%LL<YK(U#]A_PO=-XUCL/&'B[0]/\8V-K
MI^MZ?I=Q9PQW4=O;?9XSO^S&121N9PKA9"[APRL5KNOB5^U!\+?@_P"*M)\.
M>,/&NG:'K>IL!!:S%WV LJAYV0%8$)88>4HN QSA6QJ_$3X[?#[X4:?HU_XL
M\7:7HEGK4J1:?-<3@BYW%!O3&<QC>A:3[BA@S$#FGJ!B^!/V;_#?P[\;^&_%
M.G7VK3ZAH?@VW\#V\=U+$T3V,,BR)(X6,$S%D&6!"X)^45E:M^RU8R>*O%NM
M^'?'OC+P)_PE):35-/\ #-U:PVDDS($DN426WD\FX<*NZ:,JY(SG/-=U8_&;
MP!JGA34/%%IXW\/7/AK3YOLUWK,>J0M9V\OR?(\V_8K?O(^"?XU]16-X/_:2
M^&7CKP#=>-M(\;:4_A>U=8[K4+N<6JVK,_EHLRS;6B+,1MW@;MRXR"*0%"Z_
M9M\.W6K?%[49M0U8S_$[38-,UC;+$%@BAM)+5#;CR_E8QR,27+C< < <5PFE
M_L%^!?#^C?#JUT37_%&A:OX$:X_LOQ!I]S;)J$L<UP\[0W#FW*2Q!Y) $*;=
MLC@@[VW=S)^UG\(8;SQE;-X_T<3>$+=;K5U$I80QDA1Y9 Q,=[)&5B+D2.D9
M =E4] OQT\!R?"<?$T>)K-O WV7[8-7!8H8\[2NP#?YF_P"3RMN_>-FW=Q0!
MY#KW_!/_ .'WB3X.I\.[_7/%<UG)XBD\4WNLRZC'-J5_?O&\323221,IRC@?
M*BYV*3EBQ;7\<_L6^&?&7B#Q]J=IXM\6^$HO'<4,/B#3_#MU:P6]X(UVY.^W
M=E+C=OVL-^]PV0[ ^BZ'\?/AWXC^'K^.K'QGH[^$8BJSZM)>)%#;.^S;',6(
M\F0^;'^[DVN"Z@@'BLO1?VHOA+XBDU]=-^(OAV[&@HDNH2)J40CAC;RQYN\M
MM>,&6-3(A*AFVYW<4 8$_P"R1X570? -EI6N>(_#FK^"K>*RTWQ%H]W%#?S6
MJ%3]FN28C'-"SHK,C1XR#C =PT?BG]D7P[XZU;X;:KXB\5>*M9U7P'K%QK=C
M?7-U;F6[GFNH[DK<8@ ,:M"B(D8C"Q@*. ,7OV6_VF=%_:>\ OK^G16NEZC!
M.T=WHL=^MU<6B>8ZQ-+A5*^8L;$ KC@X) S6]\1/VCOAI\)[76)O%7C32M+;
M1Y8(;^U\_P ZZ@>==T*FWCW2EG0%P I.U6;&U20 ;_@+X?\ _""0Z^@\0ZYX
M@_M?5;C5=VN7GVG[%YH4?9K?@>7;IM^2/G;N;DYKS36?V/?!^N?"_P")?@2;
M4]<32?'WB&7Q+J<T<\(GAN9)H9F2 F(JL>ZW0896."WS9Y'HEY\8? VEV.D7
ME[XNT6TM-6M9K[3YIK^)8[NWBC\V:6)BV'2./YV920J\G KFO%'[5'PG\$Z3
MX7U+7?'.EZ9;>)HK6YTI9V82RV]PI:&X>/;OBA.#F61512,,P/% ';^.O!]K
MX_\  >O^%-2FGBL-;TVXTNXFM2%E6.:)HW9"00& 8XR",XX/2O*/$7['O@_Q
M/'\&%O-3UQ1\*6@.B>3/ OV@0FVV"YS$=W%I'G9Y?5^F1CTN[^+'@O3Y/#B7
M?BS1;5_$JHVB>=J$*C4]^S9]F.[$V[S(\;"<[TQ]X4S3_BUX+U374T2S\6:/
M<ZO+>7.G1V4=]&TKW5NH:X@50V3)$I5G0<J&4G (H \(F_X)Y>!)AX@T]?%'
MC"T\&Z[KJZ]?>#-/OH+;2))5D+B(1I '2+!"XC=3B.+G,:%?I#Q1X9T[QCX8
MU7P_JUO]JTG5+2:QN[?>Z>9#(A1TW(P895B,J0?0BDT_Q1H^L:YJ^C66JV=W
MJVD&(:C803J\UIYJ%XO-0'*;URPW=1R*X_XF_M%?#;X-ZEI6G>,_&.EZ#J&I
M2QQP6MQ*6DP[LBRNJ@F*'<C@S.%C!4@L* .;^&_[)7@OX>_"7Q!\.+FYU;QE
MX:UR;S;L>)KA+B;:+>"WC1'1$VK&EM#Y>!E"BE2-J[<OX:_L<>&OAOXN\&Z^
MWBWQEXJD\'Z=-IN@6?B#4XY;?3XY05=XTCBCRWEL8_F) 0(,?NX]G50?%;_A
M'_&_Q)/BWQ7X+L/"/A\:8;=8M0\N_P!.^T1G?_:7F,(XO,D*>3@_,OOBMW_A
M=?@;^S?$NHR^*M+MM-\-ZD=)U6^N;E8K>VO D3- 9&(4N/.C4J"<.2A^8$!Z
M@<*O[)GANUD^*,-EX@\1V>B?$9;J36-#6YB>TAN;A=LMU;;XB\4S#=G+,IW
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MS]EWPIXN^$WA+P#-?ZW81>$[>UAT;7],O1;:K9F")81(LRKMW/&"K IM.[(
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MA6NM>']6L];TBZW&"^TZX2>&3:Q5MKJ2IPRLIYX((ZBMF@#YQT/]AOP3X?\
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M_!?:?_)5'_#WWX-?]"[XX_\ !?:?_)5%@/N.BOAS_A[[\&O^A=\<?^"^T_\
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MX!^/WAK1O"?[17Q8M=%TJQTBU;]G;4LPV%ND*'9<-#'PH ^6***,>BQHHX
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MMY+A@TC10Q+&A<@ %MJC. .>U=!0!^9G[5F-W[='IM\"?^T:L?&;X<Z7X1^
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M)\./B<-=%F/!T-["-+^R;_M?VB%XL^;Y@\O;OSC8V<=J!'YR_%C4D\4?!O\
M:D\6^'6N)/AYJWCG36TN1I]\$UXLDCWD\<9=L>89(&W8&X%!_!M7U?X@>(M/
M^-W[2WAI?V?=1\RYTOX8ZG:RS^'[P6$4$+VLZ6%J%+((GCN9H#Y95?+9HR<&
M/Y/L7]J/X"G]I3X17O@;^W?^$=^TW,$_V_[)]JV^6^[;L\Q.N,?>KUR-?+C1
M/08JK@?E/X9\3>%?&GP/_9G^'?A9_(^*WAWQ["UUIWV"2;4-+5+B66]E92O$
M09X9F!8 B(Y \IPG-^)L_P#"#?M]\9/_  E.FG_RMW%?K]14C/@?QM8VW@__
M (*>? S1M'B&FZ5#X)>R2SMB53R(XM3*18SRJ^6F >Z*>U>*^&]<M+?_ ();
M_$_P=-(]MXHT'5XTU32+B%X[BR8ZK;%5E1E&PD[@,]2C@<HP'ZQ44 ?',?PQ
M\(P_\%%-/LX_#&DPV<'PJ\V."&RC2(,+TV@.T#'%L?(Y'^KPGW0!7RI\(Y+W
M1?@K^S1XOO-4T_1?#&@>)-?M[G6-<L6U*PTZXF.ZT>2U65&/[U)"LBLHB<AB
MPXS^N-% 'Y$?M=>&;'3_ -GKQEK^D?%#2_B-I^O?$JTO+J/0M+-I866H/IUU
M+<&)O/E\WS$E@)PY"E",[MP'V1INC:=HW_!2)WLK&WLFN_A4)[EK>)4,TBZD
MD0=\#YF$<<:9/\**.@ KZOHH ^2_^"9OB[1]6_99\.>'[/4[:?6]%DO/[2L(
MY09K7SKZXDB,BYRH=#N4D8.#CH:X+7O&'PX^%O[6/[3,WQ42WM+?7_#.G/IR
M7:&*;4[!; Q7MO:S,5RTCK&GEJX+-&,?ZLE?O&B@#\I;[2M<T;X??L'6_B#[
M0+YO$_VB+[3/YS_99-1M9+7YLG \AXL+G*#"D#;@?H'^U)XYOOAO^S[XY\1:
M?X;M_%UQ9:>V[1[N(R6\T3LL<K3( 2T*1N\CKP"B,"RC+#U>B@1^:OP_\3:G
MKW[=WP-UR#XFS?$^QU?P[>VUUXCL[*&PMI"L-U<&P:*!5"F$/:R-#*6D5Y$9
MMN55>>^'_AG2;3]D3]E/68]*M(-6F^+5H9;];=5G?=?W2,6?&[YDMX >>1#'
MG[BX_4NB@9\N?\% /%%ZOP=TGP!HUS;V_B+XAZU9^&K.22_>W:))9%,LI"*7
M>$@+#)MZ+<#.<[6\DTF'XI_ O]K;X3>(?B9;^!=.T#Q'I3^ +;_A"[2]^RV2
M(PFM8L2)B*22<QQJ 2NQ'X79N'W]10!^//AGQ?\ #^X_X)SWWP[M[">/XGZS
MK<=YIVFW%A++/JMT^H>4ES8\,"OD026Y>,KAXY$/S2#S/IS1_'7PY^'O[7W[
M3-[\0CI]K:7&D:':1SZA:[TFA;309[-'*X+3!4(MP=TOE$A6\L[?IG]FKX+_
M /#/7P;T/P'_ &Q_;_\ 9;W+?VA]E^S>9YMS+-_J][XQYFW[QSMSQG 7P)\%
MSX)^-GQ/^(/]L_;/^$V72U_L[[+Y?V/[';M#_K-Y\S?NW?=7;C'/6JU$?GK\
M+[.Y^&4?['OC#XARR:=\/K7^V8MNIV!6VL+JXFN9;2XDE((7SE>V9-V JVYD
M!VABM/6%U+7?V6?VN_&=C)=2?#WQ/XKM[WP[))&\,%P#JP\VXBC<!@&5H$+%
M1S$5ZHP7]9J*D9\#^$=*L]4_X**?M"1WEO'=12>";>!XIAN1HWL[ .C*>"K8
M&<BO)O#=Q'H_[&_[)FLWTB6>DZ;\2EGN[R9PD=O&NI7;M([$\*$1F+'@ '-?
MJC10!^??CCQ%;:=^U%\2=0UKQUX3\*^&?B#X=TZ#PWKGB?1CJUIJ.F&T*W4=
MM<K=11P(9"':-V/F[XV"]"W,W&BW_P #_&GP \3WOQ,MK[P&OA273-!\<>(=
M"N[FPM[NYG>6,O:BZB^S%[.2.(2.Y^2%MRA4W1_I510!\N_LJ:MX*^$^BZ;X
M8MOB/9^+&\>>(=8OO#D6DZ1/9Z>GDX-U;6B;Y4BA1TD=<N%8293=G<WU%110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 9'B;Q1H_@W1;C5_$&K6.AZ3;E1-?:E<I;P1EF"J&D<A1EF
M51D\D@=ZK^$_''AWQ[I\M_X8U_2_$=E%*8)+K2;V.ZC24*K%"T;$!@KJ<$YP
MR^M>+_MKK%;?#WP?JBWI76=)\9:1J6CZ/YK1C7;Z.8F/3]RHY#2@MM8J55T1
MFPJDBA^S+=:AKWQN^-.O^(])A\)>++XZ/'>>%$4SRV5M%#.MM<2WBJ(;AYP9
M3B(L(EA1"Q;(4$?2U%%% S#M_&>@W7AVX\0P:[ILWA^W2:2;58[N-K6-8F99
M6:4-M 0HX;)^4JV<8J_I.J6>N:;:ZEIUW!?Z?=Q+/;75K*LL4\3J&21'!(96
M!!!!P00:^1_ /_*-GQ]_V!_&7_I9J-5?A3KOCO7H_@E\/O#/C1O!VD7/PALM
M9GN(=*M[R<31FSB5HS,"JMAPIW!UV%QM#%9$!'U7KWC_ $/PWXJ\-^'=0O3;
MZQXCDN(M+M_)D;[0T$)FE&X*57;&K-\Q&<8&2<5TE?$7P]^(7B'XI>(_V2O$
M7BJ:VN?$$NI^*;2\N+2'RHYGMK2[MO,"YP"XA#'  RQPJC '/^%_VXF\7Z]I
M.MZ;\36>YU/Q.FGQ^ IO",OV8:2]]';I)]L5,BZ6#?<,YF:,EM@B&.78#[]H
MKYF^&/Q<U+QA\:M=T/6?B.VB^)-)UZ^@7X=7.CPV<=]I:+<):R023+Y\\CB-
M+EIHI"@ *F)5(<M_92^+6I?%2^2YUWXF277BR*RN1K_PYO-'@TY])NC+ ZF&
M-D%T(H%9H2TCRK(9 =R,I6D,^FZ*\>_:)UOQSIZ_#W2/ &KV>AZQXB\2_P!E
M7%[?V@N8X[4Z=?32R!,<R)Y"R(,@%XT5CL9@?%_$7QT^*/@_1_C#X/M-3MO$
M?C#P/K?AQ-)UR\MH8FU*WU6]AV6US"BK&"B-)"98_+WJP8+$PW$$?9-9.K^)
M--T'4-%LKVY\BXUF[:PL(]C-YTZV\UP4R 0N(K>5LM@?)C.2 ? KZZ^+FM_$
M^V^%]IXX72SIFAR>)-8\;6.C6OFSRW-U<PV-A':3>8D<48B9FDR[NL 4NC$N
MW+WWCWQ-\9M%\ 6.G>)M-TOQYH?Q,UKPO>ZS#H[M;VT]MI>L()DMI)2"[6QB
MD ,CHKR<[@I2@#ZKU?6K+P_:+=:C=QV<#30VZR3.%#2RR+%$@)/WGD=% [E@
M!5;1_%&G:]J&NV-C/YUWHMXMA?QE&7R9F@AN N2/FS%<1-E<CYL=00/!M,\>
M^/M \(^+-,UOQ#'JFL^'OB1H_AZ#6$M85FNM-O+O2Y LZB-8_-^SZ@\3-'&@
M^4%1GYCD36OQ0U+XA?'MO 6IVVAR:3KMIJ-EY]K%=)K5X-&TLM8SAR## 8XP
MI9"KEKE&#J(660 ^C_\ A+]$_P"$M'A;^U;3_A)/L7]I_P!E><OVG[+YGE^?
ML^]LW_+NQC/%;5?(=E\7OB#\:OC%H?AGPSXM;P!I_B/X3:?XQM_*TZVU#[#>
MS:A'O8&6,&3,):'#87YMVT-7G>D?&;6_@!^SW\ O#_B#XFWNGP^-;.VO$\10
M^&H+A]"T>WT^WD-E#$BOYLS.\,*S212X661F7*"@#] *Y70?B1X<\4>-?%/A
M'3-1-SXA\,_9?[6L_(E7[+]HC,D'SE0C;D!/R,<8YP:^8/"7[0'CWXF>!=&T
M3P?XVTG4M7U+QH/"T'C:X\/36;2V*:0U]/=_8I?E%RK)(@!41,5!VJIXV/V8
M-/U/2_VM_P!IRUU?4_[;OX1X85KYH%A>9183!&=4 7S-FW<R*JLP8JB A% /
MIJZ\3:;:^)K#P_+<;-7OK2XO[:W\MCYD$#P),^X#:-K7, P3D[^ <'&O7A/Q
M=M/$FI_M$?#33O#-^-&FNO#OB".]U811RS65J+G2&>2&.0%&E9E2-2ZLJF3>
M5<(4;S[PQ\=OB'X>\9>"M,\;:QI']G:?XSOOAWKMXEML?6;F2QBNM*OHXU!^
MSN_"21JY0-.>,8\H ^MZY;0_B1X<\3^-O%7A'3-1-SXA\,_9?[7M/)D7[-]I
MB,L'SE0K;D!/R,<=\&N,_9O\<:Y\2_"OB3Q5J>LV&L:-J'B34T\.MIT8$<6F
M6]PUK""P'[PNT$DN[)R)1C PJ^3_  QOO[+_ &JOVO;S^UK'0C;V?AN4:MJB
MAK6SVZ7*1-*"Z9C0_,077@'YAUH ^M**^'M+^-OQ(UJW\6>&/"7CO6/&<USX
M"G\6^'?$UUX..FW\EY;M;+Y$$,MHD%S;3F0,C(CL!,5WDA'/8P?M(:WX@^,'
MPHU"WUZST/X>^(-,TE;W2+JWB9Y+[5+'4[F!&N2?DD1K*T01*/G-V/5<@SZP
MHKR?]FGQ;K/Q"^&\GB[5K^]O;;7]6U#4-&BOK&.U>VTHW,BV,85%!93 D<@=
M\L?-ZD8KR[7OB5\1?B5#\7O$_@'QI;Z-I?P[U2\TJQT(:%%-_:UY90VL]PEW
M-*^[RW<W%NOD^25#+(7;&""/JFBOEWPA\8/'WQ@^,7A#3]$U*V\+>%M5\!Z'
MXVOH'M4O9HVENIO-LXY"$_UT>U&E93M$.416?</0/VG_ !]KOPJ^'NG^--*U
M'[#I6AZY87'B&+[$+E[G27F$-S&@P2K*)5DW+R!$?4T >Q45\J>.OVC/%>A^
M-O&MKI^H:3'IEQXN\._#_P +S-;?;(X=2N$6?4)YT5XV8I%<!0OF ;K<# )?
M.?XJ^*7Q-^#=Y\3/!>L>*CXOO[7X;7WC71O%$VG6UK/9W5NAAEMVAC3RI8_-
MV3(60%0[(WFX!#L!]=UEZYXBTWPS8F^U6\AL+,2Q0>?<2*B>9)(L4:Y)ZL[J
MH]2P'6O+O^$\\0+\6/@_HWV__B6Z]X;U2_U*#R8_W\\*Z>8WW;=RX-Q+PI .
M[D<"ND^-'B35/"?A/3;[2[LV=Q)XBT.QD81H^Z&YU:TMYD(92/FBF=<@ C.0
M00#2 ]!HKY-^)'CGXKKK7Q[UK1O&UKHOA[X;K%?Z;I?]DPW+7[+IEK>SVURS
M*&$#*)%4QLLH:Y8E]L:H;WCCXU:]#\?=#\-ZQXS?X5>&[NPL[C0I)=-AN8/$
MUR[>9<Q274L92$1I'Y(A4QR,UPKAS\B$ ^HMPWE<\@9([\__ *J=7S7X+\#^
M/+7]L/QIJ%Y\2Y+_ $2+1M-NY=&_L.UC$UI-<ZPMK:&8?,!;L&;S!\TF[#=*
M\KL_BM\;_#_PO^!7C+Q)X]LKR?XA>+_"^GOINGZ-!'%#I]Q#,TRM(R%FDN%\
MJ1RH41L&6/"T ?=%%?*&H_M!^.M+^+?[0NAZ>UCJY\.W7A/3/"^GZD!;VMM<
MZH$A9YI8X_,=!+,DA4DDA"JE<Y''_MX>!_'7A_\ 8Q\7?VY\2[GQ3% ^DS7P
MNM'M('NW^UI'+$IA5!'"9'MY47!D4PNK22+)A #[?HKFOA]H>O>&_!VG:?XF
M\2MXPUR'?]HUI[&*R-QF1F7,,7R+M4JO'7;GJ:^8-0^,WQ.UKX/ZU\?O"?BJ
MSUWPGI=]>7-GX,@TF.VM]0T>UO;JWFDEN9BTZSM B7"NI55,6PP/NH ^P'E6
M/<2P^5=S>N.><?@?RK,\*^)M.\9>&])\0:/<?;-(U6TAOK.XV,GFP2H)(WVL
M PRK X8 C/-?/7A#P3X\MOVNO'6HWOQ(DO=%BT/3[J?1?[$MD6:UFGU@6MH9
MA\X%NP9O,'S2;L-P*YG]GN]^)'@C0_V<&O?&%GK?@_Q;H\.F2:#_ &7';KIR
M)HGVJU:!QF1Y!]DD$CR2%6\[Y8DP-H!]A45\"_#S]N*?Q]XFT/5]-^(;S7WB
M#Q-'ID/PYO/"SK!;:;+?PVL;K?(O_'TL(DN&=IGB)D*"-=@SO6WQB^,VL_#_
M /:#\9Z;XNT]XOA]XIUG3].TBZTJ%1+;65S:W#B28#) M$N(54(&)F9FD)V&
M-V&?;E9DFOZ?#KMOHKW<(U:XMI+N*S+CS7AC9%>0+G)56DC4GU=?6OG@_M#Z
MI'^TRZ7-ZMO\&ETIM)_M1I+,V7]M"R35S<&?=Y@@_LYC\Y/EY4\?Q5F?"7XO
M?%'4+/P+<ZS);>*-8USX?:QXM70[-(K**ZN3=V<EA )67,6V"Z$.22!DLV\C
M=2$?5M%?&G@C]J2]T']GOXE_$37OB GB+Q;H=A']N\(W^ABP'AW6'9PEF8@J
M7#P>;/;V^Z1F)-M(1)DLJ:?P!_:8@\9_&C3O"]E\3KCXCZ9JVCSW,XN_"TFE
M/IVH0M$VV)_*C!MY4><A'$CIY"YE;=R#/KBBL7Q=9ZMJ7A76;70=1CT?7)K.
M:*QU&2$3+:W#(1'*4/#A6(;:>#C!KY9TW]K'Q%?^!OA5KZ1^=Y'A;6_$WCBT
M>.."\;^S+<VTL*1,/D#W[G!&TX@/\.\4"/L"BOC[2?C'\2/!>C?!/X@>)O%E
MMXET;XFZIIFEW/AJWT:*UBTQM1MVE@>UE#&3$3*JOYK2>8"V-AQ6CK'QO\:V
MGP%^)GB2+6L:UH_Q%FT&QN?LL)\JR778+41;=FUL0NR[F!;G.<\T ?6%4M4U
M2ST/2[K4M1NX+"PLXGN+FZNY5CB@C12SN[L<*J@$EB<  FO$O _BSQ_XR_:2
M^(VB-KMK9>"/"&I66VS%@CW%\MSI,3FW\W(,<<<S>=NVL[EPNY47:8_VTO%U
MGH?PAM_#E]JZ^'[7QKJ]IX9N-6DFMX8K.TF<O>R2/.0BK]DBN5!Y.YT &3D
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M?^'S ]O8W\4TQNI+ (GGS6HM[F/:L<2R;(FV'+ NP'Z!RR+!&\CL%11N9CT
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M_&GA?PGJ>H&V\0>)S<C2+/R)7^T_9HQ+/\ZJ43:C _.5SVS7'^$_^3GOB/\
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M[J6Y^SSRRVMM$DPC)+2+"ZE\0D*\FX&@9]AT5\"V?[7VK-X;^+6F>'/B3?\
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MYXFT?QAHUOK&@ZI9ZUI-R&,&H:=.EQ!* Q5BLB$J0&4@X/4&@#RSP3^S?9>
M?C%H7C/3=;E?3M&\!V_@2VTB>W!D\J&X69+AI@P!;:H4H(QZY'2N?T/]F/Q%
MHGP]^'NFOXZL;CQC\/KA?^$<\3_\([&HCLO*$#V-Q 9B98WA+QEHY(G.V%L[
MT+/[3X?\>>&O%FJ:MIVA^(M)UC4-(F^S:C:Z?>Q3RV4H9E\N9$8F-LHXVL <
MJWH:3POX\\->-H5G\.^(=*UZ)H5N1)I=]%<J8FDDC63*,?D+P3*&Z$Q..JG
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M=C.JL\#O&LV-Q**:U?A/^S_9?#G2_B9INHWT7B73_&_BC4O$-Q:SV8CCCCO
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M8:,#<-ZY'(KK9)%C0N[!$49+,0 /?- $4\\=C;/-/(D,,2%GD8A550,DDGH
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M]YJ7Q \+Z+X4B\3ZCXETC3_#,T<4\6LW5_%'921R8\MUF9MA5]R[2#SN&.U
M'AOA']DO6_ /PST#P7H'C];.#PCK;:SX5U Z-NN+??)=^=#??O\ ;=*\5Y)'
MF-;?U^G7>.O@;KWQ:\!KI?C#Q78_\)1INKPZYX>U[0=':U32;V!5-O*;>:XG
M$X5_,W*[8992HV$!AH?&']IKP'\%_ADGCG5-7@U72;A(Y+"#1[JWFN-35Y(T
M+6JM(JS!1*KL5;A<FO0?#?B;2/&6C6VK:#JMCK>DW(8P7^G7"7$$N&*L5="5
M.&4C@]0?2@#Q[XH?!'QE\6OA/\1O"?C'Q/HGB!==TB.WTJTL-'FTNVLKR%I)
M4N)&^T3RR%I?LQ(!V@0 ;#N;<_QW\/?&?[0WPMTW3-0U2Q\$:!XDT>S&O>'[
MG0Q>ZA:NQ$EQ%!<22K'')@B,,]NY1DWKAL8]2\-_$+PMXQU+4K'0/$VD:W?:
M;)Y5[:Z;?Q7$MJ^67;*J,2ARCC# '*-Z&B'X@>%[G3[O4(/$FDS:?:6$>J7%
MU'?Q-%#9R*[QW+ONPL++&["0G:0C$'@T >?>$_ 5SJ/[3'C;Q[J>C+8KIFCV
M/A/1;V2>0R7<(WWMU,$VJ@1I+F"($%SNM)>5R0>Q^+G@";XG> [_ $"VUB?P
M_?O-;7MEJUO$DS6EU;7$=S;RF-QMD5988R4/W@",C.1M^&?%6B^--'@U?P_J
M]AKFE7 ;R;[3;I+B"0*Q1MKH2IPRLIP>JD=JXW1?B]I\?B[QCI'B/5M(T5=/
M\26^@:.MS<K;R7K2Z;972Q@._P"\E,EU( J $JJC!()(!YU?_L=6FI:K\#KM
M_$DENOPYT^"QO39VGD2:\MN;66V25@_R1)<VJS>60XR2!@_-5;XK?L;M\3H?
MCC&?%PTS_A9C:(P/]FF;^SO[.$7!_?+YOF>7_L;=W\5>^W_B[0M+O/L=[K>G
MV=WFV'V>XNXT?-Q(T5N-I;/[V1'1/[[(P&2"*K6OQ&\*7OBZZ\*VWB?1KCQ1
M;+YEQHD6H0M>PKA3N> -O48=#DC^)?44 5-(\!MI?Q/\1^+S?>8=8TK3M-^Q
M>5CR?LDEV^_?N^;?]KQC:,>7U.>,#Q[\&#XX^,WPN\?'6/L7_"#MJA_L_P"S
M;_MOVRV6#_6;QY>S;N^ZV<XXZUV4WC#0+*QUF\FUO38+/179-3N)+N,1V++&
MLC+.V<1$1NC8;&%=3T(J/7O'?AOPKJFDZ=K7B#2](U#5Y3!IMI?WL<$U[("H
M*0HS R,"Z#"@_?7UH \+M_V1[W2+36IM,\8P1:S<?$BX^(FGW-YHB7-O;RS)
MY;6LL#2_O5$;2 2(\3ABC+M9:WO!_P"S-]CU_P"+.K>,/$$?BBX^)=A;6&L6
M]G8MI\")##<6^(0)I&56AF1<%RP,;-N.["[6O_'72=!^(GA^WNM>T&V\":AX
M8O->?Q!<W:)!E+JQA@*W!D$?E.+MN3G<=F#V)\5?VGOA_P#!^P\&W^M:Y;3V
M7BO4+:RTZ>QN[=H_)G&1>NS2J/LB#:6F4D .O!R* .:\'_LJ3>&?V?;WP!)X
MXU&Z\3WE^NL2^-/)W7+ZA%=1W%M</%,\@;R_L]M&5+?.L1Y4MD>H> ]'\;:5
M->GQ?XFT?Q CQQ):II&B2:<(BN_S'??=3EV?<G3:!LZ?-7"?M0_'*\^$G[->
MO_$WP:^E:Y/:PV4]A+<%KBSN8Y[F",2 Q.N]3'*65E;!^4\BO3/#OCGP]XKN
MM4M-&U_2]8O-*F-MJ,-A>1S/9S L#',JL3&X*L-K8/RGTH J>+_!9\5:_P""
MM1^UBV'AO5I-5,?E[OM&ZQN[0)G(VX^U[]W/^KQCYLCQKXD?LJ:[XXM_BCH=
MCX]CT+P?X^G6^N]/CT8RWEM=BVBB+QW/V@ QR/;PM)&T9R@=%,>[>/8(OBUX
M)NHO$$EOXS\/RKX>)76&CU2!AIC99<7)W_N?F1Q\^.4;T->0_LM_M,_\+C^$
M>H_$3Q9XB\)Z+I?GR%],MY!%)H<:W$T:)>W$DY5F=%B=6\N'@DX.X$ '5^*/
M@ ?$M[\7[C^WA;?\+ \-V_A\+]CW?8/*@NHO.SY@\W/VK=MPF/+QGGCTOPOH
M3>&_"NE:-Y_V@V%E%:>?LV[]B!-VW)QG&<9/UJ"Q\<>'=3\/VNNV>OZ9>:)=
MO%%;:E#>1/;3/+*(8U20-M8O*RHH!Y8A1SQ5#6_BOX)\,Z'%K.K^,= TK2);
ME[2+4+[5((;=YT9U>)9&<*75HY%*@Y!1@>AH \5\&_LCZ[X-\$^&_ =M\0HQ
MX&\.:_!KNGVD>C,E],(M2%\MO=W'VDI,GWERD,1WB-^B&-Y/B-^R7K/C:S^*
M'A^P\=0Z%X,\?78U.\T^/1FFO+:\$$*%X[DW !C>6")WC:/E=Z*4W;Q]"ZEJ
MUEHNE76J7]W;V6G6L+7-Q=W,JQPPQ(I9I'<G"JJ@DL3@ $U\]:A^V-H/BSP7
MX4\0> +_ $W4'U#QCIOAW4M/OIDDN;.WN+V2V:1XX93Y;.L3O$S'#+@X/2GJ
M!VNN_ _4KC]H72OBKHWB*VL+J'0%\-7NFW^FM=)/9B[%RS1.LT?E2DY7<PD7
MD';QSP7AW]B\Z#\%_A%X _X3 3_\(!XNA\4G4?[,V_;O+N;B?[/Y?G'RL_:-
MN_<WW,[><#WKPCX]\,>/]-FU#PQXCTGQ+I\,QMY+O2+^*ZB20*K%&>-B P#*
M<$YP0>]+X-\>>&?B#8S7WA;Q'I7B6R@E,$MUI%]%=Q)( "49HV8!@&4X)S@B
MD!XMXG_9?\1ZSHOCGPGIWQ%DTKP'XPU6;4[^S.FO+J5LMQ*LMY;VMU]H$<<4
MK>;\K0/CSY/O9S7<^ ?@F? _QH^)_C[^V1>CQLNEH-/^R^7]B^Q6[P?ZS>?,
MW[MWW5VXQ\W6N)^)W[7-G\+OVGO!7PDU'P^SV?B6T@N/[?6Z<_9I9YIX(8C;
MK"V0TT4:;RX \X$X"\W_ (Z_M26WP7^*'PU\%1Z''KU]XOU".TG*ZBL#Z;#)
M<V]NEPT>QBZL\Y 'RY\MN>N'J!@^%?V2]8\!_!'X9>"/#_CNW@U?P-K\FN6^
MM76B>;#=%VN]T+VWG@JK)>,I99,X4D8)!6D?[.^(W[<&F2Z1KQU6W\+^'A/K
M:Z8(9K2#4H9;RUMK>60;FCE$=_J3&$E2/+0G=@@?0%]\0/"^E>*+#PW>^)-(
ML_$=^IDM-(GOHDN[A 6&Z.$MO<91^5'\+>AHU7XA>%=#\36'AS4O$FD:?X@U
M!/,M-*NK^**[N%RPW1Q,P9QE6Y4'[I]*0'0L"RD X., _P!:^=?#O[+OB/0_
MAWX#T>3QY8W/BSP#>^=X;\1_\(ZBB*V,;0R6=S!YY,L;P.T9:.2)OEB8DLA+
M>A:=^T-X U;XJ7WP^M/$VES^)+.)'>"._MVWS%YT>U11)O-Q']G=GCVY560G
MKQ8\/_%73;+P-INN>-/$/A'1)KJVDOC/8:XDVG/;+*B+/%<2K%OCQ-;@MM #
M3*,G*D@%+X0_!D_#G7O&'B?5]7'B/QKXNNHKC5M4BM3:0>7"ACMK>&WWN(XX
MHSM!+,[$L69N M'QI\'/$%]\7(_B'X0\2Z7H6M2:%_8%U'K6@C4XVA6=IXGB
M9)H)(F#R2;AYC(X\O*9C4UW=]X]\,Z5X23Q5>>(]*L_##Q1SKK5Q?1)9&.0@
M1N)RVS:Q9<$'!W#'6G>'?'7AOQE)<)H'B'2M<DMHX)IUTV]CN#&DR>9"S!&.
M!(A#(3PRG(R* /%_#_[*^I> /A/\/O!_@SQK_9EWX*\0W.N6&IZII:WHFCF-
MZ#:S1B2/(,5ZT;2(RD[2RA"1MVI_V;TD^*_Q$\2-J]O<>&_B+IUMIWB?0+JR
MD>658+6:U7[-<QS1^2K1R+N#1R,2K;67<-OIOB#QYX8\):EI>GZWXCTG1K_5
MIOLVGVNH7L4$MY+E%\N%'8&1LR1C:H)^=?44:CX[\-Z/KB:+?>(=*LM:>&.X
M73KB^BCN3%+,((Y!&6W;7F98E;&"[!1R<4 <M\+?!?Q \%V=AIOB/QQIOBS2
MM/L!9PO_ &--!J$\B[ DUQ<O=RB1]JMNQ&NXOG/',&@_!5M$\(_"'1#J_GGP
M T+&86Y7[?Y>F7-AP-_[K/VGS.K?<V]]P[KQ)XHT;P?HEQK&NZO8Z)H]N%,V
MH:C=);V\>Y@JEI'(499E49/)('>JFG^/O#&L^'[37=/\2:3?:)=S);VVJ6U]
M%);32O*(4C20,59FE(C"@Y+':.: /GCXC?L;>(_&'PQ\3?#'1/B3:^&?AWJV
MJ2:G;Z6GAJ.:YLEDG^TO:"99XU-O]H+R*!&LBY5#(R*0WT-XX\&VGC_P+K_A
M34)IXK#6M.N-,N)+5PDJQRQM&Q1B& 8!C@E2,]0>E4=+^+W@36]*AU/3O&OA
MW4--FOTTJ*\MM5MY87O' *6RNK[3*P9<1@[CD<<UM_\ "4Z-_P ),/#G]L6'
M_"0FU^W_ -E?:4^U_9M^SSO*SN\O?\N[&,\9S0!XCX(_9M\3:+JGPKN->\>V
MVIV7PZB:UTS3M*T5[&&YA:QDM6-RK7,H:8!HF1U"!0)5V'S<IB^'_P!B]]#^
M"_PE^'__  F"SCP%XN@\4_VC_9I7[=Y5U//Y'E^<?*R)]N_<V-GW3GCWKQ%\
M1O"G@[5--T[7_$VCZ)J.J2>786FHZA%;S7;;E7;$CL&<[F484'EAZU8U_P 9
MZ#X7N--AUK7=-T>;4[A;.QCOKN.!KJ=L!8H@S NY)&%7).1Q0!X?XJ_98UO4
MM%^)WAG0/'<?AWPCX\N[O4+RU&DO<7UM<W$*K,([AKD+Y,DJ[GC,62DDB*R;
M@Z_12IMA5.N%VU\Y_LV_M&>(?B[\._A7KFN_\(GIVI>+'U9;NR_M"2TNG^R3
M2QI]@M7$C3X5%:7=(-@.[G.![9;_ ! \,7?BZY\*V_B329?$]K'YT^BQW\37
ML284AW@#;U7#H<D8PZ^HH \7\,_LO^(](T;P7X2U'XB/JW@+PCJL.I6%C_9C
MPZC.MO*\EG;W-T+@QRQQ,8N%@3/D1],9K0\1?LX:UK'B;XRW=MXRM;70_B5I
M7]GW.GS:,TLUC*M@;-9HYA<*&&,.R,G.T %>2?4)_B=X.L]'UG5I_%>B0:3H
MMTUAJ=])J,*PV-PK*K0SN6VQ2!G1=C$'+*,<BI9OB-X3AUJ;19?$VC)K$-Q!
M:R:>^H1"X6:9&DAB:/=N#R(CNJXRRJQ (!H XNX^ \5YXD^&>I7.J)/;^#M&
MOM'ELY+/*Z@MS#;Q%B=_R "#[I#9W]1CFI\+_A+X]^&=OX9\/I\1+'4_!&@%
MH(+&7PZJ:E/9K')';V\UT+CRSY8:(F1($9_(7.-SY[O2/B9X0\1:Q%I.E>*]
M%U+5);2/48[&SU&&:=[5PI2=45BQB8.I#XP=RX/(J8?$+PNVKV&F#Q)I#:GJ
M$MS#9V7V^+SKF2W9EN$C3=EVB9'5PH)0HP;&#0!Y/X%_99A\&_LG7/P3N==C
MU9)M/U&R&L2:>%56N99I4E\@R')C:8$#?R4!RO;!\6?L3Z5XR^''PW\+:IK[
MZA/X9U<:GJNI7ELTIUM9IS<7\$B>: B7$^V3DOL,:##8S7N_A/QYX:^(&F3:
MCX8\1:5XCT^&4P27FD7T5U"D@"L4+QL0& 93C.<,/6JVB_%3P9XF\/ZCKVC^
M+]"U70]-W_;=3L=3@FMK78F]_,D5BJ;4(8[B, @GCF@#F]>^%.K3?$K6?&F@
M^(X=&U.Z\/V>B6T<^G?:8H3!=37!D<>8F]7$QC* J0 2'!(QR%Q^S1JWB"'Q
M]J.N>-(H_&7BAM*>#5] T2*S@T]M-E$]F_DR/,TS"<%G:60[DVQKY845ZI:_
M%+P9??\ "0&U\6Z%<_\ ".AO[:$.I0-_9FW?N^TX?]SCRY,[\8V-Z&N:^ G[
M1'@W]H[P?'XA\)7X)!(N=*NI8?M]E^\DC3SXHY'\O?Y3,N3\RX(H VO >A^-
M]+O=0G\7^*]+\0Q2101VMKI.AOIT=NRF0R.Q>YG:0ONC'W@%\O@?,:Y_XB?"
MWQ)KGQ&\/>-O"/BNS\/ZQIFG7FERV^K:9-J5I<P7#P28$:W,/E.KVZDNO+9
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M?V4NIZE>:LXN)+B>2ZBCCTV!1<1>5</&S."WF$AXR(R.OH/Q,_:"\!_"/7M
MT?Q3XBT[2M0UBX\N.&YOH(6MX_*F<7,PD=66#,#1^8 1O95[G !Y;X@_8S;7
MO@]\8_ I\8>0?B'XIG\3?VA_9F[[!YD\$OD>7YW[W'D;=^Y?OYV\8/8ZY\'_
M !YI_BGQ9JO@/X@Z?X:M?$JPRW-KJGAU=0-I=QVRV_VFV=9X<%HXH<QRB5=T
M>>C,M:N@_&[1AXU\4Z'XCU[0]%:WUZ'1]#BN;V."74-^GV5R50._[V3S+LKA
M!T*#&>3V/B3XA>%O!MYIEIK_ (CTC0KO5)#%80ZE?16[W;@J"L2NP,A!=!A<
M_?7UH Z)054!CN..3C&:^4+?]@W35^#GPJ\"7^O66KOX'\1G6GU"ZT1&^W6S
MW,L\UD8VD;RXY!(BM\S ^6I*G@#Z-\1?$#POX1U#2['7?$NDZ)?:K+Y%A;:A
M?1027<F4!2)'8&1LN@PH)^=?44:]X_\ #'A75M,TS6O$>D:1J6IR"*QL[Z^B
MAFNG+*@6)&8,Y+.BX4'E@.XH \C\0_LCZ)XT\3_&:\\1:K/?:+\2+72[>73K
M6(V\NGFQB*QR)-O.]MX20;D"@H P<$YW(?A#XX\2^&[[PQX^^(%CXB\.WV@W
M.BW,>D^'1IUU/)*B)]J>1[B=/,51)A4C1-TI)4[5 ]4U;5K+0=-N=1U*\M["
MPMHFFN+JZE6*&*-5+,[NQPJ@ DDG  -<VWQF\ Q1:]-)XY\-I!H,JPZO(=7M
MP-.D9_+5;@[_ -TQ<% 'P2P(Z\4 8_P\\(_$G0M2L_\ A+OB!I/B;2[33VM#
M;Z?X;.GS74Y,>RZFE-S*-P".-D21H3*QQ\J@>0^'_P!C'6-*^&OP^\#7?CRS
MNM(\$^+K/Q/ITT6@O%<2K#/<2O;S-]J926,X D55VA.5?=D?0OBCXA>%O!.C
M6^K^(_$ND:!I%Q*L45_JE_%;02.RLRHKNP4L55F !SA2>U<3\6OVF_ /P;TK
MPAJ.LZW:S6?BG4+>QTZ>UNK<QF.;!^V%FD4?9D4JSRJ2!O7^\* . \0?L9MK
MGP=^,?@4>,/(/Q$\4S>)?M_]F;OL'F3V\WD>7YW[W'V?;OW+]_.WC!Y+XR>(
M/#GP_P#%OQ9_LOXT6/AV]U*P@AUWP?<0E]3>X6Q5$?2<W,6RXEMV@0.$F&]4
M[KM7W7PM^TM\-/&OCV3PAH7C70]7U46L-S UCJMM.EV7,X:*'9(6>1%MV=U"
M_*KH>_'6Z#\1/"WBG6M4T?1?$NCZMJVER&*_L+"_BGGM'#,I26-6+1L&5AA@
M.5([4 <Y^SGHU[X=^ 'PVTK5+6:QU*R\.V%M<VMRI62*1+= R..Q!!!]Q7E/
MC+]D_P 9>*?!_B#P7'\3;2T\&ZMK\VNK:MX=\V\A\R]^U_9S<&YQ)&)2S;MB
MR9V_/M!1O>%^(WA1K"YOE\3Z*]E;6<>I7%R-0A,45I(&,=P[;L+$P1RKD[2%
M8@G%7O#/BG1O&FBP:OX>U:QUW2;C<(=0TVY2X@EVL4;;(A*G#*RG!X(([4 >
M7:C^SN=0N?C9,/$&P_$G38]/"_8\_P!G;+#['OSYG[W/W\?)Z>]9=C^SEKO@
M_6+75?!'C:W\-W]SX?M?#^MO<:(EVM]]F79;WD0,B^3<(K2*/,,T9#(&C;;S
MZO:_$;PI>^+KCPK;>)]'N/$]LGF3Z+'J$+7L2X4[F@#;P,,IR5_B7UI++XD>
M%-2U8Z5:>*-'NM4^T3V?V*#4(7F\^ *9XM@;=OC#H77&5W+G&10!RW[-OP7;
M]GSX-Z'X#;6?^$@;3'N'_M'[+]F\WS;B2;_5[WQCS-OWCG;GC.!YOJW[)FO?
MV5\4_#FA_$"/1O"OQ!U"\U:^C;16FU"WN+F%5E2.Y^TK'Y)=!F,P[BC.F\$[
MQ[KX7^(/A?QM+?1>'/$NDZ_+8.([N/2[Z*Y:W<YPL@1CL/!X..AIOB;XB>%?
M!;,/$/B;1] 9(#=,-3OX;<B$2)'YIWL,)O>-=W3<ZCJ10!Y=>?LRF[\2?''5
M?^$DV?\ "S-$MM'\G[#G^S?)LI+7S<^;^]W>9OVX3&W&3G->+?M#? [P_JGA
MG]G/X-OJ=CKGBC1M2L+">$W1M;J?14M)5OI/+1_,CBE2U"Y!^\ N[/7Z]O\
MQYX9T?PJGBB^\1Z59^&9(HYDUFXOHDLVC?;L<3,P0JVY=I!P=PQUKBOB[^TE
MX%^#?PM;QYJ>K0:IHCJCV4>DW,$TVHAW11]F#2*LNT,')5CA58]J /5(T$:*
MBC"J, 4ZL?POXJT;QMHMMK&@:K9ZSI5QN\J^T^Y2XA?:Q5@'0E3A@RG!X*D5
ML4 %%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *1FVJ3Z<TM% 'YZ>+OB!K/BR/]GCXB68\%>%M,\2?$NS?2-)\/P^=JHMKL
MO'?O<7@D"LTCNZSQ)#P[1[Y"RD'COBA'H>H?\$U_%.J^*K/P_!\37\5W:ZFX
MBMUNTUEM;9YXQCYA*+;/RCYO) _@K] ++X%_#?3=8?5;/X?^%[35&G6Z:]AT
M>W28S+()%DWA,EQ( X;.0P!ZU-K7P7^'OB;5-3U36/ GAO5=3U2-(K^\OM(M
MYIKM$*%%E=D)=5,4> Q('EKCH*!'RQ\7I;>'5OCN^K-IJ>%/^%@^#U\1'4]W
ME_V:8=*68#'&"2N[=QL,G?%7_P!HK1?#?AWQQ\4[?PS"^GW,WP5UHZ[8V$/E
M6(6+9%IKN%4(91&M]&N266.,  +U]Q^&/POUBWUCXG:OXWL=%/\ PFM_!+)H
MMC.^H6JV\=A;VI2226"+S-_E.2ICQA@,MS7;>#OAKX2^',=S'X3\+:+X9CNR
MK7"Z/I\-HLQ7A2XC5=Q )QGIS0!\:^%;ZWD^)W[!-BLZ&\M_!FH2RV^]3(B/
MH< 1F7.0"8W ) !V-CH:S_V<_!NAZQ_P3V\!3WVDV=W-K_B71;/5I9(%+W\,
M?BB&!(YVQF15A41@,3A!M''%?8_AKX&_#GP;JEIJF@^ ?#.B:E:/(]M>:?H]
MO!-"TB;'*.J!E+)\IP>1QTK9TOP%X:T/PY:>'M-\/:78:%:3+<6^F6UG&EM#
M*DPG21(PNU668"0,!D. W7F@#YJ^+WA72/"O_#44>CZ?;Z7%=?"FQFFCM8PB
M%D@UJW0A1P L4$2 # Q&M.7X:^$K3]OC2]+C\+Z.-.@^%4J16HL(MB 7R6P
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MFW9;Y02:]0O/A#X%U/Q</%5YX,\/W7BA9$E76YM+@:]#HH5&$Y3?E550/FX
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MF-,D+!(U1DR6.9% ^;ZN\-_#WPOX-CLXM \-:3H<5G'-%:KI]E% ($F='F1
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M;$*6XT>6SC:S\I,;(_)*[-J[5PN,# H \;_9F^$WC?P%XU^)GB+QAJ_AF?\
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ME[+MA^?>H8\B,UY?\"])L/''[4'P?O/$5E#X@NX?@5I>I17&IQK<.ET+U/\
M2%+@D2_._P"\!W?.WK7V)XJ^$O@CQWJ5MJ'B?P=H'B'4+90D%WJVF07,L2@[
M@$=T)4 DGC'/-:W_  B>A_\ "3CQ)_9-G_PD(M/[/&K>0OVK[+OW^1YN-WE[
M_FV9QNYQF@#RS]I'6?L]Q\/-#L/#>BZ_XIU77B="G\3+,-,TV[@M+B474C1Q
MMND5581Q91F9B59=A9?$_P"PK.\\#_$_2-2?PWKL$WQ@\/VNIKHFFK;Z=<2/
M+H8NHS;F68;C(TBRAG8EQ)NP25'UOXP\!^&_B'IL>F^*O#NE^)-/CF$\=KJ]
MG'=1+(%90X612 VUF&1SAB.YI+'X?^&=-T\:?9^'-)MM/6>WN/LL-C$D0EMU
MB6WDVA<;XE@@"-U40Q@8VC !\S?$7X-Q:YXP_:#T+P9;S:'K=YX2\-ZE8?V+
M*+:0ZA:3:@UH$;[L8)M+:,XQ\J]CS76_LJ^,6^-?B3Q_\6H)[\Z#K9TW2-'L
M[ZT,/D6]I;;Y=K_\M/\ 2KN\C) (W0MAB,8]J\1Z;=6,&I:MX;T32K[Q3<10
MP;M0N&LEN(T=MJ27$<,KX02S,HV-RQ'R[BPY;]F[X1#X$_!'PEX':X6ZN=+M
M/]*F1RZ-<R.TTY0E5.SS9'VY4';MSS0!XG\<_%%M\1?&7Q@\.PZ9X/T;1O!O
MAB.W\5>(_$^F27]Y=17$1NH+:V2">&2.)%#OYC2;O.*^7'E=]87[.VC^#O$G
MBGP]+XQM-)O]3B^#7A[[#_:@5RUA*EVM^Y1SM*DNBNQ'W7"G <[OJW7OACX/
M\4>(M/\ $&L^$]$U?7]/,?V+5+[3H9KJVV.9$\N5E+)M<EAM(P22.:JZ]\'?
M 7BK3='T[6?!'A[5M/T>/R=,M;[2H)HK&/"KL@5D(C7"(,* ,(OH* /S^_9=
M Q^P^N/E\WQT#C_MK7HFAZ/X3L_V/OA;JVEQ6DGQ!N/%FDM;ZCXBB<7S^(I=
M5A&H+,Y43%B8[A7SR8HARP537O?B;X#7VK?M ?##Q3I=MHF@>$? R:O<QVUG
MN$][=:@BI(IA6)8XE!,DID#NSLV"@R7KT2T^$/@:Q\8-XJM?!N@6OBAY'F;6
MX--A2\9W!#L9@H<E@S G/()!ZU5P/S_^)T<FG_LA?M?VMX#:7<WQ2NIDAF!1
MG1KW3Y$8*>2&0%@0.0,CBO=_@[X+T+Q%^W7^T+K&J:39:AJ>BQ>&SIUU=0+)
M):&73R9&B)'R,WEI\PY^6OH/6O@K\/\ Q%KUWK>J>!O#FIZS>(8KG4;S2H);
MF=#'Y15Y&7<P,>$P3C;@=!BN@T_PKHNCZUJ>L66DV-GJVJ"%;^_@MD2XO/*7
M9$)I -TFQ257<3@' J0/A7X.^$]&\,_L_P#[*&K:3IMM8ZK<>-$::_AC"W#_
M &FUOA< R?>(D$42L,X(BC&,(H&M9_#'PIXB^$_Q/DU30+'4)-3^-BK=R7,(
M=Y WB*WMB QY4>1++'\I'$TG3>V?LFV\ ^&+33='TV#P[I<.GZ/,+G3;2.RB
M6*RE4,%DA4+B-@'<97!^9O4U+'X+\/V]K<VJ:'I\=K<7HU.:!;6,1R78F6?[
M0RXP9?-59/,(W;E#9R,T ?$/[06B'0[S]JNV\-V8TY7T;PD]VNGPRJ/LQN)A
M=/(MOB0Q_9ED\S;UC5\\ UI>(?A7XWT/PK\5O&WB#5/A_;:=??"S4M.CTKP&
MMS;PW:QVX-K</%(S*XBBWQ)(.B2*H^7BOM%?"^BKJ&HWJZ38B]U&&.WO;D6R
M"6ZC0,J)*V,NJAW #9 W-CJ:Y_0O@G\//"]KJ5MHW@/PSH]OJ=N;6_BL-(MX
M%NX2"#%,%0"1""1M;(Y- 'G$7PL\'^&/CUX#TW2O#FFV.G3>!-<TV6SCMU$+
MVT=YI;+"R$8*;KB=L$<F1R<YKE/^":>B:=8_LE>$-2MK"UMM1OGOA=WD4*K-
M<>7?W*Q^8X&Y]JY W'@$XKZ:;2;%M5M]1>R@?4;>&2"&Z:)3-'%(T;21J^-P
M5FCC+*."8T)Z"L_P_P" _#/A35M7U'1/#VEZ1J.L3?:-2O+"SCAEO9-S-OF=
M5!D;<[G+$G+-ZF@#XVUC0_!\GP,_:PO/%D5K=>*%US7'N)O$\,9F@<1.FCB)
MIEW>6(I(?L_)P9F$9YQ72_ GX>VWBC]K+XC:YX_T32-4\<Z'H/A<BY2'S8;2
M[DM96N'M@X^7,D*[7QN & 1N.?I/6/A)X'\0>*+?Q+JO@W0=2\1V[QR0:O>:
M9#+=Q/&P,;)*REE*$ @@\'I6Y9>&])L-:OM8MM+L[?6-06);R_AMT6>Z$0*Q
MB20#<X0,P7<3@$XH ^9/VHET>3]K;]EH:ZED^GF\UX :@$,7GFVMQ;XW\>9Y
MYBV8YW[-O.*\K\6:7I=Q\1O&6@_8[.T^"J_%C08K]=!AC^RO=#3%6ZMKU$!C
M^S_;DT]9%D4#S)'R=_3Z3^-?P!G^+7QH^$?B.ZM]&U#PMX6_MA-8TS5D,INT
MN[9(HPD9C9' =,L'(XQC->EV_P -_"=KX//A*'POHT/A4JR'1(["(6)5G+L#
M#MV<N2QXY))/)H ^7_B7\)+7XH?&SXJ^"_#&I>%_"FD:AX:T&XUV^33H;N==
M8759[BU,T!(CE,D*L'68[F$D'#*<&+X@ZE8>)_A%XGN/B)X9\%V'B3PEXU\/
MV6L:QINV2REW7.D/-<B2:-6B4V\B1.KEL)"%+%0,?2]I\&O .G^%KWPQ:^!_
M#MOX:OI5N;K18=)@6SN)05(D>$)L9@8X_F()^1?04^'X0^!;7P?<>$H?!F@0
M^%;AM\NAQZ9"EE(P8.&:$+L)W*K9(ZJ#U% SQYO _P .KS]J[6+;6=(T:6\L
M/AS86^F6-U$C0Q6#W>HQWBI ?DV;?(C8[>%?;P'8'Y\_8\L]6O\ Q=\ X?B%
M%#=:(O@;5YO"T?B'RWF%^FK(X>W67]YN6P6U:,@8$2DQ_*'Q]<W'[/OAC5_'
M.ISZUX5\-ZIX/.AZ3IFFZ-=6$4T5K):2WY++"T?EQJ([Q%7:>@<8 Z]GXB^&
MO@_QAX>LM!U[PIHNLZ)9LIM=-U#3X9[>W**40QQNI52JDJ-HX!('% CXG^$?
MA#1OB%9Z=HVI6<6L?#Z;XYZO-X>LT9CIK6$&F7\UO]E"D1FW%Q&Y"Q_NV(<<
MC<*T/VDM*U/1?"OQ-M_#%MH&FZ"WQ;T.?Q FLPPKI/V673M+D>2\4XS$]X\#
M2E/F(9R>"YK[9M?"NBV=EH]I;Z18P6FCE?[,@CMD6.QVQM$ODJ!B+$3O'\N/
ME=EZ$BBZ\)Z)=VNL6UQI-E+;ZR6_M**2W5DOMT*PMYP(Q)F)$C^;/RJJ] !0
M!\"?M._#_P 4>$_V>?V@-=\72> X-=UNP\/23V/@F&:#=LU5R+JYCF)8O(9&
M7S"?F\@C^$UZQ;_##P>O[>RZ4/"FBC36^%@#68T^'RB&O6MB"FW!'D*(1D?Z
ML;/N\5[]9_ 7X:Z;HNJ:/9_#WPM9Z5JOE_VA8V^C6T<%[Y3%HO.0)B38Q++N
M!P3D8-=.OA?1U\1#7QI=F-;^R"Q_M/R$-S]F#[Q#YF-WE[R6VYQGF@#\^O#N
MC^,]6^(7P$L?#O\ PBTRW'P>LX]-MO'MO<SZ8\S*%O4MDC8 W+6[1!PISY);
M<"M=CH7PQ/A3XG?LG^$_$EYI/B>719?%@1K.:6[M+=HC&T$,+3,S_P"C@)&H
M<EHS"!G*9KZ^USX5^#/%'AO3_#^L^$-#U;0-/V?8]*OM-AFM;;8A1/+B92J;
M4)4;0,#@<5+I?PU\(Z&NAKIGA?1[!="$PTH6MC%%]@$O^M$&U?W8?^+;C=WS
M0!\2:/X7T&;X6^)["^TK3Y=(T+XX_P!FZ=;7%O&T%A9-K5J)((58;8HF#-N1
M0%()S7U1^TCH>F+^S!\2M.33K7^SK7PIJ!MK40+Y4)BM)&BV)C"["JE<#Y2H
MQC KLKKX:^$-0T75-&NO"NCW&DZI=->W]A+81/!>7!=7::6,KMDD+JK%V!)(
M!)S6UI.DV6@Z3::7IUI!8:?9PI;VUI:QB**&) %1$51A54   = !0!\$^%_!
M^@1^*OV$(4T;3O)O-'O]2N8UM4Q-=+H]K*L[C&#*)(T?S#\VY%.<C-<Q8Z?=
M+X-\:Z+I8T:TTR/]H"^LA9Z['<'1DC6W<VT%S';LI\G[0+?:A/E^9Y>X;<Y^
M]M!^#7@#PG<V-SHW@CP[H\^GSS7-G+I^E00-;RS1K'*\91!L9T1%8K@L%4'.
M!5U_AGX2DTG6=)?PMH[Z9K5TU[JEFUA$8+ZX<J7EG3;MD=BJDLP))4$T ?%7
MCSX$^*=-T?Q.?B+>^%=0TKQUX]\+FZT'PBL\%E%(US'%=N4<[EDG0QL[!MS$
M%B>E==XV\ ZY:_M+ZEX7^'NF?"NPM+?P5:0V>B>*+&=HQ8RW-X+I;>W@94 =
M\";Y<,IBSU.?J#0_A+X'\,Z0NE:1X-T'2]+6]34A8V>FPQ0"Z0J4N BJ%\U2
MB8?&X;%P>!4WC3X8^$/B-':1>+/"NB^)HK,L;9-8T^*Z$1; ;9YBG&0JYQUP
M/2@#Y+^"/PUG\+_'#X<^%OB'J5CXLCTWX:RV.@S1Q&32)R;R1)?LWF)M:861
MM8V*'<T1;=E37FGB3P_IVI_#OX>3#3/#MWX4D^/IL/#4FFV\$D+:*]]=%H05
M&TPM,)L*/E*;.V*^^M<^$_@GQ-X?TW0-8\':#J^A::JK8:9>:;#-;V@5-BB*
M-E*H ORC:!@<=*MS> /#%UI.BZ7-X=TJ73M$EAGTJTDLHGAL)(1B%X$*XB:,
M<*5 *CIB@"WH>LZ1JEG,FBWME=V]C,]DZ6$J2)!)$=CPD*2%9&&TKP01C K\
M_/V>?AW\0_&7@7PSJ&MZC\-]-AT7QT][J^H7RW$/B6#4SJ:K<0SSK)Y?GSKY
M<.QUR\<L2X^[C[K^%OPXM/A3X1B\/VFIZEK*+<W5W)?ZM*DEU/+<7$D\K2,B
M(I)DE?HH[5%J7P9\ ZMXK'BB^\#>'K_Q,LT=PNL76E02WBR1[1'()F0N&0*N
MT@Y&!B@#Y0T^UE7XR-\ [?4]2CBT[X@?\)N+>RTY+:VM]#6)-02$MT:/^TID
MC^4D_*Q^0!5')_"'P#\2_'?@N.37;OX1V?\ 9GQ EOM7O;NVD_MBVUF/6%:1
M#,C^4LLK)'$@"@M%)$@X*U]]'POH[>)!XB.D6)\0BT^P#5?LR?:A;;]_D^;C
M=Y>_YMN<9YQFL#4?@SX!U;Q4GB:_\#^';WQ,DL4ZZS<Z3;R7@DBVB-Q,4W[D
M")M.<C:N.E 'YZ^/=(LK7]E[]KSQ"EE;1^(+7XJ7!@U6.)5NHO+OK01E9<;@
M4$TV,'CS9,?>.?K;]O@Y_8U^(1/)^Q6W_I3!7KLWPM\&W6CZSI,WA319M*UJ
M[:^U.PET^)H+ZY9E=IIHRNV20LB,68$DHISP*U]>\.:3XJT>XTC6],L]8TJX
M 6:QOX$F@E ((#(P*L 0#R.PH ^7Y?"FB7G_  4>T^2XTFQN)/\ A68U#=);
M(Q^TIJ:HD_(_UBHJJ'Z@* #Q7<?M*>'?"=QXR^#VH^(-,T>5[GQ?'ISW6IP1
M,9(WT[4-EN6<<JTI3$><%V7C)KV9?"NBKXD'B(:/8?\ "0+:_P!GC5/LR?:1
M;;]_D>;C=Y>[YMN<9YQFJWBSP/X=^(&FIIWB?0-,\1Z='*)UM=6LX[J)9 K*
M'"R!@&"NPW#G#$=S0!\O_%+X<^&-?\$_M:ZG?Z%8W.I1PM$MXT(\T);Z%87,
M*;QSL295D"YQD#BN'\7>"/'GQ$_:V^,_A_3[;P3?6FH^'-)MH+7X@PW<K2:8
MT'[T:>89$=(A<AFD9#@2B,@AQFOMZ;PCH<ECJMG+I%@]GJJ[=1MVMD,=X#$L
M.)EQB3,2+'\P.515Z "L[QI\*_!OQ(^Q#Q;X2T3Q.MD'%JNLZ=#=K!OV[]@D
M4[2VQ<X_NB@#Y&U#2=7^ VDP?&6'Q+X8^+6G:;X=T?3/%:ZGJ2S74"00QNLF
MEW;OL3SFEAN3%(-TS[&0EY4VYOBSPC\0_B)XF_:3T1;SX0:?IE_=QKK5QKT-
MRU[;V TZ!K*X>3?MC$40$@9U*)/'<,O%?7,GP'^&\FL:=JQ\ ^&FU331"+&]
M;28#-:B$*(1&^S<@C"+L"D;=HQBK7B[X.^ _B!JT6I^*?!?A_P 2ZA'&L$=U
MJ^EP74L<:LS*BM(I(4,S$ =V)[F@#B_C;;ZO:_LA^.8=?N;6\UV+P9>K?7-C
M&4@DF%F^]HU/(0MG /8UY+!\/?"\/_!031],C\-:1'IT/PI+1VJV$0B3%[]F
M!5=N!_HY,73[A*?=.*^LM4T>RUS2[K3-0M(;[3KF)H+BSN(UDAEC8$,CH1AE
M8$@J1@@U7_X1311XD'B+^R+'^WQ:?V>-4^SK]I%MOW^0)<;O+W?-MSC/.,T
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M"B57V@I'G_6#%7X1_M.:A\1O$OA&UU;PC!X2T?QGI>H:MX;N+[5PU]>16TL
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[4;AG&1GZT +12;UXY STYIOF(.K*/Q'YT"'T4FY>F1GK1N'K0,6BD9@@RQ
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MTMMP,%.K#M0(] HI%8,2 02.M&X!MNX9ZXSS0 M%<MXZU_Q+H,>B-X;\+?\
M"5/=ZK;VE^O]H1V?V"S?=YMWEP?-\O"_NEPS;N#Q73>:F0-ZY/09H&/HIAF0
M-M+J&],C-9/A_P 4Z;XJLIKO3;G[1!#=W-A([(R8FMYG@F7# 'Y9(V7(X.,@
MD8- C9HI%8'D'(HW#CD<\"@8M%<;JWQ&M?MGBO1= A_M[QAH&FI?MHF\VPF:
M5)3;1^>Z^6OFM"R[LD+@E@.,['A34]2U;PSI-[K>D_V!J]S:Q2W>E_:EN/LD
MK*"\7FJ LFQB5W+P<9% C:HI-P!Y('UHW#@YX[4#%HI%8, 0<CU%+0 4444
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M9RZ1X3U0Z!X7U26[TZ.XEU2>%YUC:W@6&5TM8 RI'@^4C$DDU]_>//A_X?\
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M$971@"2&4@@X(((KVYOA/X6;PW<Z"=,)TFYU8ZW+;FYF^:]-X+WS=V_</](
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M;?Q'^%OACXM: NC>*]*35;".YBO(1YLD,L$\;;DEBEC99(G'(W(P.&8=&8$
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M?5#>?VA?6]NB7%WY5_=+%YK@!GV*=J[B< \8KR']J+X6^#O!?[//[4ESX?\
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M1%D.YLM\S9 /CSX]>&].M?@;^U!XWCMU'BS1?B!;G2=6WL9],<-I)\RU;/\
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M'P!\9-4UF#0_"/@7X?:CH:0S^%?"NH27,3ZFDP*7H5K.!8MT!:-@GWBB%@V
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MX2\ :QJ'A=-/\=:3HD%O<*;R26"SO'MHH[N2& 2-;QRR&/#S1*&D^;<S;FR
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M!0:5X?L=$_M+XZ_8+N71X18S201ZOJ442>;#M<".,[8]K H,;<<5]FZ1\ /
M>@^.E\86>AD:^DES/#-->W$T-O+<E3<2PP/(8HI)-OS.B*S L"<,V<^;]F7X
M;S:I=:A)X?E,]QXAA\5R+_:5WY/]J1%BETL7F[%<[CN"J ^%#!MHP ?+\/A?
M2?!/C+]MO0]!TZ#2])M/!>FQV]C:QA(T7^QKC@*!W.?J36S^SOX2\-_%+4OA
MUH7CBVL]:L-(^%?A^\T?PWJSPW%I<-,)5N;P6K@Y=/+ACW'.T/\ [:U]+>//
MV?/A]\3O$:ZWXH\-PZMJ'V3[!(TD\R13VXD$@CGB5Q',JN ZB16VL 1@@&HM
M=_9X\ :_X9\-Z#=:$\=CX<MA9:3-97]S:W5I;B+R3"MS%(LWEM'\K(7(? W9
M(!H ^9?&WPA\#^%_%7[3+Z3X2T:RFTGX=PS6%Q%91^=;2S6>II-(DF-P>154
M.^<MCYB:9^S1\/\ 1OC?-INC_$7PG:ZUHF@_#/PQ!H,>I,TT)CN[:5KFYCC)
MVQS&2)8O-0!P+=<,.:^E+[]F7X<:A>0W3^'Y('BT%O# 2RU*[MHGTTHZ?9WB
MBE5'4+(V"RE@=I!!52&:[^R[\,_$6BZ1I5WX;\NVTK2O["MI;+4+JTN!IX39
M]D>>&5))(=N<QR,RDDD@DDT ?*'[..FV/QP\<?"V/QFZ^-["V\'Z\D+:I%NC
MO(K?6H[>W:XC.%FQ$%.)5;YE5S\ZA@_P7\-_$OB#X-_#;Q!;^&+'XJ^$O"-S
MKUC/X%UR[+.\::C)!!+;+*KQRR00(R*DS;50;8P&8$?:^G_#'POHOB+2M<L-
M&@L=0TK2VT6P-J6CBM[(NCF%(E(C"[HDQ\N1M !QQ7(ZE^RW\-=4T:VTF?0;
MB*PMUNXQ#9ZO>VWF1W4QGN(I3',IEC:0EO+D+*,G  .* .P^&/B#2_%_PY\,
M:]HEI-I^D:EIMO>6=I<@"6&&2-61' 9@&"D @,1G/)ZUU59^C:/9>'M*L]+T
MRUAT_3;.%;>VM;>,1Q0QJ JQHHX55    P  *T* "BBB@84444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-==RD&@#PS1_VM/#&M
MMH5_!H?B$>#]>UD:!I7B[R('T^[O&E>)$5$F:X5'DC:,2/"J9QR 03E:G^VQ
MX2TFS\9:K<^%_%B>&O!OB!O#FO>(?LMM]CLYUN$@,@'VCS94WR*<11NX!!9!
ME<\#H$?C+4/@SX$^"%YX$U[3O$^A:CH]KJFK64+0Z9!8:?>6LXOH+UE\J9Y8
MHD(C0F02,^Y5V&O-_'WPQ\9WG[(W[5>BP>$M<N-6UGXH7FH:981Z;,T]];-?
MV#K/!&$+2QE4=@Z@@A&.>*K41]/_ +;&O:IX5_99^(>K:+J5YI&JVMBDEO?6
M$[P3Q-YT8RCJ0RGD]#W-;>@_M"Z%>^*UT#6=+UCP8]QITNKZ7>^)$BMK?4[.
M(CS98F\UF1D5D=X9UCE17!9!AMN)^VMX?U7Q7^RS\0])T33+S6-5N;%$M['3
MX'GGE831G"(H+,< ]!V->1_%[P+XB_:Z^('A^.S\.ZYX(_X1GPOXDLM1G\26
M#06PU#4K1K"*VBE#?Z0$*O,9H0\>P1X;,@ D#VCP/^TUH?C;Q5X;TA?#WB#1
MK/Q5;W5UX;UC5(($MM8B@".S1*LS31AXW\U/.CCW(">O%>'_ +%/[3=S'\"O
MA38^.K#Q3<77B'4;S2H/&FL36\EE>7C7%S)%"97N/.+,J")<QX+KM'3(V_V:
MO#.A:+_PK'0M5\%_$RW\;^'+,V]U)K5UJDNBZ7=063VTLT;2W+631R!Y4B^S
MA\+*/E09V^5^ _A?XQL_V1?V5=&G\):[!K&B_$^RU#4["339EGL;9;^_=IYX
MRNZ*,*Z,78 8=3GD&@#ZSU7]H.VT'Q%#9:IX(\7:9HDVLIH2^)[BS@73_M+M
MLC)'G?:%B>4K&LS0B,LZ_-@YKQ/]ISXG^*_!/P6_:/U/1+W5EOK'Q)9Z;97U
MK.F=(MY=*TEG="[@QJ7EDP80762?> /F=>:UK3?%OBB&]MO$_A_XE:K\1E\=
MV=U<"U>]7PS::=#K%HT4EM&KI;30"W"')CDN/,$TDBJ$+IU7[37@?Q)KWP&_
M:<T_3/#^J:C?ZQXAL)].M;2RDEEO8UL-%1GA55)D4-#*I*Y ,;C^$XK4#Z(^
M'ZZ7X#^%UJTNG:EX.T72X)I9+7Q1J:W,]E"CNS/-<FXF78%!89E(5-H^7;M'
M*>!?VE-.\;:QX3M9/"'BOP]IWBZ*>7P_K&JV<(M-0\N,S!<Q32/"SPJ\R"=(
M]ZQOCD8/8?&3PC>^/_A#XV\+Z?)!%J&N:)>Z;;O=%A$LDT#QJ7*J3MW,,X4G
M&>#7@FFZIXE^-<GP5\.W'@OQ9X(U/PCJ\&K^)KJ"Q_L[3K.2TM+N!K6"5W(N
M(9IS&H$!E!MY#N92>) B_8W\7:]\1OB5\9?$/B32_$_]H6WBO4M&AO+[4XCI
M]A:6[6XATTVL5TT8GC#,QE2%E.Z3]\Q=MWK>@_%[Q!JGQXU_P1<>"=6M-&L-
M-M;N/57>R*KYDM\OGOMNF<PRBUC6)5C\P,)/,5!M-<A^QWX7UGPR?CA_;.E7
M^DG4/B?K>H6?VZV>'[3;2>1Y<\>X#?&VTX=>#@\UU$6H7>A_M3ZJD^A:S)8>
M(/"FFP6FL6]B\MBD]G=:C)+#-*O$+LEU&R;\*VUAG=M5@#B/V:?VEK7Q1X!^
M#FD7^F>)KZ7Q%HD=I!XPO(XY;&^U&TLPUY$\OFF990\-S\TT:B0PR,A=?F/:
M+^TUHS>(H[,>&/%/]@/XA_X18>+/L$?]F_VEO,7E?ZWS]GV@?9O/\GR?-^7?
MCFN7\"^%]:L_AC^RI:SZ1?PW6BFQ_M.&2V=7L-OAJ_A;SU(S%B5TC.X#YG5>
MI KRSX"_"32/A/H_AKX;^*_"7Q,UOQ!HFOJ;6]LY]170+J-=1EN;74/+BNS8
MQ1QA(9'CDQ)O'^KD;D@'I7[;7CC5/ .D_!V^T[4]6T^&;XE:/;:A'HYF::[M
M"MP9;<QP@O,K[1^Z"MN( P37;6O[3/A>PL_%\OB^TU/X>7?A2VAOM2LO$D<*
MO]EER(9X7@EECG1Y T0\MV;S$*%0Q4'B_P!MC0=?UG3/@[<^'O#>J^*)](^)
M.CZI<V>D0"65;>);@NY+,J1KDJ-\CJ@++N90<UY#\<OA%XJ_:IUCXF>,O">@
M:QH[Q^#M-\-:58>*].?2VU.YCU--3N-BS$.H14CA#NJHTCN X5&>@#Z7\*_M
M$:9K-[-:>(O"_B7X=RIHA\1(_BRV@@BDL$($TADBFE2-H=\7F1RLDB>:A*XR
M1P;?M%'XA>,/@RNFZ#XI\/6&OZQ<WUDVH+#%%KNGKH^H/N413OA YM9 EP(R
M=T;*&V,4X[XM>#]9_:^\3:+=Z#X?\2>$;31?"7B&S:X\6Z3)IT4M_J=C%;16
MI5SYV(]TK/)'&\8,0"L^:O?#WQ#XMUW4?V>O"<OP[\3:1'X-F>'Q+JFIV30V
M]I>0:/?64:0MRMQ%(QD<3QL8P# "=\P4 'M.D_M >'?$'A?X;:YI-O>:I;^/
M;F.UTZWM6MS+;LUO-<2FXS,%40I;RK($9V#KM 8\5I?%#XO:/\+1HMI<VU]K
M7B'7KO[%H_A_2$22_OY!@R,BNZ*L<2'?)*[JB*!N8$J#\U?L^?#^6']J[Q=X
M7GMM-E\._"2YU"ZT#[/ +8VG]O\ DW201Q(-NV&-+N/+'GSUPH"C'J?[0WAW
M6-+^+7PB^*%EHEWXBTCPA-JEMJMCI5K]IOXX;VV$:W,,>X%PCQJ'5 S[9"0I
MP< '7ZY\<WT,>&+)_ /BVZ\4^(#=-;^&K:&S>Z@AMB!-//-]I%K'&"\(!,^6
M,\84$D@<WK7[8/@C1?AQI/C"2SUZ==0UJ3PT=$M+%9M4M=62.=_L,UNKDK,S
MP>6%!.6EB.0C;QSFI:[/!\;O"_QE3PUXYN/"]WX>U+PO=67]BRM<:<Z:C$\%
MVU@!]I"3K%*=RQLVU8"ZIDX\ZTSX>^-M2M?!_BG4/"5]IC>(OC2GBU=)CM&-
MSINEO82PQ2WR+N$,I$:-)EB%:4 E6)4 'L=Q^UE9_P#"7>+_  M8?#KQUK7B
M3PG9V=]J^GZ=96DI@2XM1<!5?[5Y<DJA@GE(Q=VW>4LJJS#=U+]I+PW)-X3M
M/"EAJGC_ %7Q1IIUFPT[P^L F6P"@_:I_M,L*P1EF5!YC ER5"DJP'A/A?XH
M+\*_VP/VG[^;PMXF\2P2#PWA?#.F-J$HD73'9(FB0[P9!NQ(5\L%,.Z$INS?
M@M\+?%/[(^M?#K6M<T#6O$6B/X".@ZC_ &#8/J>H:;JGVRXU#R'B@+'[.?/D
MA62/>N^*/<44AB >Z:I^UOX2TOPKX)ULZ-XFN&\77-U86&EQ:61?QWMN)!+:
M30LP*2B:)X>Z!QDL(\R"_P"+/VB/^$)M+W4M9^'/C:VT'2X[>35]86SM9(--
M61(WD9E6X,LRPK)^]>VCE1=DF&;8<>*?#?X5^)]!^(OPO\0WNAZY:C6?'_BS
MQ3>V-[$K_P!BP7EG=);1RM$SQQ;U$38+_P"LF9>M8_QNT_QMXG_X7II_B;P[
M\0]<UZ>VN;3P?I_A6:]AT$Z8;60QRN8G2*:X+L_G13EV<B*.)&7B@#V74/V@
MO%%G^U]'\*X?"%Q?^'6\,1:R;RV-N+D.]XL+7)9[I5-J@8J5">?O1BJ,F"=G
MP7^T]HGC/6/#D7_"-^)=$T/Q-+-#X>\1:Q:10V6JO&&=5C E,T1EB1Y8O/CC
M\Q$..2 >!^(_A/4;/]LVRU^_TC79?"OB3X?/X/35="LI;EK6\?4ED/FM&K?9
MU$<@<2283Y6Z[37*_!'X7^&KBS^&G@_QG\/_ (E#QAX6GM':34]3U6YT*SO+
M&W5X[V*0W)L_+=EV)'&"5+E#&J@T ?9]%<K\,_'#?$CP3IWB(^']<\+&\\S_
M (E/B2R^R7\&R5X_WL6X[=VS<.>593WKJJ!A1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 45SWCGQUH7PT\):IXG\3ZE#H^A:;%Y]U>7&=J+D   #+,S$*JJ"S,R@
M D@5G:/\6O"FO_#$?$2QU;S_  ;]@EU/^TC!*@^SQAF>3RV4/P$;C;GC@4".
MRHKSWX<?&[P[\3-7U+2;&VUG2-;T]//FTKQ!I%SIMRULTTL45RB3(N^*0PL0
MRY(RH<(V5'H5 !17B_CS]I[P[X<^%6E^,?#L,OBR77=87P[H&FQAK1M2U-KB
M2W%OOE4"$"2*7,C@+B,D9RH;TRR\1&'P?;Z[XBAC\,;;%;W48;ZZCV:=B,/*
MLDP.S$?S N#M^4G.* -RBN'U;XF6>G_$CP=X4CMS=_\ "2V&H:A!?12J8T2U
M^S9'^UO%RN"#C"GUKN*!A117(W'Q'TK2F\3S:[YWAC2_#\\4,^L:YLM+&<21
M12"2&9VVM&&E$98XQ(K+VR01UU%%% PHHHH **\X\:?&*T\%_%OX;^!9=-FN
MKKQLVHB"[60*EM]CMA.Q92,G<"%&/<_7K_#FO#Q)8RW8L+[3?+O+JT\G4(?*
ME;R)Y(?-5<G]W)Y?F1M_%'(C<;L4"-BBLF^\3:/I.M:7H][JMC9ZMJGF_P!G
MV$]RB3WGE+OE\J,G=)L7#-M!P#DXK6H **YCXD>,$^'OP]\4>*YK9KR+0M+N
MM4>WC;:TJP0M*4#=B=I&<=ZO^)->/AGPOJFL_P!GWVJG3[.6[.GZ9#YUU<E$
M+^5#'D;Y&QM5<C)(% &Q163X7UP^*/#.D:R=/OM)_M"TAN_[/U2'R;NV\Q%?
MRIH\G9(N[:RY."",UK4 <)\,?A-IWPQ_MZYAU#4=>US7KW[=JFN:PT37EW($
M6-%8Q1HBQQHJJD:(JJ <#DD]W7EOQ2^/F@?#GX:^(O&-C/;>*8-"U*#2KZUT
MN\C=H;F2ZAMWA=@3LDC,ZLR-R,8XS7J5 !1110,X/PG\(=&\&?%#QYX[LKB]
MDU?QI]@_M"&=T:"/[)"T,1B4(&7*L=VYFR<8QTKO***!!1110,**** "BBB@
M HHHH **R+_Q1H^DZUI6C7NJV-GJ^J>;_9]A<7*)<7GE*'E\J,G=)L4AFV@X
M!R<5KT""BBB@84444 %%%% !17*_#7QS_P +*\%6'B(:#KGAC[89 =)\26?V
M._M]DC1XEBW':6V[ASRK*>]=50 445YMX(^,=OXV^,'Q*\ QZ;-;7'@G^S/.
MOFE#)=?;+=IUVKCY=@7:<DYS0(])HHHH&%%%% !1110 45XAX4_:>MO%+:VM
MKX-\1WO]F>/YO 4G]D6HO/*DCV[K^?!7R;4;AN<YVY'7/%W7/C]<Z#XF^(RR
M^#]0D\&> ]+FN]4\21W4!:2\BM8+PV<-L6#MFWN%;S6*KN!7_:H$>Q45Q?PF
M\9ZWX]\%V6MZ]X8D\(7ETS/'ILE]%>-Y).8I"\?R@NA#;?X<D<XS7:4#"BBB
M@ HK*_X2;1_^$C_X1W^UK'_A(/LGV_\ LG[2GVK[-O\ +\[RL[O+W_+OQC/&
M<UQ/QW^,L'P6\(66HKILFNZ[JVIVVB:'HL<P@.H:A.Q$4'G,I2($*[%WP $(
MZD @CTNBLOP[?7NJ:#IMYJ6FR:/J%Q;1RW&G23),UK*R@O$70E6*$E=RG!QQ
M6I0,**** "BLIO$VD+X@_L ZK9+KS6IOAI?VA/M1MP^PS"+.[R]_R[L8R<9S
M67\,?&R?$?X=^&?%D=HUC#KNFVVIQVSOO:)9XEE52V!D@.!P.U CJ:**QO$G
MB#_A&[&WNO[-O]4\Z\M;/RM-@\Z1/.G2'S6&1B./?OD;^%$8X.,4 ;-%9-AX
MHT?5M:U31K+5;&\U?2O*.H:?;W*/<6?FKOB\Z,'='O4%EW 9 R,UK4#"BBB@
M HI&^Z:\>^"_[15K\:/A[X"\5V7AC6;>V\67-Y;((HQ/'IWV<W +W4@("(YM
MRJD Y:1%[YH ]BHH)"@D\#K]*R?#?BC1_&6BV^KZ#JMCK>D3EQ#?Z;<I<02%
M6*-MD0E3AE93@\$$4"-:BBN6L?&B7WQ(UOPD+9DDTS2K#5&N=^5=;F:[B5 N
M."ILV.?]L4#.IHHHH ***XSQU\3-*\&^"_'&O130ZM/X2T^XOM0TVUN$\Y#'
M;&X$3CGRV>/:PW#HZGI0([.BJ.BZD-8T>POPGEBZ@2<(3TW*&Q^&:O4 %%%9
M/B/Q-H_@W1;C5]>U6RT32;?;YU_J5REO!%N8*NZ1R%&695&3R2!0,UJ*\W/Q
MGM?^&AE^%/\ 9TQO&\+_ /"4?VEY@\KROM7V;RMO7=N^;/3%>D4 %%%% !17
M+>.O'0\#_P!@$Z#KFO'5]6M]) T.S^T_8_-W?Z5<?,/+MTV_/)SMW+P<TOQ*
M\:+\.?AWXE\62VS7L6AZ;<:D]M&X1I5AC:0H&(X)"XZ4".HHI%;<H/J,TM P
MHHKSKX:_$[5/B-X@\61_\(G<:1X9TF_ETW3];N;R%VU2>"XGMKLK A+1)'+
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MR!M\I\I\M=WS[_FYZ<5A:A^ROX8N->?5K#6O$6@R7NEVVD:S#HU^MJFMV]N
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MJ*OFW[1WPIL_!?PF^)GASPGH?B?Q;K'Q*U$7]AX=M5G-G9:J\T'F78NXHO\
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M.X8AV#DY&:;:_L]Z.OB'X;Z[?:]XBUG5? S:A)8WFIWJ3R7;7L9CF:Y8I\V
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MQATSP_IOC+4M3T&VL].\-_\ ")Z_!I=K8W;6"72SWJ2:C"9_,EN$5MT#H(X
M%+-O ]J\;>,/&'AG]E77O$^IV\>A>/;'PA/?W$-HJ31V>H+:,[! 6D5E24'J
MS@A>=PZR>-OV==-\3^*M4\2:/XG\1^ ]<UBQ_LW5KSPM/;POJ,*J%B:430R
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MG"0H_FLID,A+EB:^ZI/AOIDWQ0L?'C7%X-9L]'GT2.'<OD&"6:*5F*[=Q<-
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M  ZCXI?"W0?C!X5?0M?@EV+,EU9ZA9R>3>:==1G=#<VTN,Q31GD,/<$,I92
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M]'7QI\0?%%CKVOZ1K?C,:<;RYL+J.,VK6*[86@'EGJ,;UD\Q'Y5EVDJ<6?\
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M:%8?MEJ?)\R*X"J#NWD$X)4[5V@'JM%4-)T[^R-+M+$3SW/V>)8OM%RX>23
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M2TSQ2(/"'B.7Q/X;U"STZ_\ "<(LIM21KH0M!+B.Z:$0E)@QD:55 BE)QL-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img18171159_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img18171159_2.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" :2!10# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;D_W?UHW'^[^M?A
MM^UUXZ\3Z?\ M1?%&VM/$^N6EM%KDJQP6^ISQQHNU>%4. !["O)/^%C>+_\
MH;_$7_@VN/\ XN@#^B)I-@Y4TY&WJ#C&?6OQ=_8#\:>(]8_:Y\ V>H>)-:O[
M.1KPO;7>HS2Q/BSF(W(S$'! (R.U?M%&H50!0 ZBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?$2E8P&Y/>@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ))%8HWE.W7Y6.T]=I&0:Z;]M+]NGQ9^S?XN\+:=X6\,Z5X@T_6=';5#)?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<C\0/B9X<^%FARZ[XMURT\/Z)%*D37E[($0,QP
MJ^K$^@R>IZ UUU?G9_P5DT7Q!)/\,==1RGA/3[^2*ZFDC,MO:7;M&8IIDVD%
M=BR#G@\K@DT ?5?@+]K3X8_$SP_KNL>'?%<.HP:+92ZCJ-H(7CN[6"/<6<PL
M-QR$.,#H5/\ $*X)O^"D?P*7P_;ZR?%%\;>XN9+5+9=*G-PI5%8NT87<J'<
M'/!((&<&OCY?",_BWXE77Q#G^//@3Q;X@N?"FJF73?#&G/;37ME'IT@=9(U7
M;&=K1Y$FTG8 /NX&/\(='L)O^"7/Q=OWL;<W4?B*$K<&)/-4*UF%PV,K@2.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMORX.?4OVRM4M=0_9/\ $>H6%U#<VD_]F36]S;R!XY(VO[8JRL.&4@@@]P:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*C"ER "Y X&3P*?8Z%96>I7.HI8VD6HW2JD]W'"HFE5?NJSXRP Z ].U:5%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^-5]X/M/ ,?A?0+C6/"UWKLT^N0SW<(>VU$6C^6(G4M&X!9<X(# Y)&#ZO\
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MG[)OP=\.?&WX1^$OBY\1+3_A+O'FM7C:[#K%](_F:>5N28(+?#8CB3REPJ@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV1FMNK%8V1<X^4#!Y6@#ZW5@PR.12TR+'EKC&,=NE/H **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#HH X_X@?"#P7\5-#BT?Q=X:T_7]-A(,,%Y"&\G!'W",%/NC[I&0,'BL^'X
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MHH :JA%"CH.E.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M19WWDJJ55WR>H!/3UKI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXI\-ZMX;NI]8BEB@U:SDMGD06L:EE#@$C((SZBO$_@Q^RWK7CCQ_^TM9>+O
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MB@^%?_!U;?\ Q=?CG_P[Q^/>?^29$#WU"S/_ +6KE?!_[('Q5\>:UXGT?0?
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M_10?"O\ X.K;_P"+K^>S[+!_SPC_ .^!1]E@_P">$?\ WP* /Z$_^%Z?#?\
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M_10?"O\ X.K;_P"+K^>S[+!_SPC_ .^!1]E@_P">$?\ WP* /Z$_^%Z?#?\
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M_10?"O\ X.K;_P"+K^>S[+!_SPC_ .^!1]E@_P">$?\ WP* /Z$_^%Z?#?\
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M_10?"O\ X.K;_P"+K^>S[+!_SPC_ .^!1]E@_P">$?\ WP* /Z$_^%Z?#?\
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M_10?"O\ X.K;_P"+K^>S[+!_SPC_ .^!1]E@')@3'L@S^'% ']"?_"]/AO\
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M **#X5_\'5M_\77X-3?!?QC;^%;SQ/)X)UB/PW:2M#/JK:<_V6-UD,4BM)C
M*R H>>&&#Z57C^$?BN;0M'UI?".H_P!D:U.MGI5\;%Q%?W#,56.%MN'8E6
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MKDG-?)7[9'[96K?M+>)#IFG)/I/P]TY\V.F3#;)=R#(^T7"],_W4.0@YZDT
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M]LYX;JSN(EFAN(6#))&P!5E8<$$$$$>M3X3T6@#\D?\ ATO\8?\ H/\ @_\
M\"[G_P",4?\ #I?XP_\ 0?\ !_\ X%W/_P 8K];=T1&05(_"@O$-Q)7Y>O3B
M@#\DO^'2_P 8?^@_X/\ _ NY_P#C%'_#I?XP_P#0?\'_ /@7<_\ QBOUMW1\
M'*\\CI3MJ^@_*@#\D/\ ATO\8?\ H/\ @_\ \"[G_P",4?\ #I?XP_\ 0?\
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M'2_QA_Z#_@__ ,"[G_XQ7ZV[HMV,KGTXI?DX^[STH _)'_ATO\8?^@_X/_\
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MQ1_PZ7^,/_0?\'_^!=S_ /&*_6W=$.Z_I1NB]4_2@#\DO^'2_P 8?^@_X/\
M_ NY_P#C%'_#I?XP_P#0?\'_ /@7<_\ QBOUN4QL<#:35&ZUW2K'6+#2KF_M
M+?4]061[2SDE59KA8P#(40G+!0RYQTR,]: /R?\ ^'2_QA_Z#_@__P "[G_X
MQ1_PZ7^,/_0?\'_^!=S_ /&*_6[Y,X^7-)OB'4IUQVH _)+_ (=+_&'_ *#_
M (/_ / NY_\ C%'_  Z7^,/_ $'_  ?_ .!=S_\ &*_6'6-;TOP[I%UJNJWU
MIINF6L9FN+R[E6*&)!R69V("CW)KE=(^.7PV\0:5JNIZ9X[\,ZCINDHLFH7E
MKJL$D5HK'"M*X;" D$ G% 'YD?\ #I?XP_\ 0?\ !_\ X%W/_P 8H_X=+_&'
M_H/^#_\ P+N?_C%?K;NB.,%3GITH)C R=H% 'Y)?\.E_C#_T'_!__@7<_P#Q
MBC_ATO\ &'_H/^#_ /P+N?\ XQ7ZV[HO5>N/QHWQ>J]<=O\ />@#\DO^'2_Q
MA_Z#_@__ ,"[G_XQ1_PZ7^,/_0?\'_\ @7<__&*_6Y?+8D#:2.M+M7^Z/RH
M_)#_ (=+_&'_ *#_ (/_ / NY_\ C%)_PZ5^+X7 UWP<![7=S_\ &*_7#:O]
MT?E1M7^Z/RH _)#_ (=+_&'_ *&#P>3ZF\N?_C%'_#I?XP_]!_P?_P"!=S_\
M8K];]J_W1^5&U?[H_*@#\D/^'2_QA_Z#_@__ ,"[G_XQ1_PZ7^,/_0?\'_\
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M?#[7M$D\,WWA?4S>0Z3O21+2SOKI)X8ED5MK[2) "H"XQU.:[+XO? ?Q)?\
M[/VO_$_Q_P")].\0W>B?#R:PT#2]'T][*&VBF@C+RRLTC-)(5!7G"X.=H-?<
M6J_#/PIKT^IS:GX;TG4I=4MTM;][NQBD-W"C;DCE)7YT4\A6R!6C>^%M)U+0
MY=%O-.M;O1Y8/LSV$\*O T.,>64(V[<8&,8XH ^3_@'^SMXH\::/\(O'OC/Q
M9IVI6OACPU'_ ,(MI.DZ:ULMO]ILT3S+B4R,TDBKY8RN%."=N:\>\+^/="\
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MR%V1%=JX!(&!W/K0!\P?MG2K_P (;^SI\V3_ ,)YH?\ Z+;C]:Y[X\_:9?\
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MA8HM\<B$1YE)DR%XK[P\:?#'PU\1/",_A?Q#I<>HZ!,(U>QWO$I$;!D&4*D
M$#@'M7+^)OV8/A=XSM]$@UOP=8:C%HNGMI.GB0N#!:,FSR<JP+*!TW9P>1@\
MT >7>*?B!XVTGXE_#OQ%JNLS^%OA5JUAIYF.GZ?!=V[:A.V#;WLLG[R")C)
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MWJ]:ZOI^H7=Y:6U[;7-S9LJW,$4JN\#$94.H.5)'(S7YK^'3X!TW]I[X93_
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M** "BBB@ HHHH **** &"%!T4=_UIP 7H,4M% !1110 4444 %%%% !1110
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MXV^)]AX'\6>"-!N[6ZGN?%FH2Z;:20!2D4D=M)<%I,D$+MB8# )R1QCFNSH
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MQ=XC%Q-K$/A.[BL-6LK%!Y\-Q(8=L9W[5SMN(F/.,'\* /3Z*9&6P=W!S3Z
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M?A;XM>'UT7Q9I:ZQIZ7$=U&CRR1/'*F=KI)&RLK ,PRI!(9@>#BN=\;?LO\
MPR^(WBJV\2>(_"EMJ>LVZ0QK.\\R+*L+;HEEC5PDH4]-X;TZ4 <=^T+XVUZS
M_9?36[2>XT;5M8CTNUNKNUS%)9)>3P17,J$_ZMD25RK-D*5R>E?,WQ\\+2_
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M3MQMW(2H&:^R_ 7[._P]^&]CXALO#?ABUL++Q"NS58YI);DWB;67RW,KL?+
M=P$&%&YL#FL_PI^RK\,O!-E:VNC^&EMH+74[76((Y+VYF6*[MPRPR())&V[
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M)O"_AZV\%VVJV6B^*-6_M6[62::X1IQ,9)&576)!Y)?Y2AX!:O:]'^%NCO\
MMVPZP)M5^V?\(/#K(']IW!B\\W+6Y4Q[]GE;.?*QLW?/C=S7J^C_ +*/PLT3
M1/$&DV?A2./3O$%A'IFIQO>7,C75LC.ZH[M(6X,C?,"#@XS@"N\MO .A6OC(
M>*TL%'B!=,71Q>[WS]D60R"+;G;C>2<XS[T ?-/[7&M6>I^(+C1-(T[QMX@\
M6^']!DUL6?AS63IEEIL3&01WEQ)YB"63?$=L1WY5'^7@YYSX*>%;/QI^T]X$
M\:ZG?ZG=:_JGPOL?$MU(NI3)%)>22)$Y\D-L6(@D^4%V!OFV[N:^D/B5\!?
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M*X W*<':HKV'^R+)- &B)8+#I?V<V2VL.4580FP(NW[HV\#'2@#\^O%$NJ^
M_"M[X%\3WWBCPK\5KW6O#MUJGB&/Q)<75KJ=J^HQQ37EC(YV6XWRL'AV*%)
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MWX\+\-_B#?Z#J^GV\&GIX2O/$UMJ3W> 6M'5;B*7*XC4"2$A\G=N;@;>?,]
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MCG.1Y_IW[-/Q L[/2?AY>7WAMO@[HWB$ZY9W(DN/[::))VNH+9P5\L%9V&9
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MO"W@36WL#:6^M:9JFJZNTB2,NFPZ=%F[7Y027$A55#!=RY/!^4Y?A_\ :?\
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MLR;T)9=JL1U&2 >L?%SXO>(?"'B+PQX2\&^'[/Q3XRUZ.XNX[34+XV-M;VD
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MCX=UNUU&Y\,7$.LK<7EZ+6-Y@;FW6/\ T<211LZ_,2,88*<"O,?V=_AAX_\
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MLW1/$3D7,7VNS.U;J-$DAE4C!95.-PVD\X],\1_M<>*O"]]XTFM_ 5K<^"O
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MZY]<\6>&O!'PO\+FT_X2'QIK\,82\N%2-;>U_P!*D\SY2VPF)<E!G( &2<$
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M.<L>#F@#Z4^!?QP\:_&:+1O$;^!;#1?AWK5D]]8:L-:%Q>(!MV)/;B,!&;+
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MGLXPAP^Z4-M&#QUIOA_XN^"_%7A.\\4:1XJT;4_#EEYAN=6L[Z.6UA"#+EI
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M?#;4+M&%'3<4'I0!]OVGQ6\'WWC2;P?#XETI_%<,?G2:(M[&;Q4P"6,0;=@
M@].]&G_%;PAJWBV[\*V'B72;WQ/9KON=%@OHFNX%XR7B#;@!N7/'&17P_P#!
MS2=4OOC=!X9U?XA^&_#?BW3/'E]K5UX?DT:0:]J";I9%4WOF;98I+5QRJXV
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MAE1EB$9;<7(D0@8R0PKI=;\3:;X;T>]U;5KN'3=+L8FFNKRZ<1Q0QJ,LS,>
M .IKX-^)?A[3QX!_:UUF?3K>7Q%:ZYI<2Z@T*_:49+/3SM27[PP[N001RQ/>
MOIK]L([OV5?BS@[R?#-[A2.I\IO:@#I6_:.^%L=EJMZ_Q#\,K9:5+%!?7/\
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M[Q/$>G67C+3DO]8L_@K;;UU"W$CQ,;RZ,8RP(#",HN.HVX/2H/#.BWDO@O\
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M:1XI_97AN-;TWQV)Y]>N8M<M;%4M[B!K6:>!(PV2L<?F (,X 48Q0!]4Z?\
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MN/"D].@S36^+G@M/&4OA)O%6CCQ3# US+HOVZ/[6D07<7,6=P 7YNG3GI7Q
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M%-K3:S8C28;HV4E[]H7REG$HA,1;L_FGR\==W'6ND!R,U\9:[H&H6?[6%O\
M#MEN+C0]9\20?$B.2.1T>!+:V:.8;R-C#[6EK^Y&2%DW=\C[*@SY8)SGKS0!
M)1110 4444 %%%% !1110 4444 %%%% !1110 A( )/ J*6."50DB1NN<A6
M(S4DG^K;/I7S-^U=\5I?A_=Z>MA\3Y/".I16<MZ-!TC0%UB^U':>&D3:[0VV
M1M9P%Y8_.* /H^X6/RQ&J(R, NS:"".@&.E<=X%^*G@WXB//:>'M:T_49(!*
M)K"(XE1$G>!V,3 ,$\V.1-Q&"4.#7B-O\3_'GQNU[X8^'_#?B*+X<7FJ>"X?
M&NK7ME80WXD:5XXEM8UFR%0.[L6ZL-H!&"3XI^SO\9-?^%?A?XGW=['8ZI'X
M:\-ZOKYCA@C@6>\&MZB)"'8>8L9,8PC,0HZ<DF@#]#UAMH9 ZI$CD;0P4 X'
M04L=O! S&...-FY8JH!/N:^.]>\>?%3X+QP1>)/B OC6?Q-X+UG5;*9M'MK,
MZ1J%G:+<AXP@_>0MOP$DRV4!)(R*ZK_A;WBUO$'PMMQJN;?7/AOJ'B"]!MX_
MWU]%%9M'+G;\N#-)\JX4[NG H ^E_LMH)C)Y,(EP6+[1NYZG-+Y%LT@?RXC(
M@P&VC('I^GZ5\4>"_&/QI\4:7\"+63XJ)!?_ !*TV\U.[OH]!M3]AABLH)42
M)2,&3+EBS97<S?+MVJ-#2/BW\1_&/A_X5:%:^,6T;6=6\7:]X8U#7H].MYI;
MJ*QCO%28Q,NQ')@1L*-H/8C((!]C2V]I*P,D4+D#:"R@X![?C35L;%?D6WMU
MW#&T(O(KXVL?BE\3/#N@S>)KWQL==MO"WCD>!;G2[C2[>*/5D>_BM_MDTB*&
MBD5+@$+'A?W8R#DU4\._M/>*=6^.@2'5-7O=,F\:2^%U\'6_AEVLK>S29K9[
MUM3$9'F"1?-*[\!3L(!R0 ?:\-G:V^XQ00Q[OO;$ SCUJ*)=.O;B22,6L\\+
M@.RA69& R >X."/SKXT^&GQ3^*#6WPR\:Z[XW&MZ/XH\:7?A5_#:Z;!!$D F
MO42=IE7S#*IMUX&U2, C.2>N_9+\+^(=%^)_QUDU/QI=^(HHO$WV2:WFL;>V
M\ZX^Q6C_ &DM&H(;81'M'RX4-U)H ^I9(X9HVC=8Y(SR58 @]^E-\FV8Q/Y<
M1*C$;;1P#V'IT_2OEGXD>,/B7XR\;_%:'P=XZC\%Z=\.;&W86']DP7J:K</:
MF[8SLXWI'LV1A4PWWFSR*M?!WXC>.?C1\:I[JW\2CP_X)LO#GA_Q WAU;&&:
M6:2_M9G:$W!&50%03CDE5P0,@@'TXT-LTGFF.(OM*[RHSM/49]*9':6<,@:.
M&!''=4 -?/\ \8M6^(&M?M ^$? /A'QNW@K3]2\.ZCJE[=1:;!>S,\%Q;HGE
MB4$*W[TC)R-I;C."//\ 1/C'\0?B':^!_AY:>*H_#_C"[UO7M'U;QC::=!,9
MX](<*SQ6T@*(TYEB)SD* ^!R, 'V%'%;6N5C2*(,<D*H&3ZTC26DETL):%KD
M+YBQD@OMSC<!UQD]?>OC?5/C)\2[3X;ZCISZE?S2^%O%=]H'BGQUHFD0W=[;
M6L$"SPWHL<%2&#QI)M5MH5F5>0!RWB.\\1VOQJG\=>'OBQ)XC@M?A'>ZY9:E
M'IUGMNH8V4"+(3 5YE$Y/WE9=GW<B@#[R\BU\\2^7#YW:3:-W3'7Z9I46!&.
MQ8U9OF. !G/.:^3/!WQ%^)?@'4OA?K7C'QK%XVTGQ[H]Q-)I$6EP6*Z?<Q:<
M;Y7@D4;F5DCD1@Y))<,, 8J#X?\ Q(^)MC_PIOQOXB\:0^(="^)ES]E/AM=(
M@MX])^U6LMS;&&=1O;REBV-O)W[N,4 >X-\+M5U+XXV7CO4O%,]QHVFZ?-9Z
M9X<CLUCB@DF$8FFEEW$R,?+&WY1M#,,D&O2O+MI)%EVQ-(HPKX!('L:^,?@9
M\4OB==M\"O$7BKQL/$>G_$5KNQGT4:;!;16GEV\TZ3B1%WO(?("L,A#O)"C
MKCM._:Z\9ZQ=:IKVG:UK%ZNI76K6,/AJ/PLRV.B6\,5R+>Z_M+RMDSK);QE@
M6*GS67"E: /OZ2VM79F>*%F8;69E!)'H:</(CD9@(U<_>( R<#O^ KXY\+ZU
M\6]=U[X;:)/\6KCSOB'X0?6A?QZ!9(^CRP):.WD)M(?S!<,I\S<%QE0,\<UK
M?[5?BS6M!^'&ES^)+_P5=ZE:ZO=:EX@\.^&SK$]S]BOFLD1+8))Y0D*^:[E=
MHP%!&10!]UJD D=@L8=_O' RV/7UKS[XL?#6R^(>H>!Y'U6+29M"\1V_B!%$
M:LUZ8(Y5\GJ" 1*3N&<;>G-?.FD_%#XK_&CQ+X;L-,\4W7PSAE\ +XCU&!]%
M@FN_M:7DL'RK.G[L.$#%64X4@#!^:LDZAXO^,GC;]E#QH?%\_AZ?Q!I]S=M8
MVMA;3);RK8&2X=7=,GSD_=D'[H.5P>: /IWXD?#&T\8>)/A_JKZG#I47A76V
MU1;;REVWCO:S6PAR2-N?.+9P2=N,<YKI-"\7:#KOB+7_  ]8W<4^HZ$88]1L
MEC(%L9H_,C#<;3N0[N">O->!_MR^'=<USPMX";3?%-QX=B'C'1[;9;VD,V9I
M+N-89]T@/S0ME@OW6)PW%>7^/+CQ]X$\=?M(^,/#OC>334\)6NC:C>6HTV"1
M];GBTQ"R2.X(AC<*0?+ (+$@X % 'W6(;41B(1PB/.X)M&,^N/6EVVS*Z[8B
MK'<PP,$^I_+]*^+/C]^TOXGT7XEZAI&B:]JWAU/#WAZVUJ/2]'\-OK)UN\N%
MDD2VFD6-_LT6(@G\+,9"0WR\:U[\<_'UOX@^+WC1]5^Q>#_ ^@V.M0^$9;*(
M337%QI?G&*6Y8!E1'(8C 8LN,A>" ?7JK;K(956,2$8+@#)'IFH&AMK1@T<:
M0KR7:-0H_P"!>U?#GA/]JSQ;X1\$^/+_ %'5M9^(+Z=X6&OQ:MJWAA]$MK+4
M#,L/V2-6B3S8LS)(,DMMC;D[@1U_B,_%'PAK%_\ #CQ%\4;CQ+/XG\(WVL6V
MM+HEI;2Z;-:-$+B)(U7;)',DX4;AN3!.<XH ^BOAO\0_#'Q*T>76/"EY%J&F
M)<RVC7$=NT0,B$!U 95S@D?,,J<<$UTG]L:/)XA.C?;+-M;AMA>?8?,4W"0,
MQ02[/O!"RE=W3((KQK]B_2]2TK]E_P"'7]HZS-K1N=%M;BW\VWCB-G;M ACM
MEV@;UC (#-\QZFFZ?(&_;FU8@'GX=6?S8_ZB5Q0![-H&L:+XDL4U71;NQU.S
MG9T6\LG21'9'*N-Z\$JZL#Z%2.U9GBCQ9H'A_6- T?5KJ&WO-?NGM--MI(2X
MNIDB>5D& 0"(XW;+8'R]<U\:?"+7O&LG@#X%^"_!WBH>$%\2:GXM34+U;&*[
M=%@NYY%**X(#@DX)^7DY#=*W- \<:WXYUS]GZ3Q#>_VIJVD_$/Q!HDNI&-8V
MO/LMIJ$*S,B *C,J E5& >E 'VBL<*J<(BJWWL 8.1CG]*8+6S\DP"&'R0>8
M]HVY^E?$WPM_:D\4>,?B[I=S)JVLZEIFM>)KO0SX1M_"[I8Z59HTT4=V=2\O
M$L@>%"V'*D2D8!7C3\,?&/XI26/Q$CNKV>;XP6VG-<6?PMO=*@MX+=?M&S[3
M8W (:]01*Q&7.6P&V;@* /L=X;6;R]\<4@7[F5!QWX_(4JPV_G-*L<?FD8+A
M1N(/O^%>._LU^,HO&G@.Y)\=WOCC4[74I;>^;5=-BTR^TZ1< VL]M&JA&4J2
M"1\V[()'-><:'\;_ !/J'B#3/ -SJ*_\)+I_C/4;'6)-\7VJ;2;6!KN.48C\
MLEXY;-'" %1*<8;. #ZJMX8(5(A2.,,<GRP!G\J&\BY"$B.4 [E)P>1W%?'?
MP]^*WQ'^Q_"3XHZWXR&L>%OB-K,.G_\ "'?V9;P1:7%=K*UJ8KA1YCO%Y:!M
MQ(?<V,<8T? 7QJ\;:O\ #?\ 9YU:]U?S-0\5^*;K3-<E6UB7[3;HE^43 4!,
M&"+E,$[?<T ?45_KFAZ3J6EZ9>WUA:7^IRNEA:32(DEU(B&1Q$IY=E0,QQR
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M8E #E<G;TZ9.,5V,<-HK22)'"K-]]E4 GZFOE[X<^)OB1X2\?_"VS\9>.O\
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MU_POHGA+1?#6HC1=?\7^(;;P];:T]LEQ_9PD226281/\KOL@=5!X#,"<@$4
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MVWB.V\8ZUIT,"Z8US<3PF)HD*I)&GE*4W?-EL$MQ0!]+*EG8QLZK!;QJ"[,
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MM(#\SC<"%Q0!^BS06S2+*T<1D7HY49'T/XG\ZCF^P0S)--]GCE8A%D?:&)/
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M:B\6>(/C3"\>I:Y?Z=>>+YO#)\&0>&7^P6EFDLEN;UM2$1#2!XUD8!]H#%,
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MX<_8UT+PUXL\,:M;^+_$LFE^%]6GU31/#KS0C3['SA+YD2H(@S+F8D,S%AC
M."<\=\,?VXEUKP%X'DU[P;XLU#QKXATN6_AT_P /Z,)([WRC&));=3+Q"?,!
M5W('RMSG /H]Y^U3X7C\"^&/$VGZ?KVN2>(KI[*PT#3+'S-5::/<9XWMV8;#
M%L;?DC;@=<KD [OQ9\,=/\7>-O!'B:YNKJ&[\)W-S=6D,)7RYFGMW@829!.
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M[\)>)/"/BSQ2NG>)=.\.^'O,CGU"]TXI'<SI,\+6]KACYTNY!\J_\]% .<@
M&GX:_93\(:!X1\>>&YGN=1TWQ=(_VCS(X8I+2 Y\JW@:-%VI"69H\Y*$Y!S7
M5?"OX8ZE\.]-N[/5?'?B'QV)F0Q3>(F@>2W55VE5:*--P/4EMQSWIOPE^+EC
M\5K;4C%I6M>'-3TV58KW1/$-J+:]M]R[XW9 S?*ZG*L#S@C@@BN4^*G[4V@_
M"_QKJ'A63P[XH\0:S8:3'KES'H.FBY2.S9Y$,C.74*%,9SG'!&,\X .H\2_
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MH_A_5]-TP6YFFACGL'F=8H4R?,?Y<J,Y;&* -NW_ &2M!O/#?BRR\1^)-?\
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M$^DZ)=>'?%OA:XU33;G6;6;Q-I8LXY+."-7:XW;R-I5N!]X8^8+QD ]:\?\
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MW&>.E?,?CJ\\=_#O]I;7?'.A?#/5O'>@WWA&PTQ7TF\MH9!<QW-S)MVRNN5
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M$C<0/H>W^.4,_B?QYHEOX:UF^F\)WVFV,QTZ)9Y;G[7%'(LJ1[@52,2?.6Y
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MT]U--F-3D11JS%8DS\Q5  3SUKL&.YBXC.,X;(SDCC/X<T ?$7@_X&>-=/\
MAAXVN['PUK::E8^/-.\8:/HWB/4X[O4=2AMH;4M$]T7;$K%)5#,205"^]9?Q
MI7QCXEU'QUXW\1>!M3\$Z/J*^#=,T^/5;F"6:5X=?#2!Q$[A&_>@@9/RE3G)
M('WAY96/+C=G[VU>#VKC_B!\'_"WQ4FT63Q+I\U^FBW@OK6V6YFBA:8%64RQ
MJP64 JI"N" 1D8- 'SY\2/"_Q!\,ZC\;/">@> =0\6:?\3',UEKMC=6]O;:>
M]Q9I93+=+(X8",1B3<H;>#C QSQ/B7X3_$;PSX-\7_"_1_A_J'B2UO\ QCIN
MOQ^)K::W@L3:1O8%@(W?S&F7[.VY-NW&XACCG[J9V;(QO).&7^[]:-H4XVY_
MAXSTH ^<&^'/B9M!_:IMAH]QYOBZ6Z;0XV* WV[188 4YX!E4I\V.1Z<U2OO
MACXKF\3?#FY71+AH=.^%NIZ'>/N3]S?21V0C@/S?>)BDY&1\IYKWOQQXUT;X
M9^%=1\1^(+EK#1-/19;BX\MW\M"P0?*H+$[F QCO[5T'S*RDQR$+P=O//KC-
M 'S3\/?AGXIT6\_98DO=%N+=/"OA:]L=;+,A^PSO8VL:(^&Y)>-U^7(RM>2Z
MC\!?&VE:;X/UZ;PSXLO)-+USQ3!=Z7X1U>/3M4%M?:BUQ;W*3>:H:(B--T>X
M9$@8\KM/WM)"$7**<Y[5%\ZY^5U7/U/7TH ^:?@Y\'Y_ 'Q2\'76C^'=7T?P
ME:_#^\L6&L7*3W-O>W&HQW36\SJQW29,C$C*\=:Y'X1_#7QY\-_^&<=2O?!M
M]<KHV@ZEH&LV]O)!YNF/=30.DLH,@!B586W;"QY'%?87S@DX8[1T4<_AVIZI
MN?;Y17/5B* /*/VF/ VK_$+X0W-GH5O]MUK3K^PUNSL6<1_:Y+2ZCN! '/W-
M_E[0QZ$CK7@/Q7\!_$+X[6/Q$\:?\*\U?PK>S:'I7A[2_#^I7%O)>WOEZHEY
M//F.5D157@+N^;!/&,5]M_9EV@#J#G/N>M)]D3@@E2.ZG'X?2@!T^?L[A3@[
M>"37P5^S_%XS^)WP<^"O@R/P)?Z=H&CZY;>(9_%[WD#V36]K>2SK&J;O,\YG
M58RA4!.6R<8K[X=-\94G@C!KG? ?P]T7X:>$]-\->'K=[+1=.0I;6[2M(4!=
MG/S,23\S$\F@#Y*;X=_$#_A$XO@@?!&HQZ+'XR&K'QW]HM_[.^P#4CJ0?RO,
M\SS<@0^7MQDYW=JZ7X/^#O%,/Q4U>[\.>"/$/PN\!75C>#5?#OB&\MY+.ZOI
M6+0SV$44LGD$L93+RBD%,+FOJTVN6SO8<Y I3:J?SS0!^?GPOU#QQ\(?'/P8
MTF[^&>M7^O\ ASP-JFBWFCVU]:_:9XH[FR'VJW)E"/&7*X#,K;=QQP >[T/X
M;^/_ (=Q^!_B5_PAMWKFN?VYX@U/5O".FSP"]LX=69&4+*[JDCQ&&(.,KGS#
MS\GS?5%U\.]#OO'FG^,9[5G\06%A-IEO<>:P5+>62-Y%V9VDEHDY(R,>YKH%
MM]F-KD =L<4 ?(7P]^%?C@?$3P'XSU7P[<Z.=2\<:]XFU/3I)8Y)-(M[G33:
MV\<KJQ#,WE(3MS@R;>@S6#XN^ GC'4OASJ5S_8FKOJ.E_%/4O%4&EZ-J"V.H
MWMC,\L8>VN0X$;[)2XR06"E3MW9K[:-MG^,@YZBC[/@</SG/(S0!\B^ O@[>
M:5XH^$.LZ-X2\6:1;IXLU;6O$"^+=1CO+Z"2339+5)I9!(^1(4B"@$GGG'-+
MJGPE\9/\,_%5@GA^Y>_NOC#'XBM[</'OET\:M;S&X'S8V^6C-@\X!XKZZ^S!
MA@LQ&?7K]?6D^QH,$$J1W!Q^'TH ^*/A[^SW=Z+\:Y=.\2^%?'=_IEMXPN?$
MVF:]9:^@\/9>9[N&22R\T,DBNQC8!&RV&)&XA=OP7\)O&>G_  M^!.FW?A^Z
MM[_0OB%=ZMJ=NSQYM+-I=299FPV-I$T7"DGYQQUQ]?"$]&;<,TW[*-N"['G)
M.: /"_V8]"\1>"=*\<^&_$/AF\TPP^*-2U.UOY)8Y+?4(+NZEGC:$JQ8;5*A
M@P7DGK7.?M!>$/%MY\7;/6]%\+7WB+3=0\$:SX8EN+"2%3:7$[1R1R2H[J?+
M/E$ KDY8<5]+_90JD*Y7TQV^E+]G&3AF /;TH ^8O#OPK\3C6_V>S=:5/:VN
M@^ K[1]8G+(PLKJ2TLHUC8;LL=T<@^7(^7KTKRGX0_LZ:IX?TW^P=>\'>//^
M$D\)^'M5T[1]:O?$"76A7$KV[6J?9(#*6B,T4@(4H F"N3@$_>7V15!P3DCJ
M3DGZ^M*+<+CYLGU89H ^0OB=\%_%&M?LV? V*/2M=F\0>"8]-FO]&T'4%L=4
M<"Q-K.D%SO 21/,+<-A@K+D YJ#2?A/J?@'0?A]X^\)>!/%UQJ>D>)M0U;5?
M"_B#4X+C6KG[9;-9RS^>TI1F"I$X3?RI/(QBOL1K96()Y/0^])]E Y4X/;C-
M 'QWH?PS\<ZWXS\.>/-2\,7FAOJWQ,/B6^TFXN(GFTJPCTB6RC>=@Y4[BJ,5
M7.W> ,@9KZ1^%OQ#@^*'A&V\26=E<6=A=2S+;><\;>?"DK1I.K(Q!CD"[T.<
MX(S79-:AUVLV1C'(SQ[^M1:=H]GI-G!:65M#:6D"[(;>WB6..-?154  >U '
MQ7I/[.MW9_'/5M,\2^%_'FM:!>>,&\4Z?K>DZ^L.@Q%Y1<H;FS,H/F1S(5)"
M-NPK9&<#L/#OP/\ $LWQY\26U[%+:^!K-=6U+1KE[& 6JW6IQPJXB"MO$D1^
MUEF( ?[01WKZJ6U5<>W H2U"\EBWZ"@#X)^%O[.NIZ3X+U31=8\%>/H_%OAO
MPGJFD:3J.K>(([W1KJ:2U-J%LHC*QB$JE"JE%50N,G:"?:O!OP[\3:?\3/@!
MJ%SH\\5IH'@.\TO59BR$6ET\=@%B?#=289.1D?(>>E?1GV;Y@=[<=*=';K&V
MY21[9X^N/6@#R+]H/PCK/BG7_@_/I.GR7T.D>-;?4K^2,J!;VRVMTK2MDC@,
MZ#C)RPXJ/X$>%=7\*^,OC+<ZMI\ME!K7B]M1T^1RI%Q;?8K6/S%P3QOC<<X/
M%>QR1"4 $L!_LG%,6U1<8' Y Q0!\R_$+PCXLB^.'Q)O;+PI?ZMH_B[P$-&M
M=4M)8O*M[JW2\;RY59PP,AN(U0J""2<X IGAWX5^)QKG[/9NM*GMK70? 5]H
M^L7!9&%E=26EE&L;#=ECNCD'RY'R]>E?3GV4;@VYNF.M'V15!P3DCJ3DGZ^M
M 'Q'^SK\!;GP/JVC6'B[P/X[O-4\%Z;>VEEJ%]KT=YH-\IC,&RTMFE/EF>%S
MA"BA?F4L0 3@:I\!?'/BWP3XFMO"_A'Q7X*\$64^F:MI?@+6-5A6\6^M;@22
M+IDT<SBTC>$'!9^)2"JBOOP6X7'S9/JPS1]GZ9=C]>] 'AO[+7@.R\(Z7XDU
M8>&_&7A[6-:O4^W#QSJBZC?W(AC"12"599!LVL5 +9^7H!BN;\;?#KQ-JWC#
M]I.\M-'GFM?$W@BSTS1Y0R 7ETEM?(T2Y;@AIHQS@?-UKZ7\G=N#-N5A@KBF
M_8T/4G/]X<'\Q0!\IZ]\.?B-'K'P]U'POIW]GZYH_P +M0TF+4+I4>.SU1UL
MO)BD7)R<Q/T!&5.37">!?@]X_P#$7B#QGJ=WX<\:6,^N_#C4]$DNO'FKV]P\
MVIRR+M""&1EMXVRQ"H%3'.T8K[H^SC<&W-QVS2"U'&YLM_>QB@#Y+DTOQT?#
M/[.7B-?AQKAN_!=PUKK&A&:V^W1H;![,3KF78R;R'X?<%[9XKF/@A^SM>>"_
MB-IND>)?"WCR^_X1O5[_ %+2/$)UY'\-LS&9X)TLO-S"[+.4*A#ARQSR:^V_
MLB^N..O?\Z=Y)[/CG/2@#Y5\+_#VY\/?L7^!_"?C'X9:QXTU&RMK>*Z\-Z;-
M!'>6\RRLZ3+(TJ*K1G:=R/D;N.]>G_LVZ-XRT7X7Q6OC>YU&XO/M<\FG1ZQ,
MD^I6^GD_Z/%>2)\LEPJ_>92PZ<D@UZR+4<@L2.U+]E3!!YSC].E 'PSXE^'?
MQ0\8?&/2;SQ!I7C#5[C1_'UE?V^I)J-O!X<BT>.[#)Y-H'#22)'RSNA?=O*M
MMP*ZJX^!GBWQ!^Q1=>"9M,N;3Q/;:S=:K!IWVD0S3B/5Y;N*-)P<0O(@7:_.
MPL#CBOKO[+T^;@<]!R?6E^S_ '1O) ZYYS]: /!_V5? =KX?;Q5X@E\->./#
MFNZM);V]Y_PG>KIJ-U<QP(QB='663"+YKKR0<@\=*@\6?#_Q)??&CXN:M;Z3
M-+IFK_#ZUTFQN%9-MQ=J]\6B SG<!+'R0!\XYZU] QQF/.6W9]:)(5D;+#-
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M4+O8^OO0!\Q?&#X(Z_\ %+XA?&6WAMVL]*\2_#^ST.PU28*8GNUGNW,>"V>
M\9)( &[O2_LI_#?^RM>U/Q)K7@[Q_P"'/%,>EPZ4\WC?7TU9)XB_F.EM()7(
M19$S\P7.\8'/'TX;?+ [SU]*/LJ_UH ^4?&WCKQ#X"_;&\5:AX>\":CX^=O
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MEUK.P&)-2N;H22EHRY;<QEEDVY(ZC-?636RN^XEB>HR>!]*3[&@& 2!Z9XH
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M5I"V/W8C.<5]F:!\"_ GA7P3J'@_2/!^DV'AG4#(;O3(;=?(N3(,.9%.=V<
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M&"!P.M 'UII7QD\':UK6O:39Z_9S:CH-M#>ZI;F38;2"6/S(I7+  *R?-G/
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M'QO\5>+-*A\+?$+3X++1+KP_I["2S%KMWI<+,0K3N[)][:H52H/)('1?M%>
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MQUTG4_CCK'PTL/#NE6=SX:T^UEMQ'<W3VH=XEB>-FE)8*<(01YE>L>*_B?\
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MD/BC4T^(?@;7)=&FUB7R1>*HO8O(D<H-KEK:6/+8Y);CBH8?BAXT^'?Q"O\
MPAI?Q'U/XC:;J/PZU#Q)<W%]+;S7>@7D4!,4GF0H,(S *J, ,MG).* /JSX@
M_!_P[\3?$7A?7=3-U%JGAV2XDL+NSF$3A9X6AGB8E3E'1B"OLIR"!5GX/_"C
M0O@CX T?P;X=-Y_8>DB1;47TPFE 9VD;+8&>6;Z9KXD^%?QN\<>%='_9\\47
M'Q*U7Q[<>/'DA\1^$[]K>9K>!(G>2Y@"1B2/R@FY@<[L8RO-=!)\1OBCX@^
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M-@+&F.  #ZD]LFU_9%^'L'P3UKX5FVO[CPMJM]-?S^?<A[A)Y)1*7C<K\I#
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M:7&A^-M%M?[#U!=4C39-;V<%HMI)$^&!(C=O,)VX !.3Q]A%0W4 _A1M'H*
M/DOQE\!_&^J_#/X^Z/9Z;#+?^+/$=GJ&C1->QJ)8(XK!9"6/"<V\O#<G ]14
M/QDT_P 9_#77OC3KGA71M(\1>&_%NDK)J.I7NMQVG]AW$%DT#"2+!9XS%Y4@
M"_-N<YP,5]=%0V<@'\*\V\<?L\?#?XA>+H/%'B7P9INNZY;QI$EU>1&3*H6*
MJR$[& +-PP(YYH \?D\#ZYXX_8Y^#T?AJV34]:T.T\,Z[;Z;-*L!O?L@AE,/
MFN=L;,%/S-D#'>D\-^#_ !_.OQK\3>,?A9I.L3>,9M,:U\'2ZS;RP7%O%;K
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MM??"OQEXX\>?!GQ)X3\+6OBZ#PGJUU?:CIMU?PVHEB>)$5,R\')!['&!6/\
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M^Y ;<@0Y/R9[BNKV*.B@?A0JJN< #Z"@!U%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 M
M%%(6 ZG% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+Z3X'U%-,T>#_A$])GC-BT'E1.E\2J('>5I'1Y-H'[G;R4)(!^AGA_QSX?\
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M?#GQV\+ZCH\GP1M[;X*^#EUZ;4->N9/ <,D,FES2+I\A$C.( LC;$1\",$L
MN1P:^B_V1;6&']FWX="WOVOXVTF&0NS!C$[99[?C[HA<M$%_A$87M0!W]_\
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MQ8$%TWA6R=K+GDT ?4EG\4O!VH+</:>*M$NH[95:=X=2@=80S!4+D/\ *&)
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M$NO"^GR+]ET=D*1I%"H50J.B+-TPYE+C 8  'TD#N (I:1?NC/!I: "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)/C/XRL_V<O&,LFKM%XQ\'^,+7PM<:W;0JOVQ1?VJ^=LP1ND@N%5_E'S;]H
M(KGO$GQ^\:>$_C!\?],OM?FBT!;"[LO"VZ(?Z!J=OI,=X%1MNS]XLLC!7+%F
MA.!@&@#WWP]^S'\/?"EO;V]AIVHRPV^J6NL1"]UF[NQ%=VV_R9%,LK8"[V^4
M?*>,@X%=+X8^$WA3P7XU\3>+=&TL6.O>*)(6U6ZCE?;<O$,(VPG:IP3DJ!N)
M).2:^;O%:_$+7M8^ AL?B[XHT*+Q]:107\5C;612%XM*-RTT8>%B'DD3Y@Q8
M?,< <5'\3O'US#^U'J?@35_C9XB^'^GQ:-HXTJSTBS@E-]=3RSI*79K>3:24
MB_NCYS^ !]#3?!#P9-X!U+P:VD,/#.HWTFIW=G]IES)</=?:GDW[MP_?#=@'
M';&.*W_#_@/1_#'B#7];L+.2VU3Q#<Q7>I3"5G\Z6.%84;!.% C11A0!QZ\U
M\P>!?B%/XM_:>\8>&=5^,NOZ1J>E^+'M]*\%VEE"UG=V45K#,8Y)#;L0&)E!
M_>!L#C&17V+;KU;=D'^'M0!Y?JW[./P^UWP9<^$[_P .F?1KC5)M:*_:95FB
MO9)FF>>*96$D3EW8@H1@'' J7PU^S[X*\)WGA6[TRQO!<>&3=C2Y+C4+B9HF
MN05G=B[DRN5.P-)N*J  < 5ZC10!YYK'P9\*:_?>,=0O=.N99O%VEKI&M*+N
M54N[54=%4H&VJP61P'7#88\UH2?#70)-2\(WQL'^U^%8Y(]'D\U_]&5X1"PQ
MG#YC&WYLXZ]>:[.B@#ROPS^SOX!\'>.)O%VE>'EMM88RO$?M,TEO;-)_K'@M
MF8Q0,V6R8U4_,P_B-7=?^!_@SQ1'XW@U71!>Q^-(X8M=225\7:Q1>5%T/[LJ
M@ !3:<@'.:]'HH X^/X=Z)'\.E\#?8F/A;^RSHQL3*^6M#$8?+,F=WW.-V<]
M\YK&;X%^#&\7>#O$XT3;KGA&P;3M%O/M$@-M;M'Y91ANQ)\O&7#8R2.2:])H
MH \KE_9U\ 2_$0>.I/#V=?$@N#BZF^RF<# G-KN\DS8Q^\*;L@'.1FK'B;X"
M^"/%LWB.;5]#-Z^OS:?<:@YF=3))9D&V9<,-A0C^'&02#D&O3** /+/%?[.W
M@7QI:^)[35M(EGB\3:A;:IJJQWD\+SW-ND:0R*R."A58HQA" =O/6J5C^RY\
M-=/^'>N>!8/#;KX>UR5;G5%DO9VN+V0,K*TMR7,S,I1,9;@# KV"B@#Q_2?V
M8OA_H/AFZ\/0:=J,^D7&I6FJO%>ZQ=W3"YMW1X'5Y9&90&C0[0<''(Y-==X9
M^'>A^#M7\4:KI5M<6MUXCO5U#4OW[NDUP(UC\P(Q(0[$13MQG8*[*B@!!T&>
MM+110 4444 %%%% "'@$XS7YB:E_P2+\3:IJU]>)\2=(B%U=2S[?['F^4.[-
MC_6^XYZ<5^GE% 'Y>_\ #GSQ3_T4W2/_  42_P#QVO=/V.?V$];_ &7/B5JW
MB?4?&%CXAM[S2GTX6UI820.C-+&^\L7;(_=XQCO7V=10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7,?$CX?Z?\4/ NO^$M7FN8M*UNREL+IK
M1PDHCD4JVQB" V#P<&NGKRSXR?'$_"'4O"NG0^%=9\8ZMXDNY[6RT[1/)$N8
MH3,Y/FNBX"*Q^]VH V_B%\(M'^)GPSU3P)JTUU'HNH6B64DEJRK.J+MP58J1
MNR@.2IKCM8_9>T_Q%X"M_#&K>._&VJ-:ZS#KEIK5YJ<4FHVMQ$,1B.7R<*H.
M3C;G)/-9O_#27C+_ *-]^(G_ 'WIG_R71_PTEXR_Z-]^(G_?>F?_ "70!H^%
M_P!E7PWHOBV+Q'KNMZ[\0=1ATZ73(F\8R6]^(X9)4E./W*G(9!@DG +#O5:Z
M_9)T&-M8_P"$?\7^+_!2ZEK,FN.GAF_ALUBF>W2!T0"$_NBL49V-G#+D$9-5
M_P#AI+QE_P!&^_$3_OO3/_DNC_AI+QE_T;[\1/\ OO3/_DN@#7\1_LL^$]<^
M'?A3P=8ZAKGABP\,WXU33[W1+P17BW6V4-,TK(VYF,\KL<<LV?:NT\)_#H^%
M_!DGAVX\2:[XD203*^HZ[=+<7A63.5+JBC"@X7CCWKS3_AI+QE_T;[\1/^^]
M,_\ DNC_ (:2\9?]&^_$3_OO3/\ Y+H ] T'X.Z+X=^$=K\.+2:[;P_;:-_8
M<;S.KW'D>48LE]N"VT]=N,]JQ]!_9W\/>&M=T?5+&_U1)=,\*1^#4A>2-HY;
M&,Y0N-F?,!YW @>V*Y?_ (:2\9?]&^_$3_OO3/\ Y+H_X:2\9?\ 1OOQ$_[[
MTS_Y+H Z#PE^S)X1\'2>$VM9=1O(_#?AN;PK;PWTR21SV4K1L_G (-SGRE&1
M@8+<<U#X!_9:\'?#GX&ZQ\*-)EU'_A%]4CO89FFF5KA5N@PD"L% & QVY!QQ
MUK%_X:2\9?\ 1OOQ$_[[TS_Y+H_X:2\9?]&^_$3_ +[TS_Y+H [SQE\%]&\;
M?"&Z^'-U>7]IH5UIB:1+-9NBW!MU14(#,C*"57!.WN<8K,UC]F_P7J>J>$-3
MM=/BT/4O"^HIJ5G=:3;00/*ZQ-%LF/EG>C([ C@YP000*Y;_ (:2\9?]&^_$
M3_OO3/\ Y+H_X:2\9?\ 1OOQ$_[[TS_Y+H ]*^&OPMTKX5^&_P"P]&FNI+$W
MMYJ!-VXD?S;FX>>3Y@!P'D; ],9)ZTGPQ^%FD?"?P)I_A+2);JYTNR\\1M?R
M"21A+*\K!B  1ND8#@<8%>;?\-)>,O\ HWWXB?\ ?>F?_)='_#27C+_HWWXB
M?]]Z9_\ )= &OX#_ &6?"WP^\4Z?K%EJ>N7UMI!E.AZ'J-X)M/T3S%*O]DCV
MAD^1F0;F;"L0*M77[,_A6\\,ZEH<ESJ7V._\5KXQE99D#B^%REP%4[.(M\:C
M;R<9&ZN>_P"&DO&7_1OOQ$_[[TS_ .2Z/^&DO&7_ $;[\1/^^],_^2Z .N\+
M?L^^%O!OQF\5_$S2_M4&O^)K:*VOX-Z_93Y94B14VY$AVC<2QSCH*R[S]E[P
MO<_!B+X:1:CK-GHL.H?VG#>V]PBWD4XO#>!E<H5&)6)'R\ #OS6+_P -)>,O
M^C??B)_WWIG_ ,ET?\-)>,O^C??B)_WWIG_R70!H:O\ LN6'B+P#%X6U?Q]X
MXU40:S!KEMK%WJD;ZC:SPX\L12^5A4!&[&W.2>:[SX<_#U_AWX?;2W\4>(/%
M9-P\_P!N\2W:W5T V/W>]43Y!C@8[GDUYG_PTEXR_P"C??B)_P!]Z9_\ET?\
M-)>,O^C??B)_WWIG_P ET 2>*/V,_ 'C'P'_ ,(GJ;:G)8+XEG\4PW"S1BXA
MNYIFED5&*$",EV7;C.TXSWK;T[]E_P "VFG>,+:[T]=9N?%-]=ZA>ZEJ5O!+
M=QRW"!&$4GEC8J@#:,'!]:P/^&DO&7_1OOQ$_P"^],_^2Z/^&DO&7_1OOQ$_
M[[TS_P"2Z +-Q^R#X*U+0?[(U.[U?5+7_A#E\$'[3-%DV*RB2-^(P/.1@NU\
M8^49!/-=#HW[._AG0;V]N+.6]B6Z\+V_A)H Z"-+*'S-C*H3B3]\^6Z'CY1W
MY7_AI+QE_P!&^_$3_OO3/_DNC_AI+QE_T;[\1/\ OO3/_DN@#H_@W^SW;_!=
M([:P\;^,/$&E6]C'I]II7B"_BN+6UC3:$,:K$A# *%SDC!/%3>)/V=?#/BF/
MXH+>7.I+_P +$M(;+6#%,HV1Q6Y@3R,J=AV'DG=D\URW_#27C+_HWWXB?]]Z
M9_\ )='_  TEXR_Z-]^(G_?>F?\ R70!K>(?V4_!OB+XBV7C>2?5+#Q!:^'I
M_#:W&GW"0EK:2)HM['83YJ*[;6! !/2K_@7]G?1_!<>MRW.O^(O%FL:Q9_V;
M<ZWXDO1=7JV?S8MXW"*$0,[OC;G<Y))XKFO^&DO&7_1OOQ$_[[TS_P"2Z/\
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M$_[[TS_Y+H ][HKP3_AI+QE_T;[\1/\ OO3/_DNC_AI+QE_T;[\1/^^],_\
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M: .ZHI >E<3\9_BA9_!GX;ZSXSU&SN]0L=+1&DM;$)Y\I>1(U5-Y"YW..I%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 >#?#[_D\?XP?]BYX>_P#0KZO>:\&^'W_)X_Q@_P"Q<\/?^A7U>\T
M>#?M.?\ (X? 7_L?[?\ ](+VO>:\&_:<_P"1P^ O_8_V_P#Z07M>\T %%%%
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MO_HDT ?6M?)OQH_Y2"?L\?\ 8)U[_P!$&OK*ODWXT?\ *03]GC_L$Z]_Z(-
M'UBO3\:6D7I^-+0 4UNWUIU-;M]: /!_V2?^0?\ %G_LI&O?^CQ7O+?=->#?
MLD_\@_XL?]E(U[_T>*]Y;[IH ^3/BI_RD;^"/_8JZS_Z":^LZ^3/BI_RD;^"
M'_8JZU_Z":^LZ %HHHH *\%_8]_Y%+QY_P!C]XB_]+WKWJO!/V/?^11\>?\
M8_>(O_2]Z />Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M +55O\2OBE_PAG_"-W.E[]!L-9@U)K@2Q227-LMS]F("C:RQL3N)PVTX Z4
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M*]?WA.<*: ,J'X/?&V&-4'Q]BPH"C_BB;,=/^VE/_P"%1?&[_HOL?_A%6?\
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MY(XP<8R:Z/\ X5%\;O\ HOL?_A%6?_QRO=J* /"?^%1?&[_HOL?_ (15G_\
M'*/^%0_&WO\ 'Z,#V\%66?\ T97NU% 'S1\/_P!F7XJ?##P;I?A;P[\=%L]&
MTV-H[:%_!]K(RJ6+'+-*2>6/YUT/_"HOC=_T7V/_ ,(JS_\ CE>[44 >$_\
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M#WQT6UTN&6XG6&3P?:2'S)IGFD;<9,\O(QQG'.*^EZ* /"?^%1?&[_HOL?\
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MID.J"2":WU298;:87'E J1(9%=#'D>7D9# T :__  J/XW?]%]C_ /"*L_\
MXY6C\(_@7XC\#?$;Q'XU\5^/V\;ZQK&G6>F$C2(M/2&*W>5UPL;D$DS/V':O
M0[;6]8M?#-WJ.MZ;:V-];PRRM9V=VUS&0@)&)6C0\@#C;QSUKQZS_:AU9?@C
MH'Q-U'P9;VNCZ\^E+8VL&L^;/B^N(X09,PJJE!*&(!;."!CK0!]!UY%^TK\
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MY^4C;WKU/P_\4AKGQB\6^ O[/:&7P_I]AJ#7QDRLZW1G 0)CY2OD<G)SN[4
M<I^S]^SU??!?Q)\0/$&K>,)/%^L^,KV"^O9VTY+)(Y(T9/E1&88(8?E7M%12
M.588Y_V<>]?-WA_]LZ/4/#=KK>J^$)=*M-5TK6=2T41:@MPUXVF&3[1!(/+7
MR6*Q[E/S*0V,@C! .^^-7P5U;XG7W@S5-"\7OX/USPO?S7]I?#3TO58RV[P,
MIC=@I&V1NN><5@_\*B^-W_1?8_\ PBK/_P".5>UC]H#4+73OA*^E>&%U*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/!/VC/A!>_%SQK\.+232FU#PY'-K%OK$NY=MM#<:;+ CE2P+#S&7A><XZ#FO
M(E^ ?Q.\<KX/N_$5A:Z?KE_I/BBQU>=0HAT\W%E%9V*G$CLRE8?,^4M@R,.*
M^V** /F32? 7C'5+SX+--X8N-+?X:6TOV\SW$3+?R_V:;58K5E8[PSMG>X0
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MJ"]\-^*-+UO4UANK:6!DB\P3+;N95,N-V<E4R,<9XKZ:HH ^8/''A&_\5?M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\
M A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_
M (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC
M_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALC
MXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]
M%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2
M?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"
M?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T
M ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)
MGVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS
M[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#
M?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9
M'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_
MZ*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KX
MD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\
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M  V1\<\X_P"%J^),_P#7PG_Q- '[R9]J,^U?@W_PV1\<_P#HJOB/_P "$_\
MB:!^V1\<VZ?%7Q&?^WA/_B: /WDS[49]J_!O_ALCXYYQ_P +5\29_P"OA/\
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MD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\
M A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_
M (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC
M_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALC
MXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]
M%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2
M?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"
M?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T
M ?O)GVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)
MGVHS[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS
M[5^#?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#
M?_#9'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9
M'QT_Z*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_
MZ*KXD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KX
MD_\  A/_ (FC_ALCXZ?]%5\2?^!"?_$T ?O)GVHS[5^#?_#9'QT_Z*KXD_\
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M7]YI-E)=7=U(?N6ELBJ2D6X8R<9QN8C  ^M%CMHVW!(U;&,A0#SVJ7<J]P*
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M1O\ HGGBO_P277_QNOT4UK_@HM\6_#?AIO$6K_LW:QI>@*B2MJEY=SQ6X1R
MC%S;8P2RX^HK%7_@J9XYDO[>Q7X&3M>W&G?VO#;C5)#))9;#)]I4?9\F+8K-
MOZ84F@#X%_X4I\1O^B>>*_\ P277_P ;H_X4I\1O^B>>*_\ P277_P ;K[M/
M_!6CQ0OA^+73\&E&B2W+64>H_P!L/Y#W 0.8@_D8+A"&V]<$&B]_X*S>*=-L
M=+O;OX,_9K/54:33YY-7D"7:JYC9HC]G^<!P5X[C% 'PE_PI3XC?]$\\5_\
M@DNO_C='_"E/B-_T3SQ7_P""2Z_^-U^B/C#_ (*._%;X>Z+_ &QXI_9SU7PY
MI&]8OMVJ7LT$.]ONKN:W R<' ]JR;G_@J5XZL[S4[2X^!<\%WIED-2OH)-4E
M#VMJ51A/(/L_RQE9(SN/&'7UH ^!/^%*?$;_ *)YXK_\$EU_\;H_X4I\1O\
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M !T T2[P/_(=!^"?Q%;D_#OQ43P,G0[K(^G[OWK^A R*O5A^= D1N0P/&>M
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M@G\19,!_AWXJ<8Q@Z'=#(]#B/TXH/P5^(Y&#\/?%F/\ L"70_P#:=?T("16
M(8$?6AI$7DL!]30!_/=_PI3XC[L_\*^\6]<_\@6Z_P#C?T_*C_A27Q%W%C\.
MO%18]2=#NO\ XWQ7]"'F(?XA^=.W#UH _GN_X4G\1>/^+=>*L=<?V)=X_P#0
M*3_A2?Q&P /AWXJ&!@8T.Z&!Z?ZOW/YU_0EN'K3?-3^\OYT ?SX?\*3^(_(/
MP]\6,"<\Z)=?_&Z!\$_B(N,?#GQ4-HP/^)'=_P#QO_.37]" D5C@,"?K31-&
MVT!U.[ISUQ0!_/DOP5^(T>-GP\\5H,@X71+K'';_ %=(/@I\15((^'7BH$8
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M_"WQG;6&GZ!X6U+5];TOQ!I?@H7DNH:7%)8E&\B:=U#M]H,>'(&Q1MPH.XD
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MBU&V?5[>!+F;3UE7SXXG+*CM'G<%8JP!(P2I]* /EW_AK_XJ[B?^&5?'&?\
MK]@_^)JKJ/[57Q(UB%(K_P#9)\87T4<BRI'<W%M(JNOW6 9#AAV/6OKO[1'D
M M@GIFD6\B+!=V'/(4]30!\F7'[7'Q1O+>6"?]E'QK-!*I22.2\@974C!!!7
MD$=C3+/]K/XG:?:Q6UI^R=XSM;:)0D<,-U;HB*.@"A< ?2OJ[4=:L='L+B^O
M[J*RL[>)YYI[APB1QH,N[$]% Y)/ %.LM6M=2L[>[M)ENK2XB6:&XA(9)$8
MJRD=0000: /E=OVP_BPPP?V5_'!'_7]!_P#$TP?M??%56)'[*OC@'_K]@_\
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M(ZCCN*E:X15SDGV )H ^3_\ AL#XK9S_ ,,K>.,_]?T'_P 33?\ AK[XJ_\
M1JOCCU_X_8/_ (FOIOQ-XX\/^"]-&H^(=:L-"T\R)"+O4KE((B[G"J&<@$D]
M!6M]J3OD=_F&* /DYOVOOBHYRW[*GC<G_K]@_P#B:=_PV!\5CD?\,K>./_ Z
M#_XFOK 7"-G&3]!^GUI5N$9<@\=: /DW_AK_ .*QP?\ AE;QQZ?\?T'_ ,31
M_P -@?%;.?\ AE7QQG_K]@_^)KZCUOQ-I/AK3;G4-7U*UTO3[5/-GNKR98HH
MDSC<S,0 ,\9/>KT=S'*H*G*^N,4 ?)W_  U]\5>O_#*OCC/K]M@_^)I/^&O/
MBH< _LJ>-\=1_IL'_P 37UE]IC/ ;)H^T1]-W/ICF@#Y/_X; ^*W_1JOC<_]
MOL'_ ,32?\-??%7C_C%7QQQT_P!.@_\ B:^L?M*''/M^/I0+A&QMR2?;]: /
MDT?M??%48 _95\<=<_\ '[!U_P"^:=_PV!\5N?\ C%7QQSU_TV#G_P =KZP^
MT+NQALYQT]J!=1MGD\'!XZ4 ?)S?M@?%9NO[*OC@_P#;[!_\31_PV!\5LY_X
M95\<9SG_ (_H/_B:^L%NH756616##<"IR"/7Z4?:HRQ'/'^<4 ?*#?MA?%=A
MAOV5O'!'_7]!_P#$T[_AL3XL?]&K^.?_  .@_P#B:^K_ #UVY )[8QS2?:8]
MN=W'T(H ^4?^&Q/BQ_T:OXY_\#H/_B:/^&Q/BQ_T:OXY_P# Z#_XFOJW[5&V
M=K;NW'^?>C[5'@'/H/SH ^4O^&Q/BQ_T:OXY_P# Z#_XFC_AL3XL?]&K^.?_
M  .@_P#B:^JH]0MYEW)*KKN*%E8$9!P1D>AI8KZ"X56BD656SAHSN''7D<=C
M0!\J?\-B?%C_ *-7\<_^!T'_ ,31_P -B?%C_HU?QS_X'0?_ !-?5PN(VSM.
M['I2QS"7. ?Q[T ?*'_#8GQ8_P"C5_'/_@=!_P#$T?\ #8GQ8_Z-7\<_^!T'
M_P 37UG10!\F?\-B?%C_ *-7\<_^!T'_ ,31_P -B?%C_HU?QS_X'0?_ !-?
M6=% 'R9_PV)\6/\ HU?QS_X'0?\ Q-'_  V)\6/^C5_'/_@=!_\ $U]9T4 ?
M)G_#8GQ8_P"C5_'/_@=!_P#$T?\ #8GQ8_Z-7\<_^!T'_P 37UG10!\F?\-B
M?%C_ *-7\<_^!T'_ ,31_P -B?%C_HU?QS_X'0?_ !-?6=% 'R4W[8'Q6DR&
M_95\<$>][!_\31_PV!\5NO\ PRKXXSC'_'[!_P#$U]:T4 ?)/_#7WQ5QC_AE
M7QQC_K^@_P#B:/\ AK_XJ_\ 1JOCC_P-@_\ B:^MJ* /DG_AK_XK!=O_  RM
MXXQC&/MT'_Q-'_#7WQ5X_P",5/&_'3_38/\ XFOK:B@#Y('[7WQ57D?LJ^.
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M!AT89##Y>A!S7L?[5W_)LGQ7_P"Q5U/_ -)GKLOAI_R3GPK_ -@FT_\ 1*4
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M_P")I%_;"^*ZYQ^RMXX'_;]!_P#$U]:T4 ?))_; ^*QZ_LJ^.#_V^P?_ !-
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MK:B@#Y*_X; ^*V<_\,K>.,_]?T'_ ,32#]K[XK+C'[*OC@8_Z?H/_B:^MJ*
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M$5KX5CC?1[&V.B74<\\$UO;JH>%2RR MM!XWEL9([F@#SO\ ;'\&WWB[QY\
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M*$,&SGBNBM_@'X 'Q F\=KX9@A\4W"-%/?1R2()E9=C"2)6$;[EZY4YX)YH
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M;+&0T;>7*2I9,GK7T%\*? MO\,/A[X<\(VES+>VNAZ=!IT5U, 'E6- H9@.
M3UQ[T ==1110 4444 %%%% !1110 4444 %%%% !1110 44E&: %HI-P]:,C
MKF@!:*3</6B@!:*** "BBB@ HHHH \I_:N_Y-D^*_P#V*NI_^DSUV7PT_P"2
M<^%?^P3:?^B4KC?VKO\ DV7XK_\ 8JZG_P"DSUV7PT_Y)SX5_P"P3:?^B4H
MZ2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /FS]M'5DTW3_A_;
MZ[K6I^'OAU?>(4A\5:EIMQ);>5:^3(85EGC^:&)[@1*S KP>2.M?+OAK[1\0
M+O5-+N?%/BB_\&Z?X4\4W_A:]_M6YM9KFQM;NV-E.[HR-,JL7"N^=P7G(QG]
M*KS38K[(G59HF #0R*&1AG/(/6HAHEJJJ%M[==D9A3$*_+&?X!_L_P"STH ^
M=O&T%W\0_P#@G]?R:B]YJNIZC\/4OI)+>1Q/=7 L5F!)3DEI "1T;)!!!(KY
M.US2?#-UX1\=ZWX.\1ZDUKX=^%.DZMI>H:7KMR66]2ZOBY>429D"2[P(W)5<
M8"X&!^GRZ>BPK"H5(D4*B(N !C&,=,>PJ&/P_8QQF-;2U6)D\MXU@0*Z\\$8
MZ9)X]Z /A;Q!XL\8ZM^UQ%:OXET7PQ?V>L:9!I']L>(KBSN-1THP0O<QV]@5
M:"Z$I:=?-.&#KM&"HKV;]L3X[>'?A#X1B\/R:MHVD>,/&$3:1I\VL@K;VMM(
MP6>ZN'7YEAC5B<9Y?:.Y(^A;C0[.YFAEEM+:62$@QR20JS)@Y&TGIS276@V=
M^RM>6MM>%?N^?"KD?3.<<T ?!7C#5/!?PFT_X@^'[W6X+K2O$?PKTG1_ MQ.
M/M#ZQY4%Q %@8*07:62V;:H!)(?&!D=1-\3O"OBWXN?";X-ZCX@T?2[[P;-I
M^K:Z)[C%S>:]'%M@LH'&5ED\QG>8\G[H!RQQ]G-HML_D%[>W<V_,(,*E8CQR
MO]WIV]!Z5'_PCM@+G[0+.U^T;PXE-NI?<.^[&<].: / _AOK=M\5OVKOB)XA
MBQ>Z?X&T^W\)V4RE2JWLC&>^PNX_,,0)O 7HZG.*\A_;Y\=:?8^*+K3!<2Z)
MXDT;PA=:YI&H76MW-G;W$X=BL<%O!C[3<*T*LPE)C5'&5.[C[BATV.VDD>)8
MXC(=TFR)5WM_>..I^M,N='@O9 ]Q%#.RJ50R1!BH(PV"?4<'UH ^!_%5W>WG
MC;QEXL.OZY#K.E_$#P?;6BP:G/%:1I=V^G"X3R%<1D.LL@(*G&ZHO!ZWEGXL
M\':Y;ZUKSZAK'C3QMH5Q#)J]Q)#):0IJ,D,*PE]BX>.-@0-PV@"OOW^Q;3Y@
M;>$HQ5ROE+RPQACQU&!@]L"E71[56C*0Q((W,B[8U!5SG+ XX)R<GODT ?G7
M\/\ XZ6*^$_#NH?VSJGBQ=#^"=U'KFG:5J,@N?MJSVD<H9FSLN%#/^\(++M;
M-9O@[Q!:SW']D:/KD&J>%[/X@>";RS^QZO<:I"DD[2B8)=7),CC="G^SD' &
M37Z20Z+:P$^7!!&,, (X57ACEAP.YZ^M)'H=G"%"6UNFW;C; HQMSM(P.",G
M'IF@#Y\_:PU.SM]?^&UAXKUB[T#X87M]>_\ "1ZA#?26$<<BV^^R62YB97C!
ME!P P#$ '/2OCJ7QEXG_ +#L]-A\7VMMHD&H>(9O#_B[QEXHO-,1M074VCMY
M&FC5A<RQQ*CB&10FUV..P_1'XK?"?5_B(NE?V1X^USP2]GYHF;28K:9;Q7V_
M+*D\<B':4R"%!&3SS5KX9?!?0?A;X%M?"]D)M6MTFEN[F[UAOM-Q>74K%YKB
M5FZN[,Q. !SC% 'QE\2#JD?BSXF>)+SQ'JT>N^'/$_@N*UN-/U>>*T5KF*RC
MN6$",(BL@DDZK@ALX%:7A'Q/XMUK]K'7C=^(M$T#4X-:U6TNM)N_$-RFI7VC
MQ12+;1Q:6ZF%5P(IEF1@[<G@$BONE=$M=K*UO;L&*EOW*\[<;?R &/3 I)-#
MM9;B.Y:WMWND/$[0J9 ,$<-U'7^= 'YHRS:!9_ GX2VNMZIKUOK?B?PI-K3:
M[JOB[4+>U:YBMUB2&,1N6><A@R1*50@.S!B!7T3^R'X@O/%'Q3\3:UJER;K4
MM3\ >#;VYF90I>22VNF9B!QDLQ.!QS7U-_8EILA3[/"8X>8HS$I6,XQE1CY>
M"1Q2V^CV]I_J(XX?E6/,<:J=HSA>!T . .PH ^"=>TE]6^(&K:NWB+Q';7S_
M !L'A?%GKEU#$FGW%K%YT*QK($7=TR%W+V(/-<QXH\3:SX>\ 67AB;42W@*Q
M\?>)=-FO?$7B>^TZ&VCMF']GVTNHQ;I5Y>0JK9WM& 3BOT>&CVVXDPQ,/,\[
MF-?]9_?Z?>]^M-?1;66%X9+>WDAD??)&T*E7;.22.A.0#D]Q0!^>/Q@\6_$4
MVOPVTS5O'7AF"^/A&*ZTSQE?>*+C2].N-;:9T^T02PH8[UDC$),4BA2)"3G<
M<5O%$.F>$_BK\4Y(-;N+#QQ=>-O"<C0+JDZ_:+.>;3C<S)'NVO$T[.BMCA?D
M!"_+7Z)S>&[">UCM9+2V>UB),<#0*R)GT4C ZGI3WT.UDD$C6]NT@V@2- I8
M*I! R1V(S[=J /A?4UF3XK:OXH37=8AU2Q^-MCX?B5=5N!:"RG@M?.M_L^_R
MR&#$'*^N,5B^&/$-O??$'X6WNI^,]:?XN7?Q!EMO%?AN75IU6.V!O5MO-LMW
MEPJ(8X=@4*&#[L-G(_07^Q[3/-O"W[P2G=$I)<8^;IUX'/7BO%O#W[+'V7QQ
MHWB'Q/\ $+Q-XVAT2Y>]TO2]5^SI!;W)!6.9FBB629HT9U3S6; 8T >1_M=Z
MIH,/Q<M-/^(OBO7?"/@:'PC<7NAR:7=S645SK@F8,!)",RS+%Y92%L@[FPIY
M%5_V8O"]UKW[18\5>+UU!/'J_#CP]?:CY]U+%_IDRW,,WFP A#E8UPI7"MN8
M ,Q-?9EUH]O?");B&&=(VW@2QA_FQC<,]#[]:E33XH[AIU1%E8 -(J ,0,G!
M/<9)_.@#\\OV@O%FD^#_ (R?&2UG\1MXTO\ Q%X5U6WM[2SUB5Y?#,D>FLTE
MM<V(?RO(=5#+/MW*SD'[PKJ?">M)\';[XGF";Q+K.AI\+M*\13Z3%JLL\_VF
M47,<LENTI;RFV1J!M 5=@('6OMV30;)I)I!:6WFS*4ED,*EI%/4,<9(XZ'K3
MQI<2,[K'")&C\HL8Q\RCHIQR0,GCIR: /S+\ WEMXH^*'ACP/IGBJZN/!.HZ
M_IKR)H'B>^NOFN-(U$3H+YV$S@F"/*J0@*[@%)->FZ'KGBQOVN(]*37=%\-7
M6E^(DTRUL-8\2W<6H7^@1P*JQP:=('AF63YI!<$B1G5\$8K[CCT&RA$?EVEM
M&8\>65@52F,CC XX)_,^M$V@VDUQ'<R6]O+<QD&.:6%69<'C!(R,<]#0!^=?
MPACUGP3X6^&.L^"=0U@>(O$7A'QCC35OI;FWGN;1G:S$=LY,8VR,2-@&XMSF
ML&3Q!I%Q\+_'5KX)\8>(/%FDWWPHU"]\:#5;V>[CM=:PGE;_ #1_H\[%KI6B
M7:-J+\HXS^FJ:-:QR1M'!#'Y6?+*Q &//7:1TSWQUIO]AVB^<([:WC2<EID6
M%0)2<_?'\74]?6@#\XOVF-8T2YTCXGQ^,?%&J:;XIMK?2;?P?H\=[-'#=Z8U
MO:O+BV7]W-"9C/OE925VXWKM%=)X#\4>-=:^.'BNYU3Q'H^BZJLFO1ZQH4_B
M*Y&IW-A'#,MD(M+D!C@"8@E66)MS*2Q.&(K[ZDT2UF<.]O;NX0QAVA5B$/)4
M9Z#VZ4V30;.6Z^TFVM_M(&T7!A4R8QC&XC.,$CZ'% 'YU^-M/T3P3^RO\%_&
MVH^-;J62\L;77-6\-ZKXKN[27Q*5L84<6L_F[HYHEPR1KA&+D,"2#7V[\'=8
M\*>)+35]8\,7<TLNH7RWFK6=Y<R2SV-Y);0MY#QNQ\AQ&8\Q+A023C)-=Q-H
M-E<0PQ2VMO(D(Q$KP(1&/11CCH.GI4]K81VKNZJ@=V+NRH%W'U..IQ@9]J +
M5%%% !1110 4444 %%%% !1110 4444 %%%% !39%\R-EZ9&*=36;:I(&: /
MS;_X*!Q:YXD_:^^$?@K3_%NK^&;+Q!8VUC+)I]Y)$4,U])&90BNH9E!'7L*^
M<(_"VK6^L?$&^U?Q]\1M'\(>"(8_[0EO;J4:I=/-=FUA-M$9%C,+,"^YCP 1
MSD8]L_X*9^.G^'/[6OPK\56D=O<7VAZ5;ZC#;W61'(T5]*X5L$'!*X..<5\A
M^'_CU=:7K7B^XU:QL_%&C>+.-6T/4[F7R956X-Q"JR*XD012'*[6QC((.: /
MH:S_ &?_ !#I;>(+'Q5\9/%.GSZ3XFET!M5M+Z=M/MXUTP7\5Y=,T@:-&4QQ
MLH/#. "3U]__ ."1OB36/$7A'XD2:QK.H:S)'J-FL;W]Y)<[ 87)"ER2,\$^
M]?%VE?MJ^*K?4+R[U2STC6VU#7Y==U"&XW)!>B2Q-D;.2-6VM;B/RR%()S$N
M2<9KZ_\ ^".DJR^#_B>5*-_Q,[/E#D?ZE^^?3'6@#]$J*** "BBB@ HHHH *
MY+XA>+O^$+L].U&:!6TTZA#;WUT\FP6D4F4$O^U\YC7'8.3T6NMKFOB%X&M/
MB)X2U/0+RXFM(;V((+FWQYL#JP9)$R"-RLJL,@C*C(- 'D&G_M)7NIZ'+>IX
M=BL[VTAGGO-/N+EM]O&;J&.R8L!AO.AF\TX^[@#O6A!\;-9\.VEQ>^+H-%M=
M/B\3KX=:XL9)V" (Y:5@RY!R(P%''+9/2MUOV<O#RKXB$5Y?*-9@LK9B[*YM
MTMEB"A,C^/R(RV[)R"1C-;D7PEL8;A95O[D$>(V\2$87F9D9#'T^Y\V?7CK0
M!YM=?M6:/8V>J7ER+.*S33M4O=,E8R8O&M;N6!5^[P&$:L?0M6YK'QBU2QT_
M4-?72K1O#FDSII]^LDKF[^U.(L-$@&TQAID!R0Q&3VP>@7X)6"R>(6_M2\/]
MM66H6,@VIB);NXEG=EXZJTI SG@#.:AOO@;;7S2V;:W>+X>NF2YOM'"1E+JZ
M0(%F,A&]>8XV**0I9 ?4$ Y^]^+NOJNB75EI>ER6+>%5\3ZE'/<2+*L6%+10
M$#:2,D@OCH![CU_1;V+4M-M[N'=Y5Q&DR;P VUE##('?!KR:#]G6\:'3X+WQ
MUJ5W;6^E_P!AW"+9V\37-B&4K$65<J<*06'+!CFO8K6UBLX5BAC2*-0%5(UV
MJ    !V  % $U%%% !1110 4444 >4_M7?\ )LOQ7_[%74__ $F>NR^&G_).
M?"O_ &";3_T2E<;^U=_R;+\5_P#L5=3_ /29Z[+X:?\ ).?"O_8)M/\ T2E
M'24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!C>*_$;>&-!O\ 48M+OM;FM8O,&GZ7&LES-T^5%) )Y]>E><?"7XV-\0/@
M2?B/K&C_ -@QP)J,UWIMO)]I>!;2>:-U5A@.V(>W!/0UZX]NDC!F&2"#^72O
MDRZ^"OQ M_V/;CX86=M%!X@U?5[NWOY([N("UTVYU.66:9'+ %_L\GRJ.=S
M8X- 'H7P&_: N/B[X!\0ZQJ>A1^'];T23-QI:SM(GEO;)=0,&958[HI%!)7
M8.H)VYK7\.>//%-U;>!)]<L-%MQXGN4"1:?+--Y<#6,UQDEU7#AHT' (P3TK
MSKP+\!?''P^^,GC#4+KQ-?>.="\4>%8[&;5-36TMY([Z!I%MXRD:J2HCD?#
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MZC6&Z>:2YECMQ'G>C[[@*S,-H"[@23MKU70] N[#XA^(]8E0"TOM.TV"&19
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M,ZHH0,1YG!(% 'N_[?\ _P F=_$__L'Q_P#I1%6U^Q?_ ,FI_"K_ +%^U_\
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M^A?U3_PI=3_^2:/^&'_@]_T+^J?^%+J?_P DT >[T5X1_P ,/_![_H7]4_\
M"EU/_P"2:/\ AA_X/?\ 0OZI_P"%+J?_ ,DT >[T5X1_PP_\'O\ H7]4_P#"
MEU/_ .2:/^&'_@]_T+^J?^%+J?\ \DT >[T5X1_PP_\ ![_H7]4_\*74_P#Y
M)H_X8?\ @]_T+^J?^%+J?_R30![O17A'_##_ ,'O^A?U3_PI=3_^2:/^&'_@
M]_T+^J?^%+J?_P DT >[T5X1_P ,/_![_H7]4_\ "EU/_P"2:/\ AA_X/?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MINH79L;9[B41F6XSCR@">'/7'H1ZUU6A>)=-\1"Z_LZ_M;\VLS03_995?RI
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGE@ACB>4\%V50"WXXSSZT :5%%% !1110 4444 >4_M7?\FR_%?_ +%74_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BO/_BE\0/%G@J;38_#'PXU+Q]]I#F=K#4;2T%KC;MW>>Z[MV3]
MW.-IKA_^%Z_%7_HWCQ%_X4&E_P#QZ@#WBBO!_P#A>WQ5_P"C>/$7_A0:7_\
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M7_\ 'Z/^%[?%7_HWCQ%_X4&E_P#Q^@#WBBO!_P#A>WQ5_P"C>/$7_A0:7_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[XV^+'BR3X6S:[:WEKI:^)]"OKW2#!;,UQI316CW"[V+[9B40C(";7Q@.,T
M?0#7'[QE!^Z^T\?3_&K.P5\^:'JWBKPOXN\27EU=Z5?V+>)=)T^]5;*6.:YE
MN+2QA:5"92(53S%;;^\W88$KP:^A: &[!1L%.HH ;L%&P4ZB@!NP4;!3J* &
M[!1L%.HH ;L%&P4ZB@!NP4;!3J* &[!1L%.HH ;L%&P4ZB@!NP4;!3J* &[!
M1L%.HH ;L%&P4ZB@!NP4;!3J* &[!1L%.HH ;L%&P4ZB@!NP4H7;2T4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'E/[5W_ ";)\5_^Q5U/_P!)GKLOAI_R3GPK_P!@FT_]$I7&_M7?\FR_
M%?\ [%74_P#TF>NR^&G_ "3GPK_V";3_ -$I0!TE%%% !1110 4444 %%%%
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MHDEQNLV:48EE'R^8)'RVXA\$LS8W$M5./X+::K0"75-4N8BB1W\4LT>S51&
M(S=*(P'( "Y79N555MP&*]$HH Y70_A_:^'='T+2[&\O8[/2&8Q*9R3,"KKM
MFX^<#S"P'9E4]JS-0^$-AJ7B+6-3FU34OLNL*JZEHXDB-E>!8?) =6C+_< S
MM<9VBN]HH \ZD^"FF7%G<I=:GJVH:C(T30ZQ>72R7=J(I/,A6-MFW"/\PW*Q
M)Y;=Q2Z-\$](T3Q-8:Q!?ZHZZ?-=7%GI\ET#:VSW(;SRJ!06WL[-EV8@L=N
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MMH_*N6?R%:X:4C>K[I\A5^7"8*DDM0![S]J0L!AN>AQP?QI\<@D!(!&#CFO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **C:0J>
M%)^E.W'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0
MZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T
M_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?S
MHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[
MCZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0 ZBF[CZ?SHW'T_G0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<6;Z+JUAK%K.\J_:+*_AD0-&J,5P&R3AP3M^Z""<9% 'FG_#$WPR_P"IK_\
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MO&+[^T(O)+(,NN_=C*CJ,\4 >7?\,3?#+_J:_P#PL-5_^2*/^&)OAE_U-?\
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MZ+S969 X"KN^8D'(QG(Y'% 'F'_#$WPR_P"IK_\ "PU7_P"2*/\ AB;X9?\
M4U_^%AJO_P D5[''XLT2;6I-(CU:R?5HQE[!9U,ZC:&YCSN'!!Z="*U58, 1
MTH \'_X8F^&7_4U_^%AJO_R17<?"[X%^%?@]<ZC/X<_M?S+](TF_M/6KN_&$
M+%=HGE<)]XY*XSQGH*]!HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH HZS-<6^FSRVL2S7"(S)$\GEJQ R 6P=
MH]\<5X?HOQZUK7[Q]%TJR\/ZYKQU.+33<V.I2_V<HEM;F<,79-Y*"U.Y0.=Z
M[3G->R^,/#%OXT\,:GH5W+-!::A;26LLEN^V0*ZE25/8\UQ.A_!66Q\40>(=
M3\276KZI'=6]S@VT4$"B&VN;=(T1!\J;;IV/).X=<'% '!_$#XO>(/$'PI\3
MKH^FQ0ZE::)>SZI*+YH?LZI+<VH:V8+N9O,MI9!NVX4 'YF&/8OB#XCNO#/A
M>?4;-]-B,17S+C5KEH+>%/[S%59CDX4*!R6%<3JW[/$-]X?O]+L_$E_I7]HP
M7=G?W,,43O<6\UQ/<"/# A"CW#@,.2I(/)!'9^-_!,_BRSTY;34CI%_IMTM[
M9W8A$ZI*$>/YXF^5QLD? /1@K#E10!X]XL^-&J>-OA+KTGAK3[>6YCT&]N[V
MZ74'BC6)9+FU62UDV[F8O;R2#<%PH7/S-QU'B+XQ:CX?T[6=>32;>;PUI5S+
MI;S27+B[>\1O+W"/;M\DR_)G=NQ\V,<47W[.*7'A6?1H/%NJVLM];75EJ>I>
M7"]Q?6\\\]P5;*[499+B3#*O*LP(Y!6?Q]\&7U#0?$\5C>S7&E7<5QJ*>'?*
M4K+J1!=91*?G"F4*_EYQNYSM^6@#G/&/Q<\=:;X)CFBTS1],U_4K:TU+3!]L
MDN(5MVNK2*>*8F,'>/M2@,H*D$D8*U8D^,'B6"_U2PT[1;.:6Q34KZ]GU#4I
M2J1VLZ1ND0$9)WAF* X"XP>M:FB_!>ZUCP?8VOB36[N]U%-.AM;.:2WBB?3U
M5H)MA"\2MYMO#N)QD)C R2=73?@;;V,FK3R:O<7%WJEGJ%I<3&)5&;N19)'5
M>V&7A>1@T 9/B+XV:E!:SWFAZ%#>VEE#ILFH+?7A@=?MKH(Q%A6#;$<LV2,D
M #O3OC=XH\3:+JVB:9H4UI%INH6.JMJ!N'=9\0VX96B95.&&21R,G%<_X_\
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MBJN.I))PIJEJG[/MG=7,U[:ZF(-3EO[R[-S=V$-VJQW,J220K'("H^:-</\
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MY$>;>!FC"JA*#Y0#D8XXP>1CI@42:3;S;M]M!)N^]O0'/&.3CGCCZ<4 >1_
M?7=7OO''CC2-;N[JYU+0[>PL9S<,<2,KW>V95["2/RFSU88)KVNJEM8BWG:4
M!=S*%9@.3CH,^@R<#W/K5N@ HHHH **** "BBB@#RG]J[_DV7XK_ /8JZG_Z
M3/79?#3_ ))SX5_[!-I_Z)2N-_:N_P"39?BO_P!BKJ?_ *3/79?#3_DG/A7_
M +!-I_Z)2@#I**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<CVSQ9X/O-3^&6DZ3+KZZ9X@LUM9+/5M387.V_BPRF12RB8%@05)Y&2,$ @
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M&Q9<G'7M3ZJZ7<0W=C%/;S1W$$H#QS1,&5U/(8$<$$8Y'6K5 !1110 4444
M%%%% $7V=,D],^GKZ_6G1Q"/..]/HH **** "BBB@ HHHH **** "HY(5D8$
MYR/2I** &QKY:A<DX]:26,31E&Z&GT4 ,CC$8P,X],T^BB@ HHHH *1EW*1G
M&1C-+10!0U&]MM&MQ<7-S#;1C">9<RA%YZ#)(':L\>.O#V!GQ!I8/_7[%_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHS%):S1AXG0@@JRD$$8/0C%:M% &1;^&["RCMTM=/M+<6SM+!Y<"JL3L"&=
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M,=W.H5Y508W,!P"?:@#L**** "OAC_@FS_R4#]I'_L;C_P"C;JON>OAO6O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>>@.,_CCBC[1'_>S0!X3_P -#_$#_HWGQS_X':5_\E4?\-#_ ! _Z-Y\<_\
M@=I7_P E5[MYR>O?'3OZ4BW$;#(;CH>.GM0!X5_PT/\ $#_HWGQS_P"!VE?_
M "51_P -#_$#_HWGQS_X':5_\E5[J;A%7<20/7%+YR;=V<+ZXH \)_X:'^('
M_1O/CG_P.TK_ .2J/^&A_B!_T;SXY_\  [2O_DJO=_-7=C//THDF2-26. *
M/"/^&A_B!_T;SXY_\#M*_P#DJC_AH?X@?]&\^.?_  .TK_Y*KW<3*>A_2CS5
MQD9/T% 'A'_#0_Q _P"C>?'/_@=I7_R51_PT/\0/^C>?'/\ X':5_P#)5>ZK
M<(V>3P,\@B@7,9!(;@=Z /"O^&A_B!_T;SXY_P# [2O_ )*H_P"&A_B!_P!&
M\^.?_ [2O_DJO=#=1+_%], G-.$RDXSSZ8H \)_X:'^('_1O/CG_ ,#M*_\
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M-#_$#_HWGQS_ .!VE?\ R57NWG)C.<CUH%PAS@]/:@#PG_AH?X@?]&\^.?\
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M+5(VBEUJXM)5N2Q;(3R)I""N!G=C[PQGFO0J* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RG]J[_DV3XK_
M /8JZG_Z3/79?#3_ ))SX5_[!-I_Z)2N-_:N_P"39?BO_P!BKJ?_ *3/79?#
M3_DG/A7_ +!-I_Z)2@#I**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM=4M9H;&YDM;F19 %AE1MKHQ/0@\<UM?:(BX02*7_NYY[=OQ'YU\O6>E^']
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M 'E/[5W_ ";+\5_^Q5U/_P!)GKLOAI_R3GPK_P!@FT_]$I7&_M7?\FR_%?\
M[%74_P#TF>NR^&G_ "3GPK_V";3_ -$I0!TE%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@#WJBO!?^&,_!O\ T,WQ#_\ "WU/_P"/4?\ #&?@W_H9OB'_ .%OJ?\ \>H
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M?^AF^(?_ (6^I_\ QZ@#WJBO!?\ AC/P;_T,WQ#_ /"WU/\ ^/4?\,9^#?\
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MG_Z3/79?#3_DG/A7_L$VG_HE* .DHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RG]J[_DV7XK_ /8JZG_Z
M3/79?#3_ ))SX5_[!-I_Z)2N-_:N_P"39/BO_P!BKJ?_ *3/79?#3_DG/A7_
M +!-I_Z)2@#I**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \I_:N_Y-E^*__8JZG_Z3/79?#3_DG/A7_L$V
MG_HE*XW]J[_DV7XK_P#8JZG_ .DSUV7PT_Y)SX5_[!-I_P"B4H Z2BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /*?VKO\ DV7XK_\ 8JZG_P"DSUV7PT_Y)SX5_P"P3:?^B4KC?VKO^39?
MBO\ ]BKJ?_I,]=E\-/\ DG/A7_L$VG_HE* .DHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RG]J[_DV7XK
M_P#8JZG_ .DSUV7PT_Y)SX5_[!-I_P"B4KC?VKO^39?BO_V*NI_^DSUV7PT_
MY)SX5_[!-I_Z)2@#I**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \I_:N_Y-E^*_P#V*NI_^DSUV7PT_P"2
M<^%?^P3:?^B4KC?VKO\ DV7XK_\ 8JZG_P"DSUV7PT_Y)SX5_P"P3:?^B4H
MZ2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^B4H Z2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /*?VKO^39?BO\ ]BKJ?_I,]=E\-/\ DG/A7_L$VG_H
ME*XW]J[_ )-E^*__ &*NI_\ I,]=E\-/^2<^%?\ L$VG_HE* .DHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \I_:N_P"39?BO_P!B
MKJ?_ *3/79?#3_DG/A7_ +!-I_Z)2N-_:N_Y-E^*_P#V*NI_^DSUV7PT_P"2
M<^%?^P3:?^B4H Z2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /*?VKO^39?BO_ -BKJ?\ Z3/79?#3_DG/
MA7_L$VG_ *)2N-_:N_Y-E^*__8JZG_Z3/79?#3_DG/A7_L$VG_HE* .DHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#RG]J[_DV7XK_ /8JZG_Z3/79?#3_ ))SX5_[!-I_Z)2N-_:N_P"3
M9?BO_P!BKJ?_ *3/79?#3_DG/A7_ +!-I_Z)2@#I**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \I_:N_Y-
ME^*__8JZG_Z3/79?#3_DG/A7_L$VG_HE*XW]J[_DV3XK_P#8JZG_ .DSUV7P
MT_Y)SX5_[!-I_P"B4H Z2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /*?VKO\ DV7XK_\ 8JZG_P"DSUV7
MPT_Y)SX5_P"P3:?^B4KC?VKO^39?BO\ ]BKJ?_I,]=E\-/\ DG/A7_L$VG_H
ME* .DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#RG]J[_DV7XK_P#8JZG_ .DSUV7PT_Y)SX5_[!-I_P"B
M4KC?VKO^39?BO_V*NI_^DSUV7PT_Y)SX5_[!-I_Z)2@#I**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \I_
M:N_Y-E^*_P#V*NI_^DSUV7PT_P"2<^%?^P3:?^B4KC?VKO\ DV7XK_\ 8JZG
M_P"DSUV7PT_Y)SX5_P"P3:?^B4H Z2BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#RG]J[_ )-E^*__ &*NI_\ I,]=E\-/^2<^%?\
ML$VG_HE*XW]J[_DV7XK_ /8JZG_Z3/79?#3_ ))SX5_[!-I_Z)2@#I**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH \I_:N_Y-E^*_\ V*NI_P#I,]=C\-V"_#?PLQZ#2;4_^04KCOVKO^39
M?BO_ -BKJ?\ Z3/78_#90WPW\+ \@Z3:@_\ ?E: ..^*W[4WPO\ @?KEGI'C
M?Q5%H6H7EO\ :X(9+6>7?%N*;LQHP'S*1SZ5Q/\ P\-_9[_Z*-;_ /@NO/\
MXS7Q-_P5R1?^%\>#<J"?^$9'./\ IZFKX<\M/[HH _;S_AX;^SW_ -%&M_\
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MYR2<]P*TV_9]^(B^/XO K^"]3C\9R6_VQ=$9$^T&#!_>8W8V\'OV- 'Z_?\
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M_P#P77G_ ,9H_P"'AO[/?_11K?\ \%UY_P#&:_(=OV<?B7#XYM_!<G@C4O\
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M^(?#7P^U?6M"OMS6VH6B(8IE#%&*Y8'A@1R/X30!^N'_  \-_9[_ .BC6_\
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M[5O"UAX"U6X\2:1#%/J&F*J>;;)*,QL_S8&X<CF@#]<O^'AO[/?_ $4:W_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#RG]J[_ )-E^*__ &*NI_\ I,]=E\-/^2<^%?\
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MOJOP]^ GBSX9:/HUO!_PD=RMS=>(8[N2*\0J8RHC"   "(#D\[V/?%;/A/\
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M_AV_X _Z'GXF?^%3)_\ $4 ?*W_#H7XB_P#0]>%_^_%S_P#$T?\ #H7XB_\
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M_AV_X _Z'GXF?^%3)_\ $4 ?*W_#H7XB_P#0]>%_^_%S_P#$T?\ #H7XB_\
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M7_[\7/\ \37U3_P[?\ ?]#S\3/\ PJ9/_B*/^';_ ( _Z'GXF?\ A4R?_$4
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M?^%3)_\ $4?\.W_ '_0\_$S_ ,*F3_XB@#Y6_P"'0OQ%_P"AZ\+_ /?BY_\
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M="_$7_H>O"__ 'XN?_B:^J?^';_@#_H>?B9_X5,G_P 11_P[?\ ?]#S\3/\
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MUCPKJUS<1^(-7DO%$D5Q:*A4$  X=NV>>*^QZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** /*?VKO^39?BO\ ]BKJ?_I,
M]=E\-/\ DG/A7_L$VG_HE*XW]J[_ )-E^*__ &*NI_\ I,]=E\-/^2<^%?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH \I_:N_Y-E^*_P#V*NI_^DSUV7PT_P"2<^%?^P3:?^B4KC?V
MKO\ DV7XK_\ 8JZG_P"DSUV7PT_Y)SX5_P"P3:?^B4H ^</&7_*3+X=?]D_O
M_P#TI:OK%?NBOD[QE_RDR^'7_9/[_P#]*6KZQ7[HH =1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!X1^U1_R$/@E_V4;3/_1%U79?M&?\F]_$S_L6
M=2_])9*XW]JC_D(?!+_LHVF?^B+JNR_:,_Y-[^)G_8LZE_Z2R4 <Q^Q3_P F
MG_"?_L7;7_T"O;*\3_8I_P"33_A/_P!B[:_^@5[90 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >"^+O^3V/
MAS_V)FN?^E5A7O5>"^+O^3V/AS_V)FN?^E5A7O5 !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#': /L^BOC+_A[!\$_^?3Q9_X*D_\ CM'_  ]@^"?_ #Z>+/\ P5)_\=H
M^S:*^,O^'L'P3_Y]/%G_ (*D_P#CM'_#V#X)_P#/IXL_\%2?_': /LVBOC+_
M (>P?!/_ )]/%G_@J3_X[1_P]@^"?_/IXL_\%2?_ !V@#[-HKXR_X>P?!/\
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M?_/IXL_\%2?_ !V@#[-HKXR_X>P?!/\ Y]/%G_@J3_X[1_P]@^"?_/IXL_\
M!4G_ ,=H ^S:*^,O^'L'P3_Y]/%G_@J3_P".T?\ #V#X)_\ /IXL_P#!4G_Q
MV@#[-HKXR_X>P?!/_GT\6?\ @J3_ ..T?\/8/@G_ ,^GBS_P5)_\=H ^S:*^
M,O\ A[!\$_\ GT\6?^"I/_CM'_#V#X)_\^GBS_P5)_\ ': /5OVJ/^0A\$O^
MRC:9_P"B+JNR_:,_Y-[^)G_8LZE_Z2R5\F>*/VWOAU^TE\1?@YX7\*0ZY!J5
MOXXL-09M3LEAB,:13J0&$A^;+CC%?7OQTTJ\U_X'^/\ 3=.M9+S4+SP]?V]O
M;0J6>61[=U5% ZDD@ >] ''?L4_\FG_"?_L7;7_T"O;*^0_V=/C=J7PK^!?@
M3PCK/PA^*#ZMHNDP6-U]E\-%X_,10"58R#(]#BO1O^&KA_T1[XL?^$N?_CM
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MAM['Y6,@)'([4 ?8E%>$_P##5P_Z(]\6/_"7/_QVC_AJX?\ 1'OBQ_X2Y_\
MCM 'NU9^N:]IWAK39=0U6]@T^QBQYES=2K'&F2%&68@#)(')ZD"O&?\ AJX?
M]$>^+'_A+G_X[7F'[3'QAU3XP_!/Q'X2T7X/?$[^TK_[,8OMGALQQGR[J*5L
MMYAP=L9QQUQ0!]AI() 2/7'-.KPA?VK %S_PI[XL?-S_ ,BN?_CM+_PU</\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-'C/PJ;/X_>+K/Q;HFKV_P 4A8)H>E:=<M+J-N8[F&>3[9!M'V?:L3CYB<G
M&<T <!XE_9CTW0_AK-K=GXY_M'Q3!X2LO&=YX=?2GA2+3[AT0LMT9-I=3(/E
M RV.E8_B#X-^#/"/PX\.:YKWQ.>Q\3^(_#XU_3/#</AV6970O(B1M<K)M7<\
M3#)7CKBO</&WQ;T;QM\&=1^'*:WH$5G;_#3P]J%I?;X(YI=3LGW3:<TIPTA*
MDG8S'9L(5<N:Y[XA:M>>,/V5? ^E:)XT^&ZZ98^#%@U32-4FMAK_ -ICGFE,
M=N2AE7*^6 @9<DD?Q'(!YSI'[-4UU-H+:EXECL+63PG_ ,)MKTJV4DS:5IQF
M\N'RT0YN)7!C/EC;MW$'IFN6B^%VG:[H?Q&U?PUXI.NV7A!+:[1GT][0WMG+
M((Y+C:[$QE)&0>4=Q8,2" *^A/&&I>)H_P!J"U\>>!_'F@^!;C5O">E:QI-_
MXDO%M;6\M_LL%M+:2;@R%]T<C%&#8V#D'&,^'5O"B_%+XZ>,/#5M8P>&K/P#
M<V&I'1U(LI-7O8T@D%F"<-"UR68=/E#$ B@#Y'#M@<T;F]:: <#<26[FEQ[T
M 6;%HFO;473-':M*JSNIZ1DC<P&"<@9Z#/L>E?27[3W[-O@;X(_##PKK^A^.
MO^$EUJ]A6WGL8E0%YR!.9) K-Y)$$D0\LXSRV[D*?F3%17$(:!Q\SLR$')P,
M@'!_D,>U 'W=X"_X)Y>'?&7Q$;PS)XPUFP1?!NE^)5N_*@8>?=23*T3 KRB^
M6N.A.3S7F%G^RIH_AWP;X2U;QIK^I:?<ZAX_G\$ZO#9+;^7:I&TJ^>COT^=$
M+,6(V$D<XKUCQE^U)\.[BS\;MI7BQ4U*\^%&E:'IC+;3*S:G!)<,8U)3 *EH
MSN/RY/!.*Q?VQ/VGOA[\;_V=/!$?AC48[+QDVLQZMKFEFWD'DW!M)$E=W90D
M@WA<8/S#'3I0!S6H?L8Z7X4\7?':V\3Z[JUGX;^'EC#>66H6GV9I;TS1F2&&
M3< H=AMX7!YQU(JAX#_8WA\7?LTR>/I-1U*#Q;=Z/JFOZ9IJ/";&6ULY8D<N
MQ'F*["1B%''R]LC/>_M0?M9> OB=^SS!I?AF6T@^(?C=]-_X3*5K5HWC^RQ@
M S/MVG#JFTQ9PH(QBNXT']MOX7> _B_\/M"TL2:OX0T7PW!X=E\8G4[N)(8"
MG[Y7LO) D8/%%\X )R,=* /D.V^#6F7'[*U]\5O[1O1J=KXHCT!=,55,!A:!
M91(6^_N);UZ 47'P7T^W_97TGXJ#5;R74KWQ8_A[[ %00)$J.PDSC<6^49!)
M&*]=T?5OA=K/[.?C3X5#XDZ7X4$GQ EUS2+F\TZ^O(9M-5$6)ALCW<_=RV#E
M&SUR>!U3XE>%O^&+=&^'T.LQW'BBS\=S:L]JL$JAK+RY$6<,5VX8D87.[GD4
M >C_ !-_8J\&Z7XN\8^!/!/C/7]1^(OAO1TUQ=(UFRA$&K6QB\QDMI8B")%!
M7(<<E@!QEA\Z_ OP':_%SXQ^#O!M_?3:=9:]?):2W5KM:1%9&.Y<@KN.!C(Q
MR>*^Q/BA^T1\)O#/QD\;_&3PWXR?Q?XDUKPXGA[1/#UGID\,5O(8%CDGN995
M3*#:"H0YY8=2*^3?V8_%VC?#GX^_#_Q%KMU_9NAZ3JB7%W=;7D$401EWE5!8
M]1T!/- 'I7@G]G3P-<Z5\==<\7Z_XFL]$^&NL1Z<G]BQ6SW%U&]S)"&*R_+N
M^5.X'+5XEINDZ'XE^)]CH^CW=^OAW4=9@L;:XO!&+M;>65$5G"DQ^8 X) )7
M/M7TIX'_ &E/#?@/PO\ M/S:;JVGS:_XKUN*\\-6VH::;R&^C^US.[-%(AC&
M(Y-V),=N,BOG/P_XR>Z^+VC>*=7DM+,?VY:ZA=26=JL,$:"=7D*Q( $4 $A5
M' &!0!];>+_^"<^G^$OC[HO@M_%NI7?A?6=!U#4[;45B@%VES:!-\#*!MVX>
M,[L G<1V)KQ[PC^SGX8A\&_#_4/B%XRU#PWJWQ&;9X?M;&QBE2TC+!$N;TNX
M/E.S !8OF^9>>3CZL\ _MM_"6/XB?%V/Q%KP.CSZE+JGA/5Y;:=T(GM$AGC1
M0F^,EUW?,,'>QXKYRT'XK?#/XC^#?@NWC3Q'>>%-;^%ZBUGL[2PDG.KV:2))
M"EJR@A)_W:JQD*KUQUX ,;X3_LWZ!JW[0FI?!SXA:CX@T?Q.NI-IUE=:#%!+
M;,RI)(993+\RHT:HR!03\_.,5Y5\9-'\'^%?'6IZ7X+N]>OM+TQY;2YF\010
MQS-<QRR)(5$1VB+Y5VD_-DG(KU[P#^T!HFO_ +=VG?%WQ)(N@:!-K<UY*S1N
MXM(#;R0Q;M@))(";L#[S'M7@_CW4K76/'/BK4+.;[1:76K7MS"ZY7=')/(R$
M\9&5(P".I% 'O/Q[_9;\/?L]^#=/&M:WXJNO%VI:?'J%I>VVD(?#[R-@_9//
M+>8),;OF(V\*2M4_"?[)MQ\0OAS\&]4\.:K<R^(_'VLWVERPSQ+]ELHK<R$S
MX WX"(7;.<XXP*]5TW]I/PUX-_9Z\5^#?$OQ9/Q7T/4-#.DZ%X7_ + >VN=/
ME,8,37-Q(  L(15"HSC.>3Q7.?#+]J/PU\(_A7^SX+><ZMXA\'>(M3NM8THQ
M2+)'9W/FQ[D8X1F,<NY1N/3D4 >7_%3X?_"+P#8^(=%T+QMXI\3>,M%$BG48
M]'A30[J>.0JT"MO:5>!Q+RI8=<' ]I\9?\$_;#PYHGP9UBP\3:I>:5XTU'3=
M.U@R)#YNG&\1'1X<#Y@#O'S ]N?6OJGQ<^&WA7]GGXX>&?#GQ%N-8T;QF?,\
M-^#KK3)X;K2)99V><32,"ASD?.'/RH#C)Q7J?@3]M/X8Z+\7/"-MJNMF\\#/
MX&TFQOYVMIC%8ZQ8RM)'NCV;W8$@;E! .WKDD 'S_P"%?V8?!TGB+X^_\)+K
MGB6+P_\ #"YVQC18;>6\O8_-ECR1( N["(< @9+>U97PE^"?PT^*WB#XFW=O
MK/C.S\&^#_#ZZXGG6MHNJW#+GSD,>3&!_=Y';)%>G?"SX_>$M(^(/[3VI:?\
M1H_ ]WXUN1+X9\226=Q*/^/B=S+LCC9AA77[P!YKGOA/X^\)Z#XO^.UKXM^+
M=CK+>,_"C:7;^-+C3+HPWEW(,,6B6/S!L& ?E )'% 'GOQ'_ &?]#\'ZU\.]
M8TSQ;<:M\+?'.[^S]>^QA+FS9&*-#,G(:1&V[B,!L-]W[U;/[7W[/7@_X!ZA
MX=M_"_BP>)IM1@ FM[?:Z1O"ICN9#(&;!:8?ZLD>6"%^8Y*Y/[1'Q5\)ZQX&
M^&OPQ\"7]QKOAOP/!=%]>O+3R'OKJ>0M(T2$\0_W0P!YYZ<^$#:N_$4:ECV!
MQU/(YS[XZ<^M !O8\YQ[4;F]::%P .E+CWH ]=_9#_Y.G^%!/WO^$@MQGV^:
MOWIK\%OV0_\ DZ;X4?\ 8PV_\FK]Z: $V@$D#GUI:** /G[PC^U=8>*_BA\3
M_!UUHEWHTO@GSI$O&N4>/5(H0#,8@0N'3<F5RP =22-PKH_V9/CTW[1?P[/B
ML^'[KPLRW]S8-IE[*))D,149;Y5VG##*XX.>3UKY;\>? WQUJWC36]1T?PW)
M)_;OQ!U30=4>_MI&1_#]_!:>;,J#_EGYEN,S#&-N.02*^E/V7/#.H>%=*^(%
MI?Z9=:2DWC?6;NSBNXBADM7G'DR)GJA4?*>X% 'MK*&ZC- &.E+10!RGQ8\<
MK\,?AGXI\7-:F^70]-GU$VPD$?F^4A?;N(.W.,9P<5\_^*?VY+7P_P#LWZ%\
M5(O!^I75WJ-Z=.F\-&Z1)]/F3S#/Y[[3M5%C+9*YPR$A=W'KO[3VBW_B3]G/
MXF:3I5C<:GJ=[X=OK>VL[6,R2S2- X5$4<LQ)  KXW\=? 3QNMA\7],MO"LE
M]H2^&3JGAZ&.UEFNI]4U"&VBO8T;U4VDF8^2HE7'!P #]#[&8W%I%*PVEU#;
M?3(SBI0BCD*,U7TP%=/M@PPPB4$'L<"K5 !7B/QF^.GBGP/\1='\%^#_  "W
MCC5K_1[G66C&L1V!CA@ECC8+O1@[$RI@9'6O;J^9_CAK^K_#O]I?PGXS@\%>
M*O%NDP^$M1TY_P#A&=-:[*7$ES;21I(00$!$3<G\L4 >P_"OXF:9\5_!.G>)
M-+%U;1W19)K&\3R[FSG1MDL$R<[)$8%2OT/>NVQGK7D/[,?@/7?!/PUE?Q);
MKI^NZ]J]_P"(KW35E$@L9+NX:;[/Y@^^4# %NYS7K] "  =!BBEI* /FOQ9^
MUEK_ (6\:^-[2/X9WNL>"_!=_;V6M^)+#4T>>V62".9I19;-[I&LJEL-P Q[
M8KZ)TJZBOK.*ZM[A;JWG198IHW#HRL 05(Z@C!!]Z^,_%UYXOTGQ7^T+X.TK
MX<>)=;OOB%J<5GI>J"S,6DQPRZ7;VLD\UT?E58R)"1@EMH Y-?6_P_\ #@\&
M^"]#\/I<&ZCTFPM[!)VC"&011+&&('0G;G';.* .AI-H&.*6B@"&Y+>7\O7U
MYX_*OGWXE?M>6'P@\1>.-$\3Z')::AHVF6^JZ'$EWN;Q$DSF)8X1L&R03;49
M?FP"6^Z#7T17S_\ M#?#6/QE\:/@/K!\.G6$T3Q#<3W5X(&D%E#]BE9'=APJ
M^>D!!/&Y5H ]F\-7NHZAH^G76J6/]EZA-;QR7%BLQF6W=ERR;]HW;2<9P.16
MR5#=1FA?NBEH 15"\ 8KF?'FN:OX:\)ZUJVC:,?$&I6-I)<P:2+@P&[9!N\M
M9-K!6(! XY) .!S73TU_NGMQ0!X/\,?VJM,^,WC+P[HOA#33J=G>>'E\0:KJ
M NL#2?,)2&U=-IW3,ZR94E2H3)'*@^ZV^?+P<GW->"_LI?#&+X=ZI\8)5\._
MV =5\;WMU;L8&B^U6GEQ&*1<_>3<TV".,EJ]_H 3:/04M%% '/\ C[_D1_$7
M_8-N?_135_.E8Y^QP?[B_P J_HR\9VLVH>%=8L[>,RW%Q8SQ1J"!EFC8*,GU
M)%?BQ:_\$\?VA$M8E;X>R!E4 C^U++_X]0!\]\U^H'_!'C_DG/Q)_P"PY!_Z
M3+7R1_P[T_:"_P"B?2?^#2S_ /CU?>?_  34^!7CGX$^#/'.G^.M";0KS4-5
MBN;6-KB*;S(Q JELQLP'S CGGB@#[*HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]%3L_P#P1M_\?K]-** /S+_X<\ZK_P!%3L__  1M_P#'Z/\ ASSJO_14[/\
M\$;?_'Z_32B@#\^?@]_P2[U/X4_%;PGXQD^(MIJ<>@ZC'?M9KI#1&8+GY-WG
M':3GK@U^@RG*@]*1HU?[PS2]* %HHHH B:W5V9C_ !#!I5B*L#O)'H:DHH *
M*** &LH88/3K4:VZITZYSFIJ* &QH(UP*=110 5%-;B9LEF'! VG&,]ZEHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
